baid,acvalue,aid,sid,cid,geneid,pmid,aidtype,aidmdate,hasdrc,rnai,activity,protacxn,acname,acqualifier,aidsrcname,aidname,cmpdname,targetname,targeturl,ecs,repacxn,taxid,cellids,targettaxid,anatomyid,anatomy
101446260,1.7e-07,392537,103392324,3011383,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"[(1S)-1-[(2,6-diaminopyrimidin-4-yl)oxymethyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446806,9.5e-06,392537,103651488,493054,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-(2-Amino-6-hydroxy-pyrimidin-4-yl)oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446243,1.8e-05,392537,103391778,3011374,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-(2,6-Diamino-5-methyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446249,3.5e-05,392537,103169255,60172,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,Adefovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446801,5.357e-05,392537,103246046,493059,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-(2,6-Diaminopyrimidin-4-yl)sulfanylethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446235,8.4e-05,392537,103391801,3011369,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-[2,4-Diamino-5-(cyanomethyl)-6-oxo-pyrimidin-1-yl]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345784,0.0001,217670,103389810,493485,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100345786,0.0001,217670,103389785,493486,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-hexylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100708581,0.0001,216465,103389810,493485,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (OKA),Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101735916,0.0001,304883,103389810,493485,NULL,18052321,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853248,0.0001,258989,103389810,493485,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446802,0.00011,392537,103391803,3011370,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-[2,6-Diamino-5-(cyanomethyl)pyrimidin-4-yl]oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446242,0.0001241,392537,103246089,493055,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-[2-Amino-6-[2-(phosphonomethoxy)ethoxy]pyrimidin-4-yl]oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446800,0.0001241,392537,103246048,493056,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-[2-Amino-6-oxo-4-[2-(phosphonomethoxy)ethoxy]pyrimidin-1-yl]ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101445787,0.0001374,392537,103246087,493057,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"6-[2-(Diisopropoxyphosphorylmethoxy)ethylsulfanyl]pyrimidine-2,4-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101445788,0.00015,392537,103391487,11255143,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-(2,6-Diamino-5-prop-2-enylpyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101445791,0.00015,392537,103392326,3011381,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-(2,6-Diamino-5-bromo-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101445792,0.00015,392537,103391697,3011380,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-[2,4-Diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidin-5-yl]acetic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446239,0.00015,392537,103391766,3011368,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-(2,6-Diamino-5-benzyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446245,0.00015,392537,103391775,3011376,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-(2,6-Diamino-5-phenyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446251,0.00015,392537,103391698,3011379,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-[2,4-Diamino-6-oxo-1-[2-(phosphonomethoxy)ethyl]pyrimidin-5-yl]acetic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446253,0.00015,392537,103391486,3011367,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-(2,4-Diamino-5-benzyl-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446254,0.00015,392537,103391777,3011375,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-(2,4-Diamino-6-oxo-5-phenyl-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446258,0.00015,392537,103392290,11460885,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-(2,4-Diamino-6-oxo-5-prop-2-enylpyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446803,0.00015,392537,103391925,3011371,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-[2,4-Diamino-5-(2-ethoxy-2-oxo-ethyl)-6-oxo-pyrimidin-1-yl]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101445790,0.0001501,392537,103245389,493042,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,6-[2-(Diisopropoxyphosphorylmethoxy)ethoxy]pyrimidin-4-amine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101445785,0.0001645,392537,103246612,493050,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-[2-Amino-6-(cyclopropylamino)pyrimidin-4-yl]oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446250,0.0001645,392537,103246587,493049,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-[2-Amino-4-(cyclopropylamino)-6-oxo-pyrimidin-1-yl]ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446259,0.0001712,392537,103246572,493053,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-[2-Amino-6-(dimethylamino)pyrimidin-4-yl]oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446256,0.0001779,392537,103246001,135490839,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-(4-Amino-6-hydroxy-pyrimidin-2-yl)sulfanylethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963303,0.0002,1782698,103389810,493485,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus assessed as inhibition of viral replication,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101445782,0.0002008,392537,103245943,493041,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-(4-Amino-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345451,0.0003,217659,103389810,493485,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100709409,0.0003,216467,103389810,493485,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (YS),Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437632,0.0003,415399,103633014,44582865,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[4-[(E)-pent-1-enyl]phenyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101736719,0.0003,304882,103389810,493485,NULL,18052321,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101445784,0.0003247,392537,103246542,135442218,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-Amino-6-(dimethylamino)pyrimidin-4-ol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345454,0.0005,217659,103389785,493486,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-hexylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346741,0.0005,217670,103389990,493484,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101437403,0.0005,415400,103389990,493484,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus YS infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101437408,0.0005,415400,103389810,493485,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus YS infected in HEL cells assessed as reduction in viral plaque formation after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363648560,0.00054,1410507,404716552,145992929,NULL,29670705,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,"pentyl (2S)-2-[[5-[(6-aminopurin-9-yl)methyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-methylpentanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363648553,0.00059,1410507,404700621,145982337,NULL,29670705,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,"pentyl (2S)-2-[[5-[(6-aminopurin-9-yl)methyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-4-methylpentanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437625,0.0006,415399,103389810,493485,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101437633,0.0006,415399,103633011,44582863,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"6-[4-[(E)-but-1-enyl]phenyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101437407,0.0008,415400,103633014,44582865,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus YS infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[4-[(E)-pent-1-enyl]phenyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363648556,0.00095,1410507,404717653,145993616,NULL,29670705,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,"dipentyl (2S)-2-[[5-[(6-aminopurin-9-yl)methyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]pentanedioate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363648716,0.00095,1410507,404711551,142433105,NULL,29670705,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,pentyl (2S)-2-[[[(2S)-1-(6-aminopurin-9-yl)-3-hydroxypropan-2-yl]oxymethyl-[[(2S)-3-methyl-1-oxo-1-pentoxybutan-2-yl]amino]phosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100334216,0.001,217497,160692157,667554,NULL,10891113,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"5-[(E)-2-bromovinyl]-1-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698465,0.001,296672,103389810,493485,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101710811,0.001,299444,103535172,10239290,NULL,17513108,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV in human foreskin fibroblast assessed as inhibition of virus plaque formation,"N-[(4-chlorophenyl)methyl]-2-[[[(2R)-2-hydroxy-2-pyridin-2-ylethyl]-methylamino]methyl]-3,4-dimethyl-7-oxothieno[3,2-b]pyridine-6-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321577692,0.001,675210,160707046,136232617,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,"2-amino-9-[[(5S)-2-(3-hexadecoxypropoxy)-2-oxo-1,4,2lambda5-dioxaphosphinan-5-yl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101446238,0.0012,392537,103391699,3011378,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-(2,6-Diamino-5-cyclopropyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363648558,0.0015,1410507,404713629,145991052,NULL,29670705,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,"pentyl (2S)-2-[[5-[(6-aminopurin-9-yl)methyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363648715,0.0015,1410507,404706871,145986727,NULL,29670705,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,"dipentyl (2S)-2-[[5-[(6-aminopurin-9-yl)methyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]butanedioate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437634,0.0016,415399,103389990,493484,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577811,0.0017,675212,160680244,136263937,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,[(2S)-1-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxypropan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100708579,0.002,216465,242581925,493490,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (OKA),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101710812,0.002,299444,103535141,44432250,NULL,17513108,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV in human foreskin fibroblast assessed as inhibition of virus plaque formation,"N-[(4-chlorophenyl)methyl]-2-[[[(2R)-2-hydroxy-2-pyridin-2-ylethyl]-methylamino]methyl]-7-methyl-4-oxo-3a,7a-dihydrothieno[2,3-b]pyridine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101747282,0.002,307432,103549606,44440881,NULL,17434304,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster in HFF cells by plaque reduction assay,"(R)-N-(3-chlorobenzyl)-2-(((2-hydroxy-2-(pyridin-2-yl)ethyl)(methyl)amino)methyl)-7-methyl-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100345805,0.0022,217659,103389990,493484,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577699,0.0025,675210,160680244,136263937,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,[(2S)-1-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxypropan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100320206,0.003,216302,103202903,446727,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of OKA,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345457,0.003,217659,103202903,446727,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346739,0.003,217670,103202903,446727,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346743,0.003,217670,103389906,493487,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-heptylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100364856,0.003,217508,103202903,446727,NULL,11585457,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Inhibition of viral cytopathic effect in infected human foreskin fibroblast cell in monolayers of VZV Ellen Vero cells by 50%,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100492096,0.003,216326,242582613,512291,NULL,7562946,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,antiviral activity as 50% inhibitory concentration against VZV,"4-amino-7-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437409,0.003,415400,103389896,493482,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus YS infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-propylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204409892,0.003,588201,103389810,493485,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in HEL cells assessed as reduction in virus induced cytopathicity,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204410603,0.003,588200,124963370,51357702,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363648561,0.0032,1410507,404707332,145987024,NULL,29670705,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,"pentyl (2S)-2-[[5-[(6-aminopurin-9-yl)methyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-phenylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366457433,0.00355,1604295,440219288,46200812,NULL,31557612,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"3-((2,3,5,6-Tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl)carbamoyl)thiophene-2-carboxylic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437404,0.004,415400,103632944,44582845,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus YS infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[4-[(E)-prop-1-enyl]phenyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101437629,0.004,415399,103632944,44582845,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[4-[(E)-prop-1-enyl]phenyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698734,0.004,296673,103389810,493485,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
155735267,0.004,464100,103741785,9938296,NULL,20167488,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus infected in HFF cells by plaque reduction assay,"(R)-9-(((2-(benzofuran-2-yl)-2-hydroxyethyl)(methyl)amino)methyl)-N-(4-chlorobenzyl)-1-methyl-2,7-dioxo-1,2,3,7-tetrahydropyrido[1,2,3-de]quinoxaline-6-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
204410599,0.004,588200,103389810,493485,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in HEL cells assessed as reduction in virus induced cytopathicity,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363648554,0.004,1410507,404714914,145991894,NULL,29670705,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,"pentyl (2S)-2-[[5-[(6-aminopurin-9-yl)methyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-4-methylsulfanylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363648555,0.0043,1410507,404699313,145981493,NULL,29670705,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,"pentyl (2S)-2-[[5-[(6-aminopurin-9-yl)methyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435616,0.005,216153,103202903,446727,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK+ Varicella-Zoster Virus (VZV) OKA strain,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435618,0.005,216153,103391381,9906078,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK+ Varicella-Zoster Virus (VZV) OKA strain,"5-(2-Bromo-vinyl)-1-((1S,2S,4S,5R)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435948,0.005,147625,103202903,446727,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against OKA strain of thymidine kinase positive(TK+) Varicella-Zoster Virus (VZV),Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435949,0.005,147625,103391381,9906078,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against OKA strain of thymidine kinase positive(TK+) Varicella-Zoster Virus (VZV),"5-(2-Bromo-vinyl)-1-((1S,2S,4S,5R)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709402,0.005,216467,242581925,493490,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (YS),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101735915,0.005,304883,103202903,446727,NULL,18052321,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101736721,0.005,304882,103202903,446727,NULL,18052321,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575943,0.005,675213,160707046,136232617,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,"2-amino-9-[[(5S)-2-(3-hexadecoxypropoxy)-2-oxo-1,4,2lambda5-dioxaphosphinan-5-yl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577814,0.005,675212,160707046,136232617,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,"2-amino-9-[[(5S)-2-(3-hexadecoxypropoxy)-2-oxo-1,4,2lambda5-dioxaphosphinan-5-yl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100345456,0.0054,217659,103389906,493487,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-heptylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100319616,0.006,216303,103202903,446727,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of YS,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204409891,0.006,588201,124963370,51357702,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204410604,0.006,588200,124962092,51357146,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577698,0.006,675210,103202903,446727,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
366469308,0.0066,1610151,103202903,446727,NULL,31586832,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435982,0.007,220079,103391381,9906078,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against YS strain of thymidine kinase positive(TK+) Varicella-Zoster Virus (VZV),"5-(2-Bromo-vinyl)-1-((1S,2S,4S,5R)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100436390,0.007,216154,103391381,9906078,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK+ Varicella-Zoster Virus (VZV)YS strain,"5-(2-Bromo-vinyl)-1-((1S,2S,4S,5R)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797357,0.007,216307,242582690,493477,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus OKA strain,"6-(9-chlorononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437410,0.007,415400,103633011,44582863,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus YS infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"6-[4-[(E)-but-1-enyl]phenyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101747283,0.007,307432,103549607,9870496,NULL,17434304,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster in HFF cells by plaque reduction assay,"N-[(4-chlorophenyl)methyl]-2-[[[(2R)-2-hydroxy-2-pyrazin-2-yl-ethyl]-methyl-amino]methyl]-7-methyl-4-oxo-thieno[2,3-b]pyridine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321546488,0.0075,665383,103202903,446727,NULL,22578783,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100319618,0.008,216303,103389865,492115,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of YS,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100320203,0.008,216302,103390365,492114,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of OKA,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345419,0.008,217660,103390365,492114,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346738,0.008,217670,103389896,493482,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-propylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346742,0.008,217670,103389865,492115,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100435984,0.008,220079,103202903,446727,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against YS strain of thymidine kinase positive(TK+) Varicella-Zoster Virus (VZV),Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100436391,0.008,216154,103202903,446727,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK+ Varicella-Zoster Virus (VZV)YS strain,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656751,0.008,216461,103390365,492114,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656966,0.008,216462,103389865,492115,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100699716,0.008,216135,103390365,492114,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Concentration required to give 50% inhibition of replication of VZV OKA in tissue culture,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797245,0.008,216308,103389865,492115,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus YS strain,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204409898,0.009,588201,124962092,51357146,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
373963302,0.009,1782698,103504725,135398513,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus assessed as inhibition of viral replication,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345452,0.01,217659,103389896,493482,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-propylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100699932,0.01,216135,242582685,513141,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Concentration required to give 50% inhibition of replication of VZV OKA in tissue culture,"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-(9-pentyloxy-nonyl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698455,0.01,296672,103202903,446727,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698658,0.01,296673,103202903,446727,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853244,0.01,258989,103202903,446727,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204410606,0.01,588200,124959448,51357423,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101437627,0.011,415399,103389896,493482,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-propylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
106033030,0.011,445339,103708849,45102702,NULL,19833513,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected human HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830255,0.011,607913,103202903,446727,NULL,21696963,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase infected in human HEL cells assessed as reduction in the virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100797419,0.012,216308,242582690,493477,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus YS strain,"6-(9-chlorononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204375504,0.012,553342,103202903,446727,NULL,21128666,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV OKA expressing thymidine kinase infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363955157,0.012,1498126,103202903,446727,NULL,29880251,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204409896,0.013,588201,124959448,51357423,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100709400,0.014,216467,242581923,9979184,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (YS),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797238,0.014,216308,242582691,493476,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus YS strain,"6-(9-fluorononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678402,0.014,291029,103202903,446727,NULL,17539622,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101700822,0.014,297306,103202903,446727,NULL,17672445,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100320197,0.015,216302,103389865,492115,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of OKA,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345455,0.015,217659,103389865,492115,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100656752,0.015,216461,103389865,492115,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100699929,0.015,216135,103389865,492115,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Concentration required to give 50% inhibition of replication of VZV OKA in tissue culture,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797354,0.015,216307,103389865,492115,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus OKA strain,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427975,0.015,393979,103202903,446727,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103157091,0.015,429197,103202903,446727,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204410602,0.016,588200,124964672,51356862,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-2-(hydroxymethyl)-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-3-yl] (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204409893,0.018,588201,124960457,51357968,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204409895,0.018,588201,124964672,51356862,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-2-(hydroxymethyl)-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-3-yl] (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100319646,0.02,216303,103389866,493473,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of YS,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-nonyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100320200,0.02,216302,103389866,493473,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of OKA,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-nonyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345453,0.02,217659,103389866,493473,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-nonyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346746,0.02,217670,103389866,493473,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-nonyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100699719,0.02,216135,242582684,513140,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Concentration required to give 50% inhibition of replication of VZV OKA in tissue culture,"6-(9-butoxynonyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100700438,0.02,218490,242582685,513141,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity evaluated against Varicella Zoster virus (YS),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-(9-pentyloxy-nonyl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709405,0.02,216467,242581927,90662954,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (YS),"6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100743358,0.02,216317,103184834,135972447,NULL,NULL,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro antiviral activity was evaluated against VZV using viral plaque reduction assay; Value ranges from 0.02-0.08,"2-amino-9-[(1R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100833400,0.02,217678,103204631,136002157,NULL,1849998,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,compound was tested for antiherpes activity against VZV(Ellen) in tissue culture by plaque reduction assay,"2-amino-9-[(2S,3R)-2,3-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101495262,0.02,340472,103602987,10174031,NULL,18595689,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster by plaque reduction assay,"(R)-N-(4-chlorobenzyl)-2-(((2-(furan-2-yl)-2-hydroxyethyl)(methyl)amino)methyl)-7-methyl-4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101710719,0.02,299444,103535209,10311242,NULL,17513108,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV in human foreskin fibroblast assessed as inhibition of virus plaque formation,"N-(4-fluorobenzyl)-2-{[[(2R)-2-hydroxy-2-pyrimidin-2-ylethyl](methyl)amino]methyl}-3,4-dimethyl-7-oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
155735265,0.02,464100,103741452,9805202,NULL,20167488,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus infected in HFF cells by plaque reduction assay,"N-(4-chlorobenzyl)-1-methyl-9-(morpholinomethyl)-2,7-dioxo-1,2,3,7-tetrahydropyrido[1,2,3-de]quinoxaline-6-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
380625531,0.02,1872793,103202903,446727,NULL,35305462,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV strain Oka bearing wild type thymidine kinase assessed as reduction in virus induced cytopathogenicity,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797360,0.022,216307,242582691,493476,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus OKA strain,"6-(9-fluorononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204410600,0.022,588200,124960457,51357968,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100319620,0.024,216303,103390365,492114,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of YS,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345785,0.024,217670,103390365,492114,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100656968,0.024,216462,103390365,492114,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908761,0.024,1462034,103202903,446727,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100708573,0.025,216465,242581923,9979184,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (OKA),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797361,0.026,216307,242582697,493478,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus OKA strain,"6-(9-bromononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103158369,0.026,429196,103202903,446727,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372356930,0.026,1727352,103202903,446727,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
100346740,0.027,217670,103389872,493488,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-octylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
373963301,0.027,1782698,242582545,492113,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus assessed as inhibition of viral replication,"6-Heptyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100708575,0.028,216465,242581927,90662954,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (OKA),"6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372128089,0.028,1684817,103233471,60750,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Gemcitabine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
346996278,0.029,1230100,103202903,446727,NULL,26001344,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100700439,0.03,218490,242582679,513144,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity evaluated against Varicella Zoster virus (YS),"6-[9-(4-chlorobutoxy)nonyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100700440,0.03,218490,242582684,513140,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity evaluated against Varicella Zoster virus (YS),"6-(9-butoxynonyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800618,0.03,247653,103448604,22012704,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[2-cyano-4-[1-(4-fluorophenyl)ethylcarbamoylamino]phenyl]-2-fluorobenzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101922468,0.03,273052,103504725,135398513,NULL,17004726,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Inhibition of VZV replication in HFF cells by cytopathic effect assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
155763602,0.03,481587,103751998,491954,NULL,20403696,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster infected in HFF cells assessed as reduction in plaque formation,"N-(4-Chlorobenzyl)-2-(2-morpholin-4-ylethyl)-8-(4-morpholinylmethyl)-6-oxo-6h-pyrrolo[3,2,1-ij]quinoline-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
198378434,0.03,534207,103594569,15958371,NULL,18852272,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in HFF cells by plaque reduction assay,2-[2-Amino-6-(cyclopropylamino)purin-9-yl]ethoxymethyl-(3-hexadecoxypropoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100797241,0.031,216308,242582697,493478,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus YS strain,"6-(9-bromononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204409894,0.032,588201,124962093,51353745,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in HEL cells assessed as reduction in virus induced cytopathicity,"(3S)-3-amino-4-[(2S)-2-[[(2S)-1-[[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methoxy]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100797244,0.034,216308,242582694,493479,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus YS strain,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(9-iodononyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963270,0.034,1782672,103202903,446727,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100334211,0.035,217497,103290841,6479197,NULL,10891113,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"(2S,5S)-1-[2-(Hydroxymethyl)-1,3-dioxolan-5-yl]-(E)-5-(2-iodovinyl)uracil",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372128326,0.036,1684817,103202903,446727,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393305,0.037,1572733,103202903,446727,NULL,30738653,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345804,0.04,217659,103389872,493488,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-octylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204409897,0.042,588201,124970049,51357704,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2,4-diamino-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372128322,0.042,1684817,461526474,23519645,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"4-amino-1-[(2R,4R,5S)-3,3,5-trifluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380549611,0.042,1854966,103202903,446727,NULL,35933787,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster-virus OKA strain harboring thymidine kinase infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709404,0.043,216467,242581926,90662953,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (YS),"6-(4-hexylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204375507,0.044,553342,103208535,60613,NULL,21128666,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV OKA expressing thymidine kinase infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698461,0.045,296672,103525547,16756528,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-hexylpyridin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100334219,0.05,217497,103202903,446727,NULL,10891113,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100699717,0.05,216135,242582679,513144,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Concentration required to give 50% inhibition of replication of VZV OKA in tissue culture,"6-[9-(4-chlorobutoxy)nonyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100699720,0.05,216135,242582682,513142,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Concentration required to give 50% inhibition of replication of VZV OKA in tissue culture,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(9-isopentyloxynonyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
155763598,0.05,481587,103741383,491953,NULL,20403696,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster infected in HFF cells assessed as reduction in plaque formation,"N-(4-Chlorobenzyl)-2-(2-hydroxyethyl)-8-(4-morpholinylmethyl)-6-oxo-6H-pyrrolo[3,2,1-ij]quinoline-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
372127847,0.054,1684816,103233471,60750,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Gemcitabine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899315,0.057,1457768,381846705,134382706,NULL,28682067,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,dipentyl (2S)-2-[[[(1S)-1-[(6-aminopurin-9-yl)methyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345474,0.06,217671,103389895,493481,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, which is the concentration of compounds in uM required to reduce VZV YS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(p-tolyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100345675,0.06,217660,103389895,493481,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(p-tolyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100656965,0.06,216462,242582549,492105,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oct-7-enyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100700436,0.06,218489,242582682,513142,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity evaluated against Varicella Zoster virus (YS),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(9-isopentyloxynonyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709401,0.06,216467,242581920,90662950,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (YS),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-propylphenyl)thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812562,0.06,217645,103734857,6475209,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ito strain),"5-(2-Bromoethenyl)-1-(tetrahydro-4,5-bis(hydroxymethyl)-3-furanyl)-2,4(1H,3H)-pyrimidinedione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698471,0.06,296672,103525548,16756864,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(6-pent-1-ynylpyridin-3-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698747,0.06,296673,103525547,16756528,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-hexylpyridin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800613,0.06,247653,103449146,5272232,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-2-(trifluoromethyl)phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373964296,0.06,1782705,469814808,11120681,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type Varicella zoster virus infected in HEL cells assessed as reduction in viral plaque formation incubated for 2 hrs,"3-(2-Deoxy-beta-D-ribofuranosyl)-1,3-diaza-10H-phenoxazin-2(3H)-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797359,0.061,216307,242582694,493479,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus OKA strain,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(9-iodononyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363648714,0.062,1410507,404697768,145980504,NULL,29670705,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,"dipentyl (2R)-2-[[5-[(6-aminopurin-9-yl)methyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]butanedioate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698459,0.066,296672,103389865,492115,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100334218,0.07,217497,103290843,6474951,NULL,10891113,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,Dioxolane nucleoside,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345782,0.07,217670,103389982,493483,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-ethylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698660,0.07,296673,103525546,16756757,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(5-pentylpyridin-2-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800861,0.07,247653,103449222,5272233,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,"N-[2,6-dibromo-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-fluoro-benzamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204375567,0.07,553343,103208535,60613,NULL,21128666,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237833783,0.07,609573,134448541,53357717,NULL,21745746,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,2-[2-(6-Aminopurin-9-yl)ethoxy]propylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613489,0.07,1869612,103202903,446727,NULL,35754374,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK+ infected in HEL cells assessed as reduction in virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204410601,0.073,588200,124962093,51353745,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in HEL cells assessed as reduction in virus induced cytopathicity,"(3S)-3-amino-4-[(2S)-2-[[(2S)-1-[[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methoxy]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372128087,0.074,1684817,194168035,11169170,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Acelarin,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899303,0.079,1457768,381883094,137291676,NULL,28682067,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,dipentyl (2S)-2-[[[(1S)-1-[(2-amino-6-oxo-1H-purin-9-yl)methyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366675,0.08,217507,242582656,10066295,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,"1-beta-D-Arabinofuranosyl-5-(1-azido-2-chloroethyl)-2,4(1H,3H)-pyrimidinedione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100708577,0.08,216465,242581926,90662953,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (OKA),"6-(4-hexylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204410605,0.085,588200,124970049,51357704,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2,4-diamino-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204409889,0.089,588201,124967385,25190991,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490061,0.089,1661189,103202903,446727,NULL,32676147,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372127849,0.089,1684816,194168035,11169170,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Acelarin,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345450,0.09,217659,103389982,493483,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-ethylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100656753,0.09,216461,242582560,492106,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"6-Dec-9-enyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100699931,0.09,216135,242582683,513143,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Concentration required to give 50% inhibition of replication of VZV OKA in tissue culture,"6-(9-Cyclopentylmethoxy-nonyl)-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100708578,0.09,216465,242581920,90662950,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (OKA),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-propylphenyl)thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101495264,0.09,340472,103602313,10195634,NULL,18595689,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster by plaque reduction assay,"(R)-N-(4-chlorobenzyl)-2-(((2-hydroxy-2-(pyridin-2-yl)ethyl)(methyl)amino)methyl)-7-methyl-4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698467,0.09,296672,103525549,16756529,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(6-pentylpyridin-3-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698468,0.09,296672,103525550,16756530,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(6-hexylpyridin-3-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698750,0.09,296673,103525548,16756864,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(6-pent-1-ynylpyridin-3-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800845,0.09,247653,103449293,5272234,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-2-methoxy-phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800846,0.09,247653,103449030,10072152,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]quinoline-2-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698738,0.094,296673,103389865,492115,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489610,0.098,1661190,442050922,134382709,NULL,32676147,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,dipentyl (2S)-2-[[[(1R)-1-[(4-aminopyrimidin-2-yl)oxymethyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100345806,0.1,217659,103390412,507243,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-chlorophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346744,0.1,217670,103390412,507243,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-chlorophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100656967,0.1,216462,242582560,492106,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","6-Dec-9-enyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100700437,0.1,218490,242582683,513143,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity evaluated against Varicella Zoster virus (YS),"6-(9-Cyclopentylmethoxy-nonyl)-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812647,0.1,217644,103734857,6475209,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ellen strain),"5-(2-Bromoethenyl)-1-(tetrahydro-4,5-bis(hydroxymethyl)-3-furanyl)-2,4(1H,3H)-pyrimidinedione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
155763599,0.1,481587,103751788,10185854,NULL,20403696,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster infected in HFF cells assessed as reduction in plaque formation,"N-(4-Chlorobenzyl)-2-[(2-hydroxyethoxy)methyl]-8-(morpholin-4-ylmethyl)-6-oxo-6H-pyrrolo[3,2,1-ij]quinoline-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
237833097,0.1,609512,134448541,53357717,NULL,21745746,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,2-[2-(6-Aminopurin-9-yl)ethoxy]propylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833524,0.1,609572,103208535,60613,NULL,21745746,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237837039,0.1,611619,103208535,60613,NULL,21565516,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101669757,0.11,288926,103511539,472172,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation,5-Ethynyl-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101669762,0.11,288926,103519823,11588933,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-iodoethynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800614,0.11,247653,103448556,22012706,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[1-(1-benzofuran-2-yl)ethylcarbamoylamino]-2-cyanophenyl]-2-fluorobenzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800848,0.11,247653,103448584,5272249,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[1-(benzofuran-2-yl)ethylcarbamothioylamino]-2-cyano-phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800858,0.11,247653,103448605,5272235,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[2-cyano-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800859,0.11,247653,103448605,5272235,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[2-cyano-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833518,0.11,609572,134448541,53357717,NULL,21745746,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,2-[2-(6-Aminopurin-9-yl)ethoxy]propylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
334012638,0.11,722677,164136313,71508384,NULL,23176752,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus infected in human HFF cells assessed as reduction of viral replication,"(1S,2R,3S,4R)-4-(4-amino-7-bromo-imidazo[4,5-c]pyridin-1-yl)cyclopentane-1,2,3-triol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
363899542,0.11,1457768,381854600,137291665,NULL,28682067,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,dipentyl (2S)-2-[[[(1R)-1-[(2-amino-6-oxo-1H-purin-9-yl)methyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435656,0.12,216157,103391889,6439190,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration of compound against Varicella-Zoster Virus (VZV); Range is 0.06-0.12 uM,"2,4(1H,3H)-Pyrimidinedione, 5-((E)-2-bromoethenyl)-1-(3-hydroxy-4-(hydroxymethyl)cyclopentyl)-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435981,0.12,220079,103391439,10406438,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against YS strain of thymidine kinase positive(TK+) Varicella-Zoster Virus (VZV),"1-((1R,3S,4S,6S)-4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-5-iodo-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100436389,0.12,216154,103391439,10406438,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK+ Varicella-Zoster Virus (VZV)YS strain,"1-((1R,3S,4S,6S)-4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-5-iodo-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515684,0.12,106003,103420630,44378733,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-(2-fluoroethyl)-1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
101800854,0.12,247653,103449224,5272236,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-2-methyl-phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204409890,0.127,588201,124973848,51356299,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]oxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698736,0.13,296673,103525549,16756529,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(6-pentylpyridin-3-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800621,0.13,247653,160697763,5272224,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[[(1R)-1-(4-bromophenyl)ethyl]carbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103157096,0.13,429197,103192704,135542177,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"2-amino-9-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100335019,0.14,217495,103567639,135398748,NULL,10891113,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,Penciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698737,0.14,296673,103525550,16756530,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(6-hexylpyridin-3-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100334212,0.15,217497,103290342,6479195,NULL,10891113,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"(2S,5S)-(E)-5-(2-Chlorovinyl)-1-[2-(hydroxymethyl)-1,3-dioxolan-5-yl]uracil",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709403,0.15,216467,242581919,90662949,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (YS),"6-(4-ethylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101669761,0.15,288926,103519821,16735488,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation,5-[(Trimethylsilyl)ethynyl]-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
354653366,0.15,1283361,103558814,454239,NULL,26819664,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV infected in human ARPE19 cells treated at 2 hrs post infection measured 48 hrs post infection by luciferase assay,"(2S,3R,4S,4aR,11bR)-2,3,4-trihydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204410597,0.154,588200,124967385,25190991,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-hydroxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346673,0.16,217672,103390284,493480,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration required to reduce VZV YS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-phenyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100435619,0.16,216153,103391439,10406438,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK+ Varicella-Zoster Virus (VZV) OKA strain,"1-((1R,3S,4S,6S)-4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-5-iodo-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435950,0.16,147625,103391439,10406438,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against OKA strain of thymidine kinase positive(TK+) Varicella-Zoster Virus (VZV),"1-((1R,3S,4S,6S)-4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-5-iodo-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101669714,0.16,288925,103511539,472172,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,5-Ethynyl-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061818,0.16,1251996,318393377,122192835,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"N-(4-Phenoxyphenyl)-1-[8-(4-bromophenoxy)octyl]-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-3-acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372127844,0.166,1684816,461526474,23519645,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"4-amino-1-[(2R,4R,5S)-3,3,5-trifluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100320202,0.17,216302,242582545,492113,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of OKA,"6-Heptyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100413889,0.17,147626,103392324,3011383,NULL,14584956,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"[(1S)-1-[(2,6-diaminopyrimidin-4-yl)oxymethyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100656757,0.17,216461,242582545,492113,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"6-Heptyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709408,0.18,216467,242581916,90662946,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (YS),"6-(4-heptylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101669716,0.18,288925,103519823,11588933,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-iodoethynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800624,0.18,247653,103448952,9889676,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]isoquinoline-3-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800856,0.18,247653,103449065,5272228,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[1-(benzofuran-2-yl)ethylcarbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
367489615,0.18,1661190,103202903,446727,NULL,32676147,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489788,0.18,1661190,442049161,156011488,NULL,32676147,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2R)-1-(4-aminopyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800847,0.19,247653,103449115,44393080,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,"1-[1-(4-Fluorophenyl)ethyl]-3-[4-(3-quinolin-4-yl-1,2-oxazol-5-yl)phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800853,0.19,247653,103449073,44393063,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,"1-[4-(3-Benzyl-1,2-oxazol-5-yl)phenyl]-3-[1-(4-fluorophenyl)ethyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800863,0.19,247653,103449402,5272242,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-methoxy-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204375571,0.19,553343,124969134,50925435,NULL,21128666,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,"[2,2-dimethylpropanoyloxymethoxy-[(E)-4-(5-methyl-2,4-dioxo-pyrimidin-1-yl)but-2-enyl]phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577691,0.19,675210,160685556,136252883,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,2-[2-(2-amino-6-oxo-1H-purin-9-yl)ethoxy]ethyl-(3-hexadecoxypropoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100435617,0.2,216153,103391811,11438492,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK+ Varicella-Zoster Virus (VZV) OKA strain,"5-Bromo-1-((1R,3S,4S,6S)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435947,0.2,147625,103391811,11438492,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against OKA strain of thymidine kinase positive(TK+) Varicella-Zoster Virus (VZV),"5-Bromo-1-((1R,3S,4S,6S)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435983,0.2,220079,103391811,11438492,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against YS strain of thymidine kinase positive(TK+) Varicella-Zoster Virus (VZV),"5-Bromo-1-((1R,3S,4S,6S)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100436393,0.2,216154,103391811,11438492,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK+ Varicella-Zoster Virus (VZV)YS strain,"5-Bromo-1-((1R,3S,4S,6S)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100708576,0.2,216465,242581919,90662949,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (OKA),"6-(4-ethylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100833406,0.2,217678,103204632,135839365,NULL,1849998,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,compound was tested for antiherpes activity against VZV(Ellen) in tissue culture by plaque reduction assay,"2-amino-9-[2,3-bis(hydroxymethyl)cyclobutyl]-3H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963284,0.2,1782672,469807121,164615035,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-nonoxy-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800849,0.21,247653,103449029,5272225,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[1-(4-chlorophenyl)ethylcarbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321577812,0.21,675212,103303173,135542257,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,"{[(1S)-2-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-1-(hydroxymethyl)ethoxy]methyl}phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101446805,0.226,392537,103651488,493054,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-(2-Amino-6-hydroxy-pyrimidin-4-yl)oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698751,0.23,296673,103525544,16756756,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-butylpyridin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577808,0.23,675212,160685558,135480705,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,"2-amino-9-[[(5S)-2-hydroxy-2-oxo-1,4,2$l^{5}-dioxaphosphinan-5-yl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402059,0.24,3059,103392324,3011383,NULL,14584956,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"[(1S)-1-[(2,6-diaminopyrimidin-4-yl)oxymethyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101670303,0.26,288925,103519821,16735488,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,5-[(Trimethylsilyl)ethynyl]-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800852,0.26,247653,103449260,44393167,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[2-(anilinooxymethyl)-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204410598,0.26,588200,124973848,51356299,NULL,21332170,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in HEL cells assessed as reduction in virus induced cytopathicity,"[(2R,3S,5R)-3-[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]oxy-5-[2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl (2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100656754,0.27,216461,242582549,492105,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oct-7-enyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100708574,0.27,216465,242581916,90662946,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (OKA),"6-(4-heptylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100346626,0.28,217661,103390284,493480,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration required to reduce VZV OKA plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-phenyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101735913,0.28,304883,103538406,24748860,NULL,18052321,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells after 5 days,"3-[(1R,3S,4R)-3-hydroxy-4-(hydroxymethyl)cyclopentyl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101669760,0.29,288926,103511538,14885958,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation,EYaraU,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363908714,0.29,1462035,381848373,137639298,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"(2S)-2-amino-3-[4-[[4-[(2S)-2-amino-3-(hexadecylamino)-3-oxopropyl]phenoxy]-[2-(4-amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl]phosphoryl]oxyphenyl]-N-hexadecylpropanamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363909048,0.29,1462035,381883211,137659149,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"[2-(2,6-Diaminopyrimidin-4-yl)oxyethoxymethyl-(2-methylpropanoyloxymethoxy)phosphoryl]oxymethyl 2-methylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515592,0.3,106003,103421114,23179377,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-(2-Chloroethyl)-1-[4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100812806,0.3,217658,103734857,6475209,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (ppIIa strain),"5-(2-Bromoethenyl)-1-(tetrahydro-4,5-bis(hydroxymethyl)-3-furanyl)-2,4(1H,3H)-pyrimidinedione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103158368,0.3,429196,103192704,135542177,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"2-amino-9-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
198378002,0.3,534207,103594568,15958370,NULL,18852272,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in HFF cells by plaque reduction assay,"2-(2,6-Diaminopurin-9-yl)ethoxymethyl-(3-hexadecoxypropoxy)phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321577806,0.3,675212,160685556,136252883,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,2-[2-(2-amino-6-oxo-1H-purin-9-yl)ethoxy]ethyl-(3-hexadecoxypropoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103157095,0.32,429197,103688495,45270933,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-thiophen-2-yl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272364,0.32,458869,103727604,54728125,NULL,20064723,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"5-[bis(4-hydroxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363908487,0.32,1462034,381883211,137659149,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"[2-(2,6-Diaminopyrimidin-4-yl)oxyethoxymethyl-(2-methylpropanoyloxymethoxy)phosphoryl]oxymethyl 2-methylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908757,0.32,1462034,381873597,137656328,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-(2-octadecoxyethoxy)phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101669758,0.33,288926,103519819,16735236,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation,"1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-trimethylsilylethynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363539702,0.33,1382166,404674667,145965077,NULL,29407990,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,"benzyl (2S)-2-[[[(E)-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698472,0.36,296672,103525544,16756756,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-butylpyridin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490057,0.36,1661189,442050922,134382709,NULL,32676147,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,dipentyl (2S)-2-[[[(1R)-1-[(4-aminopyrimidin-2-yl)oxymethyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490062,0.36,1661189,442049161,156011488,NULL,32676147,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2R)-1-(4-aminopyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103158374,0.38,429196,103688495,45270933,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-thiophen-2-yl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100319644,0.39,216303,242582545,492113,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of YS,"6-Heptyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656962,0.39,216462,242582545,492113,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","6-Heptyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363539701,0.39,1382166,404686217,145972873,NULL,29407990,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,"benzyl (2S)-2-[[[(E)-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812645,0.4,217644,103734865,472370,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ellen strain),"1-[[4alpha,5beta-Bis(hydroxymethyl)tetrahydrofuran]-3beta-yl]-4-aminopyrimidin-2(1H)-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204375506,0.41,553342,124969134,50925435,NULL,21128666,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV OKA expressing thymidine kinase infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,"[2,2-dimethylpropanoyloxymethoxy-[(E)-4-(5-methyl-2,4-dioxo-pyrimidin-1-yl)but-2-enyl]phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800615,0.42,247653,103449107,5272226,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[1-(4-bromophenyl)ethylcarbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103157089,0.42,429197,103684902,45269251,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-(furan-2-yl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
373963050,0.42,1782673,103202903,446727,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963268,0.42,1782672,469808836,164616264,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-octoxy-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363539695,0.43,1382166,124969134,50925435,NULL,29407990,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,"[2,2-dimethylpropanoyloxymethoxy-[(E)-4-(5-methyl-2,4-dioxo-pyrimidin-1-yl)but-2-enyl]phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363539698,0.45,1382166,404691278,145976238,NULL,29407990,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,"[[(E)-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(2-methylpropanoyloxymethoxy)phosphoryl]oxymethyl 2-methylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515698,0.46,106003,103421036,44378906,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-[(E)-prop-1-enyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
101669712,0.48,288925,103519819,16735236,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-trimethylsilylethynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101736722,0.49,304882,103538406,24748860,NULL,18052321,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells after 5 days,"3-[(1R,3S,4R)-3-hydroxy-4-(hydroxymethyl)cyclopentyl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372356599,0.49,1727352,103504725,135398513,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
100319645,0.5,216303,242582674,493474,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of YS,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-undecyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100320204,0.5,216302,242582674,493474,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of OKA,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-undecyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345783,0.5,217670,103390388,507244,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-bromophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100345807,0.5,217659,103390388,507244,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-bromophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100515696,0.5,106003,103420749,44378784,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-cyclopropyl-1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100812559,0.5,217515,103734857,6475209,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (9021 strain),"5-(2-Bromoethenyl)-1-(tetrahydro-4,5-bis(hydroxymethyl)-3-furanyl)-2,4(1H,3H)-pyrimidinedione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698281,0.5,296675,103389810,493485,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204379793,0.5,563764,103208535,60613,NULL,19770274,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellan infected in HFF assessed as decrease in viral DNA accumulation after 8 to 10 days,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
326010655,0.5,687665,163333669,71460121,NULL,23047229,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-(2-amino-6-methoxy-purin-9-yl)but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061820,0.51,1251996,318393376,122192834,NULL,26443550,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"N-(4-Phenoxyphenyl)-1-[6-(4-bromophenoxy)hexyl]-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-3-acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100827653,0.53,216165,103321859,65049,NULL,2828623,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Ability to reduce plaque formation of varicella zoster virus (VZV) by 50% in human embryonic lung fibroblast (HELF) cell cultures,Spongothymidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908489,0.56,1462034,134458538,54768471,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"ethyl (2S)-2-[[2-(2,6-diaminopyrimidin-4-yl)oxyethoxymethyl-[[(1S)-2-ethoxy-1-methyl-2-oxo-ethyl]amino]phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800862,0.57,247653,103449177,9955646,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[2-ethoxy-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953322,0.57,1498127,103202903,446727,NULL,29880251,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698456,0.58,296672,103525546,16756757,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(5-pentylpyridin-2-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363908751,0.58,1462034,381848373,137639298,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"(2S)-2-amino-3-[4-[[4-[(2S)-2-amino-3-(hexadecylamino)-3-oxopropyl]phenoxy]-[2-(4-amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl]phosphoryl]oxyphenyl]-N-hexadecylpropanamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101499181,0.59,342121,103624537,135908419,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103156783,0.59,429197,103504490,135398740,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800619,0.6,247653,103449024,5271138,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800620,0.6,247653,103449024,5271138,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
151272358,0.6,458869,103727605,54728126,NULL,20064723,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"5-[bis(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237837045,0.6,611619,134461776,53248687,NULL,21565516,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,[1-[(4-Amino-2-oxo-pyrimidin-1-yl)methyl]-2-hydroxy-ethoxy]methyl-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101446247,0.62,392537,103513627,11253110,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[(Z)-[2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl]-5-methylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446248,0.62,392537,103651236,44591202,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"6-amino-3-[(Z)-[2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl]-1,6-dihydropyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101652719,0.62,282657,103513626,11206609,NULL,15615545,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Inhibition of VZV replication in HFF cells by CPE assay,CID 11206609,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101652720,0.62,282657,103513627,11253110,NULL,15615545,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Inhibition of VZV replication in HFF cells by CPE assay,"1-[(Z)-[2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl]-5-methylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101698745,0.63,296673,103525553,16756531,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-hexylpyrimidin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103158376,0.64,429196,103684902,45269251,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-(furan-2-yl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237836760,0.64,611619,134442511,53249145,NULL,21565516,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,[1-[(4-Amino-2-oxo-pyrimidin-1-yl)methyl]-2-hydroxy-ethoxy]methyl-[2-[2-[2-[2-[2-(2-ethoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363908753,0.65,1462034,381846826,137638251,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"[2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908754,0.67,1462034,381877458,137656437,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"[2-(2,6-Diaminopyrimidin-4-yl)oxyethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446804,0.68,392537,103651338,484046,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,N-(4-Chlorobenzyl)-4-hydroxy-6-(3-hydroxy-1-propynyl)-3-quinolinecarboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963283,0.68,1782672,469806117,164614303,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"8-decoxy-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101669737,0.69,288927,103519821,16735488,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,5-[(Trimethylsilyl)ethynyl]-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100843455,0.7,216310,103184762,135972443,NULL,NULL,Confirmatory,20230629,0,0,Active,NULL,ED50,=,ChEMBL,Effective dose required to inhibit cell growth against VZV (Ellen); Value ranges from 0.7-1.7,"2-amino-9-[(1S,3S)-2-fluoro-3,4-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800616,0.7,247653,160686900,5272222,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[[(1R)-1-phenylethyl]carbamothioylamino]phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380549612,0.7,1854966,103504725,135398513,NULL,35933787,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster-virus OKA strain harboring thymidine kinase infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380625530,0.7,1872793,103504725,135398513,NULL,35305462,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV strain Oka bearing wild type thymidine kinase assessed as reduction in virus induced cytopathogenicity,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698458,0.71,296672,103525553,16756531,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-hexylpyrimidin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101498758,0.72,342118,103624537,135908419,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698457,0.72,296672,103525528,16756643,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-[(E)-dec-1-enyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101670741,0.75,288928,103511539,472172,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS in HEL cells assessed as reduction of virus plaque formation,5-Ethynyl-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100766052,0.76,217677,103437071,456904,NULL,NULL,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Compound was evaluated for the antiviral activity against varicella zoster virus(VZV),2'-Deoxy-5-ethyl-4'-thiouridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101747284,0.77,307432,103549677,9953786,NULL,17434304,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster in HFF cells by plaque reduction assay,"N-(4-Chlorobenzyl)-4-hydroxy-2-(4-morpholinylmethyl)thieno[2,3-b]pyridine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101670739,0.78,288928,103519823,11588933,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS in HEL cells assessed as reduction of virus plaque formation,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-iodoethynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363908716,0.79,1462035,381873597,137656328,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-(2-octadecoxyethoxy)phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797242,0.8,216308,242582696,5271150,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus YS strain,"5-(11-bromoundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
198378004,0.8,534207,103511437,476082,NULL,18852272,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in HFF cells by plaque reduction assay,cPrPMEDAP,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
326010626,0.8,687665,163337087,136238816,NULL,23047229,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-(2-amino-6-oxo-1H-purin-9-yl)but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010628,0.8,687665,163319820,71452911,NULL,23047229,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363810188,0.8,1433151,381879201,137657242,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,4-[4-[(7-Chloroquinolin-4-yl)amino]butylamino]-2-methylsulfanyl-6-(4-nitrophenyl)pyrimidine-5-carbonitrile,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810190,0.8,1433151,381847809,137638892,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,4-[3-[(7-Chloroquinolin-4-yl)amino]propoxy]-2-methylsulfanyl-6-phenylpyrimidine-5-carbonitrile,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810193,0.8,1433151,381860636,137647603,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,4-[4-[(7-Chloroquinolin-4-yl)amino]butylamino]-2-methylsulfanyl-6-(3-nitrophenyl)pyrimidine-5-carbonitrile,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908712,0.8,1462035,381852005,137641728,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"4-Amino-1-[2-[bis(2-octadecoxyethoxy)phosphorylmethoxy]ethyl]-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101669740,0.81,288927,103511539,472172,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,5-Ethynyl-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272558,0.84,458869,103504725,135398513,NULL,20064723,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103158370,0.87,429196,103691947,45272643,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-(5-bromothiophen-2-yl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101670076,0.89,288927,103519823,11588933,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-iodoethynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101670740,0.9,288928,103519821,16735488,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS in HEL cells assessed as reduction of virus plaque formation,5-[(Trimethylsilyl)ethynyl]-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103157094,0.93,429197,103691947,45272643,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-(5-bromothiophen-2-yl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800865,0.96,247653,103449114,5272227,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[1-(4-cyanophenyl)ethylcarbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515700,0.99,106003,103421391,44379068,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-ethyl-1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
101800851,0.99,247653,103449212,5272239,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-3-methyl-phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100319619,1,216303,103504725,135398513,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of YS,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100346745,1,217670,103504725,135398513,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TS plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100515689,1,106003,103202903,446727,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,<,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100656767,1,216462,103504725,135398513,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)",Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797420,1,216308,103504725,135398513,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus YS strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100827654,1,216165,103732750,46876177,NULL,2828623,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Ability to reduce plaque formation of varicella zoster virus (VZV) by 50% in human embryonic lung fibroblast (HELF) cell cultures,"4-(difluoromethoxy)-1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101498824,1,342119,103624537,135908419,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101669713,1,288925,103511538,14885958,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,EYaraU,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101678405,1,291029,103504725,135398513,NULL,17539622,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101701421,1,297306,103504725,135398513,NULL,17672445,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101735914,1,304883,103504725,135398513,NULL,18052321,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996068,1,1230101,103202903,446727,NULL,26001344,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
380639612,1,1876130,103192480,456214,NULL,33539089,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV,purvalanol A,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363539699,1.03,1382166,404676646,145966378,NULL,29407990,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,"propan-2-yl (2S)-2-[[[(E)-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321546489,1.08,665383,160668110,60167325,NULL,22578783,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-[4-[4-(trifluoromethoxy)phenyl]buta-1,3-diynyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100319617,1.1,216303,242582676,493475,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of YS,"6-dodecyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515688,1.1,106003,103420654,44378742,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-ethenyl-1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100708580,1.1,216465,103504725,135398513,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (OKA),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797362,1.1,216307,242582696,5271150,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus OKA strain,"5-(11-bromoundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427348,1.1,393979,103504725,135398513,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101437628,1.1,415399,103633013,6479051,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-[3-[(E)-pent-1-enyl]phenyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103158375,1.1,429196,103504490,135398740,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
224518065,1.1,595576,103504725,135398513,NULL,21376429,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
363854830,1.1,1451464,381839976,137633694,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,isopropyl (2S)-2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-[[[(1S)-2-isopropoxy-1-methyl-2-oxo-ethyl]amino]-(1-naphthyloxy)phosphoryl]oxy-propoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101445786,1.2,392537,103651337,484044,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,67DV2Kbz9Q,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698744,1.2,296673,103525528,16756643,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-[(E)-dec-1-enyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577696,1.2,675210,160680242,136266873,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,2-amino-9-[(2S)-2-[bis(3-hexadecoxypropoxy)phosphorylmethoxy]-3-hydroxypropyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363909041,1.26,1462035,381877458,137656437,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"[2-(2,6-Diaminopyrimidin-4-yl)oxyethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100320199,1.3,216302,242582676,493475,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of OKA,"6-dodecyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100320205,1.3,216302,242582544,492112,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of OKA,"6-Hexyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656758,1.3,216461,242582544,492112,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"6-Hexyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100699930,1.3,216135,242582544,492112,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Concentration required to give 50% inhibition of replication of VZV OKA in tissue culture,"6-Hexyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437750,1.3,415400,103633013,6479051,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus YS infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-[3-[(E)-pent-1-enyl]phenyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698200,1.3,296674,103389810,493485,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800857,1.3,247653,103449585,5272218,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-(1-phenylethylcarbamothioylamino)phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356929,1.3,1727352,461541911,162662244,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-[2-(9-hydroxyfluoren-9-yl)ethynyl]-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
363899313,1.32,1457768,381857518,134382946,NULL,28682067,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,dipentyl (2S)-2-[[[(1S)-1-[(4-amino-2-oxo-pyrimidin-1-yl)methyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363909040,1.32,1462035,381846826,137638251,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"[2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800844,1.37,247653,103449213,5272240,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[3-chloro-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515694,1.4,106003,103421799,44379245,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-prop-2-ynylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
101698462,1.4,296672,103504725,135398513,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853731,1.4,258989,103504725,135398513,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321577807,1.4,675212,160680242,136266873,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,2-amino-9-[(2S)-2-[bis(3-hexadecoxypropoxy)phosphorylmethoxy]-3-hydroxypropyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577815,1.4,675212,160685557,136232616,NULL,22858222,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,"9-[[(5S)-2-(3-hexadecoxypropoxy)-2-oxo-1,4,2lambda5-dioxaphosphinan-5-yl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100709407,1.5,216467,103504725,135398513,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (YS),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853727,1.5,258989,103476694,11581278,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
346996276,1.5,1230100,103504725,135398513,NULL,26001344,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
355646631,1.5,1312420,336895699,6482434,NULL,27128178,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK-deficient Varicella-zoster virus infected in HEL cells,"9-[[(4R,6S)-2-benzyl-6-[[tert-butyl(diphenyl)silyl]oxymethyl]-5,6-dihydro-4H-cyclopenta[c]pyrazol-4-yl]methyl]purin-6-amine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363908756,1.5,1462034,103504725,135398513,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356597,1.5,1727352,461559697,162674735,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[2-oxo-6-(4-pentylphenyl)-5-[2-(4-pentylphenyl)ethynyl]furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
101800866,1.54,247653,103449182,5272241,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-3-methoxy-phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468769,1.56,1610151,103504725,135398513,NULL,31586832,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101652722,1.6,282657,103504725,135398513,NULL,15615545,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Inhibition of VZV replication in HFF cells by CPE assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101700823,1.6,297306,103526516,44427738,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"5-oct-1-ynyl-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701380,1.6,297307,103526516,44427738,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"5-oct-1-ynyl-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
342820601,1.6,1118639,242612556,90665344,NULL,24312722,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of viral plaque formation after 5 days,"1-(4-Hydroxycyclopent-2-en-1-yl)-5-thiophen-2-ylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372128323,1.6,1684817,103504725,135398513,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363693104,1.64,1407618,160686773,11779021,NULL,30098481,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation,3'-c-Ethynyladenosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
151272568,1.66,458870,103727604,54728125,NULL,20064723,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"5-[bis(4-hydroxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363909044,1.69,1462035,134458538,54768471,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"ethyl (2S)-2-[[2-(2,6-diaminopyrimidin-4-yl)oxyethoxymethyl-[[(1S)-2-ethoxy-1-methyl-2-oxo-ethyl]amino]phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100843536,1.8,216311,103184762,135972443,NULL,NULL,Confirmatory,20230629,0,0,Active,NULL,ED50,=,ChEMBL,Effective dose required to inhibit cell growth against VZV (Ellen); Value ranges from 1.8-3.5,"2-amino-9-[(1S,3S)-2-fluoro-3,4-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101498942,1.8,342120,103624537,135908419,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103157093,1.8,429197,103504725,135398513,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272365,1.8,458869,103727531,46232069,NULL,20064723,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"2-amino-4-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-7-methyl-5-oxo-4H-pyrano[3,2-c]pyran-3-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363539694,1.82,1382166,404673974,145964624,NULL,29407990,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,"methyl (2S)-2-[[[(E)-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437631,1.9,415399,103632946,6479050,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"6-[3-[(E)-but-1-enyl]phenyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698742,1.9,296673,103525552,16756867,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(5-pentylpyrimidin-2-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321548989,1.9,665760,103504725,135398513,NULL,22607883,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100334220,2,217497,103504725,135398513,NULL,10891113,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100743311,2,216318,103504725,135398513,NULL,NULL,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro antiviral activity was evaluated against VZV using viral plaque reduction assay; Value ranges from 2-4,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100743312,2,216318,103184762,135972443,NULL,NULL,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro antiviral activity was evaluated against VZV using viral plaque reduction assay; Value ranges from 2-4,"2-amino-9-[(1S,3S)-2-fluoro-3,4-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812560,2,217515,103504725,135398513,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (9021 strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812561,2,217645,103504725,135398513,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ito strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100833402,2,217678,103205238,122100,NULL,1849998,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,compound was tested for antiherpes activity against VZV(Ellen) in tissue culture by plaque reduction assay,"9-(2,3-Bis(hydroxymethyl)-1-cyclobutyl)adenine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100833404,2,217678,103504490,135398740,NULL,1849998,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,compound was tested for antiherpes activity against VZV(Ellen) in tissue culture by plaque reduction assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100833405,2,217678,103204557,14378496,NULL,1849998,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,compound was tested for antiherpes activity against VZV(Ellen) in tissue culture by plaque reduction assay,"9-[(2S,3R)-2beta,3alpha-Bis(hydroxymethyl)cyclobutyl]-9H-purin-6-amine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100843651,2,216312,103504725,135398513,NULL,NULL,Confirmatory,20230629,0,0,Active,NULL,ED50,=,ChEMBL,Effective dose required to inhibit cell growth against VZV (Ellen); Value ranges from 2-4,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698463,2,296672,103525552,16756867,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(5-pentylpyrimidin-2-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103158372,2,429196,103504725,135398513,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204380290,2,563748,124971253,483947,NULL,19770274,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellan infected in HFF after 8 to 10 days by plaque reduction assay,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-5-iodo-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321575953,2,675213,160680242,136266873,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,2-amino-9-[(2S)-2-[bis(3-hexadecoxypropoxy)phosphorylmethoxy]-3-hydroxypropyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546884,2.06,665383,160694950,60167321,NULL,22578783,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-[4-(2-pyridyl)buta-1,3-diynyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363908484,2.07,1462034,103245974,493045,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"Phosphonic acid, [[2-[(2,6-diamino-4-pyrimidinyl)oxy]ethoxy]methyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372355560,2.08,1726781,461540679,162661376,NULL,34124679,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,"[1-(2-amino-6-oxo-1H-purin-9-yl)-2-cyano-3-hydroxypropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
355646633,2.1,1312420,336895700,6482436,NULL,27128178,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK-deficient Varicella-zoster virus infected in HEL cells,"9-[[(4R,6S)-2-benzyl-6-[[tert-butyl(diphenyl)silyl]oxymethyl]-5,6-dihydro-4H-cyclopenta[c]pyrazol-4-yl]methyl]-6-chloro-purin-2-amine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546492,2.18,665383,103504725,135398513,NULL,22578783,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272363,2.2,458869,103727603,54728124,NULL,20064723,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"5-[bis(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)methyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010619,2.2,687665,163319821,71452912,NULL,23047229,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-(2-amino-6-chloro-purin-9-yl)but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363693095,2.27,1407618,404698635,145981055,NULL,30098481,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation,"(2R,3S,4R,5R)-5-(3-bromo-4-chloropyrrolo[2,3-b]pyridin-1-yl)-3-ethynyl-2-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437406,2.3,415400,103632946,6479050,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus YS infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"6-[3-[(E)-but-1-enyl]phenyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698466,2.3,296672,103504490,135398740,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372128324,2.32,1684817,461528069,162652514,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"benzyl (2S)-2-[[[(2S,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2,4,4-trifluoro-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
347062307,2.34,1251996,318393370,122192828,NULL,26443550,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"N-(4-Phenoxyphenyl)-1-[5-(4-bromophenoxy)pentyl]-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-3-acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100338612,2.4,81222,103326081,480975,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1,3-Bis[(4-chlorophenyl)methyl]benzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338615,2.4,81222,103326182,480979,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"3-Benzyl-1-[(4-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366673,2.4,217507,103370999,490384,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,1-[1-(Hydroxymethyl)-2-hydroxyethoxymethyl]-5-(1-azido-2-chloroethyl)uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366674,2.4,217507,103370992,490382,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,1-(2-Hydroxyethoxymethyl)-5-(1-azido-2-iodoethyl)uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366677,2.4,217507,103370693,490380,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,1-(2-Hydroxyethoxymethyl)-5-(1-azido-2-bromoethyl)uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366678,2.4,217507,103371190,490386,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,"1-[3,3-Bis(hydroxymethyl)propyl]-5-(1-azido-2-bromoethyl)uracil",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366680,2.4,217507,103371000,490388,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,"1-[3,3-Bis(hydroxymethyl)propyl]-5-(1-azido-2-iodoethyl)uracil",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366681,2.4,217507,103371167,490387,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,"1-[3,3-Bis(hydroxymethyl)propyl]-5-(1-azido-2-chloroethyl)uracil",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366682,2.4,217507,103370630,490381,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,1-(2-Hydroxyethoxymethyl)-5-(1-azido-2-chloroethyl)uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366683,2.4,217507,103371191,490385,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,1-[1-(Hydroxymethyl)-2-hydroxyethoxymethyl]-5-(1-azido-2-iodoethyl)uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366684,2.4,217507,103371192,490383,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,1-[1-(Hydroxymethyl)-2-hydroxyethoxymethyl]-5-(1-azido-2-bromoethyl)uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435615,2.4,216153,103504725,135398513,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK+ Varicella-Zoster Virus (VZV) OKA strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100436392,2.4,216154,103504725,135398513,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK+ Varicella-Zoster Virus (VZV)YS strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380549721,2.4,1854967,103202903,446727,NULL,35933787,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster-virus O7-1 strain infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613492,2.4,1869612,482063299,168280858,NULL,35754374,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK+ infected in HEL cells assessed as reduction in virus plaque formation,"[1-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-2-methylpropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797218,2.5,216304,242582696,5271150,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient) -Varicella-Zoster virus YS/R strain,"5-(11-bromoundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101498757,2.5,342118,103504725,135398513,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853740,2.5,258991,103476809,11517272,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"6-dodec-1-ynyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103156801,2.5,429198,103504490,135398740,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204406378,2.5,581943,124956564,11513676,NULL,18212100,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV OKA infected in human embryonic lung cells assessed as inhibition of,Alisporivir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833781,2.5,609573,134460045,53357718,NULL,21745746,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-Aminopurin-9-yl)ethoxy]-3-phenyl-propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908486,2.54,1462034,381851084,137641103,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"Sodium;2-(2,6-diaminopyrimidin-4-yl)oxyethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphinate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336994,2.6,81227,103326183,480974,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"3-[(4-Chlorophenyl)methyl]-1-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337348,2.6,81222,103326183,480974,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"3-[(4-Chlorophenyl)methyl]-1-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100364849,2.6,217508,103504725,135398513,NULL,11585457,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Inhibition of viral cytopathic effect in infected human foreskin fibroblast cell in monolayers of VZV Ellen Vero cells by 50%,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100366676,2.6,217507,103504725,135398513,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101606336,2.6,333372,103618119,11752151,NULL,15497938,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV,"[(2S,3S,4S,5S,6S)-6-[[(4S,6S,6aR,9S)-1-hydroxy-3,6,9-trimethyl-4-(2-methylprop-1-enyl)-5,6,6a,7,8,9-hexahydro-4H-phenalen-2-yl]oxy]-4,5-dihydroxy-2-methyloxan-3-yl] acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
198378435,2.6,534207,123093439,10099039,NULL,18852272,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in HFF cells by plaque reduction assay,2-(4-amino-5-fluoro-2-oxo-pyrimidin-1-yl)ethoxymethyl-(3-hexadecoxypropoxy)phosphinic Acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
151272574,2.62,458870,103727605,54728126,NULL,20064723,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"5-[bis(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853243,2.7,258989,103476700,11675456,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"3-(2-deoxy-beta-D-erythro-pentofuranosyl)-6-decyn-1-yl)furo[2,3-d]pyrimidine-2(3H)-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321546487,2.77,665383,160678786,60167178,NULL,22578783,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-[4-(4-propylphenyl)buta-1,3-diynyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100319621,2.8,216303,242582544,492112,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of YS,"6-Hexyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100589793,2.8,217498,103504490,135398740,NULL,2826784,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibition of growth of varicella zoster virus(VZV) by plaque reduction assay in vero cell line,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100656769,2.8,216462,242582544,492112,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","6-Hexyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797240,2.8,216308,242582692,5271149,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus YS strain,"5-(11-chloroundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
347061817,2.8,1251996,318393375,122192833,NULL,26443550,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[4-(4-bromophenoxy)butyl]-2,6-dioxopyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577700,2.84,675210,103504725,135398513,NULL,22858222,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372127850,2.84,1684816,461528069,162652514,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"benzyl (2S)-2-[[[(2S,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2,4,4-trifluoro-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100320198,2.9,216302,103504725,135398513,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of OKA,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345473,2.9,217662,103504725,135398513,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV OKA Plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100656762,2.9,216461,103504725,135398513,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797358,2.9,216307,103504725,135398513,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus OKA strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101498822,2.9,342119,103504725,135398513,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS infected HEL cells assessed as reduction in virus plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101736720,2.9,304882,103504725,135398513,NULL,18052321,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103135052,2.9,419666,103690743,136123436,NULL,19410465,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus in HFF assessed as inhibition of virus-induced cytopathic effect,2-[(2Z)-2-[(2-amino-6-oxo-1H-purin-9-yl)methylene]-1-(hydroxymethyl)cyclopropyl]ethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
198378436,2.9,534207,103257166,64988,NULL,18852272,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in HFF cells by plaque reduction assay,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
237833800,2.9,609512,134460045,53357718,NULL,21745746,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-Aminopurin-9-yl)ethoxy]-3-phenyl-propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321548985,2.9,665760,160673603,11779856,NULL,22607883,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-propoxypurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
367489614,2.94,1661190,442055359,156015813,NULL,32676147,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2R)-1-(4-amino-5-fluoropyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100320201,3,216302,242582559,492111,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of OKA,"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pentyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435533,3,216156,103391439,10406438,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK- Varicella-Zoster Virus (VZV) YS/R strain,"1-((1R,3S,4S,6S)-4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-5-iodo-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435534,3,220080,103391439,10406438,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against YS/R strain of thymidine kinase negative(TK-) Varicella-Zoster Virus (VZV),"1-((1R,3S,4S,6S)-4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-5-iodo-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100516385,3,106003,103421390,44379067,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-propylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100656755,3,216461,242582559,492111,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pentyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100813093,3,217650,103734857,6475209,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Oka strain),"5-(2-Bromoethenyl)-1-(tetrahydro-4,5-bis(hydroxymethyl)-3-furanyl)-2,4(1H,3H)-pyrimidinedione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446237,3,392537,103651540,3006050,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,[2-(2-Amino-6-methoxy-purin-9-ylmethylene)-1-hydroxymethyl-cyclopropyl]-methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101641196,3,279714,103511726,15986984,NULL,17130297,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellen in HFF cell by CPE assay,"3-hexadecoxypropoxy-[(Z)-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)pent-3-enyl]phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
363693101,3.06,1407618,404707600,145987204,NULL,30098481,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation,"(2R,3S,4R,5R)-5-(3,4-dichloropyrrolo[2,3-b]pyridin-1-yl)-3-ethynyl-2-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101669759,3.1,288926,103519820,16735489,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation,"[(2R,3R,4S,5R)-3,4-diacetyloxy-5-[5-(2-iodoethynyl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363543657,3.1,1383906,404692980,145977385,NULL,29529501,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV,"2-[(4,6-Diamino-1,3,5-triazin-2-yl)oxy]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709972,3.2,216468,242581927,90662954,NULL,15109620,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus (thymidine kinase deficient) TK-(07/1),"6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427347,3.2,393979,103650671,25257897,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(3,4-dichlorophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427700,3.2,393980,103650671,25257897,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(3,4-dichlorophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427967,3.2,393979,103650401,25257206,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-(3-phenylpropoxy)oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363854832,3.2,1451464,381836669,137631493,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxy-propoxy]-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101498823,3.3,342119,103624442,135908417,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700825,3.3,297306,103526525,44427747,NULL,17672445,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-5-[2-(4-pentylphenyl)ethynyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204375503,3.3,553342,103504725,135398513,NULL,21128666,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV OKA expressing thymidine kinase infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204406379,3.3,581943,103230651,5284373,NULL,18212100,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV OKA infected in human embryonic lung cells assessed as inhibition of,cyclosporin A,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854821,3.3,1451464,381871591,137654983,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl 2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropoxy]-phenoxyphosphoryl]amino]-2-methylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363605566,3.39,1394845,103202903,446727,NULL,29550734,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709406,3.4,216467,242581924,90662952,NULL,15109620,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (YS),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-octylphenyl)thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963457,3.4,1782698,103202903,446727,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus assessed as inhibition of viral replication,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515685,3.5,106003,103420797,44378805,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-iodopyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
101853747,3.5,258991,103476640,11568210,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-dodec-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393110,3.5,1572733,103567639,135398748,NULL,30738653,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,Penciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955198,3.55,1498126,103504725,135398513,NULL,29880251,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800843,3.56,247653,103449136,5272229,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[1-(benzothiophen-3-yl)ethylcarbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337003,3.6,81227,103326081,480975,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1,3-Bis[(4-chlorophenyl)methyl]benzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797355,3.6,216307,242582692,5271149,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus OKA strain,"5-(11-chloroundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427306,3.6,393983,103650150,25258113,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363797284,3.6,1427826,381837836,137632270,NULL,27750154,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(2-Benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]-3-[(4-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613499,3.6,1869613,482063299,168280858,NULL,35754374,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK- infected in HEL cells assessed as reduction in virus plaque formation,"[1-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-2-methylpropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833094,3.64,609512,103504725,135398513,NULL,21745746,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673699,3.7,216319,103339109,3010082,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"4-Thiazolecarboxamide, N-[4-[[[[(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]amino]thioxomethyl]amino]phenyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673700,3.7,216319,103339118,3010076,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"N-[4-[[(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]carbamothioylamino]phenyl]thiadiazole-4-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673701,3.7,216319,103339134,3010081,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"4-Thiazolecarboxamide, N-[4-[[[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]amino]thioxomethyl]amino]phenyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673702,3.7,216319,103339095,3010086,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"4-Thiazolecarboxamide, N-[5-[[[[(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]amino]thioxomethyl]amino]-2-pyridinyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673703,3.7,216319,103339265,18463472,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"N-[4-[2-[3,5-bis(trifluoromethyl)phenyl]propan-2-ylcarbamothioylamino]phenyl]thiadiazole-4-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673704,3.7,216319,103339496,3010075,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"N-[4-[1-[3,5-bis(trifluoromethyl)phenyl]ethylcarbamothioylamino]phenyl]thiadiazole-4-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673706,3.7,216319,103339059,3010087,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"1,2,3-Thiadiazole-4-carboxamide, N-[5-[[[[(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]amino]thioxomethyl]amino]-2-pyridinyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673707,3.7,216319,103339108,3010083,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"4-Thiazolecarboxamide, N-[4-[[[[1-[3,5-bis(trifluoromethyl)phenyl]propyl]amino]thioxomethyl]amino]phenyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673709,3.7,216319,103339121,3010084,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"1,2,3-Thiadiazole-4-carboxamide, N-[5-[[[[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]thioxomethyl]amino]-2-pyridinyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673711,3.7,216319,103339273,3010079,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"1,2,3-Thiadiazole-4-carboxamide, N-[4-[[[[[3,5-bis(trifluoromethyl)phenyl]phenylmethyl]amino]thioxomethyl]amino]phenyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673712,3.7,216319,103339039,3010085,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"N-[5-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]carbamothioylamino]-2-pyridyl]thiazole-4-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673713,3.7,216319,103339171,3010078,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"N-[4-[1-[3,5-bis(trifluoromethyl)phenyl]butylcarbamothioylamino]phenyl]thiadiazole-4-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673714,3.7,216319,103339148,3010077,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"N-[4-[1-[3,5-bis(trifluoromethyl)phenyl]propylcarbamothioylamino]phenyl]thiadiazole-4-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101641197,3.7,279714,103511725,15986891,NULL,17130297,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellen in HFF cell by CPE assay,[(Z)-5-(4-amino-2-oxo-pyrimidin-1-yl)pent-3-enyl]-(3-hexadecoxypropoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101853744,3.7,258991,103476656,11516993,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"6-dec-1-ynyl-3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363693096,3.74,1407618,404712585,145990374,NULL,30098481,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation,"(2R,3S,4R,5R)-5-(4-amino-5-chloropyrrolo[2,3-d]pyrimidin-7-yl)-3-ethyl-2-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
367490274,3.79,1661189,442056608,134382943,NULL,32676147,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,[(2R)-1-(4-aminopyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100336943,3.8,81226,103326081,480975,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1,3-Bis[(4-chlorophenyl)methyl]benzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647525,4,216463,103504725,135398513,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435529,4,216156,103391811,11438492,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration against TK- Varicella-Zoster Virus (VZV) YS/R strain,"5-Bromo-1-((1R,3S,4S,6S)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100438576,4,220080,103391811,11438492,NULL,14584954,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against YS/R strain of thymidine kinase negative(TK-) Varicella-Zoster Virus (VZV),"5-Bromo-1-((1R,3S,4S,6S)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656770,4,216462,242582546,492109,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oct-7-ynyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812646,4,217644,103504725,135398513,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ellen strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812650,4,217644,103734861,470131,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ellen strain),"[(2s,3r,4s)-4-(6-Aminopurin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-yl]methanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812805,4,217658,103504725,135398513,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (ppIIa strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100813092,4,217650,103504725,135398513,NULL,8387600,Confirmatory,20230629,0,0,Active,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Oka strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698733,4,296673,103504725,135398513,NULL,17622128,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700819,4,297306,103526524,44427746,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"5-[2-(4-butylphenyl)ethynyl]-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700824,4,297306,103526523,44427745,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"5-[2-(4-methylphenyl)ethynyl]-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700834,4,297306,103526515,44427737,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"5-hept-1-ynyl-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701377,4,297307,103526515,44427737,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"5-hept-1-ynyl-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701381,4,297307,103526523,44427745,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"5-[2-(4-methylphenyl)ethynyl]-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701382,4,297307,103526525,44427747,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-5-[2-(4-pentylphenyl)ethynyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701389,4,297307,103526526,44427748,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"6-butyl-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701390,4,297307,103526524,44427746,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"5-[2-(4-butylphenyl)ethynyl]-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701420,4,297306,103526526,44427748,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"6-butyl-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321522385,4,658756,160694361,60145348,NULL,22459876,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VSV 07-1 infected in HEL cells assessed as reduction of virus plaque formation after 4 days,Isopropyl 2-[3-[(7-chloro-4-quinolyl)amino]propylamino]-4-methyl-6-(3-nitrophenyl)pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321522386,4,658756,160699726,60145502,NULL,22459876,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VSV 07-1 infected in HEL cells assessed as reduction of virus plaque formation after 4 days,Isopropyl 2-[4-[(7-chloro-4-quinolyl)amino]butylamino]-4-methyl-6-(2-nitrophenyl)pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546433,4,665385,160668110,60167325,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-[4-[4-(trifluoromethoxy)phenyl]buta-1,3-diynyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339886320,4,768205,174508404,72204121,NULL,23811093,Confirmatory,20180927,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK-positive Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of plaque formation,Ethyl 2-[3-[(7-chloro-4-quinolyl)amino]propoxy]-4-methyl-6-phenyl-pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339886321,4,768205,174487796,72204119,NULL,23811093,Confirmatory,20180927,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK-positive Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of plaque formation,Isopropyl 2-[4-[(7-chloro-4-quinolyl)amino]butylamino]-4-methyl-6-phenyl-pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339886322,4,768205,174487797,72204307,NULL,23811093,Confirmatory,20180927,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK-positive Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of plaque formation,Ethyl 2-[4-[(7-chloro-4-quinolyl)amino]butylamino]-4-(4-fluorophenyl)-6-methyl-pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339886324,4,768205,174518560,72204118,NULL,23811093,Confirmatory,20180927,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK-positive Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of plaque formation,Methyl 2-[3-[(7-chloro-4-quinolyl)amino]propylamino]-4-methyl-6-phenyl-pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339886325,4,768205,174523789,72204306,NULL,23811093,Confirmatory,20180927,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK-positive Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of plaque formation,Ethyl 4-(4-chlorophenyl)-2-[4-[(7-chloro-4-quinolyl)amino]butylamino]-6-methyl-pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339886327,4,768205,174513517,72204120,NULL,23811093,Confirmatory,20180927,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK-positive Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of plaque formation,Ethyl 2-[4-[(7-chloro-4-quinolyl)amino]butylamino]-4-methyl-6-(2-nitrophenyl)pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340060015,4,766703,174498186,136244580,NULL,23911856,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,2-amino-5-bromo-4-pentyl-1H-pyrimidin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061807,4,1251996,318393386,122192844,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[[4-(4-bromophenoxy)phenyl]methyl]-2,6-dioxopyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061815,4,1251996,318393379,122192837,NULL,26443550,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"N-(4-benzylphenyl)-2-[3-[5-(4-bromophenoxy)pentyl]-2,6-dioxopyrimidin-1-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363797285,4,1427826,381837836,137632270,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(2-Benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]-3-[(4-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810019,4,1433151,103169732,2719,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,Chloroquine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810183,4,1433151,381866705,137651709,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,"4-[4-[(7-Chloroquinolin-4-yl)amino]butylamino]-2-methylsulfanyl-6-(3,4,5-trimethoxyphenyl)pyrimidine-5-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810186,4,1433151,381837549,137632078,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,4-[3-[(7-Chloroquinolin-4-yl)amino]propylamino]-2-methylsulfanyl-6-phenylpyrimidine-5-carbonitrile,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810187,4,1433151,381852491,137642067,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,4-[4-[(7-Chloroquinolin-4-yl)amino]butylamino]-2-methylsulfanyl-6-phenylpyrimidine-5-carbonitrile,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810189,4,1433151,381844417,137636639,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,4-[4-[(7-Chloroquinolin-4-yl)amino]butylamino]-2-morpholin-4-yl-6-phenylpyrimidine-5-carbonitrile,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810191,4,1433151,381857711,137645608,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,4-[4-[(7-Chloroquinolin-4-yl)amino]butylamino]-6-(4-methylphenyl)-2-methylsulfanylpyrimidine-5-carbonitrile,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810192,4,1433151,381840421,137633976,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,4-[4-[(7-Chloroquinolin-4-yl)amino]butylamino]-6-(4-methoxyphenyl)-2-methylsulfanylpyrimidine-5-carbonitrile,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908759,4,1462034,381852005,137641728,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"4-Amino-1-[2-[bis(2-octadecoxyethoxy)phosphorylmethoxy]ethyl]-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468652,4,1610152,242651615,90683381,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(4-methylphenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356600,4,1727352,461520984,162647575,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[6-(4-methylphenyl)-2-oxo-5-[2-(4-pentylphenyl)ethynyl]furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
372357466,4,1727353,461520984,162647575,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[6-(4-methylphenyl)-2-oxo-5-[2-(4-pentylphenyl)ethynyl]furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
380625529,4,1872793,482075728,168289885,NULL,35305462,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV strain Oka bearing wild type thymidine kinase assessed as reduction in virus induced cytopathogenicity,"[(2R,3S,5R)-3-acetyloxy-5-[5-[(E)-1-chloro-2-(4-methylphenyl)sulfonylethenyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356603,4.02,1727352,461521354,162647843,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(4-hydroxybut-1-ynyl)-2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
100336936,4.09,81226,103504725,135398513,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515702,4.1,106003,103420809,44378813,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-propan-2-ylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
363854552,4.1,1451464,381887375,137661965,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-[naphthalen-1-yloxy-[[(2S)-1-oxo-1-phenylmethoxypropan-2-yl]amino]phosphoryl]oxypropoxy]-naphthalen-1-yloxyphosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372355681,4.17,1726781,103504725,135398513,NULL,34124679,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
380613434,4.17,1869619,103504725,135398513,NULL,35754374,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103134864,4.4,419667,103504725,135398513,NULL,19410465,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus in HFF by plaque reduction assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338609,4.5,81222,103331566,480977,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1-[(3,4-Dichlorophenyl)methyl]-3-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100366679,4.5,217507,242581942,488247,NULL,11708924,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus,5-(1-Azido-2-chloroethyl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100413888,4.5,147626,103245974,493045,NULL,14584956,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"Phosphonic acid, [[2-[(2,6-diamino-4-pyrimidinyl)oxy]ethoxy]methyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800860,4.51,247653,103449105,5272230,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[1-(2-naphthyl)ethylcarbamothioylamino]phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338547,4.53,81227,103504725,135398513,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100319622,4.6,216303,242582559,492111,NULL,10579812,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV strains of YS,"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pentyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656964,4.6,216462,242582559,492111,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pentyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853251,4.6,258989,103476640,11568210,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-dodec-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853328,4.6,258990,103476640,11568210,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-dodec-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321577505,4.6,675212,160680241,136232614,NULL,22858222,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,9-[(2S)-2-[bis(3-hexadecoxypropoxy)phosphorylmethoxy]-3-hydroxypropyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061816,4.6,1251996,318393374,122192832,NULL,26443550,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[3-(4-bromophenoxy)propyl]-2,6-dioxopyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
354669571,4.68,1291302,336875858,127032156,NULL,26965865,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07-1,"(2R,3S,4R,5R)-5-[2-chloro-6-[(3-chlorophenyl)methylamino]purin-9-yl]-3-ethynyl-2-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
224518480,4.7,595582,131276774,136130200,NULL,21376429,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in human HFF cells assessed as inhibition of viral replication after 1 hr by plaque reduction assay,"trisodium;bis[[(E)-[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenylidene]amino]azanidylcarbothioyl]azanide;hydrate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
237833517,4.7,609572,134460045,53357718,NULL,21745746,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-Aminopurin-9-yl)ethoxy]-3-phenyl-propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363909038,4.72,1462035,103245974,493045,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"Phosphonic acid, [[2-[(2,6-diamino-4-pyrimidinyl)oxy]ethoxy]methyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237830256,4.9,607913,103504725,135398513,NULL,21696963,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase infected in human HEL cells assessed as reduction in the virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99290485,5,3058,103391381,9906078,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),"5-(2-Bromo-vinyl)-1-((1S,2S,4S,5R)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99290486,5,3058,103391439,10406438,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),"1-((1R,3S,4S,6S)-4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-5-iodo-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99667385,5,218491,242582683,513143,NULL,14643358,Confirmatory,20181001,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity evaluated against thymidine kinase competent(TK+) Varicella Zoster virus (07),"6-(9-Cyclopentylmethoxy-nonyl)-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99667386,5,218491,242582685,513141,NULL,14643358,Confirmatory,20181001,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity evaluated against thymidine kinase competent(TK+) Varicella Zoster virus (07),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-(9-pentyloxy-nonyl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99667387,5,218491,242582684,513140,NULL,14643358,Confirmatory,20181001,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity evaluated against thymidine kinase competent(TK+) Varicella Zoster virus (07),"6-(9-butoxynonyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99667523,5,218492,242582682,513142,NULL,14643358,Confirmatory,20181001,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity evaluated against thymidine kinase deficient(TK-) Varicella Zoster virus (YS),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(9-isopentyloxynonyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99667524,5,218492,242582683,513143,NULL,14643358,Confirmatory,20181001,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity evaluated against thymidine kinase deficient(TK-) Varicella Zoster virus (YS),"6-(9-Cyclopentylmethoxy-nonyl)-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99667525,5,218492,242582685,513141,NULL,14643358,Confirmatory,20181001,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity evaluated against thymidine kinase deficient(TK-) Varicella Zoster virus (YS),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-(9-pentyloxy-nonyl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99667527,5,218492,242582684,513140,NULL,14643358,Confirmatory,20181001,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity evaluated against thymidine kinase deficient(TK-) Varicella Zoster virus (YS),"6-(9-butoxynonyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99668559,5,218491,242582682,513142,NULL,14643358,Confirmatory,20181001,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity evaluated against thymidine kinase competent(TK+) Varicella Zoster virus (07),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(9-isopentyloxynonyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673705,5,216319,103315577,3003383,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"N-[4-[[3,5-bis(trifluoromethyl)phenyl]carbamothioylamino]phenyl]thiadiazole-4-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673708,5,216319,103315641,3003386,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"1-[3,5-Bis(trifluoromethyl)phenyl]-3-[4-(4-thiazolylcarbonylamino)phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99673710,5,216319,103339425,3010074,NULL,15177441,Confirmatory,20181001,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus was determined,"N-[4-[[3,5-bis(trifluoromethyl)phenyl]methylcarbamothioylamino]phenyl]thiadiazole-4-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100032713,5,151172,103391439,10406438,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,MCC,>,ChEMBL,Minimum cytotoxic concentration that causes alterations of VZV infected Osteosarcoma cell morphology,"1-((1R,3S,4S,6S)-4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-5-iodo-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100032714,5,151172,103391381,9906078,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,MCC,>,ChEMBL,Minimum cytotoxic concentration that causes alterations of VZV infected Osteosarcoma cell morphology,"5-(2-Bromo-vinyl)-1-((1S,2S,4S,5R)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100155432,5,217806,103389906,493487,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-heptylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155442,5,217665,103389906,493487,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-heptylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155580,5,217806,103389785,493486,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-hexylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155585,5,217806,103389810,493485,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100156092,5,217665,103389785,493486,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-hexylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100338621,5,81222,103326114,480981,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1,3-Bis[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345430,5,217512,103389906,493487,NULL,11150169,Confirmatory,20220830,0,0,Active,NULL,MCC,=,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","6-(4-heptylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435531,5,216156,103391381,9906078,NULL,14584954,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration against TK- Varicella-Zoster Virus (VZV) YS/R strain,"5-(2-Bromo-vinyl)-1-((1S,2S,4S,5R)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100436299,5,216155,103391381,9906078,NULL,14584954,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration against TK- Varicella-Zoster Virus (VZV) 07/1 strain,"5-(2-Bromo-vinyl)-1-((1S,2S,4S,5R)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100436301,5,216155,103391439,10406438,NULL,14584954,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration against TK- Varicella-Zoster Virus (VZV) 07/1 strain,"1-((1R,3S,4S,6S)-4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-5-iodo-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100438575,5,220080,103391381,9906078,NULL,14584954,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against YS/R strain of thymidine kinase negative(TK-) Varicella-Zoster Virus (VZV),"5-(2-Bromo-vinyl)-1-((1S,2S,4S,5R)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656759,5,216461,242582546,492109,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oct-7-ynyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100708043,5,216468,103389810,493485,NULL,15109620,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus (thymidine kinase deficient) TK-(07/1),Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709970,5,216468,242581925,493490,NULL,15109620,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus (thymidine kinase deficient) TK-(07/1),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101081583,5,304884,103389810,493485,NULL,18052321,Confirmatory,20181022,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK- VZV 07 in HEL cells after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101081887,5,304885,103389810,493485,NULL,18052321,Confirmatory,20181022,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK- VZV YS in HEL cells after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427679,5,393983,103650669,25257896,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(2-chlorophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427711,5,393980,103650072,25257676,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5,5-Dibenzyl-4-benzyloxy-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427714,5,393979,103650072,25257676,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5,5-Dibenzyl-4-benzyloxy-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101445794,5,392537,103455446,5270689,NULL,19112024,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"2-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-6-methyl-1,2,4-triazine-3,5-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853736,5,258991,103389810,493485,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237836767,5,611619,103169255,60172,NULL,21565516,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,Adefovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363854557,5,1451464,381866079,137651276,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,cyclohexyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-[[[[(1S)-2-(cyclohexoxy)-1-methyl-2-oxo-ethyl]amino]-(1-naphthyloxy)phosphoryl]oxymethyl]butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393300,5,1572733,103504725,135398513,NULL,30738653,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797587,5.1,1427826,381862664,137648967,NULL,27750154,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(2-Benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]-3-[(2-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101499475,5.2,342118,103624539,135926125,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxyphosphoryl]amino]-3-phenylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363899314,5.21,1457768,103202903,446727,NULL,28682067,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
151272565,5.3,458870,103727531,46232069,NULL,20064723,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"2-amino-4-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-7-methyl-5-oxo-4H-pyrano[3,2-c]pyran-3-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340060016,5.3,766703,174488028,136219328,NULL,23911856,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,"2-amino-5-bromo-4-[(E)-2-(2,4,6-trimethylphenyl)ethenyl]-1H-pyrimidin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100515593,5.5,106003,103421035,44378905,NULL,8576922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-ethynyl-1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
101427325,5.6,393980,103650150,25258113,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427723,5.7,393979,103650400,25257680,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-phenethyloxy-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427961,5.7,393980,103650585,25257894,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(4-chlorophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853729,5.7,258989,103476809,11517272,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"6-dodec-1-ynyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853734,5.7,258991,103476701,11495737,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-dodec-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204387922,5.7,569235,124959276,51041062,NULL,21232828,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[1-(4-phenoxyphenyl)triazol-4-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363626307,5.73,1394845,404700964,145982558,NULL,29550734,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,"[(1S,2S,4S)-2-hydroxy-4-(5-methyl-2,4-dioxopyrimidin-1-yl)cyclopentyl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103157090,5.8,429197,103690166,44140464,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"3-(2-hydroxyethoxymethyl)-6-thiophen-2-yl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427953,5.9,393980,103650588,25257439,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-(p-tolylmethoxy)oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101921735,5.9,273053,103500441,16072395,NULL,17004726,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Inhibition of VZV replication in HFF cells by plaque reduction assay,"[(1R,2E,3S)-2-[(6-aminopurin-9-yl)methylene]-3-fluoro-cyclopropyl]methanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
363909047,5.91,1462035,381851084,137641103,NULL,28757102,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"Sodium;2-(2,6-diaminopyrimidin-4-yl)oxyethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphinate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337350,6,81222,103326489,480971,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1,3-Dibenzyl-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100699718,6,216135,242582681,511675,NULL,14643358,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Concentration required to give 50% inhibition of replication of VZV OKA in tissue culture,"6-(2-heptoxyethyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797239,6,216308,242582693,5271151,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus YS strain,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(11-iodoundec-1-ynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853316,6,258990,103476809,11517272,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"6-dodec-1-ynyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363539700,6,1382166,404677276,145966797,NULL,29407990,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,"[[(E)-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(3-pentadecoxypropoxy)phosphoryl]oxymethyl propan-2-yl carbonate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372127843,6.04,1684816,103202903,446727,NULL,33479570,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363494226,6.08,1361087,404666873,145959823,NULL,29945100,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,"5-acetyl-1,3-bis[(1-benzyltriazol-4-yl)methyl]-6-methyl-4-phenyl-4H-pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101499182,6.1,342121,103624538,135908405,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R infected HEL cells assessed as reduction in virus plaque formation after 5 days,methyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387927,6.1,569235,124975015,51040642,NULL,21232828,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"5-[1-(2,6-difluorophenyl)triazol-4-yl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427974,6.2,393979,103650402,25257681,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-(4-phenylbutoxy)oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853748,6.2,258991,103476760,11647092,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"6-dec-1-ynyl-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854551,6.2,1451464,381873544,137656288,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,"2,2-dimethylpropyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321546490,6.24,665383,160689502,60167463,NULL,22578783,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(5-hydroxypenta-1,3-diynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427957,6.3,393980,103650586,25257438,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(4-bromophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427344,6.4,393979,103650589,25257440,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(4-tert-butylphenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427728,6.4,393979,103650150,25258113,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427970,6.4,393979,103650588,25257439,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-(p-tolylmethoxy)oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347072630,6.4,1256245,103504725,135398513,NULL,26460883,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen VR-1367 infected in African green monkey Vero cells after 3 days by MTT assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
321546886,6.44,665383,160689501,60167179,NULL,22578783,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-[4-(4-hexylphenyl)buta-1,3-diynyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427327,6.5,393980,103650401,25257206,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-(3-phenylpropoxy)oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101854166,6.5,258991,103476700,11675456,NULL,16392824,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"3-(2-deoxy-beta-D-erythro-pentofuranosyl)-6-decyn-1-yl)furo[2,3-d]pyrimidine-2(3H)-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101498827,6.6,342119,103624539,135926125,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxyphosphoryl]amino]-3-phenylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363642852,6.66,1402825,103202903,446727,NULL,29268134,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK-defecient VZV 07-1 infected in HEL cells assessed as reduction in plaque formation after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427952,6.7,393980,103650511,25257893,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-[[4-(trifluoromethyl)phenyl]methoxy]oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427958,6.7,393980,103650670,25257441,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(3-chlorophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
106033031,6.7,445339,103708900,45487935,NULL,19833513,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected human HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490277,6.73,1661189,442055359,156015813,NULL,32676147,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2R)-1-(4-amino-5-fluoropyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372356602,6.84,1727352,461551395,162668872,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[6-(4-methylphenyl)-5-[2-(4-methylphenyl)ethynyl]-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
101498944,6.9,342120,103624442,135908417,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363642854,6.91,1402825,242628768,20841912,NULL,29268134,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK-defecient VZV 07-1 infected in HEL cells assessed as reduction in plaque formation after 5 days,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-4-oxidopyrazin-4-ium-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427950,7,393980,103650302,25257679,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-(cyclohexylmethoxy)-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490056,7.06,1661189,103504725,135398513,NULL,32676147,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
380613494,7.1,1869612,103504725,135398513,NULL,35754374,Confirmatory,20230629,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK+ infected in HEL cells assessed as reduction in virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101499474,7.2,342118,103624442,135908417,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101641199,7.2,279714,103511703,135541417,NULL,17130297,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellen in HFF cell by CPE assay,[(Z)-5-(2-amino-6-oxo-1H-purin-9-yl)pent-3-enyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
363854825,7.2,1451464,381850452,137640683,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl 2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-[[(2-methyl-1-oxo-1-phenylmethoxypropan-2-yl)amino]-naphthalen-1-yloxyphosphoryl]oxypropoxy]-naphthalen-1-yloxyphosphoryl]amino]-2-methylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356933,7.23,1727352,461556768,162672687,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(6-carbazol-9-ylhex-1-ynyl)-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
100338620,7.3,81222,103166684,401639,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1-Benzyl-3-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427710,7.3,393980,103650589,25257440,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(4-tert-butylphenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427977,7.3,393979,103650670,25257441,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(3-chlorophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700835,7.3,297306,103526522,44427744,NULL,17672445,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"5-[2-(4-bromophenyl)ethynyl]-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
366469846,7.31,1610152,440158367,155541068,NULL,31586832,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(2R)-2-[(1S)-2-(4-butyltriazol-1-yl)-1-hydroxyethyl]-3,4-bis(phenylmethoxy)-2H-furan-5-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338545,7.4,81227,103326489,480971,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1,3-Dibenzyl-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678590,7.4,291030,103520475,16732578,NULL,17539622,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"[1-(2,6-Dimethoxypyrimidin-4-yl)-3-fluoro-2-methylpropan-2-yl] acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321548856,7.4,665760,103517682,65275,NULL,22607883,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,2-Amino-6-methoxypurine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101427960,7.5,393980,103650400,25257680,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-phenethyloxy-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372356934,7.56,1727352,461559729,162674763,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(3-hydroxyprop-1-ynyl)-2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
101427724,7.6,393979,103650585,25257894,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(4-chlorophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101498759,7.6,342118,103624538,135908405,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation after 5 days,methyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237836766,7.6,611619,134461775,53249144,NULL,21565516,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,"2-(6-Aminopurin-9-yl)ethoxymethyl-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061058,7.6,1252401,318393997,122193267,NULL,26291038,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 expressed in HEL cells assessed as reduction in plaque formation incubated for 5 days,"3,5-bis[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrrolo[3,2-d]pyrimidin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363797586,7.6,1427826,381847499,137638691,NULL,27750154,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(2-Benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]-3-(4-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356932,7.61,1727352,461514752,162643167,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-[2-(4-methylphenyl)ethynyl]-2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
372357468,7.61,1727353,461541911,162662244,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-[2-(9-hydroxyfluoren-9-yl)ethynyl]-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
101427969,7.7,393979,103650511,25257893,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-[[4-(trifluoromethyl)phenyl]methoxy]oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061812,7.7,1251996,318393387,122192845,NULL,26443550,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[5-(4-bromophenoxy)pentyl]-2,6-dioxopyrimidin-1-yl]-N-methyl-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363855301,7.7,1451464,381851905,137641663,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,"2,2-dimethylpropyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-[[[[(1S)-2-(2,2-dimethylpropoxy)-1-methyl-2-oxo-ethyl]amino]-(1-naphthyloxy)phosphoryl]oxymethyl]butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468656,7.76,1610152,440145667,155534038,NULL,31586832,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(2R)-2-[(1S)-2-(4-decyltriazol-1-yl)-1-hydroxyethyl]-3,4-bis(phenylmethoxy)-2H-furan-5-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363494224,7.85,1361087,404655203,145951735,NULL,29945100,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,"5-acetyl-6-methyl-1,3-bis[[1-[(4-nitrophenyl)methyl]triazol-4-yl]methyl]-4-phenyl-4H-pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103158371,7.9,429196,103690166,44140464,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-(2-hydroxyethoxymethyl)-6-thiophen-2-yl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
366391637,7.9,1572734,103202903,446727,NULL,30738653,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338619,8,81222,103326271,480973,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1-[(2-Chlorophenyl)methyl]-3-(benzyloxymethyl)-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656763,8,216461,242582561,492107,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pent-4-ynyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101495261,8.1,340472,103504725,135398513,NULL,18595689,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster by plaque reduction assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678407,8.1,291029,103520475,16732578,NULL,17539622,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"[1-(2,6-Dimethoxypyrimidin-4-yl)-3-fluoro-2-methylpropan-2-yl] acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101710810,8.1,299444,103504725,135398513,NULL,17513108,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV in human foreskin fibroblast assessed as inhibition of virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101746910,8.1,307432,103504725,135398513,NULL,17434304,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster in HFF cells by plaque reduction assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
155735266,8.1,464100,103504725,135398513,NULL,20167488,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus infected in HFF cells by plaque reduction assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
155763601,8.1,481587,103504725,135398513,NULL,20403696,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Antiviral activity against VZV Webster infected in HFF cells assessed as reduction in plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
363855299,8.1,1451464,381837124,137631795,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,propyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-[[[[(1S)-1-methyl-2-oxo-2-propoxy-ethyl]amino]-(1-naphthyloxy)phosphoryl]oxymethyl]butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336931,8.2,81226,103326183,480974,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"3-[(4-Chlorophenyl)methyl]-1-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899310,8.24,1457768,381850674,134382869,NULL,28682067,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,dipentyl (2S)-2-[[[(1R)-1-[(6-aminopurin-9-yl)methyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363693098,8.26,1407618,404706338,145986362,NULL,30098481,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation,"(2R,3S,4R,5R)-5-(4-chloro-3-iodopyrrolo[2,3-b]pyridin-1-yl)-3-ethynyl-2-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100615083,8.3,216159,103408858,135480766,NULL,1846922,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,Compound was tested for its antiviral activity against VZV (Ellen) using plaque reduction assay.,2-Amino-9-[(S)-3-hydroxy-1-hydroxymethylpropyloxy]-9H-purin-6(1H)-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427976,8.3,393979,103650586,25257438,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(4-bromophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363796790,8.3,1427826,381858891,137646406,NULL,27750154,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3R,5S)-2-benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl]methyl]-3-(4-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855015,8.3,1451464,381858446,137646105,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl 2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-[[(2-methyl-1-oxo-1-phenylmethoxypropan-2-yl)amino]-phenoxyphosphoryl]oxypropoxy]-phenoxyphosphoryl]amino]-2-methylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363605568,8.38,1394845,404702678,135516822,NULL,29550734,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,[[[4alpha-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-2beta-hydroxycyclopentan-1alpha-yl]oxy]methyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100428690,8.4,81923,103401418,5271344,NULL,14736238,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"(E)-2,6-Diamino-9-{[2,2-bis(hydroxymethyl)cyclopropylidene]methyl}purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101427699,8.4,393980,103650403,25257207,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-(6-phenylhexoxy)oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101437979,8.4,415399,103633012,44582864,NULL,19328697,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-[(E)-pent-1-enyl]phenyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101498939,8.4,342120,103624539,135926125,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxyphosphoryl]amino]-3-phenylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101582113,8.5,324740,103504725,135398513,NULL,17325220,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus Ellen in HFF cells after 10 days by plaque reduction assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101669715,8.5,288925,103519820,16735489,NULL,17518459,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"[(2R,3R,4S,5R)-3,4-diacetyloxy-5-[5-(2-iodoethynyl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363797288,8.5,1427826,381838694,137632844,NULL,27750154,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3R,5S)-2-benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl]methyl]-3-(3-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797585,8.5,1427826,381887882,137662294,NULL,27750154,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(2-Benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]-3-(3-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427343,8.6,393979,103650512,25257437,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-[(4-fluorophenyl)methoxy]oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427709,8.6,393980,103650512,25257437,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-[(4-fluorophenyl)methoxy]oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427346,8.7,393979,103650403,25257207,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-(6-phenylhexoxy)oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427725,8.7,393979,103650669,25257896,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(2-chlorophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101616257,8.7,407962,103620581,44576695,NULL,18424155,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus assessed as inhibition of virus-induced cytopathogenicity in HEL cells,"2-[(Z)-4-[2,4-dioxo-5-[2-(4-pentylphenyl)ethynyl]pyrimidin-1-yl]but-2-enyl]isoindole-1,3-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103156782,8.7,429197,103693769,44140465,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"6-(5-bromothiophen-2-yl)-3-(2-hydroxyethoxymethyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
373963281,8.7,1782672,469828381,164628867,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-10-methyl-8-octoxypyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678406,8.8,291029,103520493,16732576,NULL,17539622,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"5-Bromo-6-dibromomethyl-2,4-dimethoxypyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100676470,8.81,216459,103504725,135398513,NULL,11814776,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus (VZV) was determined,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363605567,8.83,1394845,404705385,145985709,NULL,29550734,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,"[(1S,3R,4R)-3-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxycyclopentyl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363493761,8.87,1361087,404663133,145957212,NULL,29945100,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,"5-acetyl-1,3-bis[(1-benzyltriazol-4-yl)methyl]-4-(2,5-dimethoxyphenyl)-6-methyl-4H-pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321524633,8.9,659145,160677984,70685525,NULL,22464686,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation after 5 days relative to control,"1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-1H-imidazo[4',5':4,5]thieno[3,2-d]pyrimidin-5-amine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372356612,8.94,1727353,461559697,162674735,NULL,33039724,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[2-oxo-6-(4-pentylphenyl)-5-[2-(4-pentylphenyl)ethynyl]furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
363854824,9.1,1451464,381847512,137638700,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,propyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321546494,9.13,665383,160673444,60167326,NULL,22578783,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-[4-(4-fluoro-3-methyl-phenyl)buta-1,3-diynyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101582112,9.2,324740,103499483,44416677,NULL,17325220,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus Ellen in HFF cells after 10 days by plaque reduction assay,"2-amino-4-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-7,7-dimethyl-5-oxo-6,8-dihydro-4H-chromene-3-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101428086,9.3,393984,103650512,25257437,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YSR infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-[(4-fluorophenyl)methoxy]oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701378,9.3,297307,103526522,44427744,NULL,17672445,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"5-[2-(4-bromophenyl)ethynyl]-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363855024,9.4,1451464,381868566,137652939,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,cyclohexyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800850,9.48,247653,103449068,5272231,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[1-(1H-indol-3-yl)ethylcarbamothioylamino]phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99402342,9.5,3059,103245974,493045,NULL,14584956,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"Phosphonic acid, [[2-[(2,6-diamino-4-pyrimidinyl)oxy]ethoxy]methyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546442,9.5,665385,160689501,60167179,NULL,22578783,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-[4-(4-hexylphenyl)buta-1,3-diynyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363854553,9.5,1451464,381887416,137661992,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,"2,2-dimethylbutyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-[[[[(1S)-2-(2,2-dimethylbutoxy)-1-methyl-2-oxo-ethyl]amino]-(1-naphthyloxy)phosphoryl]oxymethyl]butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797217,9.6,216304,242582692,5271149,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient) -Varicella-Zoster virus YS/R strain,"5-(11-chloroundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393301,9.6,1572733,440120183,155517451,NULL,30738653,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-(4-hydroxyphenyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800623,9.7,247653,103449638,5272219,NULL,15261261,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[(1-methyl-1-phenyl-ethyl)carbamothioylamino]phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855021,9.7,1451464,381864046,137649891,NULL,28829913,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,"2,2-dimethylbutyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833091,9.9,609512,134440853,56663162,NULL,21745746,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,"2-[2-(2,4-Dioxopyrimidin-1-yl)ethoxy]propylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337347,10,81221,103326183,480974,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"3-[(4-Chlorophenyl)methyl]-1-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338611,10,81222,103325931,480970,NULL,10966745,Confirmatory,20220830,0,0,Active,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1,3-Di(benzyloxymethyl)-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100377626,10,217493,103731606,46875044,NULL,12036374,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,50 % effective concentration against Varicella-Zoster virus (VZV) was determined.,"ethyl (2Z,4E)-5-[(2R,3S,4R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]penta-2,4-dienoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100445938,10,217516,103197629,135422928,NULL,8496903,Confirmatory,20220830,0,0,Active,NULL,IC50,<,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain,(E)-9-[(4-Phosphonobut-3-enyl)oxy]guanine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515686,10,106003,103421797,44379243,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[4-Hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-(methoxymethyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100515691,10,106003,103420404,44378614,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-[(E)-2-chloroethenyl]-1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100515693,10,106003,103421798,44379244,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-(2-methoxyethyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100515703,10,106003,103421763,44379223,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-Acetyl-1-[4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100516381,10,106003,103421010,44378895,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-(2,2-difluoroethenyl)-1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100656766,10,216462,242582561,492107,NULL,11212118,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pent-4-ynyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797206,10,216305,242582692,5271149,NULL,10866384,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient)-Varicella-Zoster virus 07/1 strain,"5-(11-chloroundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427678,10,393983,103650585,25257894,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(4-chlorophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427962,10,393980,103650669,25257896,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-[(2-chlorophenyl)methoxy]-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427971,10,393979,103650220,44590599,NULL,19226140,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-2,2-dioxooxathiolan-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101499608,10,342121,103624539,135926125,NULL,18614365,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxyphosphoryl]amino]-3-phenylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101582116,10,324740,103489499,15954514,NULL,17325220,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus Ellen in HFF cells after 10 days by plaque reduction assay,"5-[bis(3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl)methyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
103158373,10,429196,103693769,44140465,NULL,19339082,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"6-(5-bromothiophen-2-yl)-3-(2-hydroxyethoxymethyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830254,10,607913,134437011,11579992,NULL,21696963,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase infected in human HEL cells assessed as reduction in the virus plaque formation,"2'-Deoxy-2',2'-difluoro-5-methyluridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
342748193,10,1153859,242648187,67781638,NULL,24844757,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella zoster virus 07-1 assessed as reduction in virus-induced cytopathogenicity by cell-based assay,"(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-9,10-dioxo-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysene-3a-carboxylic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963617,10,1782703,469814808,11120681,NULL,33894564,Confirmatory,20220830,0,0,Active,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in HEL cells assessed as reduction in viral plaque formation incubated for 2 hrs,"3-(2-Deoxy-beta-D-ribofuranosyl)-1,3-diaza-10H-phenoxazin-2(3H)-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468777,10.03,1610151,440141439,155531244,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-(4-tert-butyltriazol-1-yl)ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101701419,10.2,297306,103526521,44427743,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-5-(4-phenylbut-1-ynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363854555,10.2,1451464,103567639,135398748,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,Penciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427680,10.4,393983,103650512,25257437,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus YS infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-[(4-fluorophenyl)methoxy]oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427322,10.5,393980,103650220,44590599,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-2,2-dioxooxathiolan-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101678580,10.5,291030,103520493,16732576,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"5-Bromo-6-dibromomethyl-2,4-dimethoxypyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797289,10.7,1427826,381847369,137638613,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]-3-(4-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963277,10.7,1782672,469817814,164622782,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"8-decoxy-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-10-methylpyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468778,10.73,1610151,440145667,155534038,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(2R)-2-[(1S)-2-(4-decyltriazol-1-yl)-1-hydroxyethyl]-3,4-bis(phenylmethoxy)-2H-furan-5-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363493762,10.79,1361087,404654025,145950924,NULL,29945100,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,"5-Acetyl-6-[4-[(1-benzyltriazol-4-yl)methoxy]phenyl]-3-[(1-benzyltriazol-4-yl)methyl]-4-methyl-1,6-dihydropyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797275,10.8,1427826,381838342,137632609,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-benzoyl-1-[[(3S,5S)-2-benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl]methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854819,10.8,1451464,381885854,137660929,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,isopropyl (2S)-2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxy-propoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101498825,10.9,342119,103624538,135908405,NULL,18614365,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS infected HEL cells assessed as reduction in virus plaque formation after 5 days,methyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363797588,10.9,1427826,381864587,137650259,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-benzoyl-1-[[(3S,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356615,10.92,1727353,461551395,162668872,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[6-(4-methylphenyl)-5-[2-(4-methylphenyl)ethynyl]-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
100337339,11,81221,103326182,480979,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"3-Benzyl-1-[(4-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337341,11,81221,103326081,480975,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1,3-Bis[(4-chlorophenyl)methyl]benzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101546004,11,365168,103586479,24763817,NULL,18707089,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild-type VZV in HEL cells after 5 days by plaque reduction assay,"N-[[(5R,6R,8R,9R)-9-[tert-butyl(dimethyl)silyl]oxy-6-[[2,3-dimethylbutan-2-yl(dimethyl)silyl]oxymethyl]-8-(3,5-dimethyl-2,4-dioxopyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda6-thiaspiro[4.4]non-3-en-4-yl]carbamoyl]benzamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101546005,11,365168,103586482,25107719,NULL,18707089,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild-type VZV in HEL cells after 5 days by plaque reduction assay,"N-[[(5R,6R,8R,9R)-9-[2,3-dimethylbutan-2-yl(dimethyl)silyl]oxy-6-[[2,3-dimethylbutan-2-yl(dimethyl)silyl]oxymethyl]-8-(3,5-dimethyl-2,4-dioxopyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda6-thiaspiro[4.4]non-3-en-4-yl]carbamoyl]benzamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101546077,11,365180,103586482,25107719,NULL,18707089,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine-kinase deficient VZV in HEL cells after 5 days by plaque reduction assay,"N-[[(5R,6R,8R,9R)-9-[2,3-dimethylbutan-2-yl(dimethyl)silyl]oxy-6-[[2,3-dimethylbutan-2-yl(dimethyl)silyl]oxymethyl]-8-(3,5-dimethyl-2,4-dioxopyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda6-thiaspiro[4.4]non-3-en-4-yl]carbamoyl]benzamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101546078,11,365180,103586479,24763817,NULL,18707089,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine-kinase deficient VZV in HEL cells after 5 days by plaque reduction assay,"N-[[(5R,6R,8R,9R)-9-[tert-butyl(dimethyl)silyl]oxy-6-[[2,3-dimethylbutan-2-yl(dimethyl)silyl]oxymethyl]-8-(3,5-dimethyl-2,4-dioxopyrimidin-1-yl)-2,2-dioxo-1,7-dioxa-2lambda6-thiaspiro[4.4]non-3-en-4-yl]carbamoyl]benzamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853318,11,258990,103476656,11516993,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"6-dec-1-ynyl-3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853724,11,258989,103476656,11516993,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"6-dec-1-ynyl-3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
346996151,11,1230100,318375203,122180139,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"N-[2-[2-(Dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinoline 5-yl]-3alpha-(diethoxyphosphinoyl)-2-methylisoxazolidine-5alpha-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347071077,11.1,1256245,103504490,135398740,NULL,26460883,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen VR-1367 infected in African green monkey Vero cells after 3 days by MTT assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100428683,11.2,81923,103401380,11482796,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,[(2E)-2-[(2-amino-6-methoxy-purin-9-yl)methylene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100364848,11.4,217508,103732629,46876057,NULL,11585457,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of viral cytopathic effect in infected human foreskin fibroblast cell in monolayers of VZV Ellen Vero cells by 50%,"[1-[1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-2-iodoethyl]cyanamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
366468658,11.64,1610152,440127313,155522009,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(3-hydroxyphenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100428685,11.7,81923,103402144,11436561,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,[(2E)-2-[(6-aminopurin-9-yl)methylene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
347061811,11.7,1251996,318393380,122192838,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[5-(4-bromophenoxy)pentyl]-2,6-dioxopyrimidin-1-yl]-N-(4-phenylmethoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363855300,11.7,1451464,381838764,137632889,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[2-[[[[(1S)-2-benzyloxy-1-methyl-2-oxo-ethyl]amino]-(1-naphthyloxy)phosphoryl]oxymethyl]-4-[2-[(E)-dimethylaminomethyleneamino]-6-oxo-1H-purin-9-yl]butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468655,11.7,1610152,440141439,155531244,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-(4-tert-butyltriazol-1-yl)ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101701376,11.9,297307,103526521,44427743,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-5-(4-phenylbut-1-ynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100336937,12,81226,103166684,401639,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1-Benzyl-3-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337000,12,81227,103166684,401639,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1-Benzyl-3-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337332,12,81221,103166684,401639,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1-Benzyl-3-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337338,12,81221,103166864,466142,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"3-Benzyl-1-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338614,12,81222,103166864,466142,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"3-Benzyl-1-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100516382,12,106003,103421921,44379306,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-(1-Hydroxyethyl)-1-[4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
101437626,12,415399,103632942,42629966,NULL,19328697,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-[(E)-prop-1-enyl]phenyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853247,12,258989,103476760,11647092,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"6-dec-1-ynyl-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853317,12,258990,103476760,11647092,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"6-dec-1-ynyl-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853330,12,258990,103476701,11495737,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-dodec-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833133,12,609573,134440853,56663162,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,"2-[2-(2,4-Dioxopyrimidin-1-yl)ethoxy]propylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
326010625,12,687665,163323281,71454687,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-(2,6-diaminopurin-9-yl)but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
373963282,12,1782672,103504725,135398513,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356616,12.01,1727353,103202903,446727,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
101641200,12.2,279714,103511720,135541418,NULL,17130297,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellen in HFF cell by CPE assay,[(Z)-5-(2-amino-6-oxo-1H-purin-9-yl)pent-3-enyl]-(3-hexadecoxypropoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100334221,12.5,217497,103290937,44319468,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"5-[(E)-2-bromoethenyl]-1-[(2R)-2-[[(1S,2R,5S)-5-methyl-2-propan-2-ylcyclohexyl]oxymethyl]-1,3-oxathiolan-5-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899308,12.5,1457768,103303175,135542259,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,[(1S)-1-[(2-amino-6-oxo-1H-purin-9-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899547,12.7,1457768,381882579,134382692,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,"dipentyl (2S)-2-[[[(1R)-1-(fluoromethyl)-2-(5-methyl-2,4-dioxo-pyrimidin-1-yl)ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321546885,12.71,665383,160668111,60167462,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-(6-hydroxyhepta-1,3-diynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372356614,12.99,1727353,461521354,162647843,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(4-hydroxybut-1-ynyl)-2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
372357464,12.99,1727353,461559729,162674763,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(3-hydroxyprop-1-ynyl)-2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
100515690,13,106003,103421145,44378965,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-nitropyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100656768,13,216462,242582548,492104,NULL,11212118,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","6-Hex-5-enyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797221,13,216304,242582690,493477,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient) -Varicella-Zoster virus YS/R strain,"6-(9-chlorononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797356,13,216307,242582693,5271151,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus OKA strain,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(11-iodoundec-1-ynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437978,13,415399,103632943,6479049,NULL,19328697,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-[3-[(E)-prop-1-enyl]phenyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853322,13,258990,103476700,11675456,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"3-(2-deoxy-beta-D-erythro-pentofuranosyl)-6-decyn-1-yl)furo[2,3-d]pyrimidine-2(3H)-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237830253,13,607913,134448604,53358789,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase infected in human HEL cells assessed as reduction in the virus plaque formation,CID 53358789,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237833121,13,609572,134440853,56663162,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,"2-[2-(2,4-Dioxopyrimidin-1-yl)ethoxy]propylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
334017658,13,723372,103504725,135398513,NULL,23219702,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human MRC5 cells assessed as inhibition of viral replication by viral reduction plaque assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
363797580,13.2,1427826,381861089,137647904,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-Benzyl-1-[(2-benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356618,13.2,1727353,461556768,162672687,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(6-carbazol-9-ylhex-1-ynyl)-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
373963059,13.3,1782673,469815838,164621364,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-[2-[Bis(4-methoxyphenyl)-phenylmethoxy]ethoxymethyl]-5-bromo-6-hydroxy-1,6-dihydropyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
326010650,13.53,687665,163337086,56945006,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-(6-aminopurin-9-yl)but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363797278,13.7,1427826,381841345,137634608,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-benzoyl-1-[[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
347061777,13.8,1252400,318393997,122193267,NULL,26291038,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Oka expressed in HEL cells assessed as reduction in plaque formation incubated for 5 days,"3,5-bis[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrrolo[3,2-d]pyrimidin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321548978,13.9,665760,160689663,70690161,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(2-methoxyethoxy)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100337002,14,81227,103325931,480970,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1,3-Di(benzyloxymethyl)-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656761,14,216461,242582548,492104,NULL,11212118,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"6-Hex-5-enyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812642,14,217644,103734860,472372,NULL,8387600,Confirmatory,20230629,0,0,Unspecified,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ellen strain),"4-amino-1-[(3S,4R,5S)-4,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]-5-iodo-pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446240,14,392537,103513617,9991657,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,[(2Z)-2-[(6-aminopurin-9-yl)methylidene]-1-fluorocyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101652718,14,282657,103513617,9991657,NULL,15615545,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of VZV replication in HFF cells by CPE assay,[(2Z)-2-[(6-aminopurin-9-yl)methylidene]-1-fluorocyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
204387930,14,569235,124961860,51040860,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"5-[1-(4-bromophenyl)triazol-4-yl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546436,14,665385,160678786,60167178,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-[4-(4-propylphenyl)buta-1,3-diynyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996283,14,1230100,318375204,122180140,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"N-[2-[2-(Dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinoline 5-yl]-3alpha-(diethoxyphosphinoyl)-2-methylisoxazolidine-5beta-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
380639611,14,1876130,103176908,160355,NULL,33539089,Confirmatory,20230629,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against VZV,Seliciclib,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363605572,14.12,1394845,103504725,135398513,NULL,29550734,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963056,14.2,1782673,469807121,164615035,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-nonoxy-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963330,14.3,1782701,469800817,131723,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,MIC,=,ChEMBL,Antiviral activity against Varicella zoster virus infected in HEL cells assessed as reduction in viral plaque formation,"3,9-Dihydro-3-((1,3-dihydroxy-2-propoxy)methyl)-6-methyl-9-oxo-5H-imidazol(1,2-a)purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100364852,14.6,217508,242582466,488239,NULL,11585457,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of viral cytopathic effect in infected human foreskin fibroblast cell in monolayers of VZV Ellen Vero cells by 50%,5-[1-(Cyanoamino)-2-iodoethyl]-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
366468660,14.62,1610152,440151216,155537643,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(3,5-difluorophenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366469306,14.68,1610151,440127313,155522009,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(3-hydroxyphenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446799,14.7,392537,103651298,44591243,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"6-amino-3-[(E)-[2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl]-1,6-dihydropyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101652310,14.7,282657,103513632,6536768,NULL,15615545,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of VZV replication in HFF cells by CPE assay,CID 6536768,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
380549722,14.74,1854967,103504725,135398513,NULL,35933787,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster-virus O7-1 strain infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953327,14.87,1498127,103504725,135398513,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100445935,15,217516,103197696,135465936,NULL,8496903,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain,(E)-9-[[2-(Hydroxymethyl)-4-phosphonobut-3-enyl]oxy]guanine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100615234,15,216160,103504725,135398513,NULL,1846922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Compound was tested for its antiviral activity against VZV(Ellen) using plaque reduction assay.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797202,15,216305,242582690,493477,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient)-Varicella-Zoster virus 07/1 strain,"6-(9-chlorononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101582115,15,324740,103489424,15604878,NULL,17325220,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus Ellen in HFF cells after 10 days by plaque reduction assay,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(Z)-(3-methyl-5-oxo-1-phenylpyrazol-4-ylidene)methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101582118,15,324740,103499514,44416697,NULL,17325220,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus Ellen in HFF cells after 10 days by plaque reduction assay,"2'-Deoxy-5-(2,2-dicyanoethenyl)uridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
204375569,15,553343,124966489,50993714,NULL,21128666,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,N1-[(E)-4-bis(Pivaloyloxymethyl)phosphinyl-2-butenyl]-5-bromo-uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010621,15,687665,103504725,135398513,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347062311,15,1251996,318393381,122192839,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[5-(4-bromophenoxy)pentyl]-2,6-dioxopyrimidin-1-yl]-N-phenylacetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363797276,15,1427826,381870469,137654248,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]-3-(3-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963049,15.1,1782673,469817814,164622782,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"8-decoxy-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-10-methylpyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963055,15.2,1782673,469806117,164614303,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"8-decoxy-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908485,15.3,1462034,381841026,137634393,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"[2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613432,15.43,1869619,482047271,168269372,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,"[1-(4-amino-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)but-3-yn-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963047,15.9,1782673,469808836,164616264,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-octoxy-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100445937,16,217516,103197807,6474314,NULL,8496903,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain,(E)-9-(2-hydroxymethyl-4-phosphonobut-3-enyl)adenine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709969,16,216468,242581920,90662950,NULL,15109620,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus (thymidine kinase deficient) TK-(07/1),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-propylphenyl)thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797205,16,216305,242582696,5271150,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient)-Varicella-Zoster virus 07/1 strain,"5-(11-bromoundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427698,16,393980,103650219,25256977,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"4-Benzyloxyspiro[oxathiole-5,2'-tetralin] 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427722,16,393979,103650298,25257677,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"4-Allyloxy-5-benzyl-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427951,16,393980,103650154,25256976,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-isopropyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427959,16,393980,103650298,25257677,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"4-Allyloxy-5-benzyl-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101499180,16,342121,103624441,135508841,NULL,18614365,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R infected HEL cells assessed as reduction in virus plaque formation after 5 days,methyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101582117,16,324740,103499416,11992134,NULL,17325220,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus Ellen in HFF cells after 10 days by plaque reduction assay,"2-amino-4-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-5-oxo-4,6,7,8-tetrahydrochromene-3-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101853730,16,258989,103476701,11495737,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-dodec-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
334017657,16,723372,103567639,135398748,NULL,23219702,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human MRC5 cells assessed as inhibition of viral replication by viral reduction plaque assay,Penciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
103157092,16.4,429197,103683202,44140466,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"6-(furan-2-yl)-3-(2-hydroxyethoxymethyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387924,16.5,569235,103504725,135398513,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
224518782,16.6,595576,131280814,9613008,NULL,21376429,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,"4-[(E)-[(E)-[4-(4-fluorophenyl)-3H-thiazol-2-ylidene]hydrazono]methyl]-N,N-dimethyl-aniline",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
151272567,16.7,458870,103727603,54728124,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"5-[bis(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)methyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100335018,17,217495,103290826,476987,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,L-I-OddU,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100445934,17,217516,103197854,135410376,NULL,8496903,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain,(E)-9-[2-Hydroxymethyl-4-phosphonobut-3-enyl]guanine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698746,17,296673,103525536,16756973,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-pentylphenyl)ethynyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
224518481,17,595582,131276774,136130200,NULL,21376429,Confirmatory,20220830,0,0,Unspecified,NULL,EC90,=,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in human HFF cells assessed as inhibition of viral replication after 1 hr by plaque reduction assay,"trisodium;bis[[(E)-[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenylidene]amino]azanidylcarbothioyl]azanide;hydrate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
363494223,17.03,1361087,404652527,145949869,NULL,29945100,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,"5-acetyl-1,3-bis[(1-benzyltriazol-4-yl)methyl]-4-[4-(dimethylamino)phenyl]-6-methyl-4H-pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955165,17.03,1498126,404669813,145961829,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(Z)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100589796,17.1,217498,103210552,343428,NULL,2826784,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Inhibition of growth of varicella zoster virus(VZV) by plaque reduction assay in vero cell line,1-[[2-Hydroxy-1-(hydroxy methyl)ethoxy]methyl]cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
363693099,17.49,1407618,404707674,145987250,NULL,30098481,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation,"(2R,3S,4R,5R)-5-(4-amino-3-chloropyrrolo[2,3-b]pyridin-1-yl)-3-ethynyl-2-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101700827,17.5,297306,103526511,44427733,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"5-hex-1-ynyl-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800864,17.6,247653,103449611,5272220,NULL,15261261,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[1-(4-fluorophenyl)propylcarbamothioylamino]phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336999,18,81227,103326182,480979,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"3-Benzyl-1-[(4-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100346517,18,217511,103389906,493487,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,=,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"6-(4-heptylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346518,18,217511,103389785,493486,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,=,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"6-(4-hexylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413886,18,147626,103391778,3011374,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-methyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698740,18,296673,103525542,16756645,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-pentylphenyl)ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237836756,18.4,611619,134446382,56668650,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,2-(6-Aminopurin-9-yl)ethoxymethyl-[2-(10-hydroxydecoxy)ethoxy]phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
366468659,18.44,1610152,103202903,446727,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613491,18.83,1869612,482076393,168290377,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK+ infected in HEL cells assessed as reduction in virus plaque formation,"[1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxy-2-methylpropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435530,19,216156,103504725,135398513,NULL,14584954,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Effective concentration against TK- Varicella-Zoster Virus (VZV) YS/R strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101499476,19,342118,103624441,135508841,NULL,18614365,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation after 5 days,methyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698473,19,296672,103525536,16756973,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-pentylphenyl)ethynyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101854164,19,258991,103476752,11617745,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101800617,19.1,247653,160686900,5272222,NULL,15261261,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,inhibitory concentration against Varicella zoster virus,2-fluoro-N-[4-[[(1R)-1-phenylethyl]carbamothioylamino]phenyl]benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99290483,20,3058,103391811,11438492,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),"5-Bromo-1-((1R,3S,4S,6S)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99981163,20,216301,242582676,493475,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain YS-R,"6-dodecyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100155443,20,217665,103389810,493485,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155445,20,217665,103389872,493488,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-octylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155446,20,217665,103389990,493484,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155583,20,217806,103389872,493488,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-octylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155584,20,217806,103389990,493484,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155587,20,217806,103389896,493482,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-propylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100336932,20,81226,103326056,480980,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"3-Benzyl-1-[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336939,20,81226,103331540,480983,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1-[(3,4-Dichlorophenyl)methyl]-4-(benzyloxy)-2,1,3-benzothiadiazine 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336941,20,81226,103326143,480978,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1-Benzyl-3-[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336992,20,81227,103326056,480980,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"3-Benzyl-1-[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337334,20,81221,103326056,480980,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"3-Benzyl-1-[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337349,20,81222,103326235,480972,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1-Benzyl-4-(benzyloxy)-2,1,3-benzothiadiazine 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338618,20,81222,103326056,480980,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"3-Benzyl-1-[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345431,20,217512,103389810,493485,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ",Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345433,20,217512,103389785,493486,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,=,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","6-(4-hexylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345436,20,217512,103389872,493488,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-octylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345437,20,217512,103389990,493484,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100436300,20,216155,103391811,11438492,NULL,14584954,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration against TK- Varicella-Zoster Virus (VZV) 07/1 strain,"5-Bromo-1-((1R,3S,4S,6S)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709967,20,216468,242581923,9979184,NULL,15109620,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (thymidine kinase deficient) TK-(07/1),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709968,20,216468,242581916,90662946,NULL,15109620,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus (thymidine kinase deficient) TK-(07/1),"6-(4-heptylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709971,20,216468,242581924,90662952,NULL,15109620,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus (thymidine kinase deficient) TK-(07/1),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-octylphenyl)thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709973,20,216468,242581919,90662949,NULL,15109620,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (thymidine kinase deficient) TK-(07/1),"6-(4-ethylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797208,20,216305,242582691,493476,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient)-Varicella-Zoster virus 07/1 strain,"6-(9-fluorononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797216,20,216304,242582691,493476,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient) -Varicella-Zoster virus YS/R strain,"6-(9-fluorononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812649,20,217644,103734862,470132,NULL,8387600,Confirmatory,20230629,0,0,Unspecified,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ellen strain),"1-[(3S,4R,5S)-4,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]-5-methyl-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427717,20,393979,103650302,25257679,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-(cyclohexylmethoxy)-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427956,20,393980,103650402,25257681,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-(4-phenylbutoxy)oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101498826,20,342119,103624441,135508841,NULL,18614365,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS infected HEL cells assessed as reduction in virus plaque formation after 5 days,methyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101641203,20,279714,103511713,15986890,NULL,17130297,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV Ellen in HFF cell by CPE assay,[(Z)-5-(6-aminopurin-9-yl)pent-3-enyl]-(3-hexadecoxypropoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101669739,20,288927,103519820,16735489,NULL,17518459,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"[(2R,3R,4S,5R)-3,4-diacetyloxy-5-[5-(2-iodoethynyl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101670738,20,288928,103519820,16735489,NULL,17518459,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS in HEL cells assessed as reduction of virus plaque formation,"[(2R,3R,4S,5R)-3,4-diacetyloxy-5-[5-(2-iodoethynyl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101678237,20,291030,103520480,16732730,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"2,4-Dimethoxy-6-methyl-5-phenylpyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678403,20,291029,103520480,16732730,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"2,4-Dimethoxy-6-methyl-5-phenylpyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678584,20,291030,103520481,16732731,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"3-(2,6-Dimethoxy-5-phenylpyrimidin-4-yl)-1,1,1-trifluoro-2-methylpropan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678589,20,291030,103520486,16732887,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"4-[(E)-2-(4-fluorophenyl)prop-1-enyl]-2,6-dimethoxypyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678592,20,291030,103520489,136177300,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"(E)-2-(2,6-dimethoxypyrimidin-4-yl)-1-(4-fluorophenyl)ethenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678884,20,291029,103520486,16732887,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"4-[(E)-2-(4-fluorophenyl)prop-1-enyl]-2,6-dimethoxypyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678885,20,291029,103520481,16732731,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"3-(2,6-Dimethoxy-5-phenylpyrimidin-4-yl)-1,1,1-trifluoro-2-methylpropan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698198,20,296674,103525550,16756530,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(6-hexylpyridin-3-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698202,20,296674,103525549,16756529,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(6-pentylpyridin-3-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698280,20,296675,103525548,16756864,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(6-pent-1-ynylpyridin-3-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698283,20,296675,103525549,16756529,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(6-pentylpyridin-3-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698285,20,296675,103525550,16756530,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(6-hexylpyridin-3-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101699125,20,296674,103525548,16756864,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(6-pent-1-ynylpyridin-3-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700760,20,297307,103526533,44427755,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"6-(4-bromophenyl)-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700762,20,297307,103526520,44427742,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"5-hepta-1,6-diynyl-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700818,20,297306,103526534,44427756,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"6-(4-methylphenyl)-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700820,20,297306,103526535,44427757,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"6-(4-butylphenyl)-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700821,20,297306,103526536,44427758,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700826,20,297306,103526532,44427754,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-6-(2-phenylethyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700828,20,297306,103526527,44427749,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-6-pentylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700829,20,297306,103526528,44427750,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"6-hexyl-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700830,20,297306,103526529,44427751,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"6-octyl-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700833,20,297306,103526533,44427755,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"6-(4-bromophenyl)-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701373,20,297307,103526511,44427733,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"5-hex-1-ynyl-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701374,20,297307,103526527,44427749,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-6-pentylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701383,20,297307,103526532,44427754,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-6-(2-phenylethyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701384,20,297307,103526534,44427756,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"6-(4-methylphenyl)-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701385,20,297307,103526528,44427750,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"6-hexyl-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701386,20,297307,103526529,44427751,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"6-octyl-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701387,20,297307,103526535,44427757,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"6-(4-butylphenyl)-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701388,20,297307,103526536,44427758,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701392,20,297307,103526517,44427739,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"5-dec-1-ynyl-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701417,20,297306,103526517,44427739,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"5-dec-1-ynyl-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701422,20,297306,103526520,44427742,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"5-hepta-1,6-diynyl-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853325,20,258990,103389810,493485,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
105960645,20,445340,103389810,493485,NULL,19833513,Confirmatory,20180911,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected human HEL cells assessed as reduction in viral plaque formation after 5 days,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
105960646,20,445340,103708899,45487934,NULL,19833513,Confirmatory,20180911,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected human HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204375987,20,553342,124966489,50993714,NULL,21128666,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV OKA expressing thymidine kinase infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,N1-[(E)-4-bis(Pivaloyloxymethyl)phosphinyl-2-butenyl]-5-bromo-uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321522321,20,658756,160672877,60145346,NULL,22459876,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VSV 07-1 infected in HEL cells assessed as reduction of virus plaque formation after 4 days,"Ethyl 2-[3-[(7-chloro-4-quinolyl)amino]propylamino]-4,6-dimethyl-pyrimidine-5-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321522322,20,658756,160672850,60145026,NULL,22459876,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VSV 07-1 infected in HEL cells assessed as reduction of virus plaque formation after 4 days,Ethyl 2-[2-[(7-chloro-4-quinolyl)amino]ethylamino]-4-methyl-6-phenyl-pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321522323,20,658756,160683524,60145028,NULL,22459876,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VSV 07-1 infected in HEL cells assessed as reduction of virus plaque formation after 4 days,Ethyl 2-[4-[(7-chloro-4-quinolyl)amino]butylamino]-4-methyl-6-phenyl-pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321522324,20,658756,160705065,60145500,NULL,22459876,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VSV 07-1 infected in HEL cells assessed as reduction of virus plaque formation after 4 days,Isopropyl 2-[2-[(7-chloro-4-quinolyl)amino]ethylamino]-4-methyl-6-(2-nitrophenyl)pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321522325,20,658756,160678170,60145027,NULL,22459876,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VSV 07-1 infected in HEL cells assessed as reduction of virus plaque formation after 4 days,Ethyl 2-[3-[(7-chloro-4-quinolyl)amino]propylamino]-4-methyl-6-phenyl-pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321522326,20,658756,160667533,60145347,NULL,22459876,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VSV 07-1 infected in HEL cells assessed as reduction of virus plaque formation after 4 days,"Ethyl 2-[4-[(7-chloro-4-quinolyl)amino]butylamino]-4,6-dimethyl-pyrimidine-5-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546095,20,665385,160694950,60167321,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-[4-(2-pyridyl)buta-1,3-diynyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546435,20,665385,160668109,60167324,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-[4-(4-nitrophenyl)buta-1,3-diynyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546437,20,665385,160673444,60167326,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-[4-(4-fluoro-3-methyl-phenyl)buta-1,3-diynyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546440,20,665385,160689500,60167177,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(4-phenylbuta-1,3-diynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546486,20,665383,160689500,60167177,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(4-phenylbuta-1,3-diynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010618,20,687665,163330119,71458272,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-[2-amino-6-(cyclohexylamino)purin-9-yl]but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010620,20,687665,163312976,56945093,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[2,2-dimethylpropanoyloxymethoxy-[(E)-4-[6-(4-isopropylanilino)purin-9-yl]but-2-enyl]phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010622,20,687665,163326667,71456420,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-(6-chloropurin-9-yl)but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010649,20,687665,163312977,136238815,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[2,2-dimethylpropanoyloxymethoxy-[(E)-4-(6-oxo-1H-purin-9-yl)but-2-enyl]phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010653,20,687665,163333670,71460122,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-[6-(cyclohexylamino)purin-9-yl]but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858200,20,748732,174496256,71601409,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"methyl (2S)-2-[[[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858201,20,748732,174511855,71601408,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"2,2-dimethylpropyl (2S)-2-[[[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858202,20,748732,174522096,73356521,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"methyl (2S)-2-[[[(2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-phenoxyphosphoryl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858203,20,748732,174486211,71601407,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"methyl (2S)-2-[[[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-naphthalen-1-yloxyphosphoryl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858204,20,748732,174496257,71601410,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"cyclohexyl (2S)-2-[[[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858205,20,748732,174522093,71601270,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"methyl (2S)-2-[[[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858545,20,748732,174522095,73356520,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"cyclohexyl (2S)-2-[[[(2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858546,20,748732,174501505,73350479,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"methyl (2S)-2-[[[(2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858547,20,748732,174506710,73351995,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"methyl (2S)-2-[[[(2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-naphthalen-1-yloxyphosphoryl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858548,20,748732,174501504,73350478,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"2,2-dimethylpropyl (2S)-2-[[[(2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858549,20,748732,174522094,73356519,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"2,2-dimethylpropyl (2S)-2-[[[(2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858550,20,748732,174486209,71601269,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"2,2-dimethylpropyl (2S)-2-[[[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858551,20,748732,174486210,71601272,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"methyl (2S)-2-[[[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-phenoxyphosphoryl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858552,20,748732,174506709,73351994,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"methyl (2S)-2-[[[(2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858553,20,748732,174506702,73351993,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"cyclohexyl (2S)-2-[[[(2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339858554,20,748732,174491207,71601271,NULL,23541671,Confirmatory,20180926,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicellla-zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"cyclohexyl (2S)-2-[[[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339886323,20,768205,174518561,72204308,NULL,23811093,Confirmatory,20180927,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK-positive Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of plaque formation,Ethyl 2-[4-[(7-chloro-4-quinolyl)amino]butylamino]-4-methyl-pyrimidine-5-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340060021,20,766703,174493051,136244490,NULL,23911856,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,2-amino-5-bromo-4-butyl-1H-pyrimidin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
342786058,20,1139390,242637699,77843996,NULL,24690527,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"benzyl (2S)-2-[[[(2R,3S,5R)-3-hydroxy-5-[5-[3-(octanoylamino)prop-1-ynyl]-2,4-dioxo-pyrimidin-1-yl]tetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
342786060,20,1139390,242637695,86578942,NULL,24690527,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"benzyl (2S)-2-[[[(2R,3S,5R)-3-hydroxy-5-[5-[3-(octanoylamino)prop-1-ynyl]-2,4-dioxo-pyrimidin-1-yl]tetrahydrofuran-2-yl]methoxy-(1-naphthyloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
342786276,20,1139390,242637694,86578941,NULL,24690527,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"isobutyl (2S)-2-[[[(2R,3S,5R)-3-hydroxy-5-[5-[3-(octanoylamino)prop-1-ynyl]-2,4-dioxo-pyrimidin-1-yl]tetrahydrofuran-2-yl]methoxy-(1-naphthyloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996064,20,1230101,318375203,122180139,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"N-[2-[2-(Dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinoline 5-yl]-3alpha-(diethoxyphosphinoyl)-2-methylisoxazolidine-5alpha-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996067,20,1230101,318375208,122180144,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5S)-3-diethoxyphosphoryl-N-[1,3-dioxo-2-(2-pyrrolidin-1-ylethyl)benzo[de]isoquinolin-5-yl]-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996076,20,1230101,318375206,122180142,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5S)-3-diethoxyphosphoryl-N-[2-[2-(diethylamino)ethyl]-1,3-dioxobenzo[de]isoquinolin-5-yl]-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996077,20,1230101,318375207,122180143,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5R)-3-diethoxyphosphoryl-N-[1,3-dioxo-2-(2-pyrrolidin-1-ylethyl)benzo[de]isoquinolin-5-yl]-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996152,20,1230100,318375197,122180133,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5R)-3-diethoxyphosphoryl-N-(1,3-dioxo-2-propylbenzo[de]isoquinolin-5-yl)-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996277,20,1230100,318375208,122180144,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5S)-3-diethoxyphosphoryl-N-[1,3-dioxo-2-(2-pyrrolidin-1-ylethyl)benzo[de]isoquinolin-5-yl]-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996280,20,1230100,318375205,122180141,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5R)-3-diethoxyphosphoryl-N-[2-[2-(diethylamino)ethyl]-1,3-dioxobenzo[de]isoquinolin-5-yl]-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996282,20,1230100,318375199,122180135,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5R)-N-(2-butyl-1,3-dioxobenzo[de]isoquinolin-5-yl)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996286,20,1230100,318375206,122180142,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5S)-3-diethoxyphosphoryl-N-[2-[2-(diethylamino)ethyl]-1,3-dioxobenzo[de]isoquinolin-5-yl]-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996287,20,1230100,318375207,122180143,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5R)-3-diethoxyphosphoryl-N-[1,3-dioxo-2-(2-pyrrolidin-1-ylethyl)benzo[de]isoquinolin-5-yl]-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061808,20,1251996,318393373,122192831,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[2,6-dioxo-3-[5-(4-phenylphenoxy)pentyl]pyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363493764,20,1361087,404662561,145956822,NULL,29945100,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,"5-acetyl-6-methyl-4-[4-[[1-[(4-nitrophenyl)methyl]triazol-4-yl]methoxy]phenyl]-1,3-bis[[1-[(4-nitrophenyl)methyl]triazol-4-yl]methyl]-4H-pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363539696,20,1382166,404685307,145972280,NULL,29407990,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,"benzyl (2S)-2-[[[(E)-4-(5-chloro-2,4-dioxopyrimidin-1-yl)but-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797274,20,1427826,381887528,137662067,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-benzyl-1-[[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797281,20,1427826,381867802,137652428,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(2-Benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]-3-(2-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797283,20,1427826,381857399,137645402,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]-3-[(4-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797286,20,1427826,381840391,137633957,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]-3-[(2-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797581,20,1427826,381861089,137647904,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-Benzyl-1-[(2-benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797582,20,1427826,381884255,137659862,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-benzoyl-1-[[(3R,5S)-2-benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl]methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797583,20,1427826,381843351,137635923,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3R,5S)-2-benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl]methyl]-3-[(2-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797591,20,1427826,381858492,137646138,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(2-Benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]-3-[(3-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797592,20,1427826,381858492,137646138,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(2-Benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]-3-[(3-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810194,20,1433151,381871709,137655062,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,"4-[4-[(7-Chloroquinolin-4-yl)amino]butylamino]-6-(3,4-dimethoxyphenyl)-2-methylsulfanylpyrimidine-5-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855023,20,1451464,381846345,137637937,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-[[[[(1S)-2-benzyloxy-1-methyl-2-oxo-ethyl]amino]-phenoxy-phosphoryl]oxymethyl]butoxy]-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855029,20,1451464,381862403,137648791,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[3-[[[(1S)-2-benzyloxy-1-methyl-2-oxo-ethyl]amino]-(1-naphthyloxy)phosphoryl]oxy-2-[[2-[(E)-dimethylaminomethyleneamino]-6-oxo-1H-purin-9-yl]methylsulfanyl]propoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953542,20,1498127,404669682,145961742,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(Z)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955161,20,1498126,404658463,145953988,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955162,20,1498126,404669682,145961742,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(Z)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393115,20,1572733,440141941,155531575,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,"6-(1,3-benzodioxol-5-yl)-3-[4-hydroxy-3-(hydroxymethyl)butyl]-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468651,20,1610152,440183003,155550943,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(2R)-2-[(1S)-1-hydroxy-2-(4-trimethylsilyltriazol-1-yl)ethyl]-3,4-bis(phenylmethoxy)-2H-furan-5-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468770,20,1610151,440172526,155546731,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(2R)-2-[(1S)-2-(4-tert-butyltriazol-1-yl)-1-hydroxyethyl]-3,4-bis(phenylmethoxy)-2H-furan-5-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468771,20,1610151,440183003,155550943,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(2R)-2-[(1S)-1-hydroxy-2-(4-trimethylsilyltriazol-1-yl)ethyl]-3,4-bis(phenylmethoxy)-2H-furan-5-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468772,20,1610151,440158367,155541068,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(2R)-2-[(1S)-2-(4-butyltriazol-1-yl)-1-hydroxyethyl]-3,4-bis(phenylmethoxy)-2H-furan-5-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468776,20,1610151,440132890,155525646,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(2-methoxyphenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356931,20,1727352,461552462,162669630,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(3-methoxyprop-1-ynyl)-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
372357465,20,1727353,461514752,162643167,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-[2-(4-methylphenyl)ethynyl]-2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
373963051,20,1782673,469818741,164623455,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-[2-[Bis(4-methoxyphenyl)-phenylmethoxy]ethoxymethyl]-10-methylpyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963052,20,1782673,469827994,164628704,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-10-methyl-8-nonoxypyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963267,20,1782672,469827994,164628704,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-10-methyl-8-nonoxypyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963271,20,1782672,469818741,164623455,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-[2-[Bis(4-methoxyphenyl)-phenylmethoxy]ethoxymethyl]-10-methylpyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963276,20,1782672,469815838,164621364,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-[2-[Bis(4-methoxyphenyl)-phenylmethoxy]ethoxymethyl]-5-bromo-6-hydroxy-1,6-dihydropyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363539705,20.5,1382166,404676412,145966223,NULL,29407990,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,"[(E)-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(3-pentadecoxypropoxy)phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613541,20.54,1869619,482065549,168282507,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,"N,N-diethylethanamine;[1-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)but-3-yn-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854827,20.6,1451464,381855633,137644194,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl 2-[[[4-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[(2-methyl-1-oxo-1-phenylmethoxypropan-2-yl)amino]-phenoxyphosphoryl]oxymethyl]butoxy]-phenoxyphosphoryl]amino]-2-methylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100364853,20.7,217508,242582467,488238,NULL,11585457,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of viral cytopathic effect in infected human foreskin fibroblast cell in monolayers of VZV Ellen Vero cells by 50%,"[2-bromo-1-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2,4-dioxo-pyrimidin-5-yl]ethyl]cyanamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
363899546,20.7,1457768,103504725,135398513,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100445613,21,217517,103504725,135398513,NULL,8496903,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853733,21,258991,103476647,11523679,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854556,21.3,1451464,381848379,137639302,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-[[[(1S)-2-benzyloxy-1-methyl-2-oxo-ethyl]amino]-phenoxy-phosphoryl]oxy-propoxy]-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797277,21.4,1427826,381882985,137658997,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(3-Diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl)methyl]-3-(3-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336930,22,81226,103326182,480979,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"3-Benzyl-1-[(4-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797243,22,216308,242582695,5271148,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus YS strain,"5-(11-fluoroundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101498943,22,342120,103624538,135908405,NULL,18614365,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation after 5 days,methyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853742,22,258991,103476694,11581278,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833519,22,609572,134456227,56676851,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,2-[2-(6-Aminopurin-9-yl)ethoxy]butylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363648557,22.1,1410507,103202903,446727,NULL,29670705,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372127848,22.15,1684816,103504725,135398513,NULL,33479570,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855027,22.2,1451464,381881441,137658177,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)butoxy]-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797282,22.7,1427826,103202903,446727,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337343,23,81221,103326489,480971,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1,3-Dibenzyl-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797223,23,216304,242582695,5271148,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient) -Varicella-Zoster virus YS/R strain,"5-(11-fluoroundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853746,23,258991,103476638,11601323,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"3-Methyl-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237830252,23,607913,134460096,15340361,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase infected in human HEL cells assessed as reduction in the virus plaque formation,"5-bromo-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577809,23,675212,160707045,136232613,NULL,22858222,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,2-amino-9-[2-[2-[bis(3-hexadecoxypropoxy)phosphoryl]ethoxy]ethyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363855302,23,1451464,381855850,137644343,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899307,23.1,1457768,381867722,134382698,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,"dipentyl (2S)-2-[[[(1S)-1-(fluoromethyl)-2-(5-methyl-2,4-dioxo-pyrimidin-1-yl)ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363909039,23.2,1462035,381841026,137634393,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"[2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356613,23.22,1727353,103504725,135398513,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
321577506,23.4,675212,160685555,136232612,NULL,22858222,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,9-[2-[2-[bis(3-hexadecoxypropoxy)phosphoryl]ethoxy]ethyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101498940,24,342120,103624441,135508841,NULL,18614365,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation after 5 days,methyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698284,24,296675,103504725,135398513,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853735,24,258991,103504725,135398513,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797584,24.46,1427826,381852643,137642169,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3S,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]-3-(4-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
367489616,24.7,1661190,442053883,134382929,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,dipentyl (2S)-2-[[[(1S)-1-[(4-aminopyrimidin-2-yl)oxymethyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100656760,25,216461,242582562,492108,NULL,11212118,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"6-Hex-5-ynyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100843723,25,216313,103185541,44273066,NULL,NULL,Confirmatory,20230629,0,0,Unspecified,NULL,ED50,=,ChEMBL,Effective dose required to inhibit cell growth against VZV (Ellen); Value ranges from 25-63,"1-[(1S,3S)-2-fluoro-3,4-bis(hydroxymethyl)cyclobutyl]-5-[(E)-2-iodoethenyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853778,25,258990,103476694,11581278,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855016,25,1451464,381879493,137657352,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,methyl (2S)-2-[[[4-(2-amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797280,25.17,1427826,381863904,137649786,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(3-Diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl)methyl]-3-[(4-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
367489784,25.3,1661190,442056608,134382943,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,[(2R)-1-(4-aminopyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363796789,25.62,1427826,381854365,137643323,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(3-Diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl)methyl]-3-(2-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103157266,25.8,429198,103192704,135542177,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"2-amino-9-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100334222,26,217497,103290374,44319218,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"5-[(E)-2-bromoethenyl]-1-[(2R)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338616,26,81222,103333396,44339838,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1-(Benzoyloxymethoxymethyl)-3-benzyl-4-oxo-3,4-dihydro-1H-2,1,3-benzothiadiazine 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797353,26,216307,242582695,5271148,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using Varicella-Zoster virus OKA strain,"5-(11-fluoroundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698275,26,296675,103525528,16756643,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-[(E)-dec-1-enyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340060023,26,766703,103504725,135398513,NULL,23911856,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996075,26,1230101,318375204,122180140,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"N-[2-[2-(Dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinoline 5-yl]-3alpha-(diethoxyphosphinoyl)-2-methylisoxazolidine-5beta-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800855,26.3,247653,103449575,5272217,NULL,15261261,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-(benzylcarbamothioylamino)phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
224518783,26.5,595576,131280814,9613008,NULL,21376429,Confirmatory,20220830,0,0,Unspecified,NULL,EC90,=,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,"4-[(E)-[(E)-[4-(4-fluorophenyl)-3H-thiazol-2-ylidene]hydrazono]methyl]-N,N-dimethyl-aniline",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321522320,26.6,658756,103504725,135398513,NULL,22459876,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VSV 07-1 infected in HEL cells assessed as reduction of virus plaque formation after 4 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272563,26.7,458870,103504725,135398513,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363909045,26.8,1462035,381858984,76685072,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"ethyl (2S)-2-[[2-(4-amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-[[(2S)-1-ethoxy-1-oxo-3-phenylpropan-2-yl]amino]phosphoryl]amino]-3-phenylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337344,27,81221,103331566,480977,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1-[(3,4-Dichlorophenyl)methyl]-3-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698470,27,296672,103525534,16756193,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-propylphenyl)ethynyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
355646632,27,1312420,103504725,135398513,NULL,27128178,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK-deficient Varicella-zoster virus infected in HEL cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
380613436,27.07,1869619,482052653,168273075,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,"N,N-diethylethanamine;[1-hydroxy-2-[(5-methyl-2,4-dioxopyrimidin-1-yl)methyl]but-3-yn-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363796791,27.1,1427826,381879445,137657318,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[(3-Diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl)methyl]-3-[(3-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468773,27.59,1610151,242651615,90683381,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(4-methylphenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
346996281,28,1230100,318375198,122180134,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5S)-3-diethoxyphosphoryl-N-(1,3-dioxo-2-propylbenzo[de]isoquinolin-5-yl)-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996284,28,1230100,318375200,122180136,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5S)-N-(2-butyl-1,3-dioxobenzo[de]isoquinolin-5-yl)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363854834,28.2,1451464,381865363,137650796,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxy-propoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855026,28.6,1451464,381877799,137656604,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[2-[[[[(1S)-2-benzyloxy-1-methyl-2-oxo-ethyl]amino]-phenoxy-phosphoryl]oxymethyl]-4-[2-[(E)-dimethylaminomethyleneamino]-6-oxo-1H-purin-9-yl]butoxy]-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446241,29,392537,103202903,446727,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237830257,29,607913,134440919,56663186,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase infected in human HEL cells assessed as reduction in the virus plaque formation,"methyl (2S)-2-[[[(2R,3R,5R)-4,4-difluoro-3-hydroxy-5-(5-iodo-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363908490,29.4,1462034,381858984,76685072,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"ethyl (2S)-2-[[2-(4-amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-[[(2S)-1-ethoxy-1-oxo-3-phenylpropan-2-yl]amino]phosphoryl]amino]-3-phenylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237836763,29.7,611619,134442510,56665192,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,10-[2-[2-(6-Aminopurin-9-yl)ethoxymethyl-[2-(10-hydroxydecoxy)ethoxy]phosphoryl]oxyethoxy]decan-1-ol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363605563,29.79,1394845,404704822,145985310,NULL,29550734,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,"propan-2-yl (2S)-2-[[[(1S,2S,4S)-4-(2-amino-6-oxo-1H-purin-9-yl)-2-hydroxycyclopentyl]oxymethyl-[[(2S)-1-oxo-1-propan-2-yloxypropan-2-yl]amino]phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955164,29.91,1498126,404660846,145955644,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100334214,30,217497,103291249,503310,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"5-bromo-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100334215,30,217497,103291251,6479198,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"(2S,5R)-1-[2-(Hydroxymethyl)-1,3-dioxolan-5-yl]-(E)-5-(2-iodovinyl)uracil",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100334223,30,217497,103291285,6474954,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"(2R,5S)-E-5-(2-Bromovinyl)-1-[2-(hydroxymethyl)-1,3-dioxolan-5-yl]uracil",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100334224,30,217497,103291302,6479196,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"5-[(E)-2-chlorovinyl]-1-[(2S,4R)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100334225,30,217497,103290842,6474952,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"5-[(E)-2-bromovinyl]-1-[(2S,4R)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337342,30,81221,103326152,480976,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1-[(3-Chlorophenyl)methyl]-3-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100413044,30,147626,103169255,60172,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,Adefovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100436297,30,216155,103504725,135398513,NULL,14584954,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Effective concentration against TK- Varicella-Zoster Virus (VZV) 07/1 strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100614253,30,216159,103408831,135480764,NULL,1846922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Compound was tested for its antiviral activity against VZV (Ellen) using plaque reduction assay.,2-amino-9-[3-hydroxy-1-(hydroxymethyl)propoxy]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372355680,30,1726781,461540679,162661376,NULL,34124679,Confirmatory,20220830,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,"[1-(2-amino-6-oxo-1H-purin-9-yl)-2-cyano-3-hydroxypropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
380613437,30,1869619,482052653,168273075,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,"N,N-diethylethanamine;[1-hydroxy-2-[(5-methyl-2,4-dioxopyrimidin-1-yl)methyl]but-3-yn-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613438,30,1869619,482049347,168270789,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,"[1-(6-aminopurin-9-yl)-2-(hydroxymethyl)but-3-yn-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613439,30,1869619,482049347,168270789,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,"[1-(6-aminopurin-9-yl)-2-(hydroxymethyl)but-3-yn-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372355682,30.23,1726781,103504725,135398513,NULL,34124679,Confirmatory,20220830,0,0,Unspecified,NULL,EC90,=,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
380613435,30.23,1869619,103504725,135398513,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC90,=,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613490,30.83,1869612,482060112,168278544,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK+ infected in HEL cells assessed as reduction in virus plaque formation,"[1-(6-aminopurin-9-yl)-3-hydroxy-2-methylpropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337337,31,81221,103166655,466143,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"3-Benzyl-2,2-dioxo-1-(prop-2-ynoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797219,31,216304,242582693,5271151,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient) -Varicella-Zoster virus YS/R strain,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(11-iodoundec-1-ynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356596,31.02,1727352,461563115,162677160,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-[4-(1,3-dioxoisoindol-2-yl)but-1-ynyl]-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
100364854,31.5,217508,242582459,488237,NULL,11585457,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of viral cytopathic effect in infected human foreskin fibroblast cell in monolayers of VZV Ellen Vero cells by 50%,"[2-chloro-1-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2,4-dioxo-pyrimidin-5-yl]ethyl]cyanamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100428356,31.7,81923,160687777,10422963,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,[(2Z)-2-[(2-amino-6-fluoro-purin-9-yl)methylene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100364850,32,217508,103732685,46876110,NULL,11585457,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of viral cytopathic effect in infected human foreskin fibroblast cell in monolayers of VZV Ellen Vero cells by 50%,"[2-bromo-1-[1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]ethyl]cyanamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
101427323,32,393980,103650672,44590828,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"N,5-dibenzyl-5-ethyl-2,2-dioxo-oxathiol-4-amine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101678597,32,291030,103504725,135398513,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101700761,32,297307,103504725,135398513,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363899543,32.6,1457768,381859657,134382702,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,dipentyl (2S)-2-[[[(1R)-1-[(4-amino-2-oxo-pyrimidin-1-yl)methyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100364847,32.7,217508,103321251,66377,NULL,11585457,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of viral cytopathic effect in infected human foreskin fibroblast cell in monolayers of VZV Ellen Vero cells by 50%,Edoxudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100656771,33,216462,242582562,492108,NULL,11212118,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","6-Hex-5-ynyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797510,33,216306,242582695,5271148,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK- (thymidine kinase -deficient)-Varicella-Zoster virus 07/1 strain,"5-(11-fluoroundec-1-ynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437630,33,415399,103632945,44582846,NULL,19328697,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"6-[2-[(E)-but-1-enyl]phenyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340060017,33,766703,103202903,446727,NULL,23911856,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996066,33,1230101,103504725,135398513,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
366392097,33.4,1572734,103567639,135398748,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,Penciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101921739,33.6,273053,103500346,16072392,NULL,17004726,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of VZV replication in HFF cells by plaque reduction assay,"[(1S,2E,3S)-2-[(6-aminopurin-9-yl)methylene]-3-fluoro-cyclopropyl]methanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321546493,33.74,665383,160673445,60167464,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-(5-cyclopentylpenta-1,3-diynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853321,34,258990,103476647,11523679,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237836765,34,611619,134438645,56661755,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,11-[2-(6-Aminopurin-9-yl)ethoxymethyl-(10-hydroxydecoxy)phosphoryl]oxyundecan-1-ol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363796792,34.2,1427826,381870461,137654240,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]-3-(2-fluorobenzoyl)quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955167,34.2,1498126,404669578,145961673,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99402344,35,3059,103169255,60172,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,Adefovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387934,35,569235,124956577,51040857,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"5-[1-(4-tert-butylphenyl)triazol-4-yl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577508,35,675212,160669571,136276914,NULL,22858222,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,3-hexadecoxypropoxy-[2-[2-(6-oxo-1H-purin-9-yl)ethoxy]ethyl]phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489789,35.7,1661190,442053825,156014826,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,"pentyl (2S)-2-[[(5R)-5-[(4-aminopyrimidin-2-yl)oxymethyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489620,35.9,1661190,442047312,156010138,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2S)-1-(4-aminopyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100336934,36,81226,103326489,480971,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1,3-Dibenzyl-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338613,36,81222,103166655,466143,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"3-Benzyl-2,2-dioxo-1-(prop-2-ynoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797204,36,216305,242582693,5271151,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient)-Varicella-Zoster virus 07/1 strain,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(11-iodoundec-1-ynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101699123,36,296674,103525533,16756972,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-methylphenyl)ethynyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101699126,36,296674,103504725,135398513,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853776,36,258990,103504725,135398513,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
346996072,36,1230101,318375205,122180141,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5R)-3-diethoxyphosphoryl-N-[2-[2-(diethylamino)ethyl]-1,3-dioxobenzo[de]isoquinolin-5-yl]-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
380613501,36.05,1869613,103202903,446727,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK- infected in HEL cells assessed as reduction in virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363693100,36.74,1407618,103504725,135398513,NULL,30098481,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613502,36.88,1869613,482060112,168278544,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK- infected in HEL cells assessed as reduction in virus plaque formation,"[1-(6-aminopurin-9-yl)-3-hydroxy-2-methylpropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656765,37,216462,242582547,513044,NULL,11212118,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","6-Hept-6-ynyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427972,37,393979,103650672,44590828,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"N,5-dibenzyl-5-ethyl-2,2-dioxo-oxathiol-4-amine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830456,37,607915,134463907,56683536,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,"benzyl (2S)-2-[[[(2R,3R,5R)-4,4-difluoro-3-hydroxy-5-(5-iodo-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575941,37,675213,103504725,135398513,NULL,22858222,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
198378006,38,534207,103257036,472185,NULL,18852272,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in HFF cells by plaque reduction assay,1-[2-(Phosphonomethoxy)ethyl]-5-bromocytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
346996065,38,1230101,318375197,122180133,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5R)-3-diethoxyphosphoryl-N-(1,3-dioxo-2-propylbenzo[de]isoquinolin-5-yl)-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996071,38,1230101,318375199,122180135,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5R)-N-(2-butyl-1,3-dioxobenzo[de]isoquinolin-5-yl)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546491,38.07,665383,160668107,60167461,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella-zoster virus YS infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-[4-(3,5-dimethoxyphenyl)buta-1,3-diynyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372356610,38.07,1727353,461563115,162677160,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-[4-(1,3-dioxoisoindol-2-yl)but-1-ynyl]-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
367490060,38.2,1661189,442053883,134382929,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,dipentyl (2S)-2-[[[(1S)-1-[(4-aminopyrimidin-2-yl)oxymethyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061809,38.6,1251996,103202903,446727,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490273,38.6,1661189,442047312,156010138,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2S)-1-(4-aminopyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363909046,38.9,1462035,103504725,135398513,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446246,39,392537,103401418,5271344,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"(E)-2,6-Diamino-9-{[2,2-bis(hydroxymethyl)cyclopropylidene]methyl}purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853246,39,258989,103476752,11617745,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853320,39,258990,103476752,11617745,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955166,39.86,1498126,404671469,145962973,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(Z)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515699,40,106003,103421893,44379288,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-(2,2,2-trifluoroethyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100515704,40,106003,103421152,44378972,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[4-Hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-(1-methoxyethyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100516380,40,106003,103420798,44378806,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-bromo-1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100516383,40,106003,103420767,44378793,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-chloro-1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100516384,40,106003,103421151,44378971,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5,6,7,7a-tetrahydro-4aH-cyclopenta[d]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100516387,40,106003,103420629,44378732,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,<,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-prop-1-en-2-ylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100709966,40,216468,103504725,135398513,NULL,15109620,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus (thymidine kinase deficient) TK-(07/1),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100766051,40,217677,103437190,44386538,NULL,NULL,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Compound was evaluated for the antiviral activity against varicella zoster virus(VZV),"5-ethyl-1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812643,40,217644,103734859,135412761,NULL,8387600,Confirmatory,20230629,0,0,Unspecified,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ellen strain),"D-Arabinitol, 2-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-1,4-anhydro-2,3-dideoxy-3-(hydroxymethyl)-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446244,40,392537,103455447,5272906,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"6-Ethyl-5-hydroxy-2-(4-hydroxy-5-hydroxymethyl-tetrahydro-thiophen-2-yl)-2H-[1,2,4]triazin-3-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204375505,40,553342,124958592,50993639,NULL,21128666,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV OKA expressing thymidine kinase infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,N1-[(Z)-4-bis(Pivaloyloxymethyl)phosphinyl-2-butenyl]-thymine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204375568,40,553343,124958592,50993639,NULL,21128666,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,N1-[(Z)-4-bis(Pivaloyloxymethyl)phosphinyl-2-butenyl]-thymine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996070,40,1230101,318375198,122180134,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5S)-3-diethoxyphosphoryl-N-(1,3-dioxo-2-propylbenzo[de]isoquinolin-5-yl)-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996073,40,1230101,318375200,122180136,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5S)-N-(2-butyl-1,3-dioxobenzo[de]isoquinolin-5-yl)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272367,40.2,458869,103727602,54728123,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-[bis(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010624,40.7,687665,163319819,71452910,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[2,2-dimethylpropanoyloxymethoxy-[(E)-4-(9-oxo-5H-imidazo[1,2-a]purin-3-yl)but-2-enyl]phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363908755,40.7,1462034,381886953,137661674,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"Sodium;2-(4-amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphinate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237837043,40.9,611619,134450344,56672131,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,2-(6-Aminopurin-9-yl)ethoxymethyl-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100337345,41,81221,103504725,135398513,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698469,41,296672,103525533,16756972,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-methylphenyl)ethynyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698749,41,296673,103525534,16756193,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-propylphenyl)ethynyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363855019,41.5,1451464,381868495,137652890,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[4-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[[(1S)-2-benzyloxy-1-methyl-2-oxo-ethyl]amino]-phenoxy-phosphoryl]oxymethyl]butoxy]-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953324,41.57,1498127,404671469,145962973,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(Z)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100428351,41.8,81923,103401655,11391443,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,[(2E)-2-[(2-amino-6-fluoro-purin-9-yl)methylene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
99402060,42,3059,103391778,3011374,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-methyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
198378003,42,534207,123093438,10461379,NULL,18852272,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in HFF cells by plaque reduction assay,2-(4-amino-5-bromo-2-oxo-pyrimidin-1-yl)ethoxymethyl-(3-hexadecoxypropoxy)phosphinic Acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
237833090,42,609512,134456227,56676851,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,2-[2-(6-Aminopurin-9-yl)ethoxy]butylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363494225,42.65,1361087,404654437,145951203,NULL,29945100,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,"5-Acetyl-4-methyl-3-[[1-[(4-nitrophenyl)methyl]triazol-4-yl]methyl]-6-phenyl-1,6-dihydropyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
367489609,42.7,1661190,103504725,135398513,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363855028,42.9,1451464,381859645,137646910,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[4-(2-amino-6-chloro-purin-9-yl)-2-(hydroxymethyl)butoxy]-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101499609,43,342121,103504725,135398513,NULL,18614365,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R infected HEL cells assessed as reduction in virus plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853732,43,258989,103476647,11523679,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237830009,43,607915,103504725,135398513,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237833785,43,609573,134456227,56676851,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,2-[2-(6-Aminopurin-9-yl)ethoxy]butylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
326010651,43.6,687665,163326665,71456418,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-[2-amino-6-(butylamino)purin-9-yl]but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100336940,44,81226,103333396,44339838,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1-(Benzoyloxymethoxymethyl)-3-benzyl-4-oxo-3,4-dihydro-1H-2,1,3-benzothiadiazine 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337001,44,81227,103333396,44339838,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1-(Benzoyloxymethoxymethyl)-3-benzyl-4-oxo-3,4-dihydro-1H-2,1,3-benzothiadiazine 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337336,44,81221,103333396,44339838,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1-(Benzoyloxymethoxymethyl)-3-benzyl-4-oxo-3,4-dihydro-1H-2,1,3-benzothiadiazine 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854831,44.1,1451464,381886590,137661435,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[4-(2-amino-6-chloro-purin-9-yl)-2-[[[[(1S)-2-benzyloxy-1-methyl-2-oxo-ethyl]amino]-phenoxy-phosphoryl]oxymethyl]butoxy]-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908762,44.7,1462034,381845878,137637615,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"1-[2-[Bis(2-octadecoxyethoxy)phosphorylmethoxy]ethyl]-4-(2-octadecoxyethylamino)-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955151,44.72,1498126,404670900,145962576,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468661,44.72,1610152,440165203,155543860,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(4-bromophenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356617,44.72,1727353,461552462,162669630,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(3-methoxyprop-1-ynyl)-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
101678587,45,291030,103520485,16732890,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"1-(2,6-Dimethoxy-5-methylpyrimidin-4-yl)-2-(4-fluorophenyl)propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
346996074,45,1230101,318375201,122180137,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5R)-3-diethoxyphosphoryl-2-methyl-N-[2-(2-methylpropyl)-1,3-dioxobenzo[de]isoquinolin-5-yl]-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996285,45,1230100,318375201,122180137,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5R)-3-diethoxyphosphoryl-2-methyl-N-[2-(2-methylpropyl)-1,3-dioxobenzo[de]isoquinolin-5-yl]-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363854833,45,1451464,381846947,137638329,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[4-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)butoxy]-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613500,45.6,1869613,482076393,168290377,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK- infected in HEL cells assessed as reduction in virus plaque formation,"[1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxy-2-methylpropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
342786059,46,1139390,242637692,86578905,NULL,24690527,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"methyl (2S)-2-[[[(2R,3S,5R)-3-hydroxy-5-[5-[3-(octanoylamino)prop-1-ynyl]-2,4-dioxo-pyrimidin-1-yl]tetrahydrofuran-2-yl]methoxy-(1-naphthyloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363953316,46.66,1498127,404669000,145961262,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515687,46.8,106003,103504725,135398513,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
101470270,47,350209,103597011,135885202,NULL,19397271,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus infected in human foreskin fibroblast cells,"2-amino-9-[(Z)-[(2R)-2-[(1R)-1,2-dihydroxyethyl]cyclopropylidene]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,129044,10335,NULL,NULL
342820600,47,1118639,242612558,90665346,NULL,24312722,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of viral plaque formation after 5 days,"1-(4-Hydroxycyclopent-2-en-1-yl)-5-(1,3-thiazol-5-yl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363953325,47.19,1498127,404671876,145963246,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
326010656,47.2,687665,163333671,71460123,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-[6-(cyclopropylamino)purin-9-yl]but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204393640,47.7,574386,124963452,53320362,NULL,21256035,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Thymidine kinase-deficient Varicella-zoster virus 07-1 infected in HELF assessed as virus-induced cytopathogenicity after 5 days by microscopy,1-naphthyl (2S)-2-[[(1S)-2-amino-1-methyl-2-oxo-ethyl]carbamoyl]-2-benzyl-azetidine-1-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
151272559,47.8,458869,103727532,54728121,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-[bis(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)methyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101582114,48,324740,103499036,44416395,NULL,17325220,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus Ellen in HFF cells after 10 days by plaque reduction assay,5-[(1E)-2-Cyano-3-ethoxy-3-oxoprop-1-en-1-yl]-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101699127,48,296674,103525528,16756643,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-[(E)-dec-1-enyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387923,48,569235,124966096,51040859,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"5-[1-(4-chlorophenyl)triazol-4-yl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237833516,48,609572,134456228,56676852,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,"2-[2-(5-Methyl-2,4-dioxo-pyrimidin-1-yl)ethoxy]propylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
151272359,48.1,458869,103727461,46231998,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-(2-amino-3-cyano-7-methyl-5-oxo-4H-pyrano[3,2-c]pyran-4-yl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363493760,48.12,1361087,404672000,145963324,NULL,29945100,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,"5-Acetyl-6-(2,5-dimethoxyphenyl)-4-methyl-3-[[1-[(4-nitrophenyl)methyl]triazol-4-yl]methyl]-1,6-dihydropyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
151272564,48.6,458870,103727602,54728123,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-[bis(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363908715,48.9,1462035,381873167,137656031,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908760,48.9,1462034,381873167,137656031,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468650,48.9,1610152,440172526,155546731,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(2R)-2-[(1S)-2-(4-tert-butyltriazol-1-yl)-1-hydroxyethyl]-3,4-bis(phenylmethoxy)-2H-furan-5-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336929,49,81226,103166864,466142,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"3-Benzyl-1-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336998,49,81227,103166864,466142,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"3-Benzyl-1-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101701393,49,297307,103526519,44427741,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"5-(3-hydroxyoct-1-ynyl)-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101800622,49.1,247653,160697763,5272224,NULL,15261261,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,inhibitory concentration against Varicella zoster virus,N-[4-[[(1R)-1-(4-bromophenyl)ethyl]carbamothioylamino]phenyl]-2-fluoro-benzamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810020,49.3,1433151,103504725,135398513,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393307,49.5,1572733,440148533,155535881,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-[4-(trifluoromethyl)phenyl]-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647327,50,216464,242582559,492111,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pentyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647328,50,216464,242582545,492113,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"6-Heptyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647330,50,216464,242582549,492105,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oct-7-enyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647333,50,216464,103389865,492115,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647335,50,216464,242582544,492112,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"6-Hexyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647339,50,216464,103390365,492114,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647519,50,216463,103389865,492115,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647521,50,216463,103390365,492114,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647524,50,216463,242582559,492111,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pentyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647526,50,216463,242582545,492113,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"6-Heptyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647527,50,216463,242582544,492112,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"6-Hexyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99667526,50,218492,242582679,513144,NULL,14643358,Confirmatory,20181001,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity evaluated against thymidine kinase deficient(TK-) Varicella Zoster virus (YS),"6-[9-(4-chlorobutoxy)nonyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980713,50,216298,242582559,492111,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinase-deficient strain 07,"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pentyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980714,50,216298,242582544,492112,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinase-deficient strain 07,"6-Hexyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980715,50,216299,242582559,492111,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinase-deficient strain YS-R,"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pentyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980716,50,216299,242582544,492112,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinase-deficient strain YS-R,"6-Hexyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980755,50,216300,242582676,493475,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain 07,"6-dodecyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980757,50,216300,242582674,493474,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain 07,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-undecyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980758,50,216300,242582545,492113,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain 07,"6-Heptyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980759,50,216300,103390365,492114,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain 07,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980760,50,216300,103389865,492115,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain 07,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99981162,50,216301,103390365,492114,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain YS-R,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99981164,50,216301,242582545,492113,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain YS-R,"6-Heptyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99981165,50,216301,242582674,493474,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain YS-R,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-undecyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99981166,50,216301,103389865,492115,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain YS-R,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99985947,50,217496,103202903,446727,NULL,10891113,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,The effective concentration to show 50% of activity was measured on varicella zoster virus(Ellen) cell culture,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99991782,50,217664,103389982,493483,NULL,11150169,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZV TK -07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-ethylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100033129,50,151172,103391811,11438492,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,MCC,>,ChEMBL,Minimum cytotoxic concentration that causes alterations of VZV infected Osteosarcoma cell morphology,"5-Bromo-1-((1R,3S,4S,6S)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100155431,50,217806,103389865,492115,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155433,50,217806,103390388,507244,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-bromophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155439,50,217665,103390388,507244,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-bromophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155441,50,217665,103389865,492115,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155447,50,217665,103390412,507243,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-chlorophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155449,50,217665,103389896,493482,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-propylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155579,50,217806,103389982,493483,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-ethylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155586,50,217806,103390365,492114,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155588,50,217806,103390412,507243,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","6-(4-chlorophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100156091,50,217665,103390365,492114,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100334213,50,217497,164138876,6474728,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"5-[(E)-2-bromovinyl]-1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100334217,50,217497,160692157,667554,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"5-[(E)-2-bromovinyl]-1-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100334226,50,217497,164133221,6474729,NULL,10891113,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration to show 50% of activity was measured on varicella zoster virus(VZV) cell culture,"5-[(E)-2-bromovinyl]-1-[(2S,3S,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336933,50,81226,103326152,480976,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1-[(3-Chlorophenyl)methyl]-3-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336935,50,81226,103331566,480977,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1-[(3,4-Dichlorophenyl)methyl]-3-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336938,50,81226,103326271,480973,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1-[(2-Chlorophenyl)methyl]-3-(benzyloxymethyl)-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336942,50,81226,103325931,480970,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1,3-Di(benzyloxymethyl)-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336993,50,81227,103326143,480978,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1-Benzyl-3-[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336995,50,81227,103326235,480972,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1-Benzyl-4-(benzyloxy)-2,1,3-benzothiadiazine 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336996,50,81227,103326114,480981,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1,3-Bis[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337004,50,81227,103331540,480983,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1-[(3,4-Dichlorophenyl)methyl]-4-(benzyloxy)-2,1,3-benzothiadiazine 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337005,50,81227,103326152,480976,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1-[(3-Chlorophenyl)methyl]-3-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337330,50,81221,103326143,480978,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1-Benzyl-3-[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337331,50,81221,103326114,480981,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1,3-Bis[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337333,50,81221,103326271,480973,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1-[(2-Chlorophenyl)methyl]-3-(benzyloxymethyl)-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337335,50,81221,103331540,480983,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1-[(3,4-Dichlorophenyl)methyl]-4-(benzyloxy)-2,1,3-benzothiadiazine 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337340,50,81221,103325931,480970,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1,3-Di(benzyloxymethyl)-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100337346,50,81221,103326235,480972,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation.,"1-Benzyl-4-(benzyloxy)-2,1,3-benzothiadiazine 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338546,50,81227,103331566,480977,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1-[(3,4-Dichlorophenyl)methyl]-3-benzylbenzo[d]1,2,6-thiadiazine-2,2,4-trione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338548,50,81227,103326271,480973,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"1-[(2-Chlorophenyl)methyl]-3-(benzyloxymethyl)-2,1,3-benzothiadiazin-4-one 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338617,50,81222,103331540,480983,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1-[(3,4-Dichlorophenyl)methyl]-4-(benzyloxy)-2,1,3-benzothiadiazine 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338622,50,81222,103326143,480978,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,"1-Benzyl-3-[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100339266,50,81226,103326114,480981,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1,3-Bis[(2-chlorophenyl)methyl]-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100339267,50,81226,103326235,480972,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"1-Benzyl-4-(benzyloxy)-2,1,3-benzothiadiazine 2,2-Dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345429,50,217512,103389865,492115,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345432,50,217512,103389896,493482,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-propylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345434,50,217512,103390365,492114,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100346515,50,217511,103390365,492114,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,>,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-octyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346516,50,217511,103389865,492115,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,>,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346944,50,217512,103390388,507244,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,=,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","6-(4-bromophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100709974,50,216468,242581926,90662953,NULL,15109620,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus (thymidine kinase deficient) TK-(07/1),"6-(4-hexylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797203,50,216305,242582694,493479,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient)-Varicella-Zoster virus 07/1 strain,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(9-iodononyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797207,50,216305,242582697,493478,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient)-Varicella-Zoster virus 07/1 strain,"6-(9-bromononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797220,50,216304,103389865,492115,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient) -Varicella-Zoster virus YS/R strain,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797222,50,216304,242582697,493478,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient) -Varicella-Zoster virus YS/R strain,"6-(9-bromononyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797224,50,216304,242582694,493479,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient) -Varicella-Zoster virus YS/R strain,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(9-iodononyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100797509,50,216305,103389865,492115,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient)-Varicella-Zoster virus 07/1 strain,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101027759,50,288948,103511538,14885958,NULL,17518459,Confirmatory,20181021,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation,EYaraU,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101027760,50,288948,103519819,16735236,NULL,17518459,Confirmatory,20181021,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation,"1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-trimethylsilylethynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101081582,50,304884,103538406,24748860,NULL,18052321,Confirmatory,20181022,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK- VZV 07 in HEL cells after 5 days,"3-[(1R,3S,4R)-3-hydroxy-4-(hydroxymethyl)cyclopentyl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101669736,50,288927,103519819,16735236,NULL,17518459,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-trimethylsilylethynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101669738,50,288927,103511538,14885958,NULL,17518459,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,EYaraU,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698203,50,296674,103525540,16756295,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-propylphenyl)ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698279,50,296675,103525534,16756193,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-propylphenyl)ethynyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698464,50,296672,103525540,16756295,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-propylphenyl)ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101699124,50,296674,103525534,16756193,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-propylphenyl)ethynyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
105959827,50,445340,103708849,45102702,NULL,19833513,Confirmatory,20180911,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected human HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
105960647,50,445340,103708900,45487935,NULL,19833513,Confirmatory,20180911,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected human HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387925,50,569235,124961861,51040861,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[1-(4-methylsulfanylphenyl)triazol-4-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387926,50,569235,124961862,51041060,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[1-[4-(trifluoromethoxy)phenyl]triazol-4-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387931,50,569235,124956578,51041061,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[1-(4-nitrophenyl)triazol-4-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387932,50,569235,124963364,51040643,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"5-[1-(3,5-difluorophenyl)triazol-4-yl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387933,50,569235,124961859,51040858,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"5-[1-(4-butylphenyl)triazol-4-yl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237733608,50,607916,134460096,15340361,NULL,21696963,Confirmatory,20180919,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R infected in human HEL cells assessed as reduction in the virus plaque formation,"5-bromo-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237733609,50,607916,134440919,56663186,NULL,21696963,Confirmatory,20180919,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R infected in human HEL cells assessed as reduction in the virus plaque formation,"methyl (2S)-2-[[[(2R,3R,5R)-4,4-difluoro-3-hydroxy-5-(5-iodo-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237733610,50,607916,134463906,15340362,NULL,21696963,Confirmatory,20180919,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R infected in human HEL cells assessed as reduction in the virus plaque formation,"5-chloro-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237733611,50,607916,134437011,11579992,NULL,21696963,Confirmatory,20180919,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R infected in human HEL cells assessed as reduction in the virus plaque formation,"2'-Deoxy-2',2'-difluoro-5-methyluridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237733836,50,607916,134448604,53358789,NULL,21696963,Confirmatory,20180919,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R infected in human HEL cells assessed as reduction in the virus plaque formation,CID 53358789,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830005,50,607915,134437011,11579992,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,"2'-Deoxy-2',2'-difluoro-5-methyluridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830006,50,607915,134448605,56670045,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,"methyl (2S)-2-[[[(2R,3R,5R)-4,4-difluoro-3-hydroxy-5-(5-iodo-2,4-dioxo-pyrimidin-1-yl)tetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830007,50,607915,134440919,56663186,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,"methyl (2S)-2-[[[(2R,3R,5R)-4,4-difluoro-3-hydroxy-5-(5-iodo-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830008,50,607915,134463906,15340362,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,"5-chloro-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830010,50,607915,134448604,53358789,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,CID 53358789,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830011,50,607915,134452479,56673561,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,"benzyl (2S)-2-[[[(2R,3R,5R)-5-(5-chloro-2,4-dioxo-pyrimidin-1-yl)-4,4-difluoro-3-hydroxy-tetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830258,50,607913,134463906,15340362,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase infected in human HEL cells assessed as reduction in the virus plaque formation,"5-chloro-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830455,50,607915,134460097,56680197,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,"benzyl (2S)-2-[[[(2R,3R,5R)-5-(5-bromo-2,4-dioxo-pyrimidin-1-yl)-4,4-difluoro-3-hydroxy-tetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237830457,50,607915,134460096,15340361,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,"5-bromo-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321548981,50,665760,160684294,70688130,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(2-methylpropylsulfanyl)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
363854554,50,1451464,381880842,137657936,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[4-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)butoxy]-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854558,50,1451464,103222023,515113,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,"1,3-Propanediol, 2-(2-(2-amino-6-methoxy-9H-purin-9-yl)ethyl)-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854820,50,1451464,381849954,11425738,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,"2-(2-(2-Amino-6-chloro-9H-purin-9-yl)ethyl)propane-1,3-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854822,50,1451464,381836538,137631405,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[4-(2-amino-6-oxo-1H-purin-9-yl)-2-[[naphthalen-1-yloxy-[[(2S)-1-oxo-1-phenylmethoxypropan-2-yl]amino]phosphoryl]oxymethyl]butoxy]-naphthalen-1-yloxyphosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854829,50,1451464,381858969,137646467,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl (2S)-2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methylsulfanyl]-3-[[[(1S)-2-benzyloxy-1-methyl-2-oxo-ethyl]amino]-phenoxy-phosphoryl]oxy-propoxy]-phenoxy-phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855014,50,1451464,103188186,135480717,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,"9-((1,3-Dihydroxy-2-propylthio)methyl)guanine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855017,50,1451464,381852070,137641771,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl 2-[[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropoxy]-naphthalen-1-yloxyphosphoryl]amino]-2-methylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855018,50,1451464,381882604,137658728,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl 2-[[[4-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)butoxy]-naphthalen-1-yloxyphosphoryl]amino]-2-methylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855022,50,1451464,381865016,137650554,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl 2-[[[4-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)butoxy]-phenoxyphosphoryl]amino]-2-methylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363855025,50,1451464,381873369,137656172,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,benzyl 2-[[[4-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[(2-methyl-1-oxo-1-phenylmethoxypropan-2-yl)amino]-naphthalen-1-yloxyphosphoryl]oxymethyl]butoxy]-naphthalen-1-yloxyphosphoryl]amino]-2-methylpropanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380549815,50,1854966,482050908,168271853,NULL,35933787,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster-virus OKA strain harboring thymidine kinase infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,"1-[(3S,5S,6R)-5-hydroxy-6-(hydroxymethyl)piperidin-3-yl]-5-iodopyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363493766,50.17,1361087,404657044,145953010,NULL,29945100,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,"5-Acetyl-3-[(1-benzyltriazol-4-yl)methyl]-6-(2,5-dimethoxyphenyl)-4-methyl-1,6-dihydropyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955155,50.17,1498126,404671876,145963246,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797287,50.3,1427826,103504725,135398513,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698196,51,296674,103389865,492115,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698273,51,296675,103389865,492115,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-decyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701418,51,297306,103526519,44427741,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"5-(3-hydroxyoct-1-ynyl)-1-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427708,52,393980,103650299,25257203,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-(3-methylbut-2-enoxy)oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853737,52,258991,103476814,11515791,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hex-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953543,52.53,1498127,404670995,145962641,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321548851,53,665760,160668295,70681756,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-phenylmethoxypurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321577810,53,675212,103202903,446727,NULL,22858222,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363953318,53.48,1498127,404670428,145962249,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363641927,53.51,1402825,103504725,135398513,NULL,29268134,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK-defecient VZV 07-1 infected in HEL cells assessed as reduction in plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
367490276,53.6,1661189,442053825,156014826,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,"pentyl (2S)-2-[[(5R)-5-[(4-aminopyrimidin-2-yl)oxymethyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427963,54,393980,103650510,25257436,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-[(4-nitrophenyl)methoxy]oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577504,54,675212,103504725,135398513,NULL,22858222,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387928,54.4,569235,103202903,446727,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363539693,54.4,1382166,103504725,135398513,NULL,29407990,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
347061819,54.5,1251996,103504725,135398513,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101921737,54.6,273053,103500324,16072393,NULL,17004726,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of VZV replication in HFF cells by plaque reduction assay,"[(1S,2Z,3R)-2-[(6-aminopurin-9-yl)methylene]-3-fluoro-cyclopropyl]methanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
363648552,54.8,1410507,103504725,135398513,NULL,29670705,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953314,55.27,1498127,404669578,145961673,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
151272362,55.7,458869,103727529,46216757,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"2-amino-4-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-7-methyl-5-oxo-4,6-dihydropyrano[3,2-c]pyridine-3-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363955158,55.7,1498126,404669000,145961262,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955163,55.7,1498126,404670995,145962641,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963054,56,1782673,103504725,135398513,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101437405,58,415400,103632943,6479049,NULL,19328697,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella Zoster virus YS infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-[3-[(E)-prop-1-enyl]phenyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
334017656,58,723372,164131118,50901484,NULL,23219702,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human MRC5 cells assessed as inhibition of viral replication by viral reduction plaque assay,(S)-1-Phenyl-2-hydroxy-5-methyl-3-hexanone,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
363953321,58.48,1498127,404669141,145961361,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955154,58.48,1498126,404661536,145956113,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(Z)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955156,58.48,1498126,404670428,145962249,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204393641,58.7,574386,103504725,135398513,NULL,21256035,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Thymidine kinase-deficient Varicella-zoster virus 07-1 infected in HELF assessed as virus-induced cytopathogenicity after 5 days by microscopy,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908719,58.8,1462035,103202903,446727,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100336997,59,81227,103166655,466143,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation.,"3-Benzyl-2,2-dioxo-1-(prop-2-ynoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427720,59,393979,103650299,25257203,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-(3-methylbut-2-enoxy)oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
366392100,59.2,1572734,103504725,135398513,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101641198,60,279714,103511708,16078861,NULL,17130297,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV Ellen in HFF cell by CPE assay,[(Z)-5-(4-amino-2-oxo-pyrimidin-1-yl)pent-3-enyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101922465,60,273052,103500398,135967824,NULL,17004726,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Inhibition of VZV replication in HFF cells by cytopathic effect assay,"2-amino-7-[(Z)-[(2R,3R)-2-fluoro-3-(hydroxymethyl)cyclopropylidene]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101922467,60,273052,103500353,16072394,NULL,17004726,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Inhibition of VZV replication in HFF cells by cytopathic effect assay,"[(1R,2Z,3R)-2-[(6-aminopurin-9-yl)methylene]-3-fluoro-cyclopropyl]methanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
204393646,60,574386,124962909,53320083,NULL,21256035,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Thymidine kinase-deficient Varicella-zoster virus 07-1 infected in HELF assessed as virus-induced cytopathogenicity after 5 days by microscopy,benzyl (2R)-2-benzyl-2-[[(1S)-2-(tert-butylamino)-1-methyl-2-oxo-ethyl]carbamoyl]azetidine-1-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237830004,60,607915,103202903,446727,NULL,21696963,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321548849,60,665760,160678936,70686006,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-benzylsulfanylpurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548853,60,665760,103401663,10086263,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,"(Z)-2-Amino-6-cyclopropylamino-9-{[2,2-bis(hydroxymethyl)cyclopropylidene]methyl}purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548854,60,665760,160705787,70696460,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-methylsulfanylpurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548858,60,665760,160705788,70696461,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-octylsulfanylpurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548977,60,665760,160689661,70690159,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(cyclopentylamino)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548980,60,665760,160700486,70694378,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(benzylamino)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548986,60,665760,160678934,70686004,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-propan-2-ylsulfanylpurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548987,60,665760,160673604,66561486,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-pentoxypurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
334012639,60,722677,164147539,71508385,NULL,23176752,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus infected in human HFF cells assessed as reduction of viral replication,"(1S,2R,3S,4R)-4-(4-amino-7-iodo-imidazo[4,5-c]pyridin-1-yl)cyclopentane-1,2,3-triol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
237837042,60.7,611619,134442508,56665190,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,"11-[2-(6-Aminopurin-9-yl)ethoxymethyl-(9,10-dihydroxydecoxy)phosphoryl]oxyundecane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101498941,61,342120,103504725,135398513,NULL,18614365,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
380549723,61,1854967,482050908,168271853,NULL,35933787,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster-virus O7-1 strain infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,"1-[(3S,5S,6R)-5-hydroxy-6-(hydroxymethyl)piperidin-3-yl]-5-iodopyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100615086,62,216159,103408857,135480763,NULL,1846922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Compound was tested for its antiviral activity against VZV (Ellen) using plaque reduction assay.,"2-amino-9-[(2S)-2,3-dihydroxypropoxy]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204376490,62,553343,103504725,135398513,NULL,21128666,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103156796,62.2,429198,103504725,135398513,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363899304,62.3,1457768,103303389,135542260,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,[(1R)-1-[(2-amino-6-oxo-1H-purin-9-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204393643,62.5,574386,124960290,53318760,NULL,21256035,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Thymidine kinase-deficient Varicella-zoster virus 07-1 infected in HELF assessed as virus-induced cytopathogenicity after 5 days by microscopy,benzyl (2S)-2-benzyl-2-[[(1S)-2-(tert-butylamino)-1-methyl-2-oxo-ethyl]carbamoyl]azetidine-1-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393112,62.8,1572733,440143803,155532787,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-(4-phenoxyphenyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100338610,63,81222,103504725,135398513,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853741,63,258991,103476646,11631626,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hex-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393302,63.14,1572733,440226930,155568331,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-(4-methylphenyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237836761,64.3,611619,134446381,56668649,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,2-(6-Aminopurin-9-yl)ethoxymethyl-(10-hydroxydecoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
373963048,64.4,1782673,469820049,164624403,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204393644,64.8,574386,124968214,53322711,NULL,21256035,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Thymidine kinase-deficient Varicella-zoster virus 07-1 infected in HELF assessed as virus-induced cytopathogenicity after 5 days by microscopy,benzyl (2S)-2-benzyl-2-[[(1S)-2-(isobutylamino)-1-methyl-2-oxo-ethyl]carbamoyl]azetidine-1-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953323,65.1,1498127,404669813,145961829,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(Z)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100428688,66,81923,103401663,10086263,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"(Z)-2-Amino-6-cyclopropylamino-9-{[2,2-bis(hydroxymethyl)cyclopropylidene]methyl}purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101698748,66,296673,103525533,16756972,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-methylphenyl)ethynyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
366393304,66.87,1572733,440133128,155525804,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-(4-methoxyphenyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356595,66.87,1727352,461515903,162643964,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(3-hydroxyprop-1-ynyl)-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
100336928,67,81226,103166655,466143,NULL,10966745,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation.,"3-Benzyl-2,2-dioxo-1-(prop-2-ynoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204393647,67,574386,124960293,53318763,NULL,21256035,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Thymidine kinase-deficient Varicella-zoster virus 07-1 infected in HELF assessed as virus-induced cytopathogenicity after 5 days by microscopy,(4-nitrophenyl)methyl (2S)-2-[[(1S)-2-amino-1-methyl-2-oxo-ethyl]carbamoyl]-2-benzyl-azetidine-1-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101921736,68.3,273053,103500337,135967822,NULL,17004726,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Inhibition of VZV replication in HFF cells by plaque reduction assay,"2-amino-7-[(Z)-[(2R,3S)-2-fluoro-3-(hydroxymethyl)cyclopropylidene]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
237836757,69,611619,134438646,56661756,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,2-(6-Aminopurin-9-yl)ethoxymethyl-[2-[2-[2-[2-[2-(2-ethoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237836759,69.3,611619,103504725,135398513,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100812648,70,217644,103734858,472373,NULL,8387600,Confirmatory,20230629,0,0,Unspecified,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ellen strain),"1-[(3S,4R,5S)-4,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]-5-iodo-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698278,70,296675,103525547,16756528,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-hexylpyridin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853315,70,258990,103476639,11666388,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"6-Dec-1-ynyl-3-methylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
345430050,70,1179396,312347162,118706651,NULL,24906510,Confirmatory,20200623,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Thymidine kinase-negative Varicella-zoster virus 07-1 infected in HEL assessed as reduction in virus plaque formation,"2-[[1-[(2S,3S)-3-bis(phenylmethoxy)phosphoryl-3-hydroxy-2-phenylmethoxypropyl]triazol-4-yl]methyl]-1,2,4-triazine-3,5-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100428687,71,81923,160698596,11778491,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"(Z)-2-Amino-6-chloro-9-{[2,2-bis(hydroxymethyl)cyclopropylidene]methyl}purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100428689,71,81923,103401688,11460216,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"(E)-2-Amino-6-chloro-9-{[2,2-bis(hydroxymethyl)cyclopropylidene]methyl}purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101699121,71,296674,103525536,16756973,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-pentylphenyl)ethynyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363899545,71.1,1457768,381861455,101656590,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,1-[(S)-2-(Phosphonomethoxy)-3-fluoropropyl]cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
151272361,71.2,458869,103727530,46232068,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"2-amino-6-ethyl-4-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321524634,71.3,659145,160699517,135981162,NULL,22464686,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation after 5 days relative to control,"11-amino-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-thia-3,5,10,12-tetrazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),4,11-tetraen-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103156799,71.5,429198,103688495,45270933,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-thiophen-2-yl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363953326,71.52,1498127,404660846,145955644,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833122,71.6,609572,103504725,135398513,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427703,72,393980,103504725,135398513,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237836768,72.7,611619,134442509,56665191,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,"2-(6-Aminopurin-9-yl)ethoxymethyl-[2-(9,10-dihydroxydecoxy)ethoxy]phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363855020,73,1451464,103504725,135398513,NULL,28829913,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980761,74,216300,103504725,135398513,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain 07,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100155448,74,217665,103504725,135398513,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100797508,74,216305,103504725,135398513,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient)-Varicella-Zoster virus 07/1 strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101081585,74,304884,103504725,135398513,NULL,18052321,Confirmatory,20181022,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK- VZV 07 in HEL cells after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546098,74,665385,103202903,446727,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
366392101,74.5,1572734,440120183,155517451,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-(4-hydroxyphenyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
151272360,74.6,458869,103727462,46231999,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"2-amino-4-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-6,7-dimethyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363955160,76.47,1498126,404668783,145961122,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356598,76.47,1727352,461550554,162668265,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(4-hydroxybut-1-ynyl)-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
204393645,76.5,574386,124973456,53325363,NULL,21256035,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Thymidine kinase-deficient Varicella-zoster virus 07-1 infected in HELF assessed as virus-induced cytopathogenicity after 5 days by microscopy,(2S)-N-[(1S)-2-amino-1-methyl-2-oxo-ethyl]-2-benzyl-1-(2-naphthylsulfonyl)azetidine-2-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393111,76.5,1572733,103567640,135433410,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,9-(4-Hydroxybutyl)guanine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833136,76.9,609573,103504725,135398513,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853779,77,258990,103476638,11601323,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"3-Methyl-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101700831,78,297306,103526530,44427752,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"6-(1-hydroxyhexyl)-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
366468779,78.06,1610151,440158842,155541259,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(2-hydroxyethyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515695,78.7,106003,103567639,135398748,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,Penciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100656764,79,216461,242582547,513044,NULL,11212118,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"6-Hept-6-ynyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363605565,79,1394845,404703993,145984706,NULL,29550734,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,"[(1S,2S,4S)-4-(6-aminopurin-9-yl)-2-hydroxycyclopentyl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
340060242,79.5,766703,174513753,136260455,NULL,23911856,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,2-amino-5-bromo-4-(2-hydroxy-2-methylpropyl)-1H-pyrimidin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101446236,79.6,392537,103513618,135440532,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-Amino-9-[[(1Z)-2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl]-9H-purine-6(1H)-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446255,79.6,392537,103513629,135458117,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,2-Amino-9-[[(1E)-2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl]-9H-purine-6(1H)-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101652309,79.6,282657,103513618,135440532,NULL,15615545,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Inhibition of VZV replication in HFF cells by CPE assay,2-Amino-9-[[(1Z)-2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl]-9H-purine-6(1H)-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101652717,79.6,282657,103513629,135458117,NULL,15615545,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Inhibition of VZV replication in HFF cells by CPE assay,2-Amino-9-[[(1E)-2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl]-9H-purine-6(1H)-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101427324,80,393980,103650149,25256973,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzhydryl-4-benzyloxy-5-methyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427326,80,393980,103650218,25258115,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-isobutyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427342,80,393979,103650399,25257205,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"4-Benzhydryloxy-5-benzyl-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427345,80,393979,103650219,25256977,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"4-Benzyloxyspiro[oxathiole-5,2'-tetralin] 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427707,80,393980,103650399,25257205,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"4-Benzhydryloxy-5-benzyl-5-ethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427718,80,393979,103650153,25256975,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-propyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427721,80,393979,103650510,25257436,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-[(4-nitrophenyl)methoxy]oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427726,80,393979,103650509,25257682,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"(5-Benzyl-5-ethyl-2,2-dioxo-oxathiol-4-yl) 4-methylbenzenesulfonate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427727,80,393979,103650149,25256973,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzhydryl-4-benzyloxy-5-methyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427729,80,393979,103650218,25258115,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-isobutyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427954,80,393980,103650509,25257682,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"(5-Benzyl-5-ethyl-2,2-dioxo-oxathiol-4-yl) 4-methylbenzenesulfonate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427968,80,393979,103650154,25256976,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-isopropyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101678410,80,291029,103520485,16732890,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"1-(2,6-Dimethoxy-5-methylpyrimidin-4-yl)-2-(4-fluorophenyl)propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101701375,80,297307,103526531,44427753,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-6-pent-4-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101445789,83.4,392537,103513628,6536767,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,[(2E)-2-[(6-aminopurin-9-yl)methylidene]-1-fluorocyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101652721,83.4,282657,103513628,6536767,NULL,15615545,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Inhibition of VZV replication in HFF cells by CPE assay,[(2E)-2-[(6-aminopurin-9-yl)methylidene]-1-fluorocyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
99402339,84,3059,103391801,3011369,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-[2,4-Diamino-5-(cyanomethyl)-6-oxo-pyrimidin-1-yl]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853253,87,258989,103476693,11588003,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"6-hex-1-ynyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853323,87,258990,103476632,11528737,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"Furo[2,3-d]pyrimidin-2(3H)-one, 6-(1-hexynyl)-3-methyl-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853743,87,258991,103476632,11528737,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"Furo[2,3-d]pyrimidin-2(3H)-one, 6-(1-hexynyl)-3-methyl-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100844056,88,216314,103184762,135972443,NULL,NULL,Confirmatory,20230629,0,0,Unspecified,NULL,ED50,=,ChEMBL,Effective dose required to inhibit cell growth against VZV (Ellen); Value ranges from 88-177,"2-amino-9-[(1S,3S)-2-fluoro-3,4-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678596,88,291030,103520491,12357924,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"5-Bromo-2,4-dimethoxy-6-methylpyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797589,88.4,1427826,381857116,137645201,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-benzoyl-1-[[(3S,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853252,89,258989,103476638,11601323,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"3-Methyl-6-oct-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853745,90,258991,103476693,11588003,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"6-hex-1-ynyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100676472,91.42,216459,242582180,489669,NULL,11814776,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,In vitro antiviral activity against Varicella zoster virus (VZV) was determined,"6-azido-5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]hexahydropyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321546096,92,665385,103504725,135398513,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363539703,93.8,1382166,103202903,446727,NULL,29407990,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833513,94,609572,134452420,136099207,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(2-amino-6-oxo-1H-purin-9-yl)ethoxy]-3-benzyloxy-propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468649,96,1610152,103504725,135398513,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204375988,97,553342,124971801,50993715,NULL,21128666,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV OKA expressing thymidine kinase infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,N1-[(Z)-4-bis(Pivaloyloxymethyl)phosphinyl-2-butenyl]-5-bromo-uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204387921,97,569235,124959235,51040856,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[1-(4-propan-2-ylphenyl)triazol-4-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698460,99,296672,103525530,16756192,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV YS in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(2-phenylethynyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101699129,99,296674,103202903,446727,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853324,99,258990,103202903,446727,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100515692,100,106003,103420360,23179385,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-Fluoro-1-[4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100515697,100,106003,103421392,44379069,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-ethyl-1-[(2S)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100515701,100,106003,103421890,44379285,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"5-(2,2-dichloro-1-fluoroethenyl)-1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100515705,100,106003,103421393,44379070,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2S)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-nitropyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100515706,100,106003,103420766,44378792,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[(2R)-4-hydroxy-5-(hydroxymethyl)thiolan-2-yl]-2,4-dioxopyrimidine-5-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100516386,100,106003,103420361,44378595,NULL,8576922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibitory activity against varicella zoster virus (VZV) strain G31 in MRC-5 cells.,"1-[4-Hydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-methoxypyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100589792,100,217498,103210570,13964461,NULL,2826784,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibition of growth of varicella zoster virus(VZV) by plaque reduction assay in vero cell line,"4-Amino-1-(1,3-dihydroxypropan-2-yloxymethyl)-5-methylpyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100589794,100,217498,103210698,3010089,NULL,2826784,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibition of growth of varicella zoster virus(VZV) by plaque reduction assay in vero cell line,"1-[(1,3-Dihydroxy-2-propoxy)methyl]-5-methyluracil",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100589795,100,217498,103210737,3000770,NULL,2826784,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibition of growth of varicella zoster virus(VZV) by plaque reduction assay in vero cell line,"1-[[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100589797,100,217498,103210735,3010094,NULL,2826784,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibition of growth of varicella zoster virus(VZV) by plaque reduction assay in vero cell line,"5-Bromo-1-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100589798,100,217498,103210697,13964469,NULL,2826784,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibition of growth of varicella zoster virus(VZV) by plaque reduction assay in vero cell line,"5-Amino-1-[(1,3-dihydroxy-2-propoxy)methyl]uracil",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100589799,100,217498,103210736,16729174,NULL,2826784,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibition of growth of varicella zoster virus(VZV) by plaque reduction assay in vero cell line,Iodacyclur,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100589800,100,217498,103210745,13964471,NULL,2826784,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibition of growth of varicella zoster virus(VZV) by plaque reduction assay in vero cell line,"1-(1,3-Dihydroxypropan-2-yloxymethyl)-4-(dimethylamino)pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100589801,100,217498,103211353,44283739,NULL,2826784,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Inhibition of growth of varicella zoster virus(VZV) by plaque reduction assay in vero cell line,"4-Amino-1-(1,3-dihydroxypropan-2-yloxymethyl)-5-iodopyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100812644,100,217644,103734863,472369,NULL,8387600,Confirmatory,20230629,0,0,Unspecified,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ellen strain),"1-[(3S,4R,5S)-4,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812777,100,217646,103504725,135398513,NULL,8387600,Confirmatory,20230629,0,0,Unspecified,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Kanno-Kohmura thymidine kinase deficient strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678404,100,291029,103520491,12357924,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"5-Bromo-2,4-dimethoxy-6-methylpyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678408,100,291029,103520482,136177299,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"(E)-1-(2,6-dimethoxypyrimidin-4-yl)-3,3,3-trifluoroprop-1-en-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678409,100,291029,103520489,136177300,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"(E)-2-(2,6-dimethoxypyrimidin-4-yl)-1-(4-fluorophenyl)ethenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678581,100,291030,103520476,16732726,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"6-(3-fluoro-2-hydroxy-2-methylpropyl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678582,100,291030,103520479,16732729,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"6-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678583,100,291030,103520478,16732728,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"3-(2,6-Dimethoxypyrimidin-4-yl)-1,1,1-trifluoro-2-methylpropan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678585,100,291030,103520483,135610881,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"(Z)-1-(2,6-dimethoxypyrimidin-4-yl)-3,3,4,4,4-pentafluorobut-1-en-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678586,100,291030,103520488,16732885,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"[1-(2,4-dioxo-1H-pyrimidin-6-yl)-3-(2-fluorophenyl)-2-methylpropan-2-yl] acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678588,100,291030,103520487,16732735,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"1-(2,6-Dimethoxypyrimidin-4-yl)-3-(2-fluorophenyl)-2-methylpropan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678591,100,291030,103520482,136177299,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"(E)-1-(2,6-dimethoxypyrimidin-4-yl)-3,3,3-trifluoroprop-1-en-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678593,100,291030,103520477,16732727,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"[1-(2,4-dioxo-1H-pyrimidin-6-yl)-3-fluoro-2-methylpropan-2-yl] acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678594,100,291030,103520492,16732575,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"6-Bromomethyl-2,4-dimethoxy-5-bromopyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678595,100,291030,103520474,16732577,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"1-(2,6-Dimethoxypyrimidin-4-yl)-3-fluoro-2-methylpropan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678598,100,291030,103520484,16732734,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"1-(2,6-Dimethoxypyrimidin-4-yl)-2-(4-fluorophenyl)propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678875,100,291029,103520487,16732735,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"1-(2,6-Dimethoxypyrimidin-4-yl)-3-(2-fluorophenyl)-2-methylpropan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678876,100,291029,103520476,16732726,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"6-(3-fluoro-2-hydroxy-2-methylpropyl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678877,100,291029,103520479,16732729,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"6-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678878,100,291029,103520490,16732889,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"2-(2,6-Dimethoxypyrimidin-4-yl)-1,1-bis(4-fluorophenyl)ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678879,100,291029,103520478,16732728,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"3-(2,6-Dimethoxypyrimidin-4-yl)-1,1,1-trifluoro-2-methylpropan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678880,100,291029,103520484,16732734,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"1-(2,6-Dimethoxypyrimidin-4-yl)-2-(4-fluorophenyl)propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678881,100,291029,103520474,16732577,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"1-(2,6-Dimethoxypyrimidin-4-yl)-3-fluoro-2-methylpropan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678882,100,291029,103520477,16732727,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"[1-(2,4-dioxo-1H-pyrimidin-6-yl)-3-fluoro-2-methylpropan-2-yl] acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678883,100,291029,103520492,16732575,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"6-Bromomethyl-2,4-dimethoxy-5-bromopyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678886,100,291029,103520483,135610881,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"(Z)-1-(2,6-dimethoxypyrimidin-4-yl)-3,3,4,4,4-pentafluorobut-1-en-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101678887,100,291029,103520488,16732885,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA assessed as reduction of plaque formation,"[1-(2,4-dioxo-1H-pyrimidin-6-yl)-3-(2-fluorophenyl)-2-methylpropan-2-yl] acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101679127,100,291030,103520490,16732889,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,"2-(2,6-Dimethoxypyrimidin-4-yl)-1,1-bis(4-fluorophenyl)ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698199,100,296674,103525547,16756528,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-hexylpyridin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698272,100,296675,103525546,16756757,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(5-pentylpyridin-2-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698276,100,296675,103525553,16756531,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-hexylpyrimidin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698277,100,296675,103525552,16756867,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(5-pentylpyrimidin-2-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698287,100,296675,103525544,16756756,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-butylpyridin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101699120,100,296674,103525552,16756867,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(5-pentylpyrimidin-2-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101699128,100,296674,103525553,16756531,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-hexylpyrimidin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101699131,100,296674,103525546,16756757,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(5-pentylpyridin-2-yl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101699132,100,296674,103525544,16756756,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"6-(5-butylpyridin-2-yl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101700832,100,297306,103526531,44427753,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days,"3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]-6-pent-4-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101701391,100,297307,103526530,44427752,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,"6-(1-hydroxyhexyl)-3-[(2Z)-2-[5-oxo-3,4-bis(phenylmethoxy)furan-2-ylidene]ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101921738,100,273053,103500325,135967821,NULL,17004726,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Inhibition of VZV replication in HFF cells by plaque reduction assay,"2-amino-7-[(E)-[(2S,3R)-2-fluoro-3-(hydroxymethyl)cyclopropylidene]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101922466,100,273052,103500376,135967823,NULL,17004726,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Inhibition of VZV replication in HFF cells by cytopathic effect assay,"2-amino-7-[(E)-[(2S,3S)-2-fluoro-3-(hydroxymethyl)cyclopropylidene]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
103156794,100,429198,103693769,44140465,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"6-(5-bromothiophen-2-yl)-3-(2-hydroxyethoxymethyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103156795,100,429198,103683202,44140466,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"6-(furan-2-yl)-3-(2-hydroxyethoxymethyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103156797,100,429198,103691947,45272643,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-(5-bromothiophen-2-yl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103156798,100,429198,103208535,60613,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103156800,100,429198,103690166,44140464,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"3-(2-hydroxyethoxymethyl)-6-thiophen-2-yl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103156802,100,429198,103684902,45269251,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-(furan-2-yl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272356,100,458869,103727460,46231997,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-(2-amino-3-cyano-6-ethyl-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridin-4-yl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272357,100,458869,103727459,46231996,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-(2-amino-3-cyano-7-methyl-5-oxo-4,6-dihydropyrano[3,2-c]pyridin-4-yl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272366,100,458869,103727533,54728122,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-[bis(4-hydroxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272560,100,458869,103727380,46231929,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella Zoster Virus OKA infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-(2-amino-3-cyano-6,7-dimethyl-5-oxo-4H-pyrano[3,2-c]pyridin-4-yl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272561,100,458870,103727380,46231929,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-(2-amino-3-cyano-6,7-dimethyl-5-oxo-4H-pyrano[3,2-c]pyridin-4-yl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272562,100,458870,103727532,54728121,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-[bis(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)methyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272566,100,458870,103727533,54728122,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-[bis(4-hydroxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272569,100,458870,103727529,46216757,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"2-amino-4-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-7-methyl-5-oxo-4,6-dihydropyrano[3,2-c]pyridine-3-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272570,100,458870,103727461,46231998,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-(2-amino-3-cyano-7-methyl-5-oxo-4H-pyrano[3,2-c]pyran-4-yl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272571,100,458870,103727462,46231999,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"2-amino-4-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-6,7-dimethyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272572,100,458870,103727530,46232068,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"2-amino-6-ethyl-4-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272573,100,458870,103727460,46231997,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-(2-amino-3-cyano-6-ethyl-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridin-4-yl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151272732,100,458870,103727459,46231996,NULL,20064723,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction of viral plaque formation,"[(2R,3S,5R)-3-acetyloxy-5-[5-(2-amino-3-cyano-7-methyl-5-oxo-4,6-dihydropyrano[3,2-c]pyridin-4-yl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204376489,100,553343,103202903,446727,NULL,21128666,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546097,100,665385,160673445,60167464,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-(5-cyclopentylpenta-1,3-diynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546434,100,665385,160689502,60167463,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(5-hydroxypenta-1,3-diynyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546438,100,665385,160668107,60167461,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-[4-(3,5-dimethoxyphenyl)buta-1,3-diynyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546439,100,665385,160668108,60167323,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-[4-(4-aminophenyl)buta-1,3-diynyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546441,100,665385,160668111,60167462,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-(6-hydroxyhepta-1,3-diynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546443,100,665385,160689503,60167465,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-(4-cyclopropylbuta-1,3-diynyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321546444,100,665385,160673443,60167322,NULL,22578783,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 infected in HEL cells assessed as reduction in virus-induced cytopathicity,"5-[4-(3-aminophenyl)buta-1,3-diynyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321548855,100,665760,160673605,70683866,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-octoxypurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548988,100,665760,160668294,66561485,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-butoxypurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321550097,100,665760,160668292,70681755,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-ethoxypurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321550098,100,665760,103570072,135409256,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,Filociclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
326010648,100,687665,163323280,71454686,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-[6-(allylamino)purin-9-yl]but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010652,100,687665,163326666,71456419,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-[6-(butylamino)purin-9-yl]but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010654,100,687665,163316355,71451094,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,"[[(E)-4-[2-amino-6-(4-isopropylanilino)purin-9-yl]but-2-enyl]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340060018,100,766703,174493052,136244491,NULL,23911856,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,"2-amino-5-bromo-4-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1H-pyrimidin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340060019,100,766703,174498187,136244581,NULL,23911856,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,2-amino-5-bromo-4-[2-hydroxy-2-[2-(trifluoromethyl)phenyl]ethyl]-1H-pyrimidin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340060020,100,766703,174513754,136260456,NULL,23911856,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,2-amino-5-bromo-4-[2-(4-chlorophenyl)-2-hydroxyethyl]-1H-pyrimidin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340060022,100,766703,174503446,136239353,NULL,23911856,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,2-amino-5-bromo-4-(2-phenylethyl)-1H-pyrimidin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340060241,100,766703,174508611,135480617,NULL,23911856,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction in the virus plaque formation,2-Amino-5-bromo-6-propyl-4(3H)-pyrimidinone,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
342786061,100,1139390,242637691,53363994,NULL,24690527,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation after 5 days,"N-[3-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2,4-dioxo-pyrimidin-5-yl]prop-2-ynyl]octanamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996069,100,1230101,318375202,122180138,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5S)-3-diethoxyphosphoryl-2-methyl-N-[2-(2-methylpropyl)-1,3-dioxobenzo[de]isoquinolin-5-yl]-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
346996279,100,1230100,318375202,122180138,NULL,26001344,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus expressing thymidine kinase infected in HEL cells assessed as reduction of virus-induced plaque formation,"(3R,5S)-3-diethoxyphosphoryl-2-methyl-N-[2-(2-methylpropyl)-1,3-dioxobenzo[de]isoquinolin-5-yl]-1,2-oxazolidine-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061810,100,1251996,318393369,122192827,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[2,6-dioxo-3-(5-phenoxypentyl)pyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061813,100,1251996,318393371,122192829,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[5-(3-bromophenoxy)pentyl]-2,6-dioxopyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061814,100,1251996,318393372,122192830,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[5-(4-cyanophenoxy)pentyl]-2,6-dioxopyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347061821,100,1251996,318393382,122192840,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"N-(4-benzoylphenyl)-2-[3-[5-(4-bromophenoxy)pentyl]-2,6-dioxopyrimidin-1-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347062306,100,1251996,318393385,122192843,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[2-[(4-bromophenyl)methoxy]ethoxymethyl]-2,6-dioxopyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347062308,100,1251996,318393378,122192836,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[5-(4-bromophenoxy)pentyl]-5-iodo-2,6-dioxopyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347062309,100,1251996,318393384,122192842,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[3-[4-[(4-bromophenyl)methoxy]butyl]-2,6-dioxopyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347062310,100,1251996,318393383,122192841,NULL,26443550,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-positive Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation,"2-[2,6-dioxo-3-(6-phenylhexyl)pyrimidin-1-yl]-N-(4-phenoxyphenyl)acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
347071078,100,1256245,318397967,137028558,NULL,26460883,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen VR-1367 infected in African green monkey Vero cells after 3 days by MTT assay,"2-Amino-9-[[(1,3-dihydroxypropane-2-yl)seleno]methyl]-9H-purine-6(1H)-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
347072631,100,1256245,318397966,137028557,NULL,26460883,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen VR-1367 infected in African green monkey Vero cells after 3 days by MTT assay,2-Amino-9-[[(2-hydroxyethyl)seleno]methyl]-9H-purine-6(1H)-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
363539697,100,1382166,404682397,145970273,NULL,29407990,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,"benzyl (2S)-2-[[[(E)-4-(5-fluoro-2,4-dioxopyrimidin-1-yl)but-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363693103,100,1407618,404697405,145980265,NULL,30098481,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation,"(2R,3S,4R,5R)-5-(4-chloropyrrolo[2,3-b]pyridin-1-yl)-3-ethynyl-2-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363796788,100,1427826,381847697,137638819,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-benzoyl-1-[[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797273,100,1427826,381860804,137647717,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]-3-[(3-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797279,100,1427826,381845673,137637476,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-Benzyl-1-[(3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363797590,100,1427826,381867664,137652337,NULL,27750154,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"1-[[(3S,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]methyl]-3-[(2-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810184,100,1433151,381884673,137660148,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,4-[4-(7-Chloroquinolin-4-yl)piperazin-1-yl]-2-methylsulfanyl-6-phenylpyrimidine-5-carbonitrile,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363810185,100,1433151,381851821,137641607,NULL,26114811,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK negative Varicella-zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect by visual scoring analysis,4-[4-(7-Chloroquinolin-4-yl)piperazin-1-yl]-2-methylsulfanyl-6-(4-nitrophenyl)pyrimidine-5-carbonitrile,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908717,100,1462035,381851962,137641700,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-methoxyphosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908718,100,1462035,381845056,137637070,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"2-(4-amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-N-[(2S)-1-ethoxy-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908720,100,1462035,381845878,137637615,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"1-[2-[Bis(2-octadecoxyethoxy)phosphorylmethoxy]ethyl]-4-(2-octadecoxyethylamino)-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908750,100,1462034,381851962,137641700,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-methoxyphosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908752,100,1462034,381845056,137637070,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,"2-(4-amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-N-[(2S)-1-ethoxy-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953313,100,1498127,404661536,145956113,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(Z)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-(5,6,7,8-tetrahydronaphthalen-1-yloxy)phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953315,100,1498127,404658463,145953988,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953317,100,1498127,404671908,145963264,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953319,100,1498127,404668783,145961122,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953320,100,1498127,404656825,145952865,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363953541,100,1498127,404670900,145962576,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-3-methyl-4-(5-methyl-2,4-dioxopyrimidin-1-yl)but-2-enyl]-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955152,100,1498126,404656825,145952865,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955153,100,1498126,404669141,145961361,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"benzyl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-naphthalen-1-yloxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363955159,100,1498126,404671908,145963264,NULL,29880251,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus infected in HEL cells assessed as reduction in virus plaque formation,"propan-2-yl (2S)-2-[[[(E)-4-(2,4-dioxopyrimidin-1-yl)-3-methylbut-2-enyl]-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366391631,100,1572734,440202621,155558753,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"6-(4-ethoxyphenyl)-3-[4-hydroxy-3-(hydroxymethyl)butyl]-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366391632,100,1572734,440148533,155535881,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-[4-(trifluoromethyl)phenyl]-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366391634,100,1572734,440126828,155521687,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"6-(4-fluorophenyl)-3-[4-hydroxy-3-(hydroxymethyl)butyl]-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366391635,100,1572734,440123415,155519569,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"6-(4-chlorophenyl)-3-[4-hydroxy-3-(hydroxymethyl)butyl]-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366391636,100,1572734,440131256,155524571,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-phenyl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366392094,100,1572734,440226930,155568331,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-(4-methylphenyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366392096,100,1572734,440133128,155525804,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-(4-methoxyphenyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366392098,100,1572734,103567640,135433410,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,9-(4-Hydroxybutyl)guanine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366392099,100,1572734,440143803,155532787,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-(4-phenoxyphenyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366392102,100,1572734,440141941,155531575,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,"6-(1,3-benzodioxol-5-yl)-3-[4-hydroxy-3-(hydroxymethyl)butyl]-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393109,100,1572733,440202621,155558753,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,"6-(4-ethoxyphenyl)-3-[4-hydroxy-3-(hydroxymethyl)butyl]-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393113,100,1572733,440123415,155519569,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,"6-(4-chlorophenyl)-3-[4-hydroxy-3-(hydroxymethyl)butyl]-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393114,100,1572733,440131256,155524571,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,"3-[4-hydroxy-3-(hydroxymethyl)butyl]-6-phenyl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393299,100,1572733,440126828,155521687,NULL,30738653,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,"6-(4-fluorophenyl)-3-[4-hydroxy-3-(hydroxymethyl)butyl]-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468557,100,1610152,440158842,155541259,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(2-hydroxyethyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468653,100,1610152,440178417,155549138,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(4-methoxyphenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468654,100,1610152,440132890,155525646,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(2-methoxyphenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468657,100,1610152,440210969,155562051,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(2R)-2-[(1S)-2-(4-cyclopropyltriazol-1-yl)-1-hydroxyethyl]-3,4-bis(phenylmethoxy)-2H-furan-5-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468774,100,1610151,440178417,155549138,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(4-methoxyphenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366468775,100,1610151,440165203,155543860,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(4-bromophenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366469305,100,1610151,440151216,155537643,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(5Z)-5-[2-[4-(3,5-difluorophenyl)triazol-1-yl]ethylidene]-3,4-bis(phenylmethoxy)furan-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366469307,100,1610151,440210969,155562051,NULL,31586832,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by Giemsa staining based microscopic analysis,"(2R)-2-[(1S)-2-(4-cyclopropyltriazol-1-yl)-1-hydroxyethyl]-3,4-bis(phenylmethoxy)-2H-furan-5-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
367489608,100,1661190,442059214,156018561,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2S)-1-(4-aminopyrimidin-2-yl)oxypropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489611,100,1661190,442057171,156017091,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,"pentyl (2S)-2-[[(5R)-5-[(4-amino-5-fluoropyrimidin-2-yl)oxymethyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489613,100,1661190,442055664,156016016,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2R)-1-(4-aminopyrimidin-2-yl)oxypropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489617,100,1661190,442051846,156013421,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2R)-1-(4-amino-5-fluoropyrimidin-2-yl)oxypropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489618,100,1661190,442050393,156012412,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,butyl (2S)-2-[[1-(4-aminopyrimidin-2-yl)oxypropan-2-yloxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489619,100,1661190,442053358,156014501,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,"pentyl (2S)-2-[[(5S)-5-[(4-aminopyrimidin-2-yl)oxymethyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489621,100,1661190,442047765,134382682,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,[(2S)-1-(4-aminopyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489786,100,1661190,442053327,156014477,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2S)-1-(4-amino-5-fluoropyrimidin-2-yl)oxypropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489787,100,1661190,442059611,156018828,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2S)-1-(4-amino-5-fluoropyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489790,100,1661190,442064468,156022189,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,"pentyl (2S)-2-[[(5S)-5-[(4-amino-5-fluoropyrimidin-2-yl)oxymethyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490052,100,1661189,442059214,156018561,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2S)-1-(4-aminopyrimidin-2-yl)oxypropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490054,100,1661189,442055664,156016016,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2R)-1-(4-aminopyrimidin-2-yl)oxypropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490055,100,1661189,442064468,156022189,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,"pentyl (2S)-2-[[(5S)-5-[(4-amino-5-fluoropyrimidin-2-yl)oxymethyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490058,100,1661189,442057171,156017091,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,"pentyl (2S)-2-[[(5R)-5-[(4-amino-5-fluoropyrimidin-2-yl)oxymethyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490059,100,1661189,442051846,156013421,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2R)-1-(4-amino-5-fluoropyrimidin-2-yl)oxypropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490268,100,1661189,442050393,156012412,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,butyl (2S)-2-[[1-(4-aminopyrimidin-2-yl)oxypropan-2-yloxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490269,100,1661189,442053358,156014501,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,"pentyl (2S)-2-[[(5S)-5-[(4-aminopyrimidin-2-yl)oxymethyl]-2-oxo-1,4,2lambda5-dioxaphosphinan-2-yl]amino]-3-methylbutanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490271,100,1661189,442053327,156014477,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2S)-1-(4-amino-5-fluoropyrimidin-2-yl)oxypropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490272,100,1661189,442059611,156018828,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,pentyl (2S)-2-[[[(2S)-1-(4-amino-5-fluoropyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethyl-phenoxyphosphoryl]amino]-3-methylbutanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490275,100,1661189,442047765,134382682,NULL,32676147,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,[(2S)-1-(4-aminopyrimidin-2-yl)oxy-3-fluoropropan-2-yl]oxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372127842,100,1684816,461550891,162668522,NULL,33479570,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-5-methoxyoxolan-2-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372127845,100,1684816,461529042,162653200,NULL,33479570,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"1-((2R,4R,5S)-3,3,5-Trifluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372127846,100,1684816,461520182,162647033,NULL,33479570,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-5-methoxyoxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372127851,100,1684816,461540405,162661207,NULL,33479570,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"benzyl (2S)-2-[[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxy-2-methoxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372128090,100,1684817,461520182,162647033,NULL,33479570,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-5-methoxyoxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372128091,100,1684817,461550891,162668522,NULL,33479570,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-5-methoxyoxolan-2-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372128325,100,1684817,461540405,162661207,NULL,33479570,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"benzyl (2S)-2-[[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxy-2-methoxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372128327,100,1684817,461529042,162653200,NULL,33479570,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,"1-((2R,4R,5S)-3,3,5-Trifluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372356601,100,1727352,461524919,162650339,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"3-[3-[(2R,4S,5R)-4-acetyloxy-5-(acetyloxymethyl)oxolan-2-yl]-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-5-yl]prop-2-ynyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
372356609,100,1727353,461515903,162643964,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(3-hydroxyprop-1-ynyl)-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
372356611,100,1727353,461550554,162668265,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"[(2R,3S,5R)-3-acetyloxy-5-[5-(4-hydroxybut-1-ynyl)-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-3-yl]oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
372357467,100,1727353,461524919,162650339,NULL,33039724,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus-induced cytopathogenic effect measured after 3 days coulter counter method,"3-[3-[(2R,4S,5R)-4-acetyloxy-5-(acetyloxymethyl)oxolan-2-yl]-6-(4-methylphenyl)-2-oxofuro[2,3-d]pyrimidin-5-yl]prop-2-ynyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Lung
373963053,100,1782673,469818262,164623124,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-(2-hydroxyethoxymethyl)-8-nonoxy-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963057,100,1782673,469806631,70853392,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-(2-hydroxyethoxymethyl)-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963058,100,1782673,469815030,164620757,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-10-methylpyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963060,100,1782673,469818816,164623503,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-[2-[bis(4-methoxyphenyl)-phenylmethoxy]ethoxymethyl]-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963061,100,1782673,469822615,164626042,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"2-[(5-Bromo-6-hydroxy-2-oxo-1,6-dihydropyrimidin-3-yl)methoxy]ethyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963062,100,1782673,469823366,164626347,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-(2-Hydroxyethoxymethyl)-10-methylpyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963063,100,1782673,469828381,164628867,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-10-methyl-8-octoxypyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963269,100,1782672,469820049,164624403,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963272,100,1782672,469822615,164626042,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"2-[(5-Bromo-6-hydroxy-2-oxo-1,6-dihydropyrimidin-3-yl)methoxy]ethyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963273,100,1782672,469823366,164626347,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-(2-Hydroxyethoxymethyl)-10-methylpyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963274,100,1782672,469818262,164623124,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-(2-hydroxyethoxymethyl)-8-nonoxy-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963275,100,1782672,469818816,164623503,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-[2-[bis(4-methoxyphenyl)-phenylmethoxy]ethoxymethyl]-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963278,100,1782672,469799189,164609319,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"5-Bromo-6-hydroxy-3-(2-hydroxyethoxymethyl)-1,6-dihydropyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963279,100,1782672,469806631,70853392,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-(2-hydroxyethoxymethyl)-10H-pyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373963280,100,1782672,469815030,164620757,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-10-methylpyrimido[5,4-b][1,4]benzoxazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
373964295,100,1782673,469799189,164609319,NULL,33894564,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus,"5-Bromo-6-hydroxy-3-(2-hydroxyethoxymethyl)-1,6-dihydropyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100157288,103,217667,103389895,493481,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV activity, the concentration of compounds in uM required to reduce VZV TK-07 (laboratory wild type strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(p-tolyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100676471,103.8,216459,242582170,489671,NULL,11814776,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,NULL,ChEMBL,In vitro antiviral activity against Varicella zoster virus (VZV) was determined,"6-azido-5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-hexahydropyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363493765,104.28,1361087,103202903,446727,NULL,29945100,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237837044,105.4,611619,103202903,446727,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427964,106,393980,103650587,25257895,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-[(4-methoxyphenyl)methoxy]oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372355557,106.44,1726781,461540780,162661450,NULL,34124679,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,"[1-(6-aminopurin-9-yl)-2-cyano-3-hydroxypropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
334015919,109,723372,164131118,50901484,NULL,23219702,Confirmatory,20220830,0,0,Unspecified,NULL,IC90,=,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human MRC5 cells assessed as inhibition of viral replication by viral reduction plaque assay,(S)-1-Phenyl-2-hydroxy-5-methyl-3-hexanone,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
99402337,110,3059,103391803,3011370,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-[2,6-Diamino-5-(cyanomethyl)pyrimidin-4-yl]oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204375570,110,553343,124971801,50993715,NULL,21128666,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 5 days,N1-[(Z)-4-bis(Pivaloyloxymethyl)phosphinyl-2-butenyl]-5-bromo-uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237733612,111,607916,103504725,135398513,NULL,21696963,Confirmatory,20180919,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R infected in human HEL cells assessed as reduction in the virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853249,113,258989,103476814,11515791,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hex-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613440,115.93,1869619,482059094,168277787,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,"[1-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)but-3-yn-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237837041,117,611619,134457981,56678864,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,9-[2-[Bis[2-[2-[2-[2-[2-(2-ethoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]phosphorylmethoxy]ethyl]purin-6-amine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010627,117,687665,103202903,446727,NULL,23047229,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427719,120,393979,103650587,25257895,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-[(4-methoxyphenyl)methoxy]oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101699122,120,296674,103525542,16756645,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-pentylphenyl)ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575955,120,675213,103202903,446727,NULL,22858222,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346510,123,217511,103389982,493483,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,=,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"6-(4-ethylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99647326,125,216464,103504725,135398513,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,=,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99981167,125,216301,103504725,135398513,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain YS-R,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100155589,125,217806,103504725,135398513,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100797225,125,216304,103504725,135398513,NULL,10866384,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,The compound was tested for its effective concentration required to reduce virus plaque formation by using TK (thymidine kinase -deficient) -Varicella-Zoster virus YS/R strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101081885,125,304885,103504725,135398513,NULL,18052321,Confirmatory,20181022,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK- VZV YS in HEL cells after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237837040,125,611619,134446383,56668651,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,2-[2-[2-[2-[2-[2-[2-(6-Aminopurin-9-yl)ethoxymethyl-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]phosphoryl]oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101854165,126,258991,103202903,446727,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363909042,128,1462035,381886953,137661674,NULL,28757102,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,"Sodium;2-(4-amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphinate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101697857,130,296675,103202903,446727,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698286,130,296675,103525540,16756295,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-propylphenyl)ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698743,130,296673,103525540,16756295,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-propylphenyl)ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363899311,131,1457768,103634155,473461,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,[(1s)-1-[(6-Aminopurin-9-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363493763,133.3,1361087,103504725,135398513,NULL,29945100,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853329,135,258990,103476693,11588003,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"6-hex-1-ynyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363642855,138,1402825,404718397,18650313,NULL,29268134,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK-defecient VZV 07-1 infected in HEL cells assessed as reduction in plaque formation after 5 days,"5-ethyl-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxidopyrazin-4-ium-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100413895,140,147626,103391803,3011370,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-[2,6-Diamino-5-(cyanomethyl)pyrimidin-4-yl]oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427701,140,393980,103202903,446727,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698197,140,296674,103525530,16756192,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(2-phenylethynyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698204,140,296674,103525538,16756294,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-methylphenyl)ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698274,140,296675,103525530,16756192,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(2-phenylethynyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698739,140,296673,103525530,16756192,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(2-phenylethynyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698741,140,296673,103525538,16756294,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[2-(4-methylphenyl)ethyl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
342786062,140,1139390,103504725,135398513,NULL,24690527,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella zoster virus 07-1 infected in HEL cells assessed as reduction in viral plaque formation after 5 days,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237836764,142,611619,134434814,56658261,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,"10-[2-[2-(6-Aminopurin-9-yl)ethoxymethyl-[2-(9,10-dihydroxydecoxy)ethoxy]phosphoryl]oxyethoxy]decane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
339886319,143.6,768205,103504725,135398513,NULL,23811093,Confirmatory,20180927,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK-positive Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99980756,144,216300,103202903,446727,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,=,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain 07,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853326,144,258990,103476814,11515791,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hex-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853726,144,258989,103476646,11631626,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hex-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853777,144,258990,103476646,11631626,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hex-1-ynylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339886326,144.9,768205,103202903,446727,NULL,23811093,Confirmatory,20180927,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK-positive Varicella-zoster virus 07-1 infected in human HEL cells assessed as reduction of plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99290484,150,3058,103202903,446727,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99402061,150,3059,103391812,3011373,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,4-Diamino-5-methyl-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402063,150,3059,103391697,3011380,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-[2,4-Diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidin-5-yl]acetic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402064,150,3059,103391766,3011368,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-benzyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402065,150,3059,103391925,3011371,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-[2,4-Diamino-5-(2-ethoxy-2-oxo-ethyl)-6-oxo-pyrimidin-1-yl]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402066,150,3059,103391487,11255143,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-prop-2-enylpyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402067,150,3059,103392290,11460885,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,4-Diamino-6-oxo-5-prop-2-enylpyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402338,150,3059,103391486,3011367,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,4-Diamino-5-benzyl-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402340,150,3059,103391777,3011375,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,4-Diamino-6-oxo-5-phenyl-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402341,150,3059,103391804,3011372,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"5-Pyrimidineacetic acid, 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-, ethyl ester",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402343,150,3059,103391775,3011376,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-phenyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402345,150,3059,103391698,3011379,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-[2,4-Diamino-6-oxo-1-[2-(phosphonomethoxy)ethyl]pyrimidin-5-yl]acetic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402346,150,3059,103391700,3011377,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,4-Diamino-5-cyclopropyl-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99402347,150,3059,103392326,3011381,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-bromo-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100033130,150,151172,103202903,446727,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,MCC,>,ChEMBL,Minimum cytotoxic concentration that causes alterations of VZV infected Osteosarcoma cell morphology,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100155444,150,217665,103202903,446727,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155582,150,217806,103202903,446727,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.",Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413043,150,147626,103391487,11255143,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-prop-2-enylpyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413045,150,147626,103391698,3011379,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-[2,4-Diamino-6-oxo-1-[2-(phosphonomethoxy)ethyl]pyrimidin-5-yl]acetic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413885,150,147626,103391486,3011367,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,4-Diamino-5-benzyl-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413887,150,147626,103391801,3011369,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-[2,4-Diamino-5-(cyanomethyl)-6-oxo-pyrimidin-1-yl]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413891,150,147626,103391766,3011368,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-benzyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413893,150,147626,103391697,3011380,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-[2,4-Diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidin-5-yl]acetic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413894,150,147626,103391775,3011376,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-phenyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413896,150,147626,103391777,3011375,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,4-Diamino-6-oxo-5-phenyl-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413897,150,147626,103391804,3011372,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"5-Pyrimidineacetic acid, 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-, ethyl ester",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413898,150,147626,103392326,3011381,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-bromo-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413899,150,147626,103392290,11460885,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,4-Diamino-6-oxo-5-prop-2-enylpyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413900,150,147626,103391925,3011371,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-[2,4-Diamino-5-(2-ethoxy-2-oxo-ethyl)-6-oxo-pyrimidin-1-yl]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100435532,150,216156,103202903,446727,NULL,14584954,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration against TK- Varicella-Zoster Virus (VZV) YS/R strain,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100435535,150,220080,103202903,446727,NULL,14584954,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against YS/R strain of thymidine kinase negative(TK-) Varicella-Zoster Virus (VZV),Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100436298,150,216155,103202903,446727,NULL,14584954,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration against TK- Varicella-Zoster Virus (VZV) 07/1 strain,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853245,150,258989,103476688,11515176,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"6-Dodec-1-ynyl-3-methylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853319,150,258990,103476688,11515176,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,"6-Dodec-1-ynyl-3-methylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853749,150,258991,103476688,11515176,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"6-Dodec-1-ynyl-3-methylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237733613,150,607916,103202903,446727,NULL,21696963,Confirmatory,20180919,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R infected in human HEL cells assessed as reduction in the virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372355550,150,1726781,461516362,162644297,NULL,34124679,Confirmatory,20220830,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,"[2-cyano-1-hydroxy-3-(5-methyl-2,4-dioxopyrimidin-1-yl)propan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
372355551,150,1726781,461548084,162666559,NULL,34124679,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,"[2-cyano-1-(2,4-dioxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
372355552,150,1726781,461548084,162666559,NULL,34124679,Confirmatory,20220830,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,"[2-cyano-1-(2,4-dioxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
372355553,150,1726781,461537135,162658895,NULL,34124679,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,"[1-(4-amino-2-oxopyrimidin-1-yl)-2-cyano-3-hydroxypropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
372355554,150,1726781,461537135,162658895,NULL,34124679,Confirmatory,20220830,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,"[1-(4-amino-2-oxopyrimidin-1-yl)-2-cyano-3-hydroxypropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
372355558,150,1726781,461540780,162661450,NULL,34124679,Confirmatory,20220830,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,"[1-(6-aminopurin-9-yl)-2-cyano-3-hydroxypropan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
372355559,150,1726781,461516362,162644297,NULL,34124679,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,"[2-cyano-1-hydroxy-3-(5-methyl-2,4-dioxopyrimidin-1-yl)propan-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
380613433,150,1869619,482047271,168269372,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,"[1-(4-amino-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)but-3-yn-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613441,150,1869619,482059094,168277787,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,"[1-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)but-3-yn-2-yl]oxymethylphosphonic acid;N,N-diethylethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613542,150,1869619,482065549,168282507,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,"N,N-diethylethanamine;[1-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)but-3-yn-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100614252,154,216159,103409193,135480760,NULL,1846922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Compound was tested for its antiviral activity against VZV (Ellen) using plaque reduction assay.,"2-amino-9-(2,3-dihydroxypropoxy)-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427705,155,393980,103650151,25256974,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"4-Benzyloxy-5,5-diethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103157267,157,429198,103202903,446727,NULL,19339082,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathicity after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100156173,162,217669,103390284,493480,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,=,ChEMBL,"Evaluated for the anti-VZV, the concentration required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-phenyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427716,168,393979,103650297,25257201,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-methoxy-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101678236,168,291030,103202903,446727,NULL,17539622,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 assessed as reduction of plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101701379,168,297307,103202903,446727,NULL,17672445,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237833125,168,609572,134452421,56673536,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,2-[2-(4-Amino-2-oxo-pyrimidin-1-yl)ethoxy]propylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99402062,170,3059,103169192,464205,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,Tenofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413892,170,147626,103169192,464205,NULL,14584956,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,Tenofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363642853,174,1402825,404708498,145987778,NULL,29268134,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK-defecient VZV 07-1 infected in HEL cells assessed as reduction in plaque formation after 5 days,"5-ethyl-1-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxidopyrazin-4-ium-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427340,175,393979,103650151,25256974,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"4-Benzyloxy-5,5-diethyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853728,175,258989,103476639,11666388,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"6-Dec-1-ynyl-3-methylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853739,175,258991,103476639,11666388,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,"6-Dec-1-ynyl-3-methylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363605562,175,1394845,404704204,145984867,NULL,29550734,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,"propan-2-yl (2S)-2-[[[(1S,3R,4R)-3-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxycyclopentyl]oxymethyl-[[(2S)-1-oxo-1-propan-2-yloxypropan-2-yl]amino]phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321548860,180,665760,160705786,70696459,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(dimethylamino)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100346512,188,217511,103389896,493482,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,=,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-propylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100445933,190,217516,103197694,135432844,NULL,8496903,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain,(E)-9-(4-Phosphonobut-3-enyl)guanine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103135055,191,419666,103688999,135966066,NULL,19410465,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella zoster virus in HFF assessed as inhibition of virus-induced cytopathic effect,2-[(2E)-2-[(2-amino-6-oxo-1H-purin-9-yl)methylene]-1-(hydroxymethyl)cyclopropyl]ethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833514,197,609572,134436938,136208038,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,[3-hydroxy-2-[2-(6-oxo-1H-purin-9-yl)ethoxy]propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427341,199,393979,103650300,25257678,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"2-(5-Benzyl-5-ethyl-2,2-dioxo-oxathiol-4-yl)oxyacetonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427706,199,393980,103650300,25257678,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"2-(5-Benzyl-5-ethyl-2,2-dioxo-oxathiol-4-yl)oxyacetonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99647321,200,216463,242582549,492105,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oct-7-enyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647322,200,216463,242582561,492107,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pent-4-ynyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647329,200,216464,242582561,492107,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pent-4-ynyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647331,200,216464,242582548,492104,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"6-Hex-5-enyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647332,200,216464,242582557,492103,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pent-4-enyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647334,200,216464,242582560,492106,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"6-Dec-9-enyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647336,200,216464,242582546,492109,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oct-7-ynyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647337,200,216464,242582562,492108,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"6-Hex-5-ynyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647338,200,216464,242582547,513044,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (YSR strain),"6-Hept-6-ynyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647518,200,216463,242582557,492103,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pent-4-enyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647520,200,216463,242582560,492106,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"6-Dec-9-enyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647522,200,216463,242582547,513044,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"6-Hept-6-ynyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647523,200,216463,242582548,492104,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"6-Hex-5-enyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647528,200,216463,242582546,492109,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oct-7-ynyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99647529,200,216463,242582562,492108,NULL,11212118,Confirmatory,20180930,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of thymidine kinase deficient Varicella-Zoster Virus (071 strain),"6-Hex-5-ynyl-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99668560,200,218491,242582679,513144,NULL,14643358,Confirmatory,20181001,0,0,Unspecified,NULL,EC50,>=,ChEMBL,Antiviral activity evaluated against thymidine kinase competent(TK+) Varicella Zoster virus (07),"6-[9-(4-chlorobutoxy)nonyl]-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99980762,200,216300,103389866,493473,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain 07,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-nonyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99981161,200,216301,103389866,493473,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain YS-R,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-nonyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100033007,200,151170,103391811,11438492,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,CC50,>,ChEMBL,Cytotoxic concentration that causes growth inhibition of VZV infected Osteosarcoma cells,"5-Bromo-1-((1R,3S,4S,6S)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100033009,200,151170,103391439,10406438,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,CC50,>,ChEMBL,Cytotoxic concentration that causes growth inhibition of VZV infected Osteosarcoma cells,"1-((1R,3S,4S,6S)-4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-5-iodo-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100033011,200,151170,103391381,9906078,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,CC50,>,ChEMBL,Cytotoxic concentration that causes growth inhibition of VZV infected Osteosarcoma cells,"5-(2-Bromo-vinyl)-1-((1S,2S,4S,5R)-4-hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100033128,200,151172,103504725,135398513,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,MCC,>,ChEMBL,Minimum cytotoxic concentration that causes alterations of VZV infected Osteosarcoma cell morphology,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100155440,200,217665,103389866,493473,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-nonyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100155581,200,217806,103389866,493473,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZVTK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-nonyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100156087,200,217668,103389895,493481,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration of compounds in uM required to reduce VZV TK-YS-R ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(p-tolyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100156326,200,217666,103390284,493480,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Evaluated for the anti-VZV, the concentration required to reduce VZV TK -07 ( thymidine kinase-deficient strain ) plaque formation after 5 days in HEL cell cultures compared to untreated controls.","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-phenyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100345427,200,217512,103389866,493473,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-nonyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345428,200,217512,103390284,493480,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-phenyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345435,200,217512,103389895,493481,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(p-tolyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100345438,200,217512,103389982,493483,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,=,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","6-(4-ethylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100346508,200,217511,103389866,493473,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,>,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-nonyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346509,200,217511,103390284,493480,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,>,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-phenyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346514,200,217511,103504725,135398513,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,>,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346519,200,217511,103389810,493485,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,>,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,Unii-5xgi48Q2DH,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346520,200,217511,103389895,493481,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,>,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(p-tolyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346521,200,217511,103389872,493488,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,>,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-(4-octylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346522,200,217511,103389990,493484,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,>,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"6-(4-butylphenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346942,200,217512,103390412,507243,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,=,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ","6-(4-chlorophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100346943,200,217512,103504725,135398513,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ",Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656756,200,216461,242582557,492103,NULL,11212118,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus (OKA strain),"3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pent-4-enyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100656963,200,216462,242582557,492103,NULL,11212118,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,"Effective concentration required for reduction of plaque formation of Varicella-Zoster Virus, (YS strain)","3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-pent-4-enyl-3H-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100812641,200,217644,103734866,472371,NULL,8387600,Confirmatory,20230629,0,0,Unspecified,NULL,ID50,=,ChEMBL,Antiviral activity against Varicella zoster virus (Ellen strain),"4-amino-1-[(3S,4R,5S)-4,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]-5-methyl-pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101081584,200,304884,103202903,446727,NULL,18052321,Confirmatory,20181022,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK- VZV 07 in HEL cells after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101081886,200,304885,103202903,446727,NULL,18052321,Confirmatory,20181022,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK- VZV YS in HEL cells after 5 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101853725,217,258989,103476632,11528737,NULL,16392824,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,"Furo[2,3-d]pyrimidin-2(3H)-one, 6-(1-hexynyl)-3-methyl-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237836758,224,611619,134454145,56675521,NULL,21565516,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,"2-(6-Aminopurin-9-yl)ethoxymethyl-(9,10-dihydroxydecoxy)phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
363605570,247,1394845,404706141,145986222,NULL,29550734,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,"[(1S,3R,4R)-3-hydroxy-4-(5-methyl-2,4-dioxopyrimidin-1-yl)cyclopentyl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99597717,250,216316,103184762,135972443,NULL,NULL,Confirmatory,20180908,0,0,Unspecified,NULL,IC50,>,ChEMBL,In vitro antiviral activity was evaluated against VZV using viral plaque reduction assay,"2-amino-9-[(1S,3S)-2-fluoro-3,4-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613496,253.29,1869613,482046961,168269159,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK- infected in HEL cells assessed as reduction in virus plaque formation,"N,N-diethylethanamine;[1-hydroxy-2-methyl-3-(5-methyl-2,4-dioxopyrimidin-1-yl)propan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100428355,270,81923,160687776,3006682,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"(Z)-2,6-Diamino-9-{[2,2-bis(hydroxymethyl)cyclopropylidene]methyl}purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
204387929,270,569235,124961858,53319504,NULL,21232828,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV 07-1 infected in HEL cells assessed as inhibition of plaque formation,"5-(1-Phenyl-1H-1,2,3-triazole-4-yl)-2'-deoxyuridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
380613493,270.09,1869612,482084699,168295876,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK+ infected in HEL cells assessed as reduction in virus plaque formation,"N,N-diethylethanamine;[1-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-2-methylpropan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613497,275.83,1869613,103504725,135398513,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK- infected in HEL cells assessed as reduction in virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100445936,280,217516,103197789,473139,NULL,8496903,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain,9-(2-(Phosphonomethoxy)ethoxy)adenine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427713,285,393980,103650297,25257201,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-5-ethyl-4-methoxy-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100843262,286,216309,103185540,44273065,NULL,NULL,Confirmatory,20230629,0,0,Unspecified,NULL,ED50,=,ChEMBL,Effective dose required to inhibit cell growth against VZV (Ellen),"5-[(E)-2-bromoethenyl]-1-[(1S,3S)-2-fluoro-3,4-bis(hydroxymethyl)cyclobutyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99981160,300,216301,103202903,446727,NULL,10579812,Confirmatory,20181016,0,0,Unspecified,NULL,EC50,>,ChEMBL,Compound was evaluated for the inhibition of VZV (TK-) thymidine kinases Strain YS-R,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100364851,300,217508,242582465,488243,NULL,11585457,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Inhibition of viral cytopathic effect in infected human foreskin fibroblast cell in monolayers of VZV Ellen Vero cells by 50%,"5-(2-Azido-1-methoxy-ethyl)-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100812670,300,217647,103734857,6475209,NULL,8387600,Confirmatory,20230629,0,0,Unspecified,NULL,ID50,>,ChEMBL,Antiviral activity against Varicella zoster virus (Kanno-Kohmura thymidine kinase deficient strain),"5-(2-Bromoethenyl)-1-(tetrahydro-4,5-bis(hydroxymethyl)-3-furanyl)-2,4(1H,3H)-pyrimidinedione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101641194,300,279714,103511701,16078858,NULL,17130297,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV Ellen in HFF cell by CPE assay,[(Z)-5-(6-aminopurin-9-yl)pent-3-enyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101641195,300,279714,103528770,16078860,NULL,17130297,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV Ellen in HFF cell by CPE assay,"[(Z)-5-(2,4-dioxopyrimidin-1-yl)pent-3-enyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101641202,300,279714,103511709,16078862,NULL,17130297,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV Ellen in HFF cell by CPE assay,"[(Z)-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)pent-3-enyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
103135054,300,419666,103682027,135965916,NULL,19410465,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella zoster virus in HFF assessed as inhibition of virus-induced cytopathic effect,2-amino-9-[(E)-(6-hydroxy-6-oxo-7-oxa-6$l^{5}-phosphaspiro[2.5]octan-2-ylidene)methyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103135057,300,419666,103687259,135966025,NULL,19410465,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella zoster virus in HFF assessed as inhibition of virus-induced cytopathic effect,2-amino-9-[(Z)-(6-hydroxy-6-oxo-7-oxa-6$l^{5}-phosphaspiro[2.5]octan-2-ylidene)methyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
198378437,300,534207,123091208,11548272,NULL,18852272,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in HFF cells by plaque reduction assay,2-(4-amino-2-oxo-pyrimidin-1-yl)ethoxymethyl-(3-hexadecoxypropoxy)phosphinic Acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
198378438,300,534207,103208564,451929,NULL,18852272,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in HFF cells by plaque reduction assay,2-Phosphonylmethoxyethylcytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
224518061,300,595576,131284141,53232136,NULL,21376429,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,[(E)-(4-bromo-2-fluoro-phenyl)methyleneamino]thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
224518062,300,595576,131284141,53232136,NULL,21376429,Confirmatory,20220830,0,0,Unspecified,NULL,EC90,>,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,[(E)-(4-bromo-2-fluoro-phenyl)methyleneamino]thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
237833522,300,609572,134448542,136026151,NULL,21745746,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(2-amino-6-oxo-1H-purin-9-yl)ethoxy]-3-hydroxy-propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321398977,300,654142,160693766,57520880,NULL,22417649,Confirmatory,20180921,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV infected in HFF assessed as reduction in virus induced cytopathic effect,[(2Z)-2-[(2-aminopurin-9-yl)methylene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
321548848,300,665760,160678935,70686005,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-cyclopentylsulfanylpurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548850,300,665760,160689665,70690162,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-butylsulfanylpurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548857,300,665760,160673602,70683865,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(cyclohexylamino)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548859,300,665760,160689664,9973369,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-propylsulfanylpurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548861,300,665760,160673601,70683864,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(propylamino)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548979,300,665760,160695102,70692319,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-morpholin-4-ylpurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548982,300,665760,160695103,70692320,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-hexylsulfanylpurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548983,300,665760,160700485,70694377,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(butylamino)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548984,300,665760,160700487,70694379,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-pyrrolidin-1-ylpurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548990,300,665760,160684293,70688129,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(methylamino)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548991,300,665760,160700488,70694380,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,"[(2Z)-2-[[2-amino-6-(2,2,2-trifluoroethoxy)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548992,300,665760,103517684,30976,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,"2,6-Diaminopurine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321548993,300,665760,160668293,9972226,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-prop-2-enoxypurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321550096,300,665760,160668291,70681754,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(2-methylpropylamino)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321550099,300,665760,160705785,70696458,NULL,22607883,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[[2-amino-6-(propan-2-ylamino)purin-9-yl]methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
334012640,300,722677,164130743,71508432,NULL,23176752,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella-zoster virus infected in human HFF cells assessed as reduction of viral replication,"(1S,2R,3S,4R)-4-(4-amino-7-chloro-imidazo[4,5-c]pyridin-1-yl)cyclopentane-1,2,3-triol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
103135053,301,419666,103464367,135435109,NULL,19410465,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella zoster virus in HFF assessed as inhibition of virus-induced cytopathic effect,"2-amino-9-[(Z)-(6-hydroxy-6-oxo-5,7-dioxa-6$l^{5}-phosphaspiro[2.5]octan-2-ylidene)methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363605569,303,1394845,404704648,145985197,NULL,29550734,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,"[(1S,3R,4R)-3-(6-aminopurin-9-yl)-4-hydroxycyclopentyl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427715,306,393979,103650152,25258114,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-methyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100364855,322,217508,242582460,488242,NULL,11585457,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Inhibition of viral cytopathic effect in infected human foreskin fibroblast cell in monolayers of VZV Ellen Vero cells by 50%,"5-(2-Azido-1-hydroxy-ethyl)-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,50,10335,NULL,NULL
100428353,322,81923,103651540,3006050,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,[2-(2-Amino-6-methoxy-purin-9-ylmethylene)-1-hydroxymethyl-cyclopropyl]-methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
380613495,324.44,1869612,482046961,168269159,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against VZV TK+ infected in HEL cells assessed as reduction in virus plaque formation,"N,N-diethylethanamine;[1-hydroxy-2-methyl-3-(5-methyl-2,4-dioxopyrimidin-1-yl)propan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363605564,327,1394845,404701762,145983124,NULL,29550734,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,"[(1S,2S,4S)-4-(4-amino-2-oxopyrimidin-1-yl)-2-hydroxycyclopentyl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363605571,327,1394845,404704285,59795816,NULL,29550734,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,"[(1S,3R,4R)-3-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxycyclopentyl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899302,328,1457768,103634156,473462,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,[(1r)-1-[(6-Aminopurin-9-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100428357,331,81923,103401742,11174144,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"(E)-2-Amino-6-cyclopropylamino-9-{[2,2-bis(hydroxymethyl)cyclopropylidene]methyl}purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
363899312,338,1457768,103572234,11587603,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,"[(2R)-1-fluoro-3-(5-methyl-2,4-dioxopyrimidin-1-yl)propan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899544,338,1457768,160705411,11507634,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,"[(2S)-1-fluoro-3-(5-methyl-2,4-dioxopyrimidin-1-yl)propan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613498,339.91,1869613,482084699,168295876,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against VZV TK- infected in HEL cells assessed as reduction in virus plaque formation,"N,N-diethylethanamine;[1-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-2-methylpropan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899306,356,1457768,381843413,101656591,NULL,28682067,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,1-[(R)-2-(Phosphonomethoxy)-3-fluoropropyl]cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100428358,357,81923,103401743,135434793,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"(E)-9-{[2,2-Bis(hydroxymethyl)cyclopropylidene]methyl}guanine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100833401,377,217678,312365510,135702462,NULL,1849998,Confirmatory,20230629,0,0,Unspecified,NULL,ID50,>,ChEMBL,compound was tested for antiherpes activity against VZV(Ellen) in tissue culture by plaque reduction assay,"2-amino-9-[(1S,2S,3R)-2,3-bis(hydroxymethyl)cyclobutyl]-3H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100428686,380,81923,103570072,135409256,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,Filociclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101446233,380,392537,103401743,135434793,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"(E)-9-{[2,2-Bis(hydroxymethyl)cyclopropylidene]methyl}guanine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446257,380,392537,103570072,135409256,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,Filociclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101698659,380,296673,103525537,501705,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-phenethyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103135056,380,419666,103570072,135409256,NULL,19410465,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against Varicella zoster virus in HFF assessed as inhibition of virus-induced cytopathic effect,Filociclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100614251,390,216159,103408936,135480761,NULL,1846922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Compound was tested for its antiviral activity against VZV (Ellen) using plaque reduction assay.,"2-amino-9-(3,4-dihydroxybutoxy)-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100615085,390,216159,103408856,135480765,NULL,1846922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Compound was tested for its antiviral activity against VZV (Ellen) using plaque reduction assay.,2-Amino-9-[(R)-3-hydroxy-1-hydroxymethylpropyloxy]-9H-purin-6(1H)-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100033010,400,151170,103202903,446727,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,CC50,>,ChEMBL,Cytotoxic concentration that causes growth inhibition of VZV infected Osteosarcoma cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100155609,400,217503,103202903,446727,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,CC50,>,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100156172,400,217504,103202903,446727,NULL,11150169,Confirmatory,20200703,0,0,Unspecified,NULL,MCC,>,ChEMBL,"Minimal cytotoxic concentration, the concentration required to cause a microscopically visible alteration of normal cell morphology. ",Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100833403,400,217678,103205237,44280600,NULL,1849998,Confirmatory,20230629,0,0,Unspecified,NULL,ID50,>,ChEMBL,compound was tested for antiherpes activity against VZV(Ellen) in tissue culture by plaque reduction assay,[(1S)-3-(6-aminopurin-9-yl)-2-(hydroxymethyl)cyclobutyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101427349,400,393979,103650508,25257435,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"(5-Benzyl-5-ethyl-2,2-dioxo-oxathiol-4-yl) benzoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427702,400,393980,103650153,25256975,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-propyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427704,400,393980,103650508,25257435,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"(5-Benzyl-5-ethyl-2,2-dioxo-oxathiol-4-yl) benzoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427712,400,393980,103650152,25258114,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"5-Benzyl-4-benzyloxy-5-methyl-oxathiole 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427955,400,393980,103650301,25257204,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed reduction in viral plaque formation,"Methyl 2-(5-benzyl-5-ethyl-2,2-dioxo-oxathiol-4-yl)oxyacetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101427973,400,393979,103650301,25257204,NULL,19226140,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed reduction in viral plaque formation,"Methyl 2-(5-benzyl-5-ethyl-2,2-dioxo-oxathiol-4-yl)oxyacetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100428352,404,81923,103401705,3006039,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,[2-(6-Amino-purin-9-ylmethylene)-1-hydroxymethyl-cyclopropyl]-methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101445793,404,392537,103401705,3006039,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,[2-(6-Amino-purin-9-ylmethylene)-1-hydroxymethyl-cyclopropyl]-methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100843261,411,216309,103185530,44273062,NULL,NULL,Confirmatory,20230629,0,0,Unspecified,NULL,ED50,>,ChEMBL,Effective dose required to inhibit cell growth against VZV (Ellen),"4-amino-1-[(1S,4S)-2-fluoro-3,4-bis(hydroxymethyl)cyclobutyl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363642850,412,1402825,404715123,6454221,NULL,29268134,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK-defecient VZV 07-1 infected in HEL cells assessed as reduction in plaque formation after 5 days,"1,2-Dihydro-1-(2-deoxy-beta-erythro-pentofuranosyl)-2-oxo-5-methylpyrazine-4-oxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100615084,415,216159,103408881,135480762,NULL,1846922,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,>,ChEMBL,Compound was tested for its antiviral activity against VZV (Ellen) using plaque reduction assay.,"2-amino-9-[(2R)-2,3-dihydroxypropoxy]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100428354,420,81923,103402105,6319959,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"(Z)-1-{[2,2-Bis(hydroxymethyl)cyclopropylidene]methyl}thymine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100428682,420,81923,103402030,5271343,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"(E)-1-{[2,2-bis-(hydroxymethyl)-cyclopropylidene]methyl}thymine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101445783,420,392537,103402105,6319959,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"(Z)-1-{[2,2-Bis(hydroxymethyl)cyclopropylidene]methyl}thymine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363642849,438,1402825,404711505,13604374,NULL,29268134,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK-defecient VZV 07-1 infected in HEL cells assessed as reduction in plaque formation after 5 days,"1,2-dihydro-1-(2deoxy-beta-D-erythro-pentofuranosyl)-2-oxopyrazine 4-oxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363642851,438,1402825,404698197,22794317,NULL,29268134,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against TK-defecient VZV 07-1 infected in HEL cells assessed as reduction in plaque formation after 5 days,"1,2-Dihydro-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-2-oxopyrazine 4-oxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101446252,442,392537,103513633,6536769,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[(E)-[2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl]-5-methylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101652311,442,282657,103513633,6536769,NULL,15615545,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Inhibition of VZV replication in HFF cells by CPE assay,"1-[(E)-[2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl]-5-methylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100428359,448,81923,103402143,5495576,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"4-amino-1-[(Z)-[2,2-bis(hydroxymethyl)cyclopropylidene]methyl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
100428684,448,81923,103402028,3006047,NULL,14736238,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,In vitro effective concentration required to inhibit varicella zoster virus (VZV) replication in HFF cell line,"4-amino-1-[(E)-[2,2-bis(hydroxymethyl)cyclopropylidene]methyl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101446234,448,392537,103402143,5495576,NULL,19112024,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Varicella zoster virus,"4-amino-1-[(Z)-[2,2-bis(hydroxymethyl)cyclopropylidene]methyl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100033008,488,151170,103504725,135398513,NULL,14584954,Confirmatory,20181018,0,0,Unspecified,NULL,CC50,=,ChEMBL,Cytotoxic concentration that causes growth inhibition of VZV infected Osteosarcoma cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101699130,560,296674,103525537,501705,NULL,17622128,Confirmatory,20220830,0,0,Unspecified,NULL,EC50,>,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-phenethyl-furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
204393642,858,574386,124970860,53324053,NULL,21256035,Confirmatory,20220830,0,0,Unspecified,NULL,IC50,=,ChEMBL,Antiviral activity against Thymidine kinase-deficient Varicella-zoster virus 07-1 infected in HELF assessed as virus-induced cytopathogenicity after 5 days by microscopy,phenyl (2S)-2-[[(1S)-2-amino-1-methyl-2-oxo-ethyl]carbamoyl]-2-benzyl-azetidine-1-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204212571,2000,544073,124962547,10313073,NULL,18644965,Confirmatory,20180916,0,0,Unspecified,NULL,EC50,=,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells,2-Amino-2-hydroxy-acetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99350845,NULL,3061,103391699,3011378,NULL,14584956,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against 07/1 strain of VZV; ND=No data,"2-(2,6-Diamino-5-cyclopropyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99350937,NULL,3060,103392354,3011382,NULL,14584956,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against 07/1 strain of VZV; ND: No data,"2-(2,6-Diamino-5-chloro-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99591885,NULL,216297,103217117,489848,NULL,NULL,Literature-derived,20180908,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Effect on replication of varicella zoster virus at a concentration of 300 uM; NE=No effect,[2-[(6-Aminopurin-9-yl)amino]-2-oxo-ethoxy]methylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99591886,NULL,216297,103217151,44286506,NULL,NULL,Literature-derived,20180908,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Effect on replication of varicella zoster virus at a concentration of 300 uM; NE=No effect,2-[(6-Aminopurin-9-yl)amino]ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99596159,NULL,216321,103296258,136026542,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Tested for the concentration at which compound showed activity against its effect on replication of varicella zoster virus,3-[(2-amino-6-oxo-1H-purin-9-yl)oxy]prop-1-ynylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99600117,NULL,216138,103208535,60613,NULL,NULL,Literature-derived,20180908,0,0,Active,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient varicella Zoster virus; active,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99602195,NULL,217513,103175583,135511260,NULL,NULL,Literature-derived,20180908,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus (VZV); no activity,Phosphonate deriv,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99602196,NULL,217513,103175442,135511261,NULL,NULL,Literature-derived,20180908,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus (VZV); no activity,"[(3R,6S)-3-(2-amino-6-oxo-1H-purin-9-yl)-3,6-dihydro-2H-pyran-6-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99607694,NULL,216327,103208673,44282520,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiherpes activity against Varicella zoster virus(OKA) in HEL cells,"4-Amino-1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99607695,NULL,216327,103208138,44282166,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiherpes activity against Varicella zoster virus(OKA) in HEL cells,"1-[4,5-Dihydroxy-6-(hydroxymethyl)oxan-3-yl]-5-iodopyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99607696,NULL,216327,103208672,44282519,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiherpes activity against Varicella zoster virus(OKA) in HEL cells,"1-[4,5-Dihydroxy-6-(hydroxymethyl)oxan-3-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99607697,NULL,216327,103504725,135398513,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiherpes activity against Varicella zoster virus(OKA) in HEL cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99608858,NULL,216315,103267191,135446845,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested in vitro for antiviral activity against Varicella zoster virus (VZV) in ellen cells.,9-(4-Phosphonobutoxy)guanine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99608859,NULL,216315,103267219,19808598,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested in vitro for antiviral activity against Varicella zoster virus (VZV) in ellen cells.,"[3-[(2,6-Diaminopurin-9-yl)oxymethyl]-4-hydroxybutyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99608860,NULL,216315,103267835,135446846,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested in vitro for antiviral activity against Varicella zoster virus (VZV) in ellen cells.,[3-[(2-Amino-6-hydroxy-purin-9-yl)oxymethyl]-4-hydroxy-butyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99608861,NULL,216315,103267834,3009294,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested in vitro for antiviral activity against Varicella zoster virus (VZV) in ellen cells.,"4-(2,6-Diaminopurin-9-yl)oxybutylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99608862,NULL,216315,103267409,3009295,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested in vitro for antiviral activity against Varicella zoster virus (VZV) in ellen cells.,[3-[(6-Aminopurin-9-yl)oxymethyl]-4-hydroxy-butyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99608863,NULL,216315,103267793,461343,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested in vitro for antiviral activity against Varicella zoster virus (VZV) in ellen cells.,4-(6-Aminopurin-9-yl)oxybutylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99610277,NULL,216296,163329925,71458128,NULL,NULL,Literature-derived,20180908,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against VZV; Not active,"1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99610278,NULL,216296,163316123,71450956,NULL,NULL,Literature-derived,20180908,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against VZV; Not active,"1-[(2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99615077,NULL,216329,312365067,118718444,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration for antiviral activity was tested against Varicella-Zoster virus(VZV),"(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]-N-[(1R,3S,4S,8R,9R,10R)-9-methoxy-12,12-dimethyl-2,5,7,11,13-pentaoxatricyclo[8.4.0.03,8]tetradecan-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99615078,NULL,216329,103504725,135398513,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration for antiviral activity was tested against Varicella-Zoster virus(VZV),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99615079,NULL,216329,312365059,118718439,NULL,NULL,Literature-derived,20180908,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration for antiviral activity was tested against Varicella-Zoster virus(VZV),"(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]-N-[(1R,3S,4R,8R,9R,10R)-9-methoxy-12,12-dimethyl-2,5,7,11,13-pentaoxatricyclo[8.4.0.03,8]tetradecan-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99617672,NULL,217675,103504725,135398513,NULL,NULL,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The compound was tested for the cytopathic effect inhibition against herpes simplex virus 2; Effective concentration required to inhibit 50% virus proliferation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99618367,NULL,217676,103410916,5272259,NULL,NULL,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The compound was tested for the viral plaque reduction against VZV virus; Effective concentration required to inhibit 50% virus proliferation,"2-[2-(5,6-Dichloroimidazo[4,5-b]pyridin-3-yl)ethyl]propane-1,3-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99618368,NULL,217676,103410954,5270781,NULL,NULL,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The compound was tested for the viral plaque reduction against VZV virus; Effective concentration required to inhibit 50% virus proliferation,"1,3-Propanediol, 2-[2-(5,6-dichloro-1H-imidazo[4,5-b]pyridin-1-yl)ethyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99619800,NULL,216152,103197544,478848,NULL,9871764,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus(YS/R strain),"[(1R,2S)-2-(2,6-diaminopurin-9-yl)cyclopentyl]methanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99619801,NULL,216152,103197471,44276566,NULL,9871764,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus(YS/R strain),"[(1R,2S)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)cyclopentyl]methanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99619843,NULL,216151,103197471,44276566,NULL,9871764,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus(OKA strain),"[(1R,2S)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)cyclopentyl]methanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99619927,NULL,216150,103197471,44276566,NULL,9871764,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus (07/1strain),"[(1R,2S)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)cyclopentyl]methanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99631032,NULL,216137,103377875,6478338,NULL,10091699,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inactivation rate against Varicella Zoster Virus (VZV) was determined,"(E)-3-(2,5-Dimethyl-thiophen-3-yl)-N-[(S)-1-(5-methyl-4-oxo-4H-thieno[2,3-d][1,3]oxazin-2-yl)-ethyl]-acrylamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99631278,NULL,216136,103378228,6478343,NULL,10091699,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inactivation rate against Varicella Zoster Virus (VZV) was determined,"(E)-3-(5-Bromo-thiophen-2-yl)-N-[(S)-1-(5-methyl-4-oxo-4H-thieno[2,3-d][1,3]oxazin-2-yl)-ethyl]-acrylamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99631279,NULL,216136,103378640,6478349,NULL,10091699,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inactivation rate against Varicella Zoster Virus (VZV) was determined,"(E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]oxazin-2-yl)-ethyl]-3-quinolin-4-yl-acrylamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99631280,NULL,216136,103378148,6478320,NULL,10091699,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inactivation rate against Varicella Zoster Virus (VZV) was determined,"2-Propenamide, N-[1-(5-methyl-4-oxo-4H-thieno[2,3-d][1,3]oxazin-2-yl)ethyl]-3-phenyl-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99631281,NULL,216136,103378202,6478344,NULL,10091699,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inactivation rate against Varicella Zoster Virus (VZV) was determined,"(E)-3-(5-Chloro-thiophen-2-yl)-N-[(S)-1-(5-methyl-4-oxo-4H-thieno[2,3-d][1,3]oxazin-2-yl)-ethyl]-acrylamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99631525,NULL,229036,103377499,6478329,NULL,10091699,Literature-derived,20180909,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inactivation rate against Varicella Zoster Virus (VZV) was determined,"2-Propenamide, 3-(2,6-dichlorophenyl)-N-[1-(5-methyl-4-oxo-4H-thieno[2,3-d][1,3]oxazin-2-yl)ethyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99643699,NULL,216161,103219207,135976849,NULL,11412988,Literature-derived,20180929,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Tested for antiviral activity against VZV (TK-KOS),2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99643700,NULL,216161,103219207,135976849,NULL,11412988,Literature-derived,20180929,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Tested for antiviral activity against VZV (TK-KOS),2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99643701,NULL,216161,103504725,135398513,NULL,11412988,Literature-derived,20180929,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Tested for antiviral activity against VZV (TK-KOS),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99644114,NULL,216163,103504725,135398513,NULL,11412988,Literature-derived,20180929,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Tested for antiviral activity against VZV (YS),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99644115,NULL,216163,103219207,135976849,NULL,11412988,Literature-derived,20180929,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Tested for antiviral activity against VZV (YS),2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99644116,NULL,216163,103219207,135976849,NULL,11412988,Literature-derived,20180929,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Tested for antiviral activity against VZV (YS),2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99648831,NULL,217506,312365546,118718721,NULL,11327586,Literature-derived,20180930,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Cytotoxicity was evaluated against VZV at 200-400 uM; IA=inactive,"1-[(3R,4R,5S)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)thiolan-2-yl]-4-(1,2,4-triazol-1-yl)pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99648832,NULL,217506,312365539,118718716,NULL,11327586,Literature-derived,20180930,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Cytotoxicity was evaluated against VZV at 200-400 uM; IA=inactive,"9-[(3R,4R,5S)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)thiolan-2-yl]purin-6-amine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99648833,NULL,217506,312365540,11145250,NULL,11327586,Literature-derived,20180930,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Cytotoxicity was evaluated against VZV at 200-400 uM; IA=inactive,"1-O-Acetyl-2-O,3-O,5-O-tribenzyl-4-O-thia-L-arabinofuranose",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99648834,NULL,217506,312365541,118718717,NULL,11327586,Literature-derived,20180930,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Cytotoxicity was evaluated against VZV at 200-400 uM; IA=inactive,"4-amino-1-[(3R,4R,5S)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)thiolan-2-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99648835,NULL,217506,312365544,118718719,NULL,11327586,Literature-derived,20180930,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Cytotoxicity was evaluated against VZV at 200-400 uM; IA=inactive,"4-amino-1-[(2R,5S)-2-(hydroxymethyl)-5-methyl-1,3-oxathiolan-5-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99649061,NULL,217509,312365554,22209801,NULL,11327586,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce VZV induced cytopathogenicity by 50%,"1-[(3R)-3alpha,4beta-Dihydroxy-5alpha-(hydroxymethyl)tetrahydrothiophene-2-yl]-4-amino-1,2-dihydropyrimidine-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99649062,NULL,217509,103438365,492386,NULL,11327586,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce VZV induced cytopathogenicity by 50%,"1-[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-5-methyl-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99649063,NULL,217509,312365537,492383,NULL,11327586,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce VZV induced cytopathogenicity by 50%,"1-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99649064,NULL,217509,312365543,492384,NULL,11327586,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce VZV induced cytopathogenicity by 50%,"1-[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99649065,NULL,217509,312365552,492389,NULL,11327586,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce VZV induced cytopathogenicity by 50%,"(2R,3R,4R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrothiophene-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99649066,NULL,217509,103438480,492385,NULL,11327586,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce VZV induced cytopathogenicity by 50%,"1-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-5-methyl-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99649067,NULL,217509,312365553,492388,NULL,11327586,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce VZV induced cytopathogenicity by 50%,"(2S,3R,4R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrothiophene-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99649562,NULL,217506,312365550,118718724,NULL,11327586,Literature-derived,20180930,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Cytotoxicity was evaluated against VZV at 200-400 uM; IA=inactive,"5-bromo-1-[(3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99649563,NULL,217506,164136160,71717899,NULL,11327586,Literature-derived,20180930,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Cytotoxicity was evaluated against VZV at 200-400 uM; IA=inactive,"1-[(3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)thiolan-2-yl]-5-fluoropyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99649564,NULL,217506,312365545,118718720,NULL,11327586,Literature-derived,20180930,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Cytotoxicity was evaluated against VZV at 200-400 uM; IA=inactive,"5-chloro-1-[(3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652866,NULL,216473,103301998,497009,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,Methyl 1-(2-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652867,NULL,216473,103289091,496999,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,1-(4-Nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652868,NULL,216473,103302000,497008,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,Ethyl 1-(4-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652869,NULL,216473,103202903,446727,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652870,NULL,216473,103301534,497002,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,"5,6-Dichloro-1-isopropylsulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652871,NULL,216473,103289595,497000,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(4-nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652872,NULL,216473,103302039,497006,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(3-nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652873,NULL,216473,103504725,135398513,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652874,NULL,216473,103302048,497003,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,"1-(2,4-Dinitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652973,NULL,216479,103202903,446727,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652974,NULL,216479,103301997,497010,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,"Methyl 5,6-dichloro-1-(4-nitrophenyl)sulfonyl-benzimidazole-2-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99652975,NULL,216479,103301534,497002,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,"5,6-Dichloro-1-isopropylsulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653173,NULL,216473,103302047,497004,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(2,4-dinitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653174,NULL,216473,103301997,497010,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,"Methyl 5,6-dichloro-1-(4-nitrophenyl)sulfonyl-benzimidazole-2-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653175,NULL,216473,103302070,497001,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,"1H-Benzimidazole, 1-[(1-methylethyl)sulfonyl]-2-[2-(2-pyridinyl)ethyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653176,NULL,216473,103302060,497005,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,1-(3-Nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653177,NULL,216473,103302026,497007,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%,Methyl 1-(4-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653178,NULL,216475,103302026,497007,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,Methyl 1-(4-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653179,NULL,216475,103302060,497005,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,1-(3-Nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653180,NULL,216475,103302070,497001,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,"1H-Benzimidazole, 1-[(1-methylethyl)sulfonyl]-2-[2-(2-pyridinyl)ethyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653181,NULL,216475,103301997,497010,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,"Methyl 5,6-dichloro-1-(4-nitrophenyl)sulfonyl-benzimidazole-2-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653182,NULL,216475,103302047,497004,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(2,4-dinitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653183,NULL,216475,103302048,497003,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,"1-(2,4-Dinitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653184,NULL,216475,103302039,497006,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(3-nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653185,NULL,216475,103504725,135398513,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653186,NULL,216475,103289595,497000,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(4-nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653187,NULL,216475,103301534,497002,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,"5,6-Dichloro-1-isopropylsulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653188,NULL,216475,103202903,446727,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653189,NULL,216475,103289091,496999,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,1-(4-Nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653190,NULL,216475,103302000,497008,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,Ethyl 1-(4-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653191,NULL,216475,103301998,497009,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%,Methyl 1-(2-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653272,NULL,216472,103302039,497006,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(3-nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653273,NULL,216472,103504725,135398513,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653274,NULL,216472,103202903,446727,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653275,NULL,216472,103302060,497005,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,1-(3-Nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653276,NULL,216472,103302047,497004,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(2,4-dinitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653277,NULL,216472,103289091,496999,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,1-(4-Nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653278,NULL,216472,103302000,497008,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,Ethyl 1-(4-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653279,NULL,216472,103301998,497009,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,Methyl 1-(2-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653280,NULL,216472,103301534,497002,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,"5,6-Dichloro-1-isopropylsulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653281,NULL,216472,103302026,497007,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,Methyl 1-(4-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653282,NULL,216472,103302048,497003,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,"1-(2,4-Dinitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653283,NULL,216472,103302070,497001,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,"1H-Benzimidazole, 1-[(1-methylethyl)sulfonyl]-2-[2-(2-pyridinyl)ethyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653284,NULL,216472,103289595,497000,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(4-nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653285,NULL,216472,103301997,497010,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%,"Methyl 5,6-dichloro-1-(4-nitrophenyl)sulfonyl-benzimidazole-2-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653551,NULL,216479,103289091,496999,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,1-(4-Nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653552,NULL,216479,103302000,497008,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,Ethyl 1-(4-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653553,NULL,216479,103302048,497003,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,"1-(2,4-Dinitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653554,NULL,216479,103302026,497007,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,Methyl 1-(4-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653555,NULL,216479,103301998,497009,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,Methyl 1-(2-nitrophenyl)sulfonylbenzimidazole-2-carboxylate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653556,NULL,216479,103302039,497006,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(3-nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653557,NULL,216479,103504725,135398513,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653558,NULL,216479,103289595,497000,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(4-nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653559,NULL,216479,103302070,497001,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,"1H-Benzimidazole, 1-[(1-methylethyl)sulfonyl]-2-[2-(2-pyridinyl)ethyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653560,NULL,216479,103302060,497005,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,1-(3-Nitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99653561,NULL,216479,103302047,497004,NULL,12217359,Literature-derived,20180930,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%,"5,6-Dichloro-1-(2,4-dinitrophenyl)sulfonyl-2-[2-(2-pyridyl)ethyl]benzimidazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662327,NULL,216320,103314873,15954710,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"N-[4-[(5-chloro-2,4-dimethoxy-phenyl)carbamothioylamino]phenyl]benzamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662328,NULL,216320,103315389,3006474,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"N-[4-[(5-chloro-2,4-dimethoxy-phenyl)carbamothioylamino]-2-methyl-phenyl]furan-2-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662329,NULL,216320,103314829,3006479,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),N-[4-[[3-chloro-4-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]oxazole-4-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662330,NULL,216320,103314830,3006477,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"1-(2,4-Dimethoxy-5-chlorophenyl)-3-[2,5-dimethoxy-4-(2-furanylcarbonylamino)phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662331,NULL,216320,103315417,3006475,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"N-[4-[(5-chloro-2,4-dimethoxy-phenyl)carbamothioylamino]-3-cyano-phenyl]furan-2-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662332,NULL,216320,103315514,3006470,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"N-[4-[[3,5-bis(trifluoromethyl)phenyl]carbamothioylamino]phenyl]furan-2-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662333,NULL,216320,103315515,3006468,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),N-[4-[(3-chloro-4-fluoro-phenyl)carbamothioylamino]phenyl]furan-2-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662334,NULL,216320,103315486,3006471,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),N-[4-(m-tolylcarbamothioylamino)phenyl]furan-2-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662335,NULL,216320,103315577,3003383,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"N-[4-[[3,5-bis(trifluoromethyl)phenyl]carbamothioylamino]phenyl]thiadiazole-4-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662336,NULL,216320,103314916,3006465,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),N-[4-(phenylcarbamothioylamino)phenyl]furan-2-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662337,NULL,216320,103315088,3006467,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),N-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]furan-2-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662338,NULL,216320,103314386,3006463,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"N-[4-[(5-chloro-2,4-dimethoxy-phenyl)carbamothioylamino]phenyl]propanamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662339,NULL,216320,103314798,3006478,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),N-[4-[[3-chloro-4-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]pyridine-2-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662340,NULL,216320,103315390,3006473,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"N-[4-[(5-chloro-2,4-dimethoxy-phenyl)carbamothioylamino]-3-methyl-phenyl]furan-2-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662341,NULL,216320,103315458,3003375,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"N-[4-[(5-chloro-2,4-dimethoxy-phenyl)carbamothioylamino]phenyl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99662342,NULL,216320,103314901,3003376,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"N-[4-[(5-chloro-2,4-dimethoxy-phenyl)carbamothioylamino]phenyl]furan-2-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99663208,NULL,216320,103314385,3006476,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"1-(2,4-Dimethoxy-5-chlorophenyl)-3-[2-(trifluoromethyl)-4-(2-furanylcarbonylamino)phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99663209,NULL,216320,103315487,3006469,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),N-[4-[[3-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]furan-2-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99663210,NULL,216320,103314890,3006466,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),N-(4-{[(3-chloro-4-methylphenyl)carbamothioyl]amino}phenyl)furan-2-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99663211,NULL,216320,103315641,3003386,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"1-[3,5-Bis(trifluoromethyl)phenyl]-3-[4-(4-thiazolylcarbonylamino)phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99663212,NULL,216320,103315642,3006481,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),N-[4-[[3-chloro-4-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]thiazole-4-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99663213,NULL,216320,103314828,3006480,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"1-[3,5-Bis(trifluoromethyl)phenyl]-3-[4-(4-oxazolylcarbonylamino)phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99663214,NULL,216320,103315360,3006472,NULL,14611860,Literature-derived,20181001,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against Varicella zoster virus (VZV),"1-(2,4-Dimethoxy-5-chlorophenyl)-3-[3-methoxy-4-(2-furanylcarbonylamino)phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99751095,NULL,216469,103431086,135446903,NULL,2989523,Literature-derived,20181010,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro anti viral activity tested against VZV(KMcC) virus on MRC-5 cell monolayers; ND=Not done,"2-amino-9-[[(2S)-2,3-dihydroxypropoxy]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
99751457,NULL,216471,103431087,135446904,NULL,2989523,Literature-derived,20181010,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro anti viral activity tested against VZV(KMcC) virus on MRC-5 cell monolayers; ND=Not done,"2-amino-9-[[(2R)-2,3-dihydroxypropoxy]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
99751458,NULL,216471,103425116,135446919,NULL,2989523,Literature-derived,20181010,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro anti viral activity tested against VZV(KMcC) virus on MRC-5 cell monolayers; ND=Not done,"2-Amino-9-(((2RS)-2,3-dihydroxypropoxy)methyl)-1,9-dihydro-6H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
99800914,NULL,217499,103198859,44277171,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (Oka)-induced cytopathogenicity in HEL cells by 50%,2-Amino-9-(2-hydroxyethoxymethyl)-7-methylpurin-9-ium-6-olate;sulfuric acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99800915,NULL,217499,103198893,481076,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (Oka)-induced cytopathogenicity in HEL cells by 50%,"3,9-Dihydro-3-((2-hydroxyethoxy)methyl)-6-methyl-9-oxo-5H-imidazo(1,2-a)purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99800916,NULL,217499,103198188,5270680,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (Oka)-induced cytopathogenicity in HEL cells by 50%,"9H-Imidazo(1,2-a)purin-9-one, 3,5-dihydro-3-((2-hydroxyethoxy)methyl)-5,6-dimethyl-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99800917,NULL,217499,103198892,135435032,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (Oka)-induced cytopathogenicity in HEL cells by 50%,N2-Methylacyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99800935,NULL,217500,103504725,135398513,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (YS)-induced cytopathogenicity in HEL cells by 50%,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99800936,NULL,217500,103198188,5270680,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (YS)-induced cytopathogenicity in HEL cells by 50%,"9H-Imidazo(1,2-a)purin-9-one, 3,5-dihydro-3-((2-hydroxyethoxy)methyl)-5,6-dimethyl-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99800937,NULL,217500,103198186,5270677,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (YS)-induced cytopathogenicity in HEL cells by 50%,1-Methylacyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99800938,NULL,217500,103198859,44277171,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (YS)-induced cytopathogenicity in HEL cells by 50%,2-Amino-9-(2-hydroxyethoxymethyl)-7-methylpurin-9-ium-6-olate;sulfuric acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99800939,NULL,217500,103198893,481076,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (YS)-induced cytopathogenicity in HEL cells by 50%,"3,9-Dihydro-3-((2-hydroxyethoxy)methyl)-6-methyl-9-oxo-5H-imidazo(1,2-a)purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801087,NULL,217501,103198187,5270681,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV(7-1)-induced cytopathogenicity in PRK cells by 50%,"7-Methyl-1,N2-isopropenoacyclovir",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,129081,10335,NULL,NULL
99801088,NULL,217501,103198186,5270677,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV(7-1)-induced cytopathogenicity in PRK cells by 50%,1-Methylacyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,129081,10335,NULL,NULL
99801089,NULL,217501,103504725,135398513,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV(7-1)-induced cytopathogenicity in PRK cells by 50%,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,129081,10335,NULL,NULL
99801090,NULL,217501,103198859,44277171,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV(7-1)-induced cytopathogenicity in PRK cells by 50%,2-Amino-9-(2-hydroxyethoxymethyl)-7-methylpurin-9-ium-6-olate;sulfuric acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,129081,10335,NULL,NULL
99801091,NULL,217501,103198893,481076,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV(7-1)-induced cytopathogenicity in PRK cells by 50%,"3,9-Dihydro-3-((2-hydroxyethoxy)methyl)-6-methyl-9-oxo-5H-imidazo(1,2-a)purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,129081,10335,NULL,NULL
99801092,NULL,217501,103198188,5270680,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV(7-1)-induced cytopathogenicity in PRK cells by 50%,"9H-Imidazo(1,2-a)purin-9-one, 3,5-dihydro-3-((2-hydroxyethoxy)methyl)-5,6-dimethyl-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,129081,10335,NULL,NULL
99801093,NULL,217501,103198892,135435032,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV(7-1)-induced cytopathogenicity in PRK cells by 50%,N2-Methylacyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,129081,10335,NULL,NULL
99801290,NULL,217502,103198188,5270680,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV (YSR)-induced cytopathogenicity in HEL cells by 50%,"9H-Imidazo(1,2-a)purin-9-one, 3,5-dihydro-3-((2-hydroxyethoxy)methyl)-5,6-dimethyl-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801291,NULL,217502,103198892,135435032,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV (YSR)-induced cytopathogenicity in HEL cells by 50%,N2-Methylacyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801292,NULL,217502,103198186,5270677,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV (YSR)-induced cytopathogenicity in HEL cells by 50%,1-Methylacyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801293,NULL,217502,103504725,135398513,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV (YSR)-induced cytopathogenicity in HEL cells by 50%,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801294,NULL,217502,103198859,44277171,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV (YSR)-induced cytopathogenicity in HEL cells by 50%,2-Amino-9-(2-hydroxyethoxymethyl)-7-methylpurin-9-ium-6-olate;sulfuric acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801295,NULL,217502,103198893,481076,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV (YSR)-induced cytopathogenicity in HEL cells by 50%,"3,9-Dihydro-3-((2-hydroxyethoxy)methyl)-6-methyl-9-oxo-5H-imidazo(1,2-a)purine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801296,NULL,217502,103198187,5270681,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit thymidine deficient VZV (YSR)-induced cytopathogenicity in HEL cells by 50%,"7-Methyl-1,N2-isopropenoacyclovir",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801468,NULL,217500,103198187,5270681,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (YS)-induced cytopathogenicity in HEL cells by 50%,"7-Methyl-1,N2-isopropenoacyclovir",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801469,NULL,217500,103198892,135435032,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (YS)-induced cytopathogenicity in HEL cells by 50%,N2-Methylacyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801887,NULL,217499,103198187,5270681,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (Oka)-induced cytopathogenicity in HEL cells by 50%,"7-Methyl-1,N2-isopropenoacyclovir",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801888,NULL,217499,103198186,5270677,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (Oka)-induced cytopathogenicity in HEL cells by 50%,1-Methylacyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99801889,NULL,217499,103504725,135398513,NULL,2455050,Literature-derived,20181012,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration to inhibit VZV (Oka)-induced cytopathogenicity in HEL cells by 50%,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99840041,NULL,216158,103202903,446727,NULL,2167981,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-viral activity which is required for the inhibition of VZV (Varicella zoster virus ),Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99840076,NULL,216166,103202903,446727,NULL,2167981,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration which is active against Varicella zoster virus (VZV); value ranges from 0.0002-0.003 ug/mL,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886189,NULL,217673,103202903,446727,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain OKA in human embryonic lung (HEL) cell culture,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886190,NULL,217673,103207636,5905,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain OKA in human embryonic lung (HEL) cell culture,Idoxuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886191,NULL,217673,103254011,22910966,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain OKA in human embryonic lung (HEL) cell culture,4-Amino-1-[5-hydroxy-6-(hydroxymethyl)oxan-3-yl]pyrimidin-2-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886192,NULL,217673,103504725,135398513,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain OKA in human embryonic lung (HEL) cell culture,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886193,NULL,217673,103253808,492032,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain OKA in human embryonic lung (HEL) cell culture,5-(6-Amino-purin-9-yl)-2-hydroxymethyl-tetrahydro-pyran-3-ol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886194,NULL,217673,103165448,4472114,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain OKA in human embryonic lung (HEL) cell culture,"1-[5-Hydroxy-6-(hydroxymethyl)oxan-3-yl]-5-iodopyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886195,NULL,217673,103504490,135398740,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain OKA in human embryonic lung (HEL) cell culture,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886237,NULL,217514,103254687,44304707,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VSV in human embryonic skin muscle (ESM) fibroblast cell culture,[1-(6-Amino-2-methylpurin-9-yl)-3-hydroxypropan-2-yl]-methoxyphosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,129044,10335,NULL,NULL
99886282,NULL,209539,103202903,446727,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain YS-R in human embryonic lung (HEL) cell culture,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886283,NULL,209539,103253872,22910962,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain YS-R in human embryonic lung (HEL) cell culture,"1-[5-Hydroxy-6-(hydroxymethyl)oxan-3-yl]-5-methylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886284,NULL,209539,103165448,4472114,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain YS-R in human embryonic lung (HEL) cell culture,"1-[5-Hydroxy-6-(hydroxymethyl)oxan-3-yl]-5-iodopyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886302,NULL,209538,103165448,4472114,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain 07-1 in human embryonic lung (HEL) cell culture,"1-[5-Hydroxy-6-(hydroxymethyl)oxan-3-yl]-5-iodopyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886303,NULL,209538,103504490,135398740,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain 07-1 in human embryonic lung (HEL) cell culture,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886304,NULL,209538,103202903,446727,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain 07-1 in human embryonic lung (HEL) cell culture,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886305,NULL,209538,103253872,22910962,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain 07-1 in human embryonic lung (HEL) cell culture,"1-[5-Hydroxy-6-(hydroxymethyl)oxan-3-yl]-5-methylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886306,NULL,209538,103253808,492032,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain 07-1 in human embryonic lung (HEL) cell culture,5-(6-Amino-purin-9-yl)-2-hydroxymethyl-tetrahydro-pyran-3-ol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886344,NULL,217674,103254688,135450943,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain YS in human embryonic lung (HEL) cell culture,Anhydrohexitol G,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886345,NULL,217674,103504725,135398513,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain YS in human embryonic lung (HEL) cell culture,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886346,NULL,217674,103207636,5905,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain YS in human embryonic lung (HEL) cell culture,Idoxuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886347,NULL,217674,103253808,492032,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain YS in human embryonic lung (HEL) cell culture,5-(6-Amino-purin-9-yl)-2-hydroxymethyl-tetrahydro-pyran-3-ol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886348,NULL,217674,103202903,446727,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain YS in human embryonic lung (HEL) cell culture,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886349,NULL,217674,103253872,22910962,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain YS in human embryonic lung (HEL) cell culture,"1-[5-Hydroxy-6-(hydroxymethyl)oxan-3-yl]-5-methylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886350,NULL,217674,103254011,22910966,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain YS in human embryonic lung (HEL) cell culture,4-Amino-1-[5-hydroxy-6-(hydroxymethyl)oxan-3-yl]pyrimidin-2-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886351,NULL,217674,103165448,4472114,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain YS in human embryonic lung (HEL) cell culture,"1-[5-Hydroxy-6-(hydroxymethyl)oxan-3-yl]-5-iodopyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886352,NULL,217674,103504490,135398740,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain YS in human embryonic lung (HEL) cell culture,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886354,NULL,209538,103207636,5905,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain 07-1 in human embryonic lung (HEL) cell culture,Idoxuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886355,NULL,209538,103254011,22910966,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain 07-1 in human embryonic lung (HEL) cell culture,4-Amino-1-[5-hydroxy-6-(hydroxymethyl)oxan-3-yl]pyrimidin-2-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886356,NULL,209538,103254688,135450943,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain 07-1 in human embryonic lung (HEL) cell culture,Anhydrohexitol G,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886357,NULL,209538,103504725,135398513,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain 07-1 in human embryonic lung (HEL) cell culture,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886553,NULL,93991,103253808,492032,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain YS-R in human embryonic lung (HEL) cell culture,5-(6-Amino-purin-9-yl)-2-hydroxymethyl-tetrahydro-pyran-3-ol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886591,NULL,217673,103254688,135450943,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain OKA in human embryonic lung (HEL) cell culture,Anhydrohexitol G,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886592,NULL,217673,103253872,22910962,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against VZV strain OKA in human embryonic lung (HEL) cell culture,"1-[5-Hydroxy-6-(hydroxymethyl)oxan-3-yl]-5-methylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886806,NULL,209539,103504490,135398740,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain YS-R in human embryonic lung (HEL) cell culture,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886807,NULL,209539,103254011,22910966,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain YS-R in human embryonic lung (HEL) cell culture,4-Amino-1-[5-hydroxy-6-(hydroxymethyl)oxan-3-yl]pyrimidin-2-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886808,NULL,209539,103207636,5905,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain YS-R in human embryonic lung (HEL) cell culture,Idoxuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886809,NULL,209539,103254688,135450943,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain YS-R in human embryonic lung (HEL) cell culture,Anhydrohexitol G,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99886810,NULL,209539,103504725,135398513,NULL,8393114,Literature-derived,20181013,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibitory concentration against TK-VZV strain YS-R in human embryonic lung (HEL) cell culture,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900098,NULL,209537,103202903,446727,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900099,NULL,209537,134461086,10316159,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,5-(5-Nitrothiophen-2-yl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900100,NULL,209537,134445663,10019889,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,5-(5-Vinylthiophen-2-yl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900101,NULL,209537,134461084,515215,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,"5-Furan-3-yl-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900102,NULL,209537,103733280,46876710,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,"5-(5-bromothiophen-2-yl)-1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900103,NULL,209537,134437992,10409079,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,5-[5-[(Trimethylsilyl)ethynyl]thiophen-2-yl]-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900104,NULL,209537,134449620,10094536,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,5-(5-Iodothiophen-2-yl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900105,NULL,209537,134461085,515211,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,"1-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-(5-methyl-thiophen-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900106,NULL,209537,134437991,512323,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,5-(2'-Thienyl)-2'-beta-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900227,NULL,217510,134445663,10019889,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,5-(5-Vinylthiophen-2-yl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900228,NULL,217510,134437991,512323,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,5-(2'-Thienyl)-2'-beta-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900229,NULL,217510,134437992,10409079,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,5-[5-[(Trimethylsilyl)ethynyl]thiophen-2-yl]-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900230,NULL,217510,134461086,10316159,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,5-(5-Nitrothiophen-2-yl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900231,NULL,217510,103202903,446727,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900232,NULL,217510,103733289,46876720,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,"5-(5-chlorothiophen-2-yl)-1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900233,NULL,217510,103733280,46876710,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,"5-(5-bromothiophen-2-yl)-1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900324,NULL,209536,103202903,446727,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900325,NULL,209536,134453454,10382215,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,Rtkmkaohsdbzek-dmdpscgwsa-,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900326,NULL,209536,134449620,10094536,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,5-(5-Iodothiophen-2-yl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900327,NULL,209536,134461085,515211,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,"1-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-(5-methyl-thiophen-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900328,NULL,209536,134437992,10409079,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,5-[5-[(Trimethylsilyl)ethynyl]thiophen-2-yl]-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900329,NULL,209536,103733289,46876720,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,"5-(5-chlorothiophen-2-yl)-1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900330,NULL,209536,134445663,10019889,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,5-(5-Vinylthiophen-2-yl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900331,NULL,209536,134461084,515215,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,"5-Furan-3-yl-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900332,NULL,209536,134461086,10316159,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,5-(5-Nitrothiophen-2-yl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900333,NULL,209536,134434124,515213,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,"1-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-thiophen-3-yl-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900334,NULL,209536,103733280,46876710,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,"5-(5-bromothiophen-2-yl)-1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900335,NULL,209536,134437991,512323,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%,5-(2'-Thienyl)-2'-beta-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900673,NULL,209537,103733289,46876720,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,"5-(5-chlorothiophen-2-yl)-1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900674,NULL,209537,134453454,10382215,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,Rtkmkaohsdbzek-dmdpscgwsa-,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900675,NULL,209537,134441874,515216,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,"1-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-isoxazol-5-yl-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99900676,NULL,209537,134434124,515213,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%,"1-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-thiophen-3-yl-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99901260,NULL,217510,134434124,515213,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,"1-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-thiophen-3-yl-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99901261,NULL,217510,134449620,10094536,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,5-(5-Iodothiophen-2-yl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99901262,NULL,217510,134461085,515211,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,"1-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-(5-methyl-thiophen-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99901263,NULL,217510,134441874,515216,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,"1-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-isoxazol-5-yl-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99901264,NULL,217510,134461084,515215,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,"5-Furan-3-yl-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99901265,NULL,217510,134453454,10382215,NULL,8388474,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%,Rtkmkaohsdbzek-dmdpscgwsa-,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99910954,NULL,63767,103329392,44338098,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-(1,1'-biphenyl-4-yl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99910955,NULL,63767,103329391,44338097,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-phenyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99910956,NULL,63767,103504490,135398740,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99910957,NULL,63767,103329117,44337969,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,"3-[(2-Hydroxyethoxy)methyl]-6-(4-bromophenyl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99910958,NULL,63767,103207636,5905,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,Idoxuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99910959,NULL,63767,103329085,44337953,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,"3-[(2-Hydroxyethoxy)methyl]-2-bromo-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99910960,NULL,63767,103329603,44338200,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,"3-[(2-Hydroxyethoxy)methyl]-6-(1,1'-biphenyl-4-yl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99911057,NULL,83328,103329630,44338214,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(2-Hydroxyethoxy)methyl]-6-phenyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911058,NULL,83328,103328924,44337871,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(2-Hydroxyethoxy)methyl]-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911059,NULL,83328,103329086,44337954,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-tert-butyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911060,NULL,83328,103329392,44338098,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-(1,1'-biphenyl-4-yl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911061,NULL,83328,103329082,44337950,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(2-Hydroxyethoxy)methyl]-6-tert-butyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911062,NULL,83328,103329123,44337972,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(2-Hydroxyethoxy)methyl]-7-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911063,NULL,83328,103504490,135398740,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911064,NULL,83328,103329117,44337969,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(2-Hydroxyethoxy)methyl]-6-(4-bromophenyl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911065,NULL,83328,103329391,44338097,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-phenyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911066,NULL,83328,103504725,135398513,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911067,NULL,83328,103202903,446727,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911068,NULL,83328,103329085,44337953,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(2-Hydroxyethoxy)methyl]-2-bromo-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911069,NULL,83328,103329603,44338200,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(2-Hydroxyethoxy)methyl]-6-(1,1'-biphenyl-4-yl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911070,NULL,83328,103328950,44337881,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911408,NULL,83332,103329117,44337969,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(2-Hydroxyethoxy)methyl]-6-(4-bromophenyl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911409,NULL,83332,103328950,44337881,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911410,NULL,83332,103329085,44337953,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(2-Hydroxyethoxy)methyl]-2-bromo-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911411,NULL,83332,103329603,44338200,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(2-Hydroxyethoxy)methyl]-6-(1,1'-biphenyl-4-yl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911412,NULL,83332,103202903,446727,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911413,NULL,83332,103504725,135398513,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911414,NULL,83332,103329392,44338098,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-(1,1'-biphenyl-4-yl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911415,NULL,83332,103329391,44338097,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-phenyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911416,NULL,83332,103329082,44337950,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(2-Hydroxyethoxy)methyl]-6-tert-butyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911417,NULL,83332,103329123,44337972,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(2-Hydroxyethoxy)methyl]-7-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911418,NULL,83332,103329630,44338214,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(2-Hydroxyethoxy)methyl]-6-phenyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911419,NULL,83332,103328924,44337871,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(2-Hydroxyethoxy)methyl]-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911420,NULL,83332,103504490,135398740,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99911421,NULL,83332,103329086,44337954,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-tert-butyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99912028,NULL,63767,103328950,44337881,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99912029,NULL,63767,103504725,135398513,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99912030,NULL,63767,103329123,44337972,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,"3-[(2-Hydroxyethoxy)methyl]-7-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99912031,NULL,63767,103329630,44338214,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,"3-[(2-Hydroxyethoxy)methyl]-6-phenyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99912032,NULL,63767,103329086,44337954,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-tert-butyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99912033,NULL,63767,103328924,44337871,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,"3-[(2-Hydroxyethoxy)methyl]-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99912034,NULL,63767,103202903,446727,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99912035,NULL,63767,103619997,37542,NULL,7932543,Literature-derived,20181014,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus,Ribavirin,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99934369,NULL,216139,103311732,511748,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"2-[(8-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934370,NULL,216139,103311630,511755,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"3-[[8-Chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]methylsulfanyl]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934371,NULL,216139,103311303,511758,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"1-(Imidazo[1,2-a]pyrimidin-3-ylmethylsulfanyl)propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934372,NULL,216139,103310835,511746,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"3-Ethylsulfanylmethyl-8-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934373,NULL,216139,103311684,511750,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"3-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934374,NULL,216139,103311601,511757,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"3-(Benzylsulfanylmethyl)imidazo[1,2-a]pyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934375,NULL,216139,103311683,511752,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"2-[(6,8-Dibromo-5,7-dimethyl-imidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934376,NULL,216139,103311714,511753,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"Ethyl 2-[(7-methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934422,NULL,216169,103504725,135398513,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934423,NULL,216169,103311320,511745,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"3-Benzylsulfanylmethyl-6,8-dibromo-7-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934424,NULL,216169,103311291,491419,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"3-[(Benzylthio)methyl]-8-methylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934433,NULL,216147,103311630,511755,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"3-[[8-Chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]methylsulfanyl]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934434,NULL,216147,103311601,511757,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"3-(Benzylsulfanylmethyl)imidazo[1,2-a]pyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934435,NULL,216147,103311683,511752,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"2-[(6,8-Dibromo-5,7-dimethyl-imidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934436,NULL,216147,103311714,511753,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"Ethyl 2-[(7-methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934437,NULL,216147,103311731,511742,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"2-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934438,NULL,216147,103311048,511744,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"3-[(7-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934439,NULL,216147,103311684,511750,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"3-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934440,NULL,216147,103311056,511740,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"Methyl 3-(2-hydroxyethylsulfanylmethyl)imidazo[1,2-a]pyridine-2-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934441,NULL,216147,103310835,511746,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"3-Ethylsulfanylmethyl-8-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934442,NULL,216147,103311057,326951,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"2-(Imidazo[1,2-a]pyridin-3-ylmethylsulfanyl)ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934443,NULL,216147,103311019,511743,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"1-[(7-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934444,NULL,216147,103311631,511754,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"2-[[(7-Methyl-6,8-dibromoimidazo[1,2-a]pyridin-3-yl)methyl]thio]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934445,NULL,216147,103311732,511748,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"2-[(8-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934446,NULL,216147,103311020,511741,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"3-Ethylsulfanylmethyl-7-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934463,NULL,216145,103311020,511741,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration( MIC) for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"3-Ethylsulfanylmethyl-7-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934464,NULL,216171,103311320,511745,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"3-Benzylsulfanylmethyl-6,8-dibromo-7-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934465,NULL,216171,103208535,60613,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934466,NULL,216171,103202903,446727,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934467,NULL,216171,103504725,135398513,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934468,NULL,216171,103311307,511751,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"3-Benzylsulfanylmethyl-6,8-dibromo-5,7-dimethyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934489,NULL,216143,103311057,326951,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain,"2-(Imidazo[1,2-a]pyridin-3-ylmethylsulfanyl)ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934505,NULL,216140,103311159,511749,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"1-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934506,NULL,216140,103311319,511756,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"3-[(7-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934507,NULL,216141,103311057,326951,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain,"2-(Imidazo[1,2-a]pyridin-3-ylmethylsulfanyl)ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934508,NULL,216172,103311291,491419,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"3-[(Benzylthio)methyl]-8-methylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934509,NULL,216172,103202903,446727,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934510,NULL,216172,103504725,135398513,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934511,NULL,216172,103208535,60613,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934512,NULL,216172,103311307,511751,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"3-Benzylsulfanylmethyl-6,8-dibromo-5,7-dimethyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934513,NULL,216295,103311320,511745,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration( MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"3-Benzylsulfanylmethyl-6,8-dibromo-7-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934572,NULL,216167,103310613,491418,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus (VZV) using YS (TK+) strain.,"7-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934635,NULL,216149,103311020,511741,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"3-Ethylsulfanylmethyl-7-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934636,NULL,216149,103311303,511758,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"1-(Imidazo[1,2-a]pyrimidin-3-ylmethylsulfanyl)propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934637,NULL,216149,103311601,511757,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"3-(Benzylsulfanylmethyl)imidazo[1,2-a]pyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934638,NULL,216149,103311731,511742,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"2-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934639,NULL,216149,103311732,511748,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"2-[(8-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934640,NULL,216149,103310835,511746,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"3-Ethylsulfanylmethyl-8-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934718,NULL,216294,103311291,491419,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration( MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"3-[(Benzylthio)methyl]-8-methylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934719,NULL,216331,103311631,511754,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"2-[[(7-Methyl-6,8-dibromoimidazo[1,2-a]pyridin-3-yl)methyl]thio]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99934723,NULL,216147,103311303,511758,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"1-(Imidazo[1,2-a]pyrimidin-3-ylmethylsulfanyl)propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935335,NULL,216146,103311319,511756,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"3-[(7-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935336,NULL,216168,103310613,491418,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus (VZV) using YS/R (TK-) strain.,"7-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935529,NULL,216148,103311683,511752,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"2-[(6,8-Dibromo-5,7-dimethyl-imidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935530,NULL,216148,103311319,511756,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"3-[(7-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935531,NULL,216148,103311019,511743,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"1-[(7-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935532,NULL,216148,103311630,511755,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"3-[[8-Chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]methylsulfanyl]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935533,NULL,216148,103311056,511740,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"Methyl 3-(2-hydroxyethylsulfanylmethyl)imidazo[1,2-a]pyridine-2-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935968,NULL,216142,103311159,511749,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"1-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935969,NULL,216142,103311048,511744,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"3-[(7-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935970,NULL,216142,103311684,511750,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"3-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935971,NULL,216142,103311714,511753,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"Ethyl 2-[(7-methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935972,NULL,216142,103311731,511742,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"2-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935973,NULL,216142,103310835,511746,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"3-Ethylsulfanylmethyl-8-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935974,NULL,216142,103311601,511757,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"3-(Benzylsulfanylmethyl)imidazo[1,2-a]pyrimidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935975,NULL,216142,103311631,511754,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"2-[[(7-Methyl-6,8-dibromoimidazo[1,2-a]pyridin-3-yl)methyl]thio]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935976,NULL,216142,103311732,511748,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"2-[(8-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935977,NULL,216142,103311020,511741,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"3-Ethylsulfanylmethyl-7-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935978,NULL,216142,103311303,511758,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS(TK+) strain.,"1-(Imidazo[1,2-a]pyrimidin-3-ylmethylsulfanyl)propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935979,NULL,216144,103311319,511756,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"3-[(7-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935980,NULL,216144,103311631,511754,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"2-[[(7-Methyl-6,8-dibromoimidazo[1,2-a]pyridin-3-yl)methyl]thio]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935981,NULL,216144,103311683,511752,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"2-[(6,8-Dibromo-5,7-dimethyl-imidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935982,NULL,216144,103311019,511743,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"1-[(7-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935983,NULL,216144,103311714,511753,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"Ethyl 2-[(7-methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935984,NULL,216144,103311056,511740,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"Methyl 3-(2-hydroxyethylsulfanylmethyl)imidazo[1,2-a]pyridine-2-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935985,NULL,216144,103311048,511744,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"3-[(7-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935986,NULL,216144,103311684,511750,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"3-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935987,NULL,216144,103311159,511749,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"1-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99935988,NULL,216144,103311630,511755,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using YS/R (TK-) strain.,"3-[[8-Chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]methylsulfanyl]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936172,NULL,216170,103208535,60613,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936173,NULL,216170,103311320,511745,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"3-Benzylsulfanylmethyl-6,8-dibromo-7-methyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936174,NULL,216170,103202903,446727,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936175,NULL,216170,103310613,491418,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"7-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936176,NULL,216170,103311291,491419,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"3-[(Benzylthio)methyl]-8-methylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936177,NULL,216170,103311307,511751,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,"3-Benzylsulfanylmethyl-6,8-dibromo-5,7-dimethyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936178,NULL,216170,103504725,135398513,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using OKA (TK+) strain,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936475,NULL,216139,103311731,511742,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"2-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]ethanol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936476,NULL,216139,103311159,511749,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibitory Concentration (MIC) tested for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"1-[(5-Methylimidazo[1,2-a]pyridin-3-yl)methylsulfanyl]propan-2-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936514,NULL,216169,103311307,511751,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,"3-Benzylsulfanylmethyl-6,8-dibromo-5,7-dimethyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936515,NULL,216169,103202903,446727,NULL,8709116,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum Inhibition Concentration (MIC) for activity against Varicella-Zoster Virus(VZV) using 07/1 (TK-) strain.,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99936849,NULL,83491,103336034,512353,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,2-tert-Butyl-1-(1-adamantylmethyl)pyrrolidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99936850,NULL,83491,103336084,512340,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,1-Methyl-2-(1-adamantyl)pyrrolidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99936851,NULL,83491,103335995,44340940,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,"1-[(1R,2R)-3-(1-adamantyl)-2-phenylcyclopentyl]-N,N-dimethylmethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99936852,NULL,83491,103336079,512352,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,4-(1-Adamantylmethyl)-4-azaspiro[4.5]decane,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99936853,NULL,83491,103336037,512341,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,1-Ethyl-2-(1-adamantyl)pyrrolidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99936854,NULL,83491,103336039,512343,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,1-(Adamantan-1-yl)cyclopentan-1-amine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99936855,NULL,83491,103336035,512345,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,"1-(1-adamantyl)-N,N-dimethyl-cyclopentanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99936856,NULL,83491,103336083,512351,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,9-(1-Adamantylmethyl)-9-azaspiro[4.4]nonane,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99936857,NULL,83491,103336085,511811,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,2-(1-Adamantyl)pyrrolidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937150,NULL,83491,103335454,10846006,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,"Spiro[adamantane-2,3'-morpholine]",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937151,NULL,83491,103336036,512344,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,1-(1-adamantyl)-N-methyl-cyclopentanamine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937152,NULL,83491,103335298,44340684,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,"1-[(1S,2R)-3-(1-adamantyl)-2-phenylcyclopentyl]-N,N-dimethylmethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937153,NULL,83491,103335835,10331033,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,"1-Methylspiro[piperidine-2,2'-adamantane]",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937154,NULL,83491,103336033,512342,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,1-Butyl-2-(1-adamantyl)pyrrolidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937155,NULL,83491,103335539,10489838,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,"1-Ethylspiro[piperidine-2,2'-adamantane]",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937156,NULL,83491,103335297,512350,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,"2,2-Dimethyl-1-(1-adamantylmethyl)pyrrolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937157,NULL,83491,103335540,10398047,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+VZV virus infected HEL cell lines.,"Spiro[adamantane-2,2'-piperidine]",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937158,NULL,83493,103335297,512350,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,"2,2-Dimethyl-1-(1-adamantylmethyl)pyrrolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937159,NULL,83493,103335540,10398047,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,"Spiro[adamantane-2,2'-piperidine]",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937160,NULL,83493,103335539,10489838,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,"1-Ethylspiro[piperidine-2,2'-adamantane]",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937161,NULL,83493,103335835,10331033,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,"1-Methylspiro[piperidine-2,2'-adamantane]",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937162,NULL,83493,103336033,512342,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,1-Butyl-2-(1-adamantyl)pyrrolidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937163,NULL,83493,103335298,44340684,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,"1-[(1S,2R)-3-(1-adamantyl)-2-phenylcyclopentyl]-N,N-dimethylmethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937164,NULL,83493,103336036,512344,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,1-(1-adamantyl)-N-methyl-cyclopentanamine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937165,NULL,83493,103335454,10846006,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,"Spiro[adamantane-2,3'-morpholine]",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937166,NULL,83493,103336035,512345,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,"1-(1-adamantyl)-N,N-dimethyl-cyclopentanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937167,NULL,83493,103336083,512351,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,9-(1-Adamantylmethyl)-9-azaspiro[4.4]nonane,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937168,NULL,83493,103336085,511811,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,2-(1-Adamantyl)pyrrolidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937169,NULL,83493,103336037,512341,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,1-Ethyl-2-(1-adamantyl)pyrrolidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937170,NULL,83493,103336039,512343,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,1-(Adamantan-1-yl)cyclopentan-1-amine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937171,NULL,83493,103336079,512352,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,4-(1-Adamantylmethyl)-4-azaspiro[4.5]decane,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937172,NULL,83493,103335995,44340940,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,"1-[(1R,2R)-3-(1-adamantyl)-2-phenylcyclopentyl]-N,N-dimethylmethanamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937173,NULL,83493,103336084,512340,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,1-Methyl-2-(1-adamantyl)pyrrolidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99937174,NULL,83493,103336034,512353,NULL,8765514,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK-VZV virus infected HEL cell lines.,2-tert-Butyl-1-(1-adamantylmethyl)pyrrolidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941875,NULL,82860,103363560,135480697,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1R)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941876,NULL,82860,103365857,513267,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941877,NULL,82860,103365894,5496273,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1R)-2-(7-aminotriazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941878,NULL,82860,103365895,513258,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941879,NULL,82860,103365893,513261,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1R)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941880,NULL,82860,103366232,5496275,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1R)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941881,NULL,82860,103504725,135398513,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941882,NULL,82860,103363063,135480698,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1R)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941883,NULL,82860,103366222,513256,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"2-(5,7-Diaminotriazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941884,NULL,82860,103366236,455703,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"2-(7-Aminotriazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941885,NULL,82860,103365779,10738995,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"(2S)-3-(7-aminotriazolo[4,5-d]pyrimidin-2-yl)-2-[di(propan-2-yloxy)phosphorylmethoxy]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941886,NULL,82860,103363636,135400980,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1S)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941887,NULL,82860,103365856,513268,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941888,NULL,82860,103365807,513269,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941889,NULL,82860,103366252,513257,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941890,NULL,82860,103365858,513266,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941891,NULL,82860,103366167,513270,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"(2S)-3-(7-aminotriazolo[4,5-d]pyrimidin-3-yl)propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941892,NULL,82860,103366208,5496274,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"[(1R)-2-(7-aminotriazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99941893,NULL,82860,103365805,513272,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"(2S)-3-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942121,NULL,82859,103363561,135435074,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942122,NULL,82859,103365858,513266,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942123,NULL,82859,103366167,513270,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"(2S)-3-(7-aminotriazolo[4,5-d]pyrimidin-3-yl)propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942124,NULL,82859,103363636,135400980,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1S)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942125,NULL,82859,103365856,513268,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942126,NULL,82859,103366208,5496274,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1R)-2-(7-aminotriazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942127,NULL,82859,103504725,135398513,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942128,NULL,82859,103363560,135480697,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1R)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942129,NULL,82859,103365894,5496273,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1R)-2-(7-aminotriazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942130,NULL,82859,103365895,513258,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942131,NULL,82859,103363063,135480698,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1R)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942132,NULL,82859,103366222,513256,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"2-(5,7-Diaminotriazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942133,NULL,82859,103366236,455703,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"2-(7-Aminotriazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942134,NULL,82859,103365805,513272,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"(2S)-3-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942135,NULL,82859,103365936,455705,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"2-(7-Aminotriazolo[4,5-d]pyrimidin-2-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942136,NULL,82859,103365779,10738995,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"(2S)-3-(7-aminotriazolo[4,5-d]pyrimidin-2-yl)-2-[di(propan-2-yloxy)phosphorylmethoxy]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942137,NULL,82859,103365807,513269,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942138,NULL,82859,103366252,513257,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942139,NULL,82859,103366006,135483761,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-2-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942140,NULL,82859,103365893,513261,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1R)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942162,NULL,82857,103365807,513269,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942297,NULL,83357,103363561,135435074,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942301,NULL,82860,103365936,455705,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"2-(7-Aminotriazolo[4,5-d]pyrimidin-2-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942302,NULL,82860,103366006,135483761,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS/R strain in HEL cell culture,"2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-2-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942511,NULL,82857,103366252,513257,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942512,NULL,82857,103363636,135400980,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1S)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942513,NULL,82857,103365856,513268,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942514,NULL,82857,103365857,513267,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942515,NULL,82857,103365893,513261,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1R)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942516,NULL,82857,103366232,5496275,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1R)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942517,NULL,82857,103363560,135480697,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1R)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942518,NULL,82857,103365805,513272,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"(2S)-3-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942519,NULL,82857,103365936,455705,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"2-(7-Aminotriazolo[4,5-d]pyrimidin-2-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942520,NULL,82857,103366006,135483761,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-2-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942521,NULL,82857,103504725,135398513,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942522,NULL,82857,103363561,135435074,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942523,NULL,82857,103365858,513266,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942524,NULL,82857,103366167,513270,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"(2S)-3-(7-aminotriazolo[4,5-d]pyrimidin-3-yl)propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942525,NULL,82857,103366208,5496274,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1R)-2-(7-aminotriazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942526,NULL,82857,103366222,513256,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"2-(5,7-Diaminotriazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942527,NULL,82857,103366236,455703,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"2-(7-Aminotriazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942528,NULL,82857,103365894,5496273,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1R)-2-(7-aminotriazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942529,NULL,82857,103365895,513258,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) 07/1 strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942726,NULL,82859,103366232,5496275,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1R)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99942727,NULL,82859,103365857,513267,NULL,8831773,Literature-derived,20181015,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) YS strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969843,NULL,83526,103311291,491419,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"3-[(Benzylthio)methyl]-8-methylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969844,NULL,83526,103202903,446727,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969845,NULL,83526,103310613,491418,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"7-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969846,NULL,83526,103392400,501927,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"6,8-Dibromo-5-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969847,NULL,83526,103393004,512362,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"6-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969848,NULL,83526,103393005,512361,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"3-(Benzylsulfanylmethyl)-8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969849,NULL,83526,103504725,135398513,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969850,NULL,83526,103393210,512366,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"2-Phenyl-8-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969877,NULL,83522,103392550,512358,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"7-Methyl-3-[(2-chlorobenzyl)thiomethyl]imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969878,NULL,83522,103311291,491419,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"3-[(Benzylthio)methyl]-8-methylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969879,NULL,83522,103393143,512367,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"2,7-Dimethyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969880,NULL,83522,103392227,512363,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"5,8-Dimethyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969881,NULL,83522,103393144,512368,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"2-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969882,NULL,83522,103392400,501927,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"6,8-Dibromo-5-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969883,NULL,83522,103392530,512355,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"7-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969884,NULL,83522,103202903,446727,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969885,NULL,83522,103392529,512359,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"7-Methyl-3-[(4-chlorobenzyl)thiomethyl]imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969886,NULL,83522,103392596,512364,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"8-Bromo-6-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969887,NULL,83522,103392229,491420,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"6-Bromo-8-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969888,NULL,83522,103393142,512365,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"2-Phenyl-7-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969889,NULL,83522,103393004,512362,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"6-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969890,NULL,83522,103393005,512361,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"3-(Benzylsulfanylmethyl)-8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969891,NULL,83522,103504725,135398513,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99969892,NULL,83522,103393210,512366,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against 07/1 TK- in HEL cells,"2-Phenyl-8-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99970342,NULL,83526,103392529,512359,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"7-Methyl-3-[(4-chlorobenzyl)thiomethyl]imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99970343,NULL,83526,103392550,512358,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"7-Methyl-3-[(2-chlorobenzyl)thiomethyl]imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99970344,NULL,83526,103392596,512364,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"8-Bromo-6-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99970345,NULL,83526,103392229,491420,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"6-Bromo-8-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99970346,NULL,83526,103393142,512365,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"2-Phenyl-7-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99970347,NULL,83526,103392227,512363,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"5,8-Dimethyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99970348,NULL,83526,103393144,512368,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"2-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99970349,NULL,83526,103392530,512355,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"7-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99970350,NULL,83526,103393143,512367,NULL,9836626,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS TK+ in HEL cells,"2,7-Dimethyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99983276,NULL,216322,103166655,466143,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"3-Benzyl-2,2-dioxo-1-(prop-2-ynoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983277,NULL,216322,103166864,466142,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"3-Benzyl-1-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983278,NULL,216322,103178401,493633,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"1-(Benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983317,NULL,216323,103178411,493635,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"1-[(2-Hydroxyethoxy)methyl]-3-benzyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983318,NULL,216323,103178454,493626,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"3-(Benzyloxymethyl)-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983319,NULL,216323,103178591,493634,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"1-[(2-Acetoxyethoxy)methyl]-2,1,3-benzothiadiazin-4(3H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983320,NULL,216323,103178453,493625,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"3-[(2-Acetoxyethoxy)methyl]-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983321,NULL,216323,103178505,493629,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"3-Benzyl-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983322,NULL,216323,103504725,135398513,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983323,NULL,216323,103166656,493637,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"1-[(2-Benzoyloxyethoxy)methyl]-3-benzyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983324,NULL,216323,103178489,493631,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"2-[(3-Benzyl-2,2,4-trioxo-2$l^{6},1,3-benzothiadiazin-1-yl)methoxy]ethyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983333,NULL,216325,103166684,401639,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"1-Benzyl-3-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983334,NULL,216325,103178567,493636,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"1-(2-Hydroxyethoxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983335,NULL,216325,103166655,466143,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"3-Benzyl-2,2-dioxo-1-(prop-2-ynoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983336,NULL,216325,103166864,466142,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"3-Benzyl-1-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983337,NULL,216325,103178401,493633,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"1-(Benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983338,NULL,216325,103504725,135398513,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983339,NULL,216325,103178453,493625,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"3-[(2-Acetoxyethoxy)methyl]-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983340,NULL,216325,103178411,493635,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"1-[(2-Hydroxyethoxy)methyl]-3-benzyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983341,NULL,216325,103178454,493626,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"3-(Benzyloxymethyl)-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983342,NULL,216325,103178591,493634,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"1-[(2-Acetoxyethoxy)methyl]-2,1,3-benzothiadiazin-4(3H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983343,NULL,216325,103178466,493627,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"3-(Propargyloxymethyl)-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983344,NULL,216325,103166656,493637,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"1-[(2-Benzoyloxyethoxy)methyl]-3-benzyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983414,NULL,216324,103178505,493629,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"3-Benzyl-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983415,NULL,216324,103178591,493634,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"1-[(2-Acetoxyethoxy)methyl]-2,1,3-benzothiadiazin-4(3H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983628,NULL,216322,103178497,493632,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"2,2-Dioxo-1-(propoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983629,NULL,216322,103178591,493634,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"1-[(2-Acetoxyethoxy)methyl]-2,1,3-benzothiadiazin-4(3H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983630,NULL,216322,103504725,135398513,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983631,NULL,216322,103178411,493635,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"1-[(2-Hydroxyethoxy)methyl]-3-benzyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983632,NULL,216322,103178454,493626,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"3-(Benzyloxymethyl)-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983633,NULL,216322,103178409,493628,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"3-[(2-Hydroxyethoxy)methyl]-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983634,NULL,216322,103178466,493627,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"3-(Propargyloxymethyl)-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983635,NULL,216322,103178505,493629,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"3-Benzyl-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983636,NULL,216322,103166684,401639,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"1-Benzyl-3-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983637,NULL,216322,103178567,493636,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"1-(2-Hydroxyethoxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983638,NULL,216322,103178453,493625,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"3-[(2-Acetoxyethoxy)methyl]-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983639,NULL,216322,103166656,493637,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"1-[(2-Benzoyloxyethoxy)methyl]-3-benzyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983640,NULL,216322,103178489,493631,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on 07/1 strain of VZV expressing viral thymidine kinase(TK-),"2-[(3-Benzyl-2,2,4-trioxo-2$l^{6},1,3-benzothiadiazin-1-yl)methoxy]ethyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983649,NULL,216324,103166684,401639,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"1-Benzyl-3-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983650,NULL,216324,103178567,493636,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"1-(2-Hydroxyethoxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983651,NULL,216324,103178411,493635,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"1-[(2-Hydroxyethoxy)methyl]-3-benzyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983652,NULL,216324,103178454,493626,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"3-(Benzyloxymethyl)-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983653,NULL,216324,103178409,493628,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"3-[(2-Hydroxyethoxy)methyl]-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983654,NULL,216324,103166655,466143,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"3-Benzyl-2,2-dioxo-1-(prop-2-ynoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983655,NULL,216324,103166864,466142,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"3-Benzyl-1-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983656,NULL,216324,103178401,493633,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"1-(Benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983657,NULL,216324,103166656,493637,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"1-[(2-Benzoyloxyethoxy)methyl]-3-benzyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983658,NULL,216324,103178489,493631,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"2-[(3-Benzyl-2,2,4-trioxo-2$l^{6},1,3-benzothiadiazin-1-yl)methoxy]ethyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983659,NULL,216324,103504725,135398513,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983660,NULL,216324,103178497,493632,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"2,2-Dioxo-1-(propoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983661,NULL,216324,103178453,493625,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"3-[(2-Acetoxyethoxy)methyl]-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983662,NULL,216324,103178466,493627,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS strain of VZV expressing viral thymidine kinase(TK+),"3-(Propargyloxymethyl)-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983714,NULL,216325,103178489,493631,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"2-[(3-Benzyl-2,2,4-trioxo-2$l^{6},1,3-benzothiadiazin-1-yl)methoxy]ethyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983715,NULL,216325,103178505,493629,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"3-Benzyl-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983716,NULL,216325,103178409,493628,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"3-[(2-Hydroxyethoxy)methyl]-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99983717,NULL,216325,103178497,493632,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on YS/Rstrain of VZV expressing viral thymidine kinase(TK-),"2,2-Dioxo-1-(propoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99984037,NULL,216323,103166655,466143,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"3-Benzyl-2,2-dioxo-1-(prop-2-ynoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99984038,NULL,216323,103166864,466142,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"3-Benzyl-1-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99984039,NULL,216323,103178401,493633,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"1-(Benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99984040,NULL,216323,103178409,493628,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"3-[(2-Hydroxyethoxy)methyl]-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99984041,NULL,216323,103178497,493632,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"2,2-Dioxo-1-(propoxymethyl)-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99984042,NULL,216323,103178466,493627,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"3-(Propargyloxymethyl)-2,1,3-benzothiadiazin-4(1H)-one 2,2-dioxide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99984043,NULL,216323,103166684,401639,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"1-Benzyl-3-(benzyloxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99984044,NULL,216323,103178567,493636,NULL,10197958,Literature-derived,20181016,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The concentration required to reduce virus plaque formation by 50% was measured on OKA strain of VZV expressing viral thymidine kinase(TK+),"1-(2-Hydroxyethoxymethyl)-2,2-dioxo-2$l^{6},1,3-benzothiadiazin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
99992596,NULL,217651,103219207,135976849,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (TK-07/1) in HEL cells,2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992597,NULL,217651,103219207,135976849,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (TK-07/1) in HEL cells,2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992598,NULL,217651,103202903,446727,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (TK-07/1) in HEL cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992599,NULL,217652,103504725,135398513,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (TK-YS/R) in HEL cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992616,NULL,217654,103219207,135976849,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (TK-YS/R) in HEL cells,2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992617,NULL,217654,103202903,446727,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (TK-YS/R) in HEL cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992645,NULL,217653,103219207,135976849,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (TK-YS/R) in HEL cells,2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992665,NULL,217649,103504725,135398513,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (TK-07/1) in HEL cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992703,NULL,217657,103219207,135976849,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (YS) in HEL cells,2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992704,NULL,217657,103219207,135976849,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (YS) in HEL cells,2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992705,NULL,217657,103202903,446727,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (YS) in HEL cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992862,NULL,217656,103504725,135398513,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (OKA) in HEL cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992879,NULL,217655,103504490,135398740,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against HSV-1 (TK-/TK+VMW1837) in E6SM cell culture,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,115034,10335,NULL,NULL
99992949,NULL,217648,103202903,446727,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (OKA) in HEL cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992950,NULL,217648,103219207,135976849,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (OKA) in HEL cells,2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
99992951,NULL,217648,103219207,135976849,NULL,10691698,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Minimum inhibitory concentration was determined against VZV (OKA) in HEL cells,2-amino-9-[5-hydroxy-4-(hydroxymethyl)cyclohex-2-en-1-yl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100020824,NULL,217505,103273450,6312482,NULL,14561099,Literature-derived,20181017,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral selectivity against varicella zoster virus; exhibited wide range selectivity,(Z)-(2-((6-Amino-9H-purin-9-yl)methylene)cyclopropyl)methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100021326,NULL,217494,103273875,6531437,NULL,14561099,Literature-derived,20181017,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral selectivity against varicella zoster virus; Inactive,Synadenol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100068632,NULL,218011,103260024,72828,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 0.32 ug/ml,Cyclopentenyl cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100068633,NULL,218013,103260024,72828,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 10 ug/ml,Cyclopentenyl cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100068634,NULL,218013,103227217,135668177,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 10 ug/ml,"9-[1,3-Dihydroxypropoxymethyl]guanine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100068658,NULL,218015,103260024,72828,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 3.2 ug/ml,Cyclopentenyl cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100068659,NULL,218015,103227217,135668177,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 3.2 ug/ml,"9-[1,3-Dihydroxypropoxymethyl]guanine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100068660,NULL,218017,103227217,135668177,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 320 ug/ml,"9-[1,3-Dihydroxypropoxymethyl]guanine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100068661,NULL,218017,103260024,72828,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 320 ug/ml,Cyclopentenyl cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100068850,NULL,218008,103260024,72828,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 0.01 ug/ml,Cyclopentenyl cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100068976,NULL,218009,103260024,72828,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 0.032 ug/ml,Cyclopentenyl cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100069075,NULL,218010,103260024,72828,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 0.1 ug/ml,Cyclopentenyl cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100069076,NULL,218012,103260024,72828,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 1 ug/ml,Cyclopentenyl cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100069077,NULL,218012,103227217,135668177,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 1 ug/ml,"9-[1,3-Dihydroxypropoxymethyl]guanine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100069312,NULL,218014,103260024,72828,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 100 ug/ml,Cyclopentenyl cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100069313,NULL,218014,103227217,135668177,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 100 ug/ml,"9-[1,3-Dihydroxypropoxymethyl]guanine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100069314,NULL,218016,103227217,135668177,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 32 ug/ml,"9-[1,3-Dihydroxypropoxymethyl]guanine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100069315,NULL,218016,103260024,72828,NULL,3411597,Literature-derived,20200628,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was tested for antiviral activity against Varicella-Zoster from human diploid foreskin cells in mono layer culture at 32 ug/ml,Cyclopentenyl cytosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100141732,NULL,218408,103196918,44276333,NULL,10890159,Literature-derived,20200702,0,0,Inactive,NULL,NULL,NULL,ChEMBL,In vitro antiviral activity against 07/1 and YS/R strain of thymidine kinase (-ve) versilla zosta virus; Inactive,"5-Chloro-1-(3,4,5-trihydroxythiolan-2-yl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100142229,NULL,218409,103196711,44276267,NULL,10890159,Literature-derived,20200702,0,0,Inactive,NULL,NULL,NULL,ChEMBL,In vitro antiviral activity against YS and OKA strain of thymidine kinase (+ve) versilla zosta virus; Inactive,"5-Bromo-1-(3,4,5-trihydroxythiolan-2-yl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100142230,NULL,218409,103196945,44276345,NULL,10890159,Literature-derived,20200702,0,0,Inactive,NULL,NULL,NULL,ChEMBL,In vitro antiviral activity against YS and OKA strain of thymidine kinase (+ve) versilla zosta virus; Inactive,"5-Fluoro-1-(3,4,5-trihydroxythiolan-2-yl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100142231,NULL,218409,103196918,44276333,NULL,10890159,Literature-derived,20200702,0,0,Inactive,NULL,NULL,NULL,ChEMBL,In vitro antiviral activity against YS and OKA strain of thymidine kinase (+ve) versilla zosta virus; Inactive,"5-Chloro-1-(3,4,5-trihydroxythiolan-2-yl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100142730,NULL,218407,103196711,44276267,NULL,10890159,Literature-derived,20200702,0,0,Inactive,NULL,NULL,NULL,ChEMBL,In vitro antiviral activity against 07/1 and YS/R strain of thymidine kinase (-ve) versilla zosta virus; Inactive,"5-Bromo-1-(3,4,5-trihydroxythiolan-2-yl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100142731,NULL,218407,103196945,44276345,NULL,10890159,Literature-derived,20200702,0,0,Inactive,NULL,NULL,NULL,ChEMBL,In vitro antiviral activity against 07/1 and YS/R strain of thymidine kinase (-ve) versilla zosta virus; Inactive,"5-Fluoro-1-(3,4,5-trihydroxythiolan-2-yl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100167838,NULL,82694,103245357,493046,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-(2-Amino-4-methyl-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100167839,NULL,82694,103245943,493041,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-(4-Amino-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100167840,NULL,82694,103245974,493045,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,"Phosphonic acid, [[2-[(2,6-diamino-4-pyrimidinyl)oxy]ethoxy]methyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100167841,NULL,82694,103246588,135509791,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-Amino-4-cyclopropylamino-6-hydroxypyrimidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100167842,NULL,82694,103245358,493044,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,"2-(2,4-Diamino-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100167843,NULL,82694,103245389,493042,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,6-[2-(Diisopropoxyphosphorylmethoxy)ethoxy]pyrimidin-4-amine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100167844,NULL,82694,103245973,493043,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-(6-Aminopyrimidin-4-yl)oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168315,NULL,82694,103246542,135442218,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-Amino-6-(dimethylamino)pyrimidin-4-ol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168316,NULL,82694,103246612,493050,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-[2-Amino-6-(cyclopropylamino)pyrimidin-4-yl]oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168317,NULL,82694,103245953,493060,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,"[(1R)-2-(2,6-diaminopyrimidin-4-yl)oxy-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168318,NULL,82694,103246046,493059,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,"2-(2,6-Diaminopyrimidin-4-yl)sulfanylethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168319,NULL,82694,103245906,135431272,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,4-Amino-6-hydroxypyrimidine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168320,NULL,82694,103245997,493061,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,"[(1S)-2-(2,6-diaminopyrimidin-4-yl)oxy-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168321,NULL,82694,103246572,493053,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-[2-Amino-6-(dimethylamino)pyrimidin-4-yl]oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168322,NULL,82694,103169255,60172,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,Adefovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168323,NULL,82694,103246587,493049,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-[2-Amino-4-(cyclopropylamino)-6-oxo-pyrimidin-1-yl]ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168324,NULL,82694,103246089,493055,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-[2-Amino-6-[2-(phosphonomethoxy)ethoxy]pyrimidin-4-yl]oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168325,NULL,82694,103246019,493047,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-(2-Amino-6-methyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168326,NULL,82694,103246048,493056,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-[2-Amino-6-oxo-4-[2-(phosphonomethoxy)ethoxy]pyrimidin-1-yl]ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168327,NULL,82694,103246573,493052,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-[2-Amino-4-(dimethylamino)-6-oxo-pyrimidin-1-yl]ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168328,NULL,82694,103245952,493062,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-(6-Amino-2-methylsulfanyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168329,NULL,82694,103246001,135490839,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,2-(4-Amino-6-hydroxy-pyrimidin-2-yl)sulfanylethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100168330,NULL,82694,103246087,493057,NULL,11960502,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Inhibition of Thymidine kinase deficient (TK-) Varicella-Zoster virus (VZV) 07/1 strain induced cytopathicity n HEL cell line,"6-[2-(Diisopropoxyphosphorylmethoxy)ethylsulfanyl]pyrimidine-2,4-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100188877,NULL,83329,103329086,44337954,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-tert-butyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100188894,NULL,83331,103329392,44338098,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-(1,1'-biphenyl-4-yl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100188895,NULL,83331,103504725,135398513,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100188896,NULL,83331,103504490,135398740,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100188897,NULL,83331,103329391,44338097,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-phenyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100188898,NULL,83331,103329630,44338214,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(2-Hydroxyethoxy)methyl]-6-phenyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100188899,NULL,83331,103329117,44337969,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(2-Hydroxyethoxy)methyl]-6-(4-bromophenyl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100188900,NULL,83331,103328950,44337881,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100188901,NULL,83331,103202903,446727,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189146,NULL,83329,103504490,135398740,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189147,NULL,83329,103329392,44338098,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-(1,1'-biphenyl-4-yl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189148,NULL,83329,103329117,44337969,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),"3-[(2-Hydroxyethoxy)methyl]-6-(4-bromophenyl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189149,NULL,83329,103329391,44338097,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-phenyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189150,NULL,83329,103504725,135398513,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189151,NULL,83329,103329630,44338214,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),"3-[(2-Hydroxyethoxy)methyl]-6-phenyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189152,NULL,83329,103328924,44337871,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),"3-[(2-Hydroxyethoxy)methyl]-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189153,NULL,83329,103328950,44337881,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189154,NULL,83329,103329082,44337950,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),"3-[(2-Hydroxyethoxy)methyl]-6-tert-butyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189155,NULL,83329,103329123,44337972,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),"3-[(2-Hydroxyethoxy)methyl]-7-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189156,NULL,83329,103202903,446727,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100189157,NULL,83329,103329085,44337953,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain),"3-[(2-Hydroxyethoxy)methyl]-2-bromo-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100190134,NULL,83331,103329082,44337950,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(2-Hydroxyethoxy)methyl]-6-tert-butyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100190135,NULL,83331,103329123,44337972,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(2-Hydroxyethoxy)methyl]-7-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100190136,NULL,83331,103329085,44337953,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(2-Hydroxyethoxy)methyl]-2-bromo-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100190137,NULL,83331,103329603,44338200,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(2-Hydroxyethoxy)methyl]-6-(1,1'-biphenyl-4-yl)-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100190138,NULL,83331,103328924,44337871,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(2-Hydroxyethoxy)methyl]-6-methyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100190139,NULL,83331,103329086,44337954,NULL,7932543,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain),"3-[(1-Hydroxymethyl-2-hydroxyethoxy)methyl]-6-tert-butyl-1,2,3,5-tetrahydro-9H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100203494,NULL,82858,103365894,5496273,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1R)-2-(7-aminotriazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100203495,NULL,82858,103365895,513258,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100203496,NULL,82858,103365779,10738995,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"(2S)-3-(7-aminotriazolo[4,5-d]pyrimidin-2-yl)-2-[di(propan-2-yloxy)phosphorylmethoxy]propan-1-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100203497,NULL,82858,103365857,513267,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100203498,NULL,82858,103365893,513261,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1R)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100203499,NULL,82858,103366232,5496275,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1R)-2-(5,7-diaminotriazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100203500,NULL,82858,103365805,513272,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"(2S)-3-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100203501,NULL,82858,103365936,455705,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"2-(7-Aminotriazolo[4,5-d]pyrimidin-2-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204283,NULL,82858,103366006,135483761,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-2-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204284,NULL,82858,103365807,513269,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204285,NULL,82858,103366252,513257,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-2-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204286,NULL,82858,103363063,135480698,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1R)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204287,NULL,82858,103366222,513256,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"2-(5,7-Diaminotriazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204288,NULL,82858,103366236,455703,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"2-(7-Aminotriazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204289,NULL,82858,103363561,135435074,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204290,NULL,82858,103365858,513266,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1S)-1-[(7-aminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204291,NULL,82858,103366167,513270,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"(2S)-3-(7-aminotriazolo[4,5-d]pyrimidin-3-yl)propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204292,NULL,82858,103363636,135400980,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1S)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204293,NULL,82858,103365856,513268,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1S)-1-[(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)methyl]-2-fluoro-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204294,NULL,82858,103504725,135398513,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204295,NULL,82858,103363560,135480697,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1R)-2-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204296,NULL,82858,103365806,513271,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"(2S)-3-(7-aminotriazolo[4,5-d]pyrimidin-2-yl)propane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100204297,NULL,82858,103366208,5496274,NULL,8831773,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity in TK+ varicella zoster virus (VZV) OKA strain in HEL cell culture,"[(1R)-2-(7-aminotriazolo[4,5-d]pyrimidin-2-yl)-1-methyl-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216561,NULL,83528,103392550,512358,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"7-Methyl-3-[(2-chlorobenzyl)thiomethyl]imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216607,NULL,83524,103392227,512363,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"5,8-Dimethyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216608,NULL,83524,103393144,512368,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"2-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216609,NULL,83524,103392229,491420,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"6-Bromo-8-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216610,NULL,83524,103393142,512365,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"2-Phenyl-7-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216611,NULL,83524,103392400,501927,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"6,8-Dibromo-5-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216612,NULL,83524,103392618,10587450,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"7-Methyl-3-(cyclohexylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216613,NULL,83524,103392403,512357,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"7-Methyl-3-(2,2,2-trifluoroethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216813,NULL,83528,103392530,512355,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"7-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216814,NULL,83528,103311291,491419,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"3-[(Benzylthio)methyl]-8-methylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216815,NULL,83528,103393004,512362,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"6-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216816,NULL,83528,103393005,512361,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"3-(Benzylsulfanylmethyl)-8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216817,NULL,83528,103504725,135398513,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216818,NULL,83528,103392227,512363,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"5,8-Dimethyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216819,NULL,83528,103393144,512368,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"2-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216820,NULL,83528,103393143,512367,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"2,7-Dimethyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216821,NULL,83528,103392400,501927,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"6,8-Dibromo-5-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216822,NULL,83528,103202903,446727,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216823,NULL,83528,103310613,491418,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"7-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216824,NULL,83528,103393210,512366,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"2-Phenyl-8-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216825,NULL,83528,103392596,512364,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"8-Bromo-6-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216826,NULL,83528,103392529,512359,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"7-Methyl-3-[(4-chlorobenzyl)thiomethyl]imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216827,NULL,83528,103392229,491420,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"6-Bromo-8-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100216828,NULL,83528,103393142,512365,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against YS/R TK- in HEL cells,"2-Phenyl-7-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217693,NULL,83524,103393004,512362,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"6-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217694,NULL,83524,103393005,512361,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"3-(Benzylsulfanylmethyl)-8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217695,NULL,83524,103504725,135398513,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217696,NULL,83524,103392550,512358,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"7-Methyl-3-[(2-chlorobenzyl)thiomethyl]imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217697,NULL,83524,103393143,512367,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"2,7-Dimethyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217698,NULL,83524,103393210,512366,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"2-Phenyl-8-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217699,NULL,83524,103311291,491419,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"3-[(Benzylthio)methyl]-8-methylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217700,NULL,83524,103392401,512360,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"Imidazo[1,2-a]pyridine, 7-methyl-3-[(propylthio)methyl]-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217701,NULL,83524,103392446,512356,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"7-Methyl-3-(cyclopentylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217702,NULL,83524,103392530,512355,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"7-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217703,NULL,83524,103202903,446727,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217704,NULL,83524,103310613,491418,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"7-Methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217705,NULL,83524,103392529,512359,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"7-Methyl-3-[(4-chlorobenzyl)thiomethyl]imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100217706,NULL,83524,103392596,512364,NULL,9836626,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Anti-VZV activity against OKA strain TK+ in HEL cells,"8-Bromo-6-methyl-3-(benzylthiomethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100232411,NULL,147627,103391812,3011373,NULL,14584956,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against OKA strain of VZV; ND: No data,"2-(2,4-Diamino-5-methyl-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100232412,NULL,147627,103392354,3011382,NULL,14584956,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against OKA strain of VZV; ND: No data,"2-(2,6-Diamino-5-chloro-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100232569,NULL,147628,103391700,3011377,NULL,14584956,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against OKA strain of VZV; ND=No data,"2-(2,4-Diamino-5-cyclopropyl-6-oxo-pyrimidin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100234072,NULL,217643,103197853,135499552,NULL,8496903,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain; Not active,(Z)-9-[(4-Phosphonobut-3-enyl)oxy]guanine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100234073,NULL,217643,103197790,6474330,NULL,8496903,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain; Not active,"[(E)-4-(2,6-diaminopurin-9-yl)but-1-enyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100234074,NULL,217643,103197945,6474323,NULL,8496903,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain; Not active,[(E)-4-(6-aminopurin-9-yl)oxybut-1-enyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100234075,NULL,217643,103197806,6474311,NULL,8496903,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Compound was evaluated for anti-herpesvirus activity against Varicella Zoster virus (Ellen) strain; Not active,(E)-9-(4-Phosphonobut-3-enyl)adenine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100246383,NULL,216164,103504490,135398740,NULL,11412988,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Tested for antiviral activity against VZV (YS); Not determined,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100247163,NULL,216162,103504490,135398740,NULL,11412988,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Tested for antiviral activity against VZV (TK-KOS); Not determined,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100247560,NULL,216480,103504490,135398740,NULL,12217359,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%; ND denotes no data,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100247561,NULL,216480,103208535,60613,NULL,12217359,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%; ND denotes no data,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100247603,NULL,216478,103208535,60613,NULL,12217359,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- Varicella-Zoster virus 07/1 wihch reduces virus plaque formation by 50%; ND denotes no data,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100247929,NULL,216474,103504490,135398740,NULL,12217359,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%; ND denotes no data,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100247930,NULL,216474,103208535,60613,NULL,12217359,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%; ND denotes no data,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100248013,NULL,216460,242582177,489672,NULL,11814776,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,In vitro antiviral activity against Varicella zoster virus (VZV) was determined; ND= Not determined,"6-azido-5-chloro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-hexahydropyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100248014,NULL,216460,103504490,135398740,NULL,11814776,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,In vitro antiviral activity against Varicella zoster virus (VZV) was determined; ND= Not determined,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100248015,NULL,216460,242582178,489670,NULL,11814776,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,In vitro antiviral activity against Varicella zoster virus (VZV) was determined; ND= Not determined,"6-azido-5-chloro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]hexahydropyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100248016,NULL,216460,103589817,65510,NULL,11814776,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,In vitro antiviral activity against Varicella zoster virus (VZV) was determined; ND= Not determined,5-Chloro-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100248061,NULL,216476,103208535,60613,NULL,12217359,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%; ND denotes no data,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100248210,NULL,216477,103504490,135398740,NULL,12217359,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%; ND denotes no data,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100248468,NULL,216476,103504490,135398740,NULL,12217359,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%; ND denotes no data,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100249793,NULL,216466,242581924,90662952,NULL,15109620,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus (OKA); No data,"3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-octylphenyl)thieno[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100255023,NULL,216328,103504490,135398740,NULL,NULL,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Compound was tested for antiherpes activity against Varicella zoster virus(OKA) in HEL cells; Not determined,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100255588,NULL,216330,103507642,3385,NULL,NULL,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,In vitro minimum inhibitory concentration for antiviral activity was tested against Varicella-Zoster virus(VZV); No data,Fluorouracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100346511,NULL,217511,103390388,507244,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,=,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"6-(4-bromophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100346513,NULL,217511,103390412,507243,NULL,11150169,Confirmatory,20220830,0,0,Unspecified,NULL,CC50,=,ChEMBL,cytostatic concentration required to reduce the HEL cell number by 50%. after 5 days in the absence of virus,"6-(4-chlorophenyl)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100413890,NULL,147626,103391699,3011378,NULL,14584956,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against OKA strain of VZV in HEL (human erythroleukemia) cells.,"2-(2,6-Diamino-5-cyclopropyl-pyrimidin-4-yl)oxyethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817021,NULL,82701,103265176,482497,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"1-[(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-5-methyl-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817022,NULL,82701,103265675,5282192,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,Sorivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817023,NULL,82701,103302350,21704,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,Vidarabine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817024,NULL,82701,103265030,10715151,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"1-[(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-5-iodo-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817025,NULL,82701,103265303,482505,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"(2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrothiophene-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817026,NULL,82701,103265703,6475799,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"5-[(E)-2-bromovinyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817027,NULL,82701,103504725,135398513,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817028,NULL,82701,103265177,5274348,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-5-ethyl-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817029,NULL,82701,103265195,482507,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"(2R,3S,4S,5R)-2-(2,6-diaminopurin-9-yl)-5-(hydroxymethyl)tetrahydrothiophene-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817030,NULL,82701,103264712,482506,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"(2S,3S,4S,5R)-2-(2,6-diaminopurin-9-yl)-5-(hydroxymethyl)tetrahydrothiophene-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817031,NULL,82701,103264710,135398592,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,2'-Deoxyguanosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817032,NULL,82701,103264711,135453973,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"2-amino-9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817033,NULL,82701,103265701,6475797,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"5-[(E)-2-chlorovinyl]-1-[(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817712,NULL,82701,103265133,482498,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-5-methyl-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817713,NULL,82701,103265340,482504,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"(2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrothiophene-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817714,NULL,82701,103265365,6532420,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"5-[(E)-2-bromovinyl]-1-[(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817715,NULL,82701,103265674,6475798,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"5-[(E)-2-chlorovinyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817716,NULL,82701,103265068,482499,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-5-iodo-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817717,NULL,82701,103265238,482495,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,"1-[(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrothiophen-2-yl]-5-ethyl-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817718,NULL,82701,103504490,135398740,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100817719,NULL,82701,103265699,97188,NULL,9216836,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus (VZV) Oka strain in HEL (human erythroleukemia) cells.,2-Amino-2'-deoxyadenosine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100823243,NULL,216470,103504725,135398513,NULL,2989523,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro anti viral activity tested against VZV(KMcC) virus on MRC-5 cell monolayers; 1-2,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100823244,NULL,216470,103504490,135398740,NULL,2989523,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,In vitro anti viral activity tested against VZV(KMcC) virus on MRC-5 cell monolayers; 1-2,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,416,10335,NULL,NULL
100831297,NULL,217805,103184834,135972447,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity tested against herpesvirus, VZV, OKA strain by plaque reduction assay in human foreskin fibroblasts","2-amino-9-[(1R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831298,NULL,217805,103192087,451656,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity tested against herpesvirus, VZV, OKA strain by plaque reduction assay in human foreskin fibroblasts","1,2-Cyclobutanedimethanol, 3-(6-amino-9H-purin-9-yl)-, (1S,2R,3R)-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831319,NULL,217803,103504725,135398513,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity tested against herpesvirus, VZV, OKA strain by plaque reduction assay in human foreskin fibroblasts.",Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831366,NULL,217802,103192087,451656,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity tested against herpesvirus, VZV, OKA strain by plaque reduction assay in human foreskin fibroblasts","1,2-Cyclobutanedimethanol, 3-(6-amino-9H-purin-9-yl)-, (1S,2R,3R)-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831367,NULL,217802,103184834,135972447,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity tested against herpesvirus, VZV, OKA strain by plaque reduction assay in human foreskin fibroblasts","2-amino-9-[(1R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831522,NULL,217800,103504725,135398513,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity against herpesvirus, VZV, Ellen strain by plaque reduction assay in human foreskin fibroblasts.",Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831561,NULL,217798,103184834,135972447,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity tested against herpesvirus, VZV, Ellen strain by plaque reduction assay in human foreskin fibroblasts","2-amino-9-[(1R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831562,NULL,217798,103192087,451656,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity tested against herpesvirus, VZV, Ellen strain by plaque reduction assay in human foreskin fibroblasts","1,2-Cyclobutanedimethanol, 3-(6-amino-9H-purin-9-yl)-, (1S,2R,3R)-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831892,NULL,217799,103504725,135398513,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity tested against herpesvirus, VZV, Ellen strain by plaque reduction assay in human foreskin fibroblasts.",Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831952,NULL,217801,103184834,135972447,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity tested against herpesvirus, VZV, Ellen strain by plaque reduction assay in human foreskin fibroblasts","2-amino-9-[(1R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831953,NULL,217801,103192087,451656,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity tested against herpesvirus, VZV, Ellen strain by plaque reduction assay in human foreskin fibroblasts","1,2-Cyclobutanedimethanol, 3-(6-amino-9H-purin-9-yl)-, (1S,2R,3R)-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100831981,NULL,217804,103504725,135398513,NULL,2329551,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"In vitro antiviral activity against herpesvirus, VZV, OKA strain by plaque reduction assay in human foreskin fibroblasts.",Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100845805,NULL,217663,103519825,6478043,NULL,10206544,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was evaluated for the antiviral activity against Varicella-Zoster virus (VZV) Oka strain by using plaque reduction assay.,5-(2-Bromovinyl)uridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100845806,NULL,217663,242583120,9841193,NULL,10206544,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was evaluated for the antiviral activity against Varicella-Zoster virus (VZV) Oka strain by using plaque reduction assay.,4'-Methyl-5-(2-bromoethenyl)-2'-deoxyuridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100845807,NULL,217663,242583121,90663531,NULL,10206544,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was evaluated for the antiviral activity against Varicella-Zoster virus (VZV) Oka strain by using plaque reduction assay.,"4-amino-1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)-5-methyloxolan-2-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100846010,NULL,217663,103202903,446727,NULL,10206544,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was evaluated for the antiviral activity against Varicella-Zoster virus (VZV) Oka strain by using plaque reduction assay.,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100846011,NULL,217663,103733589,46877020,NULL,10206544,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Compound was evaluated for the antiviral activity against Varicella-Zoster virus (VZV) Oka strain by using plaque reduction assay.,"5-[(E)-2-bromoethenyl]-1-[(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-5-methyloxolan-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100855384,NULL,393894,103595127,44565555,NULL,18485540,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,Fenoprofen 3-hydroxypropylamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100855385,NULL,393894,103594221,24282881,NULL,18485540,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,Diclofenac 3-hydroxypropylamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100855386,NULL,393894,103594223,25197644,NULL,18485540,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,methyl (2S)-2-[[3-[2-(3-benzoylphenyl)propanoylamino]propoxy-(4-chlorophenoxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100855387,NULL,393894,103594400,25197643,NULL,18485540,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,methyl (2S)-2-[[3-[[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]amino]propoxy-(4-chlorophenoxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100855388,NULL,393894,103595129,24285940,NULL,18485540,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,Ibuprofen 3-hydroxypropylamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100855389,NULL,393894,103594401,25197645,NULL,18485540,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"methyl (2S)-2-[[(4-chlorophenoxy)-[3-[[2-[2-(2,6-dichloroanilino)phenyl]acetyl]amino]propoxy]phosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100855390,NULL,393894,103595128,44565556,NULL,18485540,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,Ketoprofen 3-hydroxypropylamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100855391,NULL,393894,103194714,11546127,NULL,18485540,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,Indomethacin 3-Hydroxypropylamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100855392,NULL,393894,103594222,25197514,NULL,18485540,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,methyl (2S)-2-[[(4-chlorophenoxy)-[3-[2-(3-phenoxyphenyl)propanoylamino]propoxy]phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100855393,NULL,393894,103594284,25197642,NULL,18485540,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,methyl (2S)-2-[[(4-chlorophenoxy)-[3-[2-[4-(2-methylpropyl)phenyl]propanoylamino]propoxy]phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889801,NULL,349898,103596628,42637244,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,3-difluoro-4-hydroxy-4-phenylpyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889802,NULL,349898,103596711,54729987,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"3-fluoro-4-hydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889803,NULL,349898,103596710,54729986,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,3-Fluoro-3-deazauridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889804,NULL,349898,103596630,42637318,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"4-ethynyl-3,3-difluoro-4-hydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889805,NULL,349898,103596539,42637316,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"3,3-difluoro-4-hydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-methylpyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889806,NULL,349898,103596538,42637243,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,3-difluoro-4-hydroxy-4-methylpyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889850,NULL,349899,103596629,42637317,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"3,3-difluoro-4-hydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-phenylpyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889851,NULL,349899,103596632,42637164,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"2-[3-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyridin-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889852,NULL,349899,103596628,42637244,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,3-difluoro-4-hydroxy-4-phenylpyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889853,NULL,349899,103596711,54729987,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"3-fluoro-4-hydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889854,NULL,349899,103596633,42638110,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"2-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-fluoro-2-oxopyridin-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889855,NULL,349899,103596539,42637316,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"3,3-difluoro-4-hydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-methylpyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889856,NULL,349899,103596538,42637243,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,3-difluoro-4-hydroxy-4-methylpyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889857,NULL,349899,103596710,54729986,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,3-Fluoro-3-deazauridine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889858,NULL,349899,103596630,42637318,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"4-ethynyl-3,3-difluoro-4-hydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889859,NULL,349899,103596712,54729988,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-fluoro-4-hydroxypyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889860,NULL,349899,103596537,42636965,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-ethynyl-3,3-difluoro-4-hydroxypyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100889861,NULL,349899,103596631,42638109,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-fluoro-2-oxopyridin-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100890003,NULL,349898,103596631,42638109,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-fluoro-2-oxopyridin-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100890004,NULL,349898,103596537,42636965,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-ethynyl-3,3-difluoro-4-hydroxypyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100890005,NULL,349898,103596629,42637317,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"3,3-difluoro-4-hydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-phenylpyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100890006,NULL,349898,103596632,42637164,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"2-[3-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyridin-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100890007,NULL,349898,103596633,42638110,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"2-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-fluoro-2-oxopyridin-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100890008,NULL,349898,103596712,54729988,NULL,19378989,Literature-derived,20180910,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella zoster virus Oka infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect at <=100 uM,"1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-fluoro-4-hydroxypyridin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100920597,NULL,246634,103440365,44387960,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-(2-oxo-1-phenyl-2-piperidin-1-ylethyl)benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920598,NULL,246634,103440548,5273848,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,"3-Cyclopentyl-5-isopropyl-imidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920599,NULL,246634,103440373,44387962,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[1-(cyclohexylamino)-3-methyl-1-oxobutan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920600,NULL,246634,103440424,44387989,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[1-(benzhydrylamino)-1-oxo-3-phenylpropan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920601,NULL,246634,103440363,44387959,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[1-(cyclohexylamino)-1-oxo-3-phenylpropan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920602,NULL,246634,103440438,14842475,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[2-(cyclohexylamino)-2-oxo-1-phenylethyl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920603,NULL,246634,103440357,21158011,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[1-(cyclopentylamino)-3-methyl-1-oxobutan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920604,NULL,246634,103440475,44388017,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[2-(cyclohexylmethylamino)-2-oxo-1-phenylethyl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920605,NULL,246634,103440384,44387968,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[1-(cyclopentylamino)-3-methyl-1-oxopentan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920606,NULL,246634,103440600,5273851,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,"5-(Butan-2-yl)-3-cyclohexylimidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920607,NULL,246634,103440400,44387976,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[1-(cyclohexylamino)-3-methyl-1-oxopentan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920608,NULL,246634,103440435,44387998,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[1-(benzhydrylamino)-3-methyl-1-oxopentan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920609,NULL,246634,103440615,44388091,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,"3-Benzyl-5-butan-2-ylimidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920610,NULL,246634,103440380,44387964,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[2-(benzhydrylamino)-2-oxo-1-phenylethyl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920611,NULL,246634,103440403,44387978,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-(1-oxo-3-phenyl-1-pyrrolidin-1-ylpropan-2-yl)benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920612,NULL,246634,103440458,44388008,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[1-(cyclopentylamino)-1-oxo-3-phenylpropan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920613,NULL,246634,103405218,9860116,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,"1-Benzyl-4-phenylimidazolidine-2,5-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920614,NULL,246634,103504725,135398513,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920615,NULL,246634,103440413,44387982,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[1-(benzylamino)-3-methyl-1-oxopentan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920616,NULL,246634,103440549,5273849,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,"3-Cyclohexyl-5-isopropylimidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920617,NULL,246634,103440387,14842479,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,N-[1-(benzylamino)-1-oxo-3-phenylpropan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920618,NULL,246634,103440569,5273850,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,"3-Cyclopentyl-5-sec-butyl-imidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920619,NULL,246634,103440629,5273854,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells,"3-Cyclopentyl-5-phenyl-imidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920620,NULL,246675,103440629,5273854,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,"3-Cyclopentyl-5-phenyl-imidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920621,NULL,246675,103440569,5273850,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,"3-Cyclopentyl-5-sec-butyl-imidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920622,NULL,246675,103440387,14842479,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[1-(benzylamino)-1-oxo-3-phenylpropan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920623,NULL,246675,103440549,5273849,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,"3-Cyclohexyl-5-isopropylimidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920624,NULL,246675,103440413,44387982,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[1-(benzylamino)-3-methyl-1-oxopentan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920625,NULL,246675,103405218,9860116,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,"1-Benzyl-4-phenylimidazolidine-2,5-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920626,NULL,246675,103504725,135398513,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920627,NULL,246675,103440458,44388008,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[1-(cyclopentylamino)-1-oxo-3-phenylpropan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920628,NULL,246675,103440380,44387964,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[2-(benzhydrylamino)-2-oxo-1-phenylethyl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920629,NULL,246675,103440403,44387978,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-(1-oxo-3-phenyl-1-pyrrolidin-1-ylpropan-2-yl)benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920630,NULL,246675,103440400,44387976,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[1-(cyclohexylamino)-3-methyl-1-oxopentan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920631,NULL,246675,103440435,44387998,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[1-(benzhydrylamino)-3-methyl-1-oxopentan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920632,NULL,246675,103440615,44388091,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,"3-Benzyl-5-butan-2-ylimidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920633,NULL,246675,103440384,44387968,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[1-(cyclopentylamino)-3-methyl-1-oxopentan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920634,NULL,246675,103440600,5273851,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,"5-(Butan-2-yl)-3-cyclohexylimidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920635,NULL,246675,103440357,21158011,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[1-(cyclopentylamino)-3-methyl-1-oxobutan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920636,NULL,246675,103440475,44388017,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[2-(cyclohexylmethylamino)-2-oxo-1-phenylethyl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920637,NULL,246675,103440363,44387959,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[1-(cyclohexylamino)-1-oxo-3-phenylpropan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920638,NULL,246675,103440438,14842475,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[2-(cyclohexylamino)-2-oxo-1-phenylethyl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920639,NULL,246675,103440373,44387962,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[1-(cyclohexylamino)-3-methyl-1-oxobutan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920640,NULL,246675,103440424,44387989,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-[1-(benzhydrylamino)-1-oxo-3-phenylpropan-2-yl]benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100920641,NULL,246675,103440365,44387960,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,N-(2-oxo-1-phenyl-2-piperidin-1-ylethyl)benzotriazole-1-carboxamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100921756,NULL,246708,103504725,135398513,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration to reduce plaque formation of thymidine kinase positive Varicella zoster virus TK+ VZ OKA strain in human embryonic lung cell cultures,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100921757,NULL,246712,103504725,135398513,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Effective concentration to reduce plaque formation of thymidine kinase deficient Varicella zoster virus TK- VZV 07/1 strain in human embryonic lung cell cultures,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100921784,NULL,246675,103440548,5273848,NULL,15658861,Literature-derived,20181018,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Reduction of plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells,"3-Cyclopentyl-5-isopropyl-imidazolidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100944036,NULL,260292,103480229,11580118,NULL,16480257,Literature-derived,20181020,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/10 in human embryonic lung cells,"(E)-3-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]prop-2-enenitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100944037,NULL,260292,103480230,11536570,NULL,16480257,Literature-derived,20181020,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/10 in human embryonic lung cells,"3-[5-(6-Amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-yl]-acrylonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100944038,NULL,260292,103202903,446727,NULL,16480257,Literature-derived,20181020,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/10 in human embryonic lung cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100944039,NULL,260292,103479397,11537088,NULL,16480257,Literature-derived,20181020,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/10 in human embryonic lung cells,"(E)-3-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]-2-chloroprop-2-enenitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100944040,NULL,260292,103504725,135398513,NULL,16480257,Literature-derived,20181020,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/10 in human embryonic lung cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100944131,NULL,260291,103202903,446727,NULL,16480257,Literature-derived,20181020,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in human embryonic lung cells,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100944132,NULL,260291,103479397,11537088,NULL,16480257,Literature-derived,20181020,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in human embryonic lung cells,"(E)-3-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]-2-chloroprop-2-enenitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100944133,NULL,260291,103504725,135398513,NULL,16480257,Literature-derived,20181020,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in human embryonic lung cells,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100944134,NULL,260291,103480230,11536570,NULL,16480257,Literature-derived,20181020,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in human embryonic lung cells,"3-[5-(6-Amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-yl]-acrylonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100944135,NULL,260291,103480229,11580118,NULL,16480257,Literature-derived,20181020,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in human embryonic lung cells,"(E)-3-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]prop-2-enenitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
100999394,NULL,280179,103509152,15151762,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,(S)-HPMP-6-azaC,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999395,NULL,280179,103504725,135398513,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999396,NULL,280179,103509140,16110732,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,"[(2R)-1-(4-amino-2-oxo-1,3,5-triazin-1-yl)propan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999397,NULL,280179,103202903,446727,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999398,NULL,280179,103509177,16110731,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,[(2S)-1-(diaminomethylidenecarbamoylamino)-3-hydroxypropan-2-yl]oxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999399,NULL,280179,103208535,60613,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999400,NULL,280179,103509175,44420631,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,"[(3S)-3-[(6-amino-2-oxo-1,4-dihydro-1,3,5-triazin-3-yl)methyl]-4-hydroxybutyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999401,NULL,280179,103509151,16110080,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,HPMP-5-azaC,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999402,NULL,280179,103509176,137629162,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,[(2S)-1-[(N-formylcarbamimidoyl)carbamoylamino]-3-hydroxypropan-2-yl]oxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999403,NULL,280179,103509153,16110734,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,"2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999404,NULL,280179,103509154,16110729,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,"4-amino-1-[(2S)-2,3-dihydroxypropyl]-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999405,NULL,280179,103509178,16110740,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as inhibition of plaque formation,"[(1R)-1-[(4-amino-2-oxo-1,3,5-triazin-1-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999581,NULL,280180,103509152,15151762,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,(S)-HPMP-6-azaC,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999582,NULL,280180,103504725,135398513,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999583,NULL,280180,103509140,16110732,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,"[(2R)-1-(4-amino-2-oxo-1,3,5-triazin-1-yl)propan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999584,NULL,280180,103509176,137629162,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,[(2S)-1-[(N-formylcarbamimidoyl)carbamoylamino]-3-hydroxypropan-2-yl]oxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999585,NULL,280180,103208535,60613,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999586,NULL,280180,103509175,44420631,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,"[(3S)-3-[(6-amino-2-oxo-1,4-dihydro-1,3,5-triazin-3-yl)methyl]-4-hydroxybutyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999587,NULL,280180,103509154,16110729,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,"4-amino-1-[(2S)-2,3-dihydroxypropyl]-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999588,NULL,280180,103202903,446727,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999589,NULL,280180,103509151,16110080,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,HPMP-5-azaC,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999590,NULL,280180,103509177,16110731,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,[(2S)-1-(diaminomethylidenecarbamoylamino)-3-hydroxypropan-2-yl]oxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
100999591,NULL,280180,103509153,16110734,NULL,17298047,Literature-derived,20181021,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07-1 in HEL cells assessed as inhibition of plaque formation,"2-(4-Amino-2-oxo-1,3,5-triazin-1-yl)ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101013325,NULL,284460,103515100,135993365,NULL,17085053,Literature-derived,20181021,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus,"2-amino-7-[(1S,4R,5S)-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101013326,NULL,284460,103515099,16126689,NULL,17085053,Literature-derived,20181021,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus,9-Deazaneplanocin,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101013327,NULL,284460,103515101,44422395,NULL,17085053,Literature-derived,20181021,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus,"2-amino-5-[(1S,4R,5S)-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]-1H-pyrimidin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101013580,NULL,284460,103515110,44422400,NULL,17085053,Literature-derived,20181021,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against varicella zoster virus,"5-[(1S,4R,5S)-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]-1H-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101076338,NULL,303213,103202903,446727,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as reduction of virus-induced cytopathogenicity,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101076339,NULL,303213,103543251,16754950,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as reduction of virus-induced cytopathogenicity,"Octadecyl Ester of 1-{[(5S)-2-Hydroxy-2-oxido-1,4,2-dioxaphosphinan-5-yl]methyl}-5-azacytosine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101076340,NULL,303213,103504725,135398513,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as reduction of virus-induced cytopathogenicity,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101076341,NULL,303213,103531593,122873,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as reduction of virus-induced cytopathogenicity,Cyclic-hpmpc,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101076342,NULL,303213,103208535,60613,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as reduction of virus-induced cytopathogenicity,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101076343,NULL,303213,103543253,16061444,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as reduction of virus-induced cytopathogenicity,"4-amino-1-[[(5S)-2-(2-hexadecoxyethoxy)-2-oxo-1,4,2$l^{5}-dioxaphosphinan-5-yl]methyl]-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101076344,NULL,303213,103543250,16061427,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as reduction of virus-induced cytopathogenicity,"1-{[(5S)-2-Hydroxy-2-oxido-1,4,2-dioxaphosphinan-5-yl]methyl}-5-azacytosine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101076345,NULL,303213,103543252,44436718,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as reduction of virus-induced cytopathogenicity,"4-amino-1-[[(5S)-2-[(E)-docos-13-enoxy]-2-oxo-1,4,2$l^{5}-dioxaphosphinan-5-yl]methyl]-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101076346,NULL,303213,103543254,16754951,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as reduction of virus-induced cytopathogenicity,"[(5S)-5-[(4-amino-2-oxo-1,3,5-triazin-1-yl)methyl]-2-oxo-1,4,2$l^{5}-dioxaphosphinan-2-yl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101076347,NULL,303213,103509151,16110080,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA in HEL cells assessed as reduction of virus-induced cytopathogenicity,HPMP-5-azaC,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101078293,NULL,303214,103202903,446727,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 07-1 TK- in HEL cells assessed as reduction of virus-induced cytopathogenicity,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101078294,NULL,303214,103543251,16754950,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 07-1 TK- in HEL cells assessed as reduction of virus-induced cytopathogenicity,"Octadecyl Ester of 1-{[(5S)-2-Hydroxy-2-oxido-1,4,2-dioxaphosphinan-5-yl]methyl}-5-azacytosine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101078295,NULL,303214,103543250,16061427,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 07-1 TK- in HEL cells assessed as reduction of virus-induced cytopathogenicity,"1-{[(5S)-2-Hydroxy-2-oxido-1,4,2-dioxaphosphinan-5-yl]methyl}-5-azacytosine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101078296,NULL,303214,103509151,16110080,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 07-1 TK- in HEL cells assessed as reduction of virus-induced cytopathogenicity,HPMP-5-azaC,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101078297,NULL,303214,103543252,44436718,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 07-1 TK- in HEL cells assessed as reduction of virus-induced cytopathogenicity,"4-amino-1-[[(5S)-2-[(E)-docos-13-enoxy]-2-oxo-1,4,2$l^{5}-dioxaphosphinan-5-yl]methyl]-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101078298,NULL,303214,103504725,135398513,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 07-1 TK- in HEL cells assessed as reduction of virus-induced cytopathogenicity,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101078299,NULL,303214,103531593,122873,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 07-1 TK- in HEL cells assessed as reduction of virus-induced cytopathogenicity,Cyclic-hpmpc,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101078300,NULL,303214,103543254,16754951,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 07-1 TK- in HEL cells assessed as reduction of virus-induced cytopathogenicity,"[(5S)-5-[(4-amino-2-oxo-1,3,5-triazin-1-yl)methyl]-2-oxo-1,4,2$l^{5}-dioxaphosphinan-2-yl]oxymethyl 2,2-dimethylpropanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101078301,NULL,303214,103208535,60613,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 07-1 TK- in HEL cells assessed as reduction of virus-induced cytopathogenicity,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101078302,NULL,303214,103543253,16061444,NULL,17948980,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 07-1 TK- in HEL cells assessed as reduction of virus-induced cytopathogenicity,"4-amino-1-[[(5S)-2-(2-hexadecoxyethoxy)-2-oxo-1,4,2$l^{5}-dioxaphosphinan-5-yl]methyl]-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094904,NULL,309810,103545292,44438037,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"6-Methyl-3-(phenethylsulfanylmethyl)-8-phenyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094905,NULL,309810,103545308,44438053,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"3-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094906,NULL,309810,103545302,44438047,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"6-(3-Methoxyphenyl)-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094907,NULL,309810,103545304,44438049,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"6-(4-Methoxyphenyl)-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094908,NULL,309810,103545297,44438042,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"2-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]phenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094909,NULL,309810,103545310,44438055,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"8-(3-Fluorophenyl)-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094910,NULL,309810,103545298,44438043,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"3-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]phenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094911,NULL,309810,103545307,44438052,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"6-Methyl-8-(3-nitrophenyl)-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094912,NULL,309810,103208535,60613,NULL,17869124,Literature-derived,20181022,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094913,NULL,309810,103545309,44438054,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"4-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094998,NULL,309810,103545286,44438033,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"8-Iodo-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101094999,NULL,309810,103545303,44438048,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"8-(3-Methoxyphenyl)-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095000,NULL,309810,103545305,44438050,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"8-(4-Methoxyphenyl)-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095001,NULL,309810,103504725,135398513,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095002,NULL,309810,103545288,23661573,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"6-Iodo-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095003,NULL,309810,103545289,44438035,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"6-Bromo-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095004,NULL,309810,103545299,44438044,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"3-[6-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-8-yl]phenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095005,NULL,309810,103504490,135398740,NULL,17869124,Literature-derived,20181022,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095006,NULL,309810,103545306,44438051,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"8-Methyl-6-(3-nitrophenyl)-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095007,NULL,309810,103545291,23661574,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"3-(Phenethylsulfanylmethyl)-6-phenyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095008,NULL,309810,103545293,44438038,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"8-Methyl-3-(phenethylsulfanylmethyl)-6-(3-thienyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095009,NULL,309810,103545300,44438045,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"4-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]phenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095010,NULL,309810,103545294,44438039,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"6-Methyl-3-(phenethylsulfanylmethyl)-8-(3-thienyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095011,NULL,309810,103545295,44438040,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"8-Methyl-3-(phenethylsulfanylmethyl)-6-(2-thienyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095012,NULL,309810,103545290,44438036,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"8-Methyl-3-(phenethylsulfanylmethyl)-6-phenyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095013,NULL,309810,103545301,44438046,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"4-[6-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-8-yl]phenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095014,NULL,309810,103545296,44438041,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,"6-Methyl-3-(phenethylsulfanylmethyl)-8-(2-thienyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095015,NULL,309810,103202903,446727,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095120,NULL,309811,103545292,44438037,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"6-Methyl-3-(phenethylsulfanylmethyl)-8-phenyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095121,NULL,309811,103545298,44438043,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"3-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]phenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095122,NULL,309811,103545307,44438052,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"6-Methyl-8-(3-nitrophenyl)-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095123,NULL,309811,103545297,44438042,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"2-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]phenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095124,NULL,309811,103545310,44438055,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"8-(3-Fluorophenyl)-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095125,NULL,309811,103545302,44438047,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"6-(3-Methoxyphenyl)-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095126,NULL,309811,103545304,44438049,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"6-(4-Methoxyphenyl)-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095127,NULL,309811,103545294,44438039,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"6-Methyl-3-(phenethylsulfanylmethyl)-8-(3-thienyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095128,NULL,309811,103545295,44438040,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"8-Methyl-3-(phenethylsulfanylmethyl)-6-(2-thienyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095129,NULL,309811,103545308,44438053,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"3-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095130,NULL,309811,103545299,44438044,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"3-[6-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-8-yl]phenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095131,NULL,309811,103545296,44438041,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"6-Methyl-3-(phenethylsulfanylmethyl)-8-(2-thienyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095132,NULL,309811,103504725,135398513,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095133,NULL,309811,103545288,23661573,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"6-Iodo-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095134,NULL,309811,103545289,44438035,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"6-Bromo-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095135,NULL,309811,103208535,60613,NULL,17869124,Literature-derived,20181022,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095136,NULL,309811,103545309,44438054,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"4-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095205,NULL,309811,103545291,23661574,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"3-(Phenethylsulfanylmethyl)-6-phenyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095206,NULL,309811,103545293,44438038,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"8-Methyl-3-(phenethylsulfanylmethyl)-6-(3-thienyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095207,NULL,309811,103545300,44438045,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"4-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]phenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095208,NULL,309811,103545306,44438051,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"8-Methyl-6-(3-nitrophenyl)-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095209,NULL,309811,103202903,446727,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095210,NULL,309811,103545286,44438033,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"8-Iodo-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095211,NULL,309811,103545303,44438048,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"8-(3-Methoxyphenyl)-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095212,NULL,309811,103545305,44438050,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"8-(4-Methoxyphenyl)-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095213,NULL,309811,103545290,44438036,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"8-Methyl-3-(phenethylsulfanylmethyl)-6-phenyl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095214,NULL,309811,103545301,44438046,NULL,17869124,Literature-derived,20181022,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,"4-[6-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-8-yl]phenol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101095215,NULL,309811,103504490,135398740,NULL,17869124,Literature-derived,20181022,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 in HEL cells assessed as reduction of virus plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101146206,NULL,400422,103504490,135398740,NULL,9599250,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV 3CV-1 infected in human Hep2 cells after 3 days by plaque neutralization assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,4362,10335,NULL,NULL
101176019,NULL,383528,103202903,446727,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176020,NULL,383528,103619995,24814790,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-phenyl-3-[4-[(4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176021,NULL,383528,103620088,24814650,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-ethyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-phenyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176022,NULL,383528,103620002,24814793,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"3-[(4-aminophenoxy)methyl]-4-phenyl-1H-1,2,4-triazole-5-thione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176023,NULL,383528,103620085,24814932,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-ethyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-methyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176024,NULL,383528,103619994,24814937,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-allyl-3-[4-[(4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176025,NULL,383528,103620077,24814647,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-methyl-3-[4-[(4-methyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176026,NULL,383528,103504725,135398513,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176027,NULL,383528,103620086,24814649,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-ethyl-3-[4-[(4-ethyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176028,NULL,383528,103620097,24814651,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-allyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-ethyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176029,NULL,383528,103620084,24814795,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-methyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-phenyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176030,NULL,383528,103620100,24814936,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-methyl-3-[4-[(4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176031,NULL,383528,103620101,24814789,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-ethyl-3-[4-[(4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176032,NULL,383528,103620098,24814935,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-allyl-3-[4-[(4-allyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176033,NULL,383528,103619999,24814508,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"3-[(4-aminophenoxy)methyl]-4-methyl-1H-1,2,4-triazole-5-thione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176034,NULL,383528,103620079,24814648,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-allyl-3-[4-[(4-methyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176035,NULL,383528,103620000,24814792,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"3-[(4-aminophenoxy)methyl]-4-ethyl-1H-1,2,4-triazole-5-thione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176036,NULL,383528,103620099,24814652,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-allyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-phenyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176037,NULL,383528,103620001,24814646,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"4-allyl-3-[(4-aminophenoxy)methyl]-1H-1,2,4-triazole-5-thione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176038,NULL,383528,103620078,24814794,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-ethyl-3-[4-[(4-methyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176039,NULL,383528,103620089,24814934,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-allyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-methyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176214,NULL,383528,103620087,24814933,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- VZV 07/1 infected HEL cells assessed as reduction in virus plaque formation,"1-allyl-3-[4-[(4-ethyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176751,NULL,383527,103202903,446727,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176752,NULL,383527,103619995,24814790,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-phenyl-3-[4-[(4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101176753,NULL,383527,103620088,24814650,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-ethyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-phenyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177099,NULL,383527,103620077,24814647,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-methyl-3-[4-[(4-methyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177100,NULL,383527,103620084,24814795,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-methyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-phenyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177101,NULL,383527,103620100,24814936,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-methyl-3-[4-[(4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177102,NULL,383527,103620101,24814789,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-ethyl-3-[4-[(4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177103,NULL,383527,103620001,24814646,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"4-allyl-3-[(4-aminophenoxy)methyl]-1H-1,2,4-triazole-5-thione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177104,NULL,383527,103620087,24814933,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-allyl-3-[4-[(4-ethyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177105,NULL,383527,103619999,24814508,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"3-[(4-aminophenoxy)methyl]-4-methyl-1H-1,2,4-triazole-5-thione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177106,NULL,383527,103504725,135398513,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177107,NULL,383527,103620078,24814794,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-ethyl-3-[4-[(4-methyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177108,NULL,383527,103620089,24814934,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-allyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-methyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177109,NULL,383527,103620098,24814935,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-allyl-3-[4-[(4-allyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177110,NULL,383527,103620079,24814648,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-allyl-3-[4-[(4-methyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177111,NULL,383527,103619994,24814937,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-allyl-3-[4-[(4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177112,NULL,383527,103620086,24814649,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-ethyl-3-[4-[(4-ethyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177113,NULL,383527,103620097,24814651,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-allyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-ethyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177114,NULL,383527,103620000,24814792,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"3-[(4-aminophenoxy)methyl]-4-ethyl-1H-1,2,4-triazole-5-thione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177115,NULL,383527,103620099,24814652,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-allyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-phenyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177116,NULL,383527,103620002,24814793,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"3-[(4-aminophenoxy)methyl]-4-phenyl-1H-1,2,4-triazole-5-thione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101177117,NULL,383527,103620085,24814932,NULL,17583388,Literature-derived,20181024,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA infected HEL cells assessed as reduction in virus plaque formation,"1-[4-[(4-ethyl-5-thioxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]-3-methyl-thiourea",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101240854,NULL,343666,103543251,16754950,NULL,18554916,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV,"Octadecyl Ester of 1-{[(5S)-2-Hydroxy-2-oxido-1,4,2-dioxaphosphinan-5-yl]methyl}-5-azacytosine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101248157,NULL,388919,103646075,44588594,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-Methyl-3-(phenethylsulfanylmethyl)-8-pyrrolidin-1-yl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248158,NULL,388919,103646077,44588596,NULL,18835175,Literature-derived,20181026,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-Methyl-8-(4-methylpiperazin-1-yl)-3-(2-phenylethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248159,NULL,388919,103647022,44589009,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-Methyl-3-phenethylthiomethyl-6-(pyrrol-1-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248160,NULL,388919,103646960,44588983,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-(2-Furyl)-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248161,NULL,388919,103647019,44589006,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-Methyl-3-(phenethylsulfanylmethyl)-6-pyrrolidin-1-yl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248162,NULL,388919,103647084,44589033,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-Methyl-3-phenethylthiomethyl-6-(pyrrolo[2,3-b]pyridin-1-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248163,NULL,388919,103504490,135398740,NULL,18835175,Literature-derived,20181026,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248164,NULL,388919,103504725,135398513,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248165,NULL,388919,103646298,44588705,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-(Imidazol-1-yl)-6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248166,NULL,388919,103646362,44588727,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-(4-Chlorophenylthio)-6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248167,NULL,388919,103647083,44589032,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-(Indol-1-yl)-8-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248168,NULL,388919,103646959,44588982,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"3-Benzylthiomethyl-8-methyl-6-(thien-3-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248169,NULL,388919,103647023,25110652,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"3-(Benzylsulfanylmethyl)-8-methyl-6-pyrrol-1-yl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248170,NULL,388919,103208535,60613,NULL,18835175,Literature-derived,20181026,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248171,NULL,388919,103646074,44588593,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"4-[6-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-8-yl]morpholine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248172,NULL,388919,103646961,44588984,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-(3-Furyl)-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248173,NULL,388919,103647163,44589080,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-(4-Hydroxyphenylthio)-8-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248174,NULL,388919,103202903,446727,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248175,NULL,388919,103646133,44588616,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-Methyl-3-phenethylthiomethyl-8-(pyrrol-1-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248197,NULL,388919,103647085,44589034,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine-6-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248198,NULL,388919,103646076,44588595,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"3-Benzylthiomethyl-6-methyl-8-(pyrrolidin-1-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248199,NULL,388919,103646301,44588708,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-Methyl-3-(2-phenylethylsulfanylmethyl)imidazo[1,2-a]pyridine-8-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248200,NULL,388919,103646962,44588985,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"4-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]morpholine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248201,NULL,388919,103647021,44589008,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"N-(8-Methyl-3-phenethylthiomethylimidazo[1,2-a]pyridin-6-yl)pyrrolidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248202,NULL,388919,103647164,25110665,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-(4-Aminophenylthio)-8-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248203,NULL,388919,103646300,44588707,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-(Pyrrolo[2,3-b]pyridin-1-yl)-6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248204,NULL,388919,103647086,44589035,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-(4-Chlorophenylthio)-8-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248205,NULL,388919,103646078,44588597,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"N-(6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridin-8-yl)pyrrolidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248206,NULL,388919,103647082,44589031,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"6-(Imidazol-1-yl)-8-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248207,NULL,388919,103647165,44589081,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"3-(Benzylsulfanylmethyl)-6-methyl-8-(3-thienyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248208,NULL,388919,103647167,44589083,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-(3-Furyl)-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248209,NULL,388919,103647020,44589007,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-Methyl-6-(4-methylpiperazin-1-yl)-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248210,NULL,388919,103646297,25110666,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"3-Benzylthiomethyl-6-methyl-8-(pyrrol-1-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248211,NULL,388919,103646299,44588706,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-(Indol-1-yl)-6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248212,NULL,388919,103646363,25110667,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-(4-Hydroxyphenylthio)-6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248213,NULL,388919,103647166,44589082,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07/1 in HEL cells assessed as inhibition of viral cytopathicity,"8-(2-Furyl)-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248347,NULL,388918,103646078,44588597,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"N-(6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridin-8-yl)pyrrolidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248348,NULL,388918,103647082,44589031,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-(Imidazol-1-yl)-8-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248349,NULL,388918,103647165,44589081,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"3-(Benzylsulfanylmethyl)-6-methyl-8-(3-thienyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248350,NULL,388918,103647167,44589083,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-(3-Furyl)-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248351,NULL,388918,103646300,44588707,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-(Pyrrolo[2,3-b]pyridin-1-yl)-6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248352,NULL,388918,103647086,44589035,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-(4-Chlorophenylthio)-8-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248353,NULL,388918,103646297,25110666,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"3-Benzylthiomethyl-6-methyl-8-(pyrrol-1-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248354,NULL,388918,103646299,44588706,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-(Indol-1-yl)-6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248355,NULL,388918,103646960,44588983,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-(2-Furyl)-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248356,NULL,388918,103647019,44589006,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-Methyl-3-(phenethylsulfanylmethyl)-6-pyrrolidin-1-yl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248357,NULL,388918,103646961,44588984,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-(3-Furyl)-8-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248358,NULL,388918,103647163,44589080,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-(4-Hydroxyphenylthio)-8-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248359,NULL,388918,103647020,44589007,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-Methyl-6-(4-methylpiperazin-1-yl)-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248360,NULL,388918,103504490,135398740,NULL,18835175,Literature-derived,20181026,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248361,NULL,388918,103646363,25110667,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-(4-Hydroxyphenylthio)-6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248362,NULL,388918,103647166,44589082,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-(2-Furyl)-6-methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248363,NULL,388918,103646959,44588982,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"3-Benzylthiomethyl-8-methyl-6-(thien-3-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248364,NULL,388918,103647023,25110652,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"3-(Benzylsulfanylmethyl)-8-methyl-6-pyrrol-1-yl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248365,NULL,388918,103646076,44588595,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"3-Benzylthiomethyl-6-methyl-8-(pyrrolidin-1-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248366,NULL,388918,103646301,44588708,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-Methyl-3-(2-phenylethylsulfanylmethyl)imidazo[1,2-a]pyridine-8-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248367,NULL,388918,103646962,44588985,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"4-[8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-6-yl]morpholine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248368,NULL,388918,103647021,44589008,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"N-(8-Methyl-3-phenethylthiomethylimidazo[1,2-a]pyridin-6-yl)pyrrolidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248369,NULL,388918,103647164,25110665,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-(4-Aminophenylthio)-8-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248370,NULL,388918,103504725,135398513,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248371,NULL,388918,103646298,44588705,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-(Imidazol-1-yl)-6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248372,NULL,388918,103646362,44588727,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-(4-Chlorophenylthio)-6-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248373,NULL,388918,103647083,44589032,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-(Indol-1-yl)-8-methyl-3-phenethylthiomethylimidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248374,NULL,388918,103647084,44589033,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-Methyl-3-phenethylthiomethyl-6-(pyrrolo[2,3-b]pyridin-1-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248375,NULL,388918,103646075,44588594,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-Methyl-3-(phenethylsulfanylmethyl)-8-pyrrolidin-1-yl-imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248376,NULL,388918,103646077,44588596,NULL,18835175,Literature-derived,20181026,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-Methyl-8-(4-methylpiperazin-1-yl)-3-(2-phenylethylsulfanylmethyl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248377,NULL,388918,103647022,44589009,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-Methyl-3-phenethylthiomethyl-6-(pyrrol-1-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248378,NULL,388918,103202903,446727,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248379,NULL,388918,103646133,44588616,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"6-Methyl-3-phenethylthiomethyl-8-(pyrrol-1-yl)imidazo[1,2-a]pyridine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248380,NULL,388918,103647085,44589034,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"8-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridine-6-carbonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248381,NULL,388918,103208535,60613,NULL,18835175,Literature-derived,20181026,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101248382,NULL,388918,103646074,44588593,NULL,18835175,Literature-derived,20181026,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase expressing Varicella-Zoster virus Oka in HEL cells assessed as inhibition of viral cytopathicity,"4-[6-Methyl-3-(phenethylsulfanylmethyl)imidazo[1,2-a]pyridin-8-yl]morpholine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101416933,NULL,246710,103504490,135398740,NULL,15658861,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells; ND=Not determined,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101416934,NULL,246710,103208535,60613,NULL,15658861,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by OKA strain of thymidine kinase positive VZ virus TK+ in human embryonic lung cells; ND=Not determined,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101416935,NULL,246718,103208535,60613,NULL,15658861,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells; ND=Not determined,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101416936,NULL,246718,103504490,135398740,NULL,15658861,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Effective concentration of compound required to reduce plaque formation by VZV07/1 strain of thymidine kinase(TK-) deficient VZ virus in human embryonic lung cells; ND=Not determined,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101417169,NULL,246728,103504490,135398740,NULL,15658861,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Effective concentration to reduce plaque formation of thymidine kinase deficient Varicella zoster virus TK- VZV 07/1 strain in human embryonic lung cell cultures; ND=Not determined,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101417170,NULL,246728,103208535,60613,NULL,15658861,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Effective concentration to reduce plaque formation of thymidine kinase deficient Varicella zoster virus TK- VZV 07/1 strain in human embryonic lung cell cultures; ND=Not determined,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101417344,NULL,246725,103504490,135398740,NULL,15658861,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Effective concentration to reduce plaque formation of thymidine kinase positive Varicella zoster virus TK+ VZ OKA strain in human embryonic lung cell cultures; ND=Not determined,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101417345,NULL,246725,103208535,60613,NULL,15658861,Literature-derived,20220318,0,0,Inconclusive,NULL,NULL,NULL,ChEMBL,Effective concentration to reduce plaque formation of thymidine kinase positive Varicella zoster virus TK+ VZ OKA strain in human embryonic lung cell cultures; ND=Not determined,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101495263,NULL,340472,103504490,135398740,NULL,18595689,Confirmatory,20220830,0,0,Inconclusive,NULL,IC50,NULL,ChEMBL,Antiviral activity against VZV Webster by plaque reduction assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101499179,NULL,342121,103624442,135908417,NULL,18614365,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R infected HEL cells assessed as reduction in virus plaque formation after 5 days,benzyl (2S)-2-[[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-(1-naphthyloxy)phosphoryl]amino]propanoate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101641201,NULL,279714,103511722,15986985,NULL,17130297,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against VZV Ellen in HFF cell by CPE assay,"[(Z)-5-(2,4-dioxopyrimidin-1-yl)pent-3-enyl]-(3-hexadecoxypropoxy)phosphinic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101698201,NULL,296674,103504490,135398740,NULL,17622128,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient VZV 07/1 in HEL cells assessed as reduction of virus plaque formation after 5 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698282,NULL,296675,103504490,135398740,NULL,17622128,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient VZV YS/R in HEL cells assessed as reduction of virus plaque formation after 5 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101698735,NULL,296673,103504490,135398740,NULL,17622128,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against TK+ VZV OKA in HEL cells assessed as reduction of virus plaque formation after 5 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
101710813,NULL,299444,103504490,135398740,NULL,17513108,Confirmatory,20220830,0,0,Inconclusive,NULL,IC50,NULL,ChEMBL,Antiviral activity against VZV in human foreskin fibroblast assessed as inhibition of virus plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101747281,NULL,307432,103504490,135398740,NULL,17434304,Confirmatory,20220830,0,0,Inconclusive,NULL,IC50,NULL,ChEMBL,Antiviral activity against VZV Webster in HFF cells by plaque reduction assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
101853250,NULL,258989,103504490,135398740,NULL,16392824,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus YS strain,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853327,NULL,258990,103504490,135398740,NULL,16392824,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus 07/1 strain,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
101853738,NULL,258991,103504490,135398740,NULL,16392824,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-Zoster virus YS/R strain,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
103093355,NULL,434324,103687021,44225225,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus OKA infected in HEL cells assessed as reduction in virus plaque formation,1-Ethyl-3-[4-(methanesulfonamido)-3-phenoxy-phenyl]thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103093356,NULL,434324,103690504,44225221,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus OKA infected in HEL cells assessed as reduction in virus plaque formation,1-[4-(Methanesulfonamido)-3-phenoxy-phenyl]-3-propyl-thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103093357,NULL,434324,103208535,60613,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus OKA infected in HEL cells assessed as reduction in virus plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103093358,NULL,434324,103504490,135398740,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus OKA infected in HEL cells assessed as reduction in virus plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103093359,NULL,434324,103687026,44225222,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus OKA infected in HEL cells assessed as reduction in virus plaque formation,1-[4-(Methanesulfonamido)-3-phenoxy-phenyl]-3-phenethyl-thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103093360,NULL,434324,103692288,44225466,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus OKA infected in HEL cells assessed as reduction in virus plaque formation,1-Allyl-3-[4-(methanesulfonamido)-3-phenoxy-phenyl]thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103093361,NULL,434324,103681835,44225467,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus OKA infected in HEL cells assessed as reduction in virus plaque formation,1-Benzyl-3-[4-(methanesulfonamido)-3-phenoxy-phenyl]thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103093362,NULL,434324,103688807,44225469,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus OKA infected in HEL cells assessed as reduction in virus plaque formation,1-[4-(Methanesulfonamido)-3-phenoxy-phenyl]-3-(4-nitrophenyl)thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103093363,NULL,434324,103687034,44225223,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus OKA infected in HEL cells assessed as reduction in virus plaque formation,1-Cyclohexyl-3-[4-(methanesulfonamido)-3-phenoxy-phenyl]thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103094683,NULL,434325,103504490,135398740,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella Zoster Virus 07/1 infected in HEL cells assessed as reduction in virus plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103094684,NULL,434325,103687026,44225222,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella Zoster Virus 07/1 infected in HEL cells assessed as reduction in virus plaque formation,1-[4-(Methanesulfonamido)-3-phenoxy-phenyl]-3-phenethyl-thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103094685,NULL,434325,103692288,44225466,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella Zoster Virus 07/1 infected in HEL cells assessed as reduction in virus plaque formation,1-Allyl-3-[4-(methanesulfonamido)-3-phenoxy-phenyl]thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103094686,NULL,434325,103687021,44225225,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella Zoster Virus 07/1 infected in HEL cells assessed as reduction in virus plaque formation,1-Ethyl-3-[4-(methanesulfonamido)-3-phenoxy-phenyl]thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103094687,NULL,434325,103690504,44225221,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella Zoster Virus 07/1 infected in HEL cells assessed as reduction in virus plaque formation,1-[4-(Methanesulfonamido)-3-phenoxy-phenyl]-3-propyl-thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103094688,NULL,434325,103208535,60613,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella Zoster Virus 07/1 infected in HEL cells assessed as reduction in virus plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103094689,NULL,434325,103687034,44225223,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella Zoster Virus 07/1 infected in HEL cells assessed as reduction in virus plaque formation,1-Cyclohexyl-3-[4-(methanesulfonamido)-3-phenoxy-phenyl]thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103094690,NULL,434325,103681835,44225467,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella Zoster Virus 07/1 infected in HEL cells assessed as reduction in virus plaque formation,1-Benzyl-3-[4-(methanesulfonamido)-3-phenoxy-phenyl]thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103094691,NULL,434325,103688807,44225469,NULL,19324473,Literature-derived,20180911,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella Zoster Virus 07/1 infected in HEL cells assessed as reduction in virus plaque formation,1-[4-(Methanesulfonamido)-3-phenoxy-phenyl]-3-(4-nitrophenyl)thiourea,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103105736,NULL,425648,103686161,45269825,NULL,19442526,Literature-derived,20200704,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation at 10 to 100 ug/ml,"2-[(5-Fluoro-2,4-dioxopyrimidin-1-yl)methyl-(4-methylphenyl)sulfonylamino]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103105737,NULL,425648,103693227,45273249,NULL,19442526,Literature-derived,20200704,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation at 10 to 100 ug/ml,"2-[(2,4-Dioxopyrimidin-1-yl)methyl-(4-methylphenyl)sulfonylamino]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103105738,NULL,425648,103684376,45268966,NULL,19442526,Literature-derived,20200704,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation at 10 to 100 ug/ml,2-[(4-Amino-2-oxopyrimidin-1-yl)methyl-(4-methylphenyl)sulfonylamino]ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103105739,NULL,425648,103689615,44187553,NULL,19442526,Literature-derived,20200704,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster virus Oka infected in HEL cells assessed as reduction in viral plaque formation at 10 to 100 ug/ml,"2-[(5-Methyl-2,4-dioxopyrimidin-1-yl)methyl-(4-methylphenyl)sulfonylamino]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103105740,NULL,425649,103689615,44187553,NULL,19442526,Literature-derived,20200704,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation at 10 to 100 ug/ml,"2-[(5-Methyl-2,4-dioxopyrimidin-1-yl)methyl-(4-methylphenyl)sulfonylamino]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103105741,NULL,425649,103684376,45268966,NULL,19442526,Literature-derived,20200704,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation at 10 to 100 ug/ml,2-[(4-Amino-2-oxopyrimidin-1-yl)methyl-(4-methylphenyl)sulfonylamino]ethoxymethylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103105742,NULL,425649,103693227,45273249,NULL,19442526,Literature-derived,20200704,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation at 10 to 100 ug/ml,"2-[(2,4-Dioxopyrimidin-1-yl)methyl-(4-methylphenyl)sulfonylamino]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103105743,NULL,425649,103686161,45269825,NULL,19442526,Literature-derived,20200704,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation at 10 to 100 ug/ml,"2-[(5-Fluoro-2,4-dioxopyrimidin-1-yl)methyl-(4-methylphenyl)sulfonylamino]ethoxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108397,NULL,429203,103192704,135542177,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to Acyclovir EC50 for Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"2-amino-9-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108398,NULL,429205,103683202,44140466,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"6-(furan-2-yl)-3-(2-hydroxyethoxymethyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108399,NULL,429205,103690166,44140464,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-(2-hydroxyethoxymethyl)-6-thiophen-2-yl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108400,NULL,429205,103684902,45269251,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-(furan-2-yl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108401,NULL,429205,103686701,11964538,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-phenyl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108402,NULL,429205,103691947,45272643,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-(5-bromothiophen-2-yl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108403,NULL,429205,103688495,45270933,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-thiophen-2-yl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108404,NULL,429205,103693769,44140465,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus YS infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"6-(5-bromothiophen-2-yl)-3-(2-hydroxyethoxymethyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108465,NULL,429206,103683202,44140466,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"6-(furan-2-yl)-3-(2-hydroxyethoxymethyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108466,NULL,429206,103693769,44140465,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"6-(5-bromothiophen-2-yl)-3-(2-hydroxyethoxymethyl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108467,NULL,429206,103684902,45269251,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-(furan-2-yl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108468,NULL,429206,103686701,11964538,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-phenyl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108469,NULL,429206,103691947,45272643,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-(5-bromothiophen-2-yl)-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108470,NULL,429206,103690166,44140464,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-(2-hydroxyethoxymethyl)-6-thiophen-2-yl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108471,NULL,429206,103688495,45270933,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to RA-5021 EC50 for Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"3-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-6-thiophen-2-yl-5H-imidazo[1,2-a]purin-9-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
103108669,NULL,429204,103192704,135542177,NULL,19339082,Literature-derived,20200704,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to Acyclovir EC50 for Varicella zoster virus OKA infected in human HEL cells assessed as inhibition of virus induced cytopathicity after 5 days,"2-amino-9-[[1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151238874,NULL,456808,103543253,16061444,NULL,19914075,Literature-derived,20180912,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus infected in HEL cells,"4-amino-1-[[(5S)-2-(2-hexadecoxyethoxy)-2-oxo-1,4,2$l^{5}-dioxaphosphinan-5-yl]methyl]-1,3,5-triazin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151250902,NULL,456815,103723729,46229326,NULL,19914075,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to HPMP-5-azaC EC50 for Varicella zoster virus infected in HEL cells,"[(2S)-1-(4-amino-2-butyl-6-oxo-1,3,5-triazin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151250903,NULL,456815,103723728,46229325,NULL,19914075,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to HPMP-5-azaC EC50 for Varicella zoster virus infected in HEL cells,"[(2S)-1-(4-amino-2-oxo-6-propyl-1,3,5-triazin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151250904,NULL,456815,103724302,46229715,NULL,19914075,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to HPMP-5-azaC EC50 for Varicella zoster virus infected in HEL cells,"[(2S)-1-(4-amino-2-methyl-6-oxo-1,3,5-triazin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151250905,NULL,456815,103723730,46229327,NULL,19914075,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to HPMP-5-azaC EC50 for Varicella zoster virus infected in HEL cells,"[(2S)-1-(4-amino-2-oxo-6-phenyl-1,3,5-triazin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
151251171,NULL,456815,103723727,46229324,NULL,19914075,Literature-derived,20200703,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Ratio of compound EC50 to HPMP-5-azaC EC50 for Varicella zoster virus infected in HEL cells,"[(2S)-1-(4-amino-2-ethyl-6-oxo-1,3,5-triazin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
155763600,NULL,481587,103751933,46830304,NULL,20403696,Confirmatory,20220830,0,0,Inconclusive,NULL,IC50,NULL,ChEMBL,Antiviral activity against VZV Webster infected in HFF cells assessed as reduction in plaque formation,"2-{2-[bis(2-hydroxyethyl)amino]ethyl}-N-(4-chlorobenzyl)-8-(morpholin-4-ylmethyl)-6-oxo-6H-pyrrolo[3,2,1-ij]quinoline-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
155763603,NULL,481587,103504490,135398740,NULL,20403696,Confirmatory,20220830,0,0,Inconclusive,NULL,IC50,NULL,ChEMBL,Antiviral activity against VZV Webster infected in HFF cells assessed as reduction in plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
198378005,NULL,534207,123084368,11543540,NULL,18852272,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in HFF cells by plaque reduction assay,2-(4-amino-5-fluoro-2-oxo-pyrimidin-1-yl)ethoxymethylphosphonic Acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
204254158,NULL,562213,124969207,53323191,NULL,19786605,Literature-derived,20180917,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA infected in HFF assessed as viral plaque formation at 5 uM after 8 days by microscopy relative to control,"[(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2-bromo-4,5,6-trichlorobenzimidazol-1-yl)oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204254159,NULL,562213,103651610,465094,NULL,19786605,Literature-derived,20180917,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA infected in HFF assessed as viral plaque formation at 5 uM after 8 days by microscopy relative to control,Bdcrb,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
204254160,NULL,562213,124961267,53319245,NULL,19786605,Literature-derived,20180917,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV OKA infected in HFF assessed as viral plaque formation at 5 uM after 8 days by microscopy relative to control,"[(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2,4,5,6-tetrachlorobenzimidazol-1-yl)oxolan-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
224518063,NULL,595576,103504490,135398740,NULL,21376429,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
224518064,NULL,595576,103504490,135398740,NULL,21376429,Confirmatory,20220830,0,0,Inconclusive,NULL,EC90,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
224518066,NULL,595576,103504725,135398513,NULL,21376429,Confirmatory,20220830,0,0,Inconclusive,NULL,EC90,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
224518784,NULL,595576,131274725,53232137,NULL,21376429,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,(E)-4-(Trifluoromethoxy)benzaldehyde thiosemicarbazone,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
224518785,NULL,595576,131274725,53232137,NULL,21376429,Confirmatory,20220830,0,0,Inconclusive,NULL,EC90,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,(E)-4-(Trifluoromethoxy)benzaldehyde thiosemicarbazone,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
224518786,NULL,595576,103208535,60613,NULL,21376429,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
224518787,NULL,595576,103208535,60613,NULL,21376429,Confirmatory,20220830,0,0,Inconclusive,NULL,EC90,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
224518788,NULL,595576,103529720,6436743,NULL,21376429,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,4-(Dimethylamino)benzaldehyde thiosemicarbazone,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
224518789,NULL,595576,103529720,6436743,NULL,21376429,Confirmatory,20220830,0,0,Inconclusive,NULL,EC90,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Ellen infected in 1 hr pretreated human HFF cells assessed as reduction in viral-induced cytopathic effect by neutral red uptake assay,4-(Dimethylamino)benzaldehyde thiosemicarbazone,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
237768693,NULL,603381,134436724,53307132,NULL,21621997,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"(4R,5R,6S,7R)-7-(6-aminopurin-9-yl)-4-(hydroxymethyl)spiro[2.4]heptane-5,6-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237809238,NULL,614951,134454543,46913823,NULL,21664010,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period,"1-[(2R,4R)-4-hydroxytetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237809239,NULL,614951,134446800,54768281,NULL,21664010,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period,"(3R,5R)-5-(6-aminopurin-9-yl)tetrahydrofuran-3-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237809240,NULL,614951,134439029,54768280,NULL,21664010,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period,"1-[(2R,4R)-4-hydroxytetrahydrofuran-2-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237809241,NULL,614951,134442791,54768283,NULL,21664010,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period,"4-amino-1-[(2R,4R)-4-hydroxytetrahydrofuran-2-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237809391,NULL,614951,134458363,54768282,NULL,21664010,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella Zoster Virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period,"N-[1-[(2R,4R)-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
237833092,NULL,609512,103208535,60613,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833093,NULL,609512,134436938,136208038,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,[3-hydroxy-2-[2-(6-oxo-1H-purin-9-yl)ethoxy]propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833095,NULL,609512,134452422,56673537,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-Aminopurin-9-yl)ethoxy]-3-hydroxypropyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833096,NULL,609512,134463852,136068698,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-oxo-1H-purin-9-yl)ethoxy]-3-phenylmethoxypropyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833098,NULL,609512,134456229,56676853,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,"[2-[2-(2,4-Dioxopyrimidin-1-yl)ethoxy]-3-hydroxypropyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833099,NULL,609512,134436939,56659702,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,"2-[2-(2,6-Diaminopurin-9-yl)ethoxy]propylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833100,NULL,609512,134460046,56680174,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-Aminopurin-9-yl)ethoxy]-3-phenylmethoxypropyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833101,NULL,609512,134452421,56673536,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,2-[2-(4-Amino-2-oxo-pyrimidin-1-yl)ethoxy]propylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833102,NULL,609512,134436940,56659703,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,"[3-Hydroxy-2-[2-(5-methyl-2,4-dioxopyrimidin-1-yl)ethoxy]propyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833103,NULL,609512,134456228,56676852,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,"2-[2-(5-Methyl-2,4-dioxo-pyrimidin-1-yl)ethoxy]propylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833123,NULL,609572,134452422,56673537,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-Aminopurin-9-yl)ethoxy]-3-hydroxypropyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833124,NULL,609572,134463852,136068698,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-oxo-1H-purin-9-yl)ethoxy]-3-phenylmethoxypropyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833134,NULL,609573,134448542,136026151,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(2-amino-6-oxo-1H-purin-9-yl)ethoxy]-3-hydroxy-propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833135,NULL,609573,134452420,136099207,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(2-amino-6-oxo-1H-purin-9-yl)ethoxy]-3-benzyloxy-propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833137,NULL,609573,134452422,56673537,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-Aminopurin-9-yl)ethoxy]-3-hydroxypropyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833138,NULL,609573,134463852,136068698,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-oxo-1H-purin-9-yl)ethoxy]-3-phenylmethoxypropyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833139,NULL,609573,103504490,135398740,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833140,NULL,609573,134436938,136208038,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,[3-hydroxy-2-[2-(6-oxo-1H-purin-9-yl)ethoxy]propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833512,NULL,609572,134456229,56676853,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,"[2-[2-(2,4-Dioxopyrimidin-1-yl)ethoxy]-3-hydroxypropyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833515,NULL,609572,134436940,56659703,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,"[3-Hydroxy-2-[2-(5-methyl-2,4-dioxopyrimidin-1-yl)ethoxy]propyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833520,NULL,609572,134436939,56659702,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,"2-[2-(2,6-Diaminopurin-9-yl)ethoxy]propylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833521,NULL,609572,134460046,56680174,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-Aminopurin-9-yl)ethoxy]-3-phenylmethoxypropyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833523,NULL,609572,103504490,135398740,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/1 assessed as reduction of virus induced cytopathicity by cell based assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833782,NULL,609573,103208535,60613,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833784,NULL,609573,134456229,56676853,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,"[2-[2-(2,4-Dioxopyrimidin-1-yl)ethoxy]-3-hydroxypropyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833786,NULL,609573,134452421,56673536,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,2-[2-(4-Amino-2-oxo-pyrimidin-1-yl)ethoxy]propylphosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833787,NULL,609573,134436939,56659702,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,"2-[2-(2,6-Diaminopurin-9-yl)ethoxy]propylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833788,NULL,609573,134460046,56680174,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(6-Aminopurin-9-yl)ethoxy]-3-phenylmethoxypropyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833789,NULL,609573,134436940,56659703,NULL,21745746,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,"[3-Hydroxy-2-[2-(5-methyl-2,4-dioxopyrimidin-1-yl)ethoxy]propyl]phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833790,NULL,609573,134456228,56676852,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus YS/R assessed as reduction of virus induced cytopathicity by cell based assay,"2-[2-(5-Methyl-2,4-dioxo-pyrimidin-1-yl)ethoxy]propylphosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833801,NULL,609512,134448542,136026151,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(2-amino-6-oxo-1H-purin-9-yl)ethoxy]-3-hydroxy-propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833802,NULL,609512,134452420,136099207,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,[2-[2-(2-amino-6-oxo-1H-purin-9-yl)ethoxy]-3-benzyloxy-propyl]phosphonic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237833803,NULL,609512,103504490,135398740,NULL,21745746,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS expressing thymidine kinase assessed as reduction of virus induced cytopathicity by cell based assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
237836762,NULL,611619,103504490,135398740,NULL,21565516,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection against virus-induced cytopathicity,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352253,NULL,634754,103208535,60613,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352254,NULL,634754,136937910,56969297,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5S)-3-diethoxyphosphoryl-5-[4-(2-fluorophenyl)triazol-1-yl]-2-methyl-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352255,NULL,634754,136931184,56969295,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"methyl 1-[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]triazole-4-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352256,NULL,634754,136928098,56969734,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5R)-3-diethoxyphosphoryl-2-methyl-5-(4-phenyltriazol-1-yl)-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352257,NULL,634754,103619996,73124,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(S)-9-(2,3-Dihydroxypropyl)adenine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352258,NULL,634754,136937911,56969731,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"N-[1-[[1-[(3R,5R)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]triazol-4-yl]methyl]-2-oxopyrimidin-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352259,NULL,634754,103375662,65028,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,Oseltamivir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352260,NULL,634754,136928097,56969733,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"methyl 1-[(3R,5R)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]triazole-4-carboxylate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352261,NULL,634754,103504490,135398740,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352262,NULL,634754,136921574,56969521,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"1-[[1-[(3R,5R)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]triazol-4-yl]methyl]-5-methylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352263,NULL,634754,136931375,56969519,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5S)-3-diethoxyphosphoryl-2-methyl-5-[4-(1-methylimidazol-2-yl)triazol-1-yl]-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352264,NULL,634754,136934621,56969296,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5S)-3-diethoxyphosphoryl-2-methyl-5-(4-phenyltriazol-1-yl)-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352502,NULL,634754,103202903,446727,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352503,NULL,634754,103619997,37542,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,Ribavirin,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352504,NULL,634754,136921573,56969518,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5S)-3-diethoxyphosphoryl-2-methyl-5-(4-pyridin-2-yltriazol-1-yl)-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352505,NULL,634754,136921575,56969732,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"9-[[1-[(3R,5R)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]triazol-4-yl]methyl]purin-6-amine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352506,NULL,634754,136934811,56969516,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5S)-3-diethoxyphosphoryl-5-[4-(3-fluorophenyl)triazol-1-yl]-2-methyl-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352507,NULL,634754,136937912,56969941,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5R)-3-diethoxyphosphoryl-2-methyl-5-(4-pyridin-2-yltriazol-1-yl)-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352508,NULL,634754,136931376,56969736,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5R)-3-diethoxyphosphoryl-5-[4-(3-fluorophenyl)triazol-1-yl]-2-methyl-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352509,NULL,634754,136934620,56969293,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"N-[1-[[1-[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]triazol-4-yl]methyl]-2-oxopyrimidin-4-yl]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352510,NULL,634754,136924867,56969520,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"1-[[1-[(3R,5R)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]triazol-4-yl]methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352511,NULL,634754,136928100,56969940,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5R)-3-diethoxyphosphoryl-5-[4-(2,4-difluorophenyl)triazol-1-yl]-2-methyl-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352512,NULL,634754,103504725,135398513,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352513,NULL,634754,136921572,56969517,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5S)-3-diethoxyphosphoryl-5-[4-(2,4-difluorophenyl)triazol-1-yl]-2-methyl-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352514,NULL,634754,136927921,56969292,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"1-[[1-[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]triazol-4-yl]methyl]-5-methylpyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352515,NULL,634754,136927922,56969294,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"9-[[1-[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]triazol-4-yl]methyl]purin-6-amine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352516,NULL,634754,136928099,56969735,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5R)-3-diethoxyphosphoryl-5-[4-(2-fluorophenyl)triazol-1-yl]-2-methyl-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352517,NULL,634754,136944373,56969942,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"(3R,5R)-3-diethoxyphosphoryl-2-methyl-5-[4-(1-methylimidazol-2-yl)triazol-1-yl]-1,2-oxazolidine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
254352518,NULL,634754,136940945,56969072,NULL,22137458,Literature-derived,20180920,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07/1 infected in human HEL cells assessed as inhibition of viral plaque formation at 250 uM,"1-[[1-[(3R,5S)-3-diethoxyphosphoryl-2-methyl-1,2-oxazolidin-5-yl]triazol-4-yl]methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321522319,NULL,658756,103202903,446727,NULL,22459876,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient VSV 07-1 infected in HEL cells assessed as reduction of virus plaque formation after 4 days,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321548852,NULL,665760,160689662,70690160,NULL,22607883,Confirmatory,20220830,0,0,Inconclusive,NULL,IC50,NULL,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in cytopathic effect after 7 days by crystal violet staining,[(2Z)-2-[(2-amino-6-hexoxypurin-9-yl)methylidene]-1-(hydroxymethyl)cyclopropyl]methanol,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
321575942,NULL,675213,160707045,136232613,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,2-amino-9-[2-[2-[bis(3-hexadecoxypropoxy)phosphoryl]ethoxy]ethyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575944,NULL,675213,103208535,60613,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575945,NULL,675213,160669571,136276914,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,3-hexadecoxypropoxy-[2-[2-(6-oxo-1H-purin-9-yl)ethoxy]ethyl]phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575946,NULL,675213,160685556,136252883,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,2-[2-(2-amino-6-oxo-1H-purin-9-yl)ethoxy]ethyl-(3-hexadecoxypropoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575947,NULL,675213,103303173,135542257,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,"{[(1S)-2-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-1-(hydroxymethyl)ethoxy]methyl}phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575948,NULL,675213,103504490,135398740,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575949,NULL,675213,160680243,136232615,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,3-hexadecoxypropoxy-[[(2S)-1-hydroxy-3-(6-oxo-1H-purin-9-yl)propan-2-yl]oxymethyl]phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575950,NULL,675213,160680241,136232614,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,9-[(2S)-2-[bis(3-hexadecoxypropoxy)phosphorylmethoxy]-3-hydroxypropyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575951,NULL,675213,160685555,136232612,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,9-[2-[2-[bis(3-hexadecoxypropoxy)phosphoryl]ethoxy]ethyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575952,NULL,675213,160685557,136232616,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,"9-[[(5S)-2-(3-hexadecoxypropoxy)-2-oxo-1,4,2lambda5-dioxaphosphinan-5-yl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575954,NULL,675213,160685558,135480705,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,"2-amino-9-[[(5S)-2-hydroxy-2-oxo-1,4,2$l^{5}-dioxaphosphinan-5-yl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321575956,NULL,675213,160680244,136263937,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV YS/R infected in HEL cells by plaque formation assay,[(2S)-1-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxypropan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577507,NULL,675212,103208535,60613,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577685,NULL,675210,160707045,136232613,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,2-amino-9-[2-[2-[bis(3-hexadecoxypropoxy)phosphoryl]ethoxy]ethyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577686,NULL,675210,160680241,136232614,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,9-[(2S)-2-[bis(3-hexadecoxypropoxy)phosphorylmethoxy]-3-hydroxypropyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577687,NULL,675210,160685555,136232612,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,9-[2-[2-[bis(3-hexadecoxypropoxy)phosphoryl]ethoxy]ethyl]-1H-purin-6-one,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577688,NULL,675210,160685557,136232616,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,"9-[[(5S)-2-(3-hexadecoxypropoxy)-2-oxo-1,4,2lambda5-dioxaphosphinan-5-yl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577689,NULL,675210,103208535,60613,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577690,NULL,675210,160669571,136276914,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,3-hexadecoxypropoxy-[2-[2-(6-oxo-1H-purin-9-yl)ethoxy]ethyl]phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577693,NULL,675210,160680243,136232615,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,3-hexadecoxypropoxy-[[(2S)-1-hydroxy-3-(6-oxo-1H-purin-9-yl)propan-2-yl]oxymethyl]phosphinic acid,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577694,NULL,675210,103303173,135542257,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,"{[(1S)-2-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-1-(hydroxymethyl)ethoxy]methyl}phosphonic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577695,NULL,675210,103504490,135398740,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577697,NULL,675210,160685558,135480705,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive VZV YS infected in HEL cells by plaque formation assay,"2-amino-9-[[(5S)-2-hydroxy-2-oxo-1,4,2$l^{5}-dioxaphosphinan-5-yl]methyl]-1H-purin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
321577813,NULL,675212,103504490,135398740,NULL,22858222,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase negative VZV 07/01 infected in HEL cells by plaque formation assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
326010623,NULL,687665,103208535,60613,NULL,23047229,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human HEL cells assessed as reduction of virus-induced cytopathogenicity after 3 days,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
333988951,NULL,736021,164135402,71525096,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-benzyl-1-[(E)-cinnamyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333988952,NULL,736021,164138292,71525013,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(4-fluorophenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333988953,NULL,736021,164135401,5304848,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(2-naphthyloxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333988954,NULL,736021,164143842,71525015,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(3,4-dimethylphenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333988955,NULL,736021,164143844,5306011,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[2-(4-Methylphenoxy)ethyl]-3-(p-tolylmethyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333988956,NULL,736021,164149519,5306012,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[2-(4-Methylphenoxy)ethyl]-3-(1-phenylethyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333988957,NULL,736021,164146561,5306010,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(4-tert-butylphenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333988958,NULL,736021,164129744,71525138,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[(E)-cinnamyl]-3-(1-naphthylmethyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333988959,NULL,736021,164143845,5306016,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-[(3,5-Dimethylphenyl)methyl]-1-[2-(4-methylphenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333988960,NULL,736021,164132585,71525136,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[(E)-cinnamyl]-3-[(3,5-dibromophenyl)methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989244,NULL,736021,164143847,71525097,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[(E)-cinnamyl]-3-[(3,5-dimethylphenyl)methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989245,NULL,736021,164138294,5302094,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-5-methyl-1-[2-(4-methylphenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989246,NULL,736021,164138296,71524969,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-(2-phenoxyethyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989247,NULL,736021,164138293,71525054,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(3,5-dimethylphenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989248,NULL,736021,164146562,5303134,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-[(2,5-Dimethylphenyl)methyl]-1-[2-(4-methylphenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989249,NULL,736021,164146563,71525057,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[2-(4-Methylphenoxy)ethyl]-3-[(2,4,6-trimethylphenyl)methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989250,NULL,736021,164135400,71525011,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(4-phenylphenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989251,NULL,736021,164146564,71525134,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[(E)-cinnamyl]-3-[(3,5-difluorophenyl)methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989252,NULL,736021,164149520,71525137,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-[(3-bromo-5-methyl-phenyl)methyl]-1-[(E)-cinnamyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989253,NULL,736021,164141041,71525014,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"4-[2-(3-Benzyl-2,4-dioxo-pyrimidin-1-yl)ethoxy]benzonitrile",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989254,NULL,736021,164138297,71525010,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(4-methylphenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989255,NULL,736021,164143843,71525055,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[2-(4-Methylphenoxy)ethyl]-3-(o-tolylmethyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989256,NULL,736021,164132584,71525012,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(4-chlorophenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989257,NULL,736021,164143846,71525095,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(4-methylphenoxy)ethyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989258,NULL,736021,164129743,71525056,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[2-(4-Methylphenoxy)ethyl]-3-(m-tolylmethyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989259,NULL,736021,164141042,71525135,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[(E)-cinnamyl]-3-[(3,5-dichlorophenyl)methyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989260,NULL,736021,164143848,71524970,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(2-methylphenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989261,NULL,736021,164132586,71524971,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"3-Benzyl-1-[2-(3-methylphenoxy)ethyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333989262,NULL,736021,164138295,5306013,NULL,23357038,Literature-derived,20200626,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"1-[2-(4-Methylphenoxy)ethyl]-3-phenethyl-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
333990754,NULL,734104,164132301,71524787,NULL,23375089,Literature-derived,20200626,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against TK- Varicella zoster virus O7-1,"[[(R)-1-Methyl-2-(2,6-diamino-9H-purine-9-yl)ethoxy]methyl]phosphonic acid sodium[3-(hexadecyloxy)propyl] ester salt",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
334011898,NULL,722677,164130742,71508433,NULL,23176752,Confirmatory,20220830,0,0,Inactive,NULL,Activity,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in human HFF cells assessed as reduction of viral replication,"1-[(1R)-2alpha,3alpha,4beta-Trihydroxycyclopentane-1beta-yl]-7-methyl-1H-imidazo[4,5-c]pyridine-4-amine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,128878,10335,NULL,NULL
339937215,NULL,756514,174522670,71722439,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(4-Isopropylphenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937216,NULL,756514,174496854,71722719,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(4-Bromophenoxy)pentyl]-5-methyl-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937217,NULL,756514,174517447,71722722,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[6-(4-Bromophenoxy)hexyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937218,NULL,756514,174496857,71722574,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(4-Nitrophenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937219,NULL,756514,174491800,71722436,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(3-Methylphenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937220,NULL,756514,174496855,71722438,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(3,5-Dimethylphenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937221,NULL,756514,174522672,71722576,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(4-Bromophenoxy)pentyl]-5-iodo-pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937222,NULL,756514,174496856,71722573,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(4-Bromophenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937223,NULL,756514,174522671,71722440,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(4-Tert-butylphenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937224,NULL,756514,174496858,71722575,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"5-Bromo-1-[5-(4-bromophenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937225,NULL,756514,174522669,71722723,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[8-(4-Bromophenoxy)octyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937226,NULL,756514,174502078,71722721,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[4-(4-Bromophenoxy)butyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937227,NULL,756514,174507274,71722434,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-(5-Phenoxypentyl)pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937228,NULL,756514,174512400,71722570,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,1-[5-(4-Cyanophenoxy)pentyl]uracil,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937229,NULL,756514,174517448,71722725,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(4-Aminophenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937230,NULL,756514,174486763,71722571,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"Propyl 4-[5-(2,4-dioxopyrimidin-1-yl)pentoxy]benzoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937398,NULL,756335,174522617,71723318,NULL,23727195,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"(1R,2S,3R,5R)-3-(6-aminopurin-9-yl)-5-[(2S)-2-hydroxypropyl]cyclopentane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339937399,NULL,756335,174517400,71723319,NULL,23727195,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus,"(1R,2S,3R,5R)-3-(6-aminopurin-9-yl)-5-[(2R)-2-hydroxypropyl]cyclopentane-1,2-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339938167,NULL,756514,174502080,71722437,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(4-Methylphenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339938168,NULL,756514,174517449,71722569,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(4-Phenylphenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339938169,NULL,756514,174507273,71722724,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"4-[5-(2,4-Dioxopyrimidin-1-yl)pentoxy]benzoic acid",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339938170,NULL,756514,174522668,71722720,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[3-(4-Bromophenoxy)propyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339938171,NULL,756514,174517450,71722572,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(4-Chlorophenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339938172,NULL,756514,174502079,71722435,NULL,23743443,Literature-derived,20200629,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus YS,"1-[5-(2-Methylphenoxy)pentyl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
339992475,NULL,774682,174504160,73350964,NULL,23932449,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus VR-1367 infected in African green monkey BSC1 cells assessed as inhibition of virus plaque formation,"3-[3-(Hydroxymethyl)-2-methyl-1,2-oxazolidin-5-yl]-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,579,10335,NULL,NULL
339992476,NULL,774682,174493761,73347859,NULL,23932449,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus VR-1367 infected in African green monkey BSC1 cells assessed as inhibition of virus plaque formation,"3-[3-(Hydroxymethyl)-2-methyl-1,2-oxazolidin-5-yl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,579,10335,NULL,NULL
339992477,NULL,774682,103504725,135398513,NULL,23932449,Literature-derived,20220318,0,0,Active,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus VR-1367 infected in African green monkey BSC1 cells assessed as inhibition of virus plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,579,10335,NULL,NULL
339992478,NULL,774682,174504161,73350965,NULL,23932449,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus VR-1367 infected in African green monkey BSC1 cells assessed as inhibition of virus plaque formation,"3-[3-(Hydroxymethyl)-2-methyl-1,2-oxazolidin-5-yl]-6-phenylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,579,10335,NULL,NULL
339992479,NULL,774682,174509273,73352434,NULL,23932449,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus VR-1367 infected in African green monkey BSC1 cells assessed as inhibition of virus plaque formation,"3-[3-(Hydroxymethyl)-2-methyl-1,2-oxazolidin-5-yl]furo[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,579,10335,NULL,NULL
339992480,NULL,774682,174519446,73355443,NULL,23932449,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus VR-1367 infected in African green monkey BSC1 cells assessed as inhibition of virus plaque formation,"3-[3-(Hydroxymethyl)-2-methyl-1,2-oxazolidin-5-yl]-6-propylfuro[2,3-d]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,579,10335,NULL,NULL
340860710,NULL,1097059,194135918,71466640,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(2-bromo-4-cyanophenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860711,NULL,1097059,194142795,9590064,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,(Naphthalen-1-yloxy)-acetic acid (1-phenyl-ethylidene)-hydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860712,NULL,1097059,194163580,136183922,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"N-[(E)-(4-hydroxy-3,5-dimethoxyphenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860713,NULL,1097059,194184071,76333932,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(2-bromophenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860714,NULL,1097059,103504725,135398513,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860715,NULL,1097059,194177294,9617358,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(3-hydroxyphenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860723,NULL,1097060,194177295,9611242,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"2-naphthalen-1-yloxy-N-[(E)-(3,4,5-trimethoxyphenyl)methylideneamino]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860724,NULL,1097060,194184097,9616655,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(3-chlorophenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860725,NULL,1097060,103504725,135398513,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860726,NULL,1097060,194177294,9617358,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(3-hydroxyphenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860727,NULL,1097060,194177296,9556536,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-Benzylidene-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860728,NULL,1097060,194184096,6870631,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-(4-Methoxybenzylidene)-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860729,NULL,1097060,194149661,9656161,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-[(1E)-(3-hydroxy-4-methoxyphenyl)methylene]-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860730,NULL,1097060,194163534,9640004,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"2-(1-naphthyloxy)-N'-[(1E,2E)-3-phenylprop-2-enylidene]acetohydrazide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860731,NULL,1097060,194170435,9617301,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(2-chlorophenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860732,NULL,1097060,194135918,71466640,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(2-bromo-4-cyanophenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860733,NULL,1097060,194142795,9590064,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,(Naphthalen-1-yloxy)-acetic acid (1-phenyl-ethylidene)-hydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860734,NULL,1097060,194163580,136183922,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"N-[(E)-(4-hydroxy-3,5-dimethoxyphenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860735,NULL,1097060,194177297,9615930,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,(E)-2-(naphthalen-1-yloxy)-N'-(2-nitrobenzylidene)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340860736,NULL,1097060,194149659,135613960,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-(2-hydroxybenzylidene)-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861113,NULL,1097059,194177296,9556536,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-Benzylidene-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861114,NULL,1097059,194184096,6870631,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-(4-Methoxybenzylidene)-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861115,NULL,1097059,194177295,9611242,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"2-naphthalen-1-yloxy-N-[(E)-(3,4,5-trimethoxyphenyl)methylideneamino]acetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861116,NULL,1097059,194184097,9616655,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(3-chlorophenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861117,NULL,1097059,194142833,9617324,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(4-fluorophenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861118,NULL,1097059,194156682,9629664,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(2-bromophenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861119,NULL,1097059,194156683,9615919,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,2-(1-naphthyloxy)-N'-(4-nitrobenzylidene)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861120,NULL,1097059,194163535,9661653,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(4-chlorophenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861121,NULL,1097059,194163584,9610944,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-[(E)-(4-bromophenyl)methylidene]-2-(naphthalen-1-yloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861122,NULL,1097059,194149659,135613960,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-(2-hydroxybenzylidene)-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861123,NULL,1097059,194149662,76315820,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(4-ethoxy-3-hydroxyphenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861124,NULL,1097059,194135919,136135899,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"N-[(E)-1-(2,4-dihydroxyphenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861125,NULL,1097059,194163538,135560497,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(4-hydroxyphenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861126,NULL,1097059,194142834,9615931,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,2-(1-naphthyloxy)-N'-[(E)-(3-nitrophenyl)methylidene]acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861127,NULL,1097059,194163536,9661449,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,2-naphthalen-1-yloxy-N-[(E)-1-(3-nitrophenyl)ethylideneamino]acetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861128,NULL,1097059,194163579,6870868,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"N'-[(1E)-(3,4-dimethoxyphenyl)methylene]-2-(1-naphthyloxy)acetohydrazide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861129,NULL,1097059,194177297,9615930,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,(E)-2-(naphthalen-1-yloxy)-N'-(2-nitrobenzylidene)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861130,NULL,1097059,103202903,446727,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861131,NULL,1097059,194142832,19189957,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"N-[(E)-(2,5-dimethoxyphenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861132,NULL,1097060,194135919,136135899,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"N-[(E)-1-(2,4-dihydroxyphenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861133,NULL,1097060,194163538,135560497,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(4-hydroxyphenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861134,NULL,1097060,194142834,9615931,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,2-(1-naphthyloxy)-N'-[(E)-(3-nitrophenyl)methylidene]acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861135,NULL,1097060,194142833,9617324,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(4-fluorophenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861136,NULL,1097060,194163537,5530571,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,2-naphthalen-1-yloxy-N-[(E)-1-(4-nitrophenyl)ethylideneamino]acetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861137,NULL,1097060,103202903,446727,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,Brivudine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861138,NULL,1097060,194142832,19189957,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"N-[(E)-(2,5-dimethoxyphenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861139,NULL,1097060,194149662,76315820,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(4-ethoxy-3-hydroxyphenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861140,NULL,1097060,194156682,9629664,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(2-bromophenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861141,NULL,1097060,194156683,9615919,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,2-(1-naphthyloxy)-N'-(4-nitrobenzylidene)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861142,NULL,1097060,194163535,9661653,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(4-chlorophenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861143,NULL,1097060,194163584,9610944,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-[(E)-(4-bromophenyl)methylidene]-2-(naphthalen-1-yloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861144,NULL,1097060,194142793,135560476,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(2-hydroxynaphthalen-1-yl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861145,NULL,1097060,194142794,135411530,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-[(1E)-1H-indol-3-ylmethylene]-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861146,NULL,1097060,194149660,135603264,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-[(E)-(4-hydroxyphenyl)methylidene]-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861147,NULL,1097060,194163582,9617322,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-(4-Chlorobenzylidene)-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861148,NULL,1097060,194163583,5335218,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(3-bromophenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861149,NULL,1097060,194170434,9611260,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(4-methylsulfanylphenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861150,NULL,1097060,194184071,76333932,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(2-bromophenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861333,NULL,1097059,194163581,9617313,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-(4-Methylbenzylidene)-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861334,NULL,1097059,194142793,135560476,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(2-hydroxynaphthalen-1-yl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861335,NULL,1097059,194163537,5530571,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,2-naphthalen-1-yloxy-N-[(E)-1-(4-nitrophenyl)ethylideneamino]acetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861336,NULL,1097059,194177259,135560498,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(2-hydroxyphenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861337,NULL,1097059,194156642,9619508,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(4-bromophenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861338,NULL,1097059,194149661,9656161,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-[(1E)-(3-hydroxy-4-methoxyphenyl)methylene]-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861339,NULL,1097059,194163534,9640004,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"2-(1-naphthyloxy)-N'-[(1E,2E)-3-phenylprop-2-enylidene]acetohydrazide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861340,NULL,1097059,194170435,9617301,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(2-chlorophenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861341,NULL,1097059,194142794,135411530,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-[(1E)-1H-indol-3-ylmethylene]-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861342,NULL,1097059,194149660,135603264,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-[(E)-(4-hydroxyphenyl)methylidene]-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861343,NULL,1097059,194163582,9617322,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-(4-Chlorobenzylidene)-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861344,NULL,1097059,194163583,5335218,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(3-bromophenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861345,NULL,1097059,194170434,9611260,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-(4-methylsulfanylphenyl)methylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861878,NULL,1097060,194156642,9619508,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(4-bromophenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861879,NULL,1097060,194163581,9617313,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N'-(4-Methylbenzylidene)-2-(1-naphthyloxy)acetohydrazide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861880,NULL,1097060,194177259,135560498,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,N-[(E)-1-(2-hydroxyphenyl)ethylideneamino]-2-naphthalen-1-yloxyacetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861881,NULL,1097060,194163536,9661449,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,2-naphthalen-1-yloxy-N-[(E)-1-(3-nitrophenyl)ethylideneamino]acetamide,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340861882,NULL,1097060,194163579,6870868,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-positive Human herpesvirus 3 infected in HEL cells assessed as inhibition of viral plaque formation,"N'-[(1E)-(3,4-dimethoxyphenyl)methylene]-2-(1-naphthyloxy)acetohydrazide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906598,NULL,1106967,194143550,76312683,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-(4-Methylphenyl)-4-{[4-(3-chlorophenyl)piperazin-1-yl]methyl}sydnone,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906599,NULL,1106967,194157379,14063117,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-[4-[[4-(5-Oxidooxadiazol-3-ium-3-yl)phenyl]methyl]phenyl]oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906600,NULL,1106967,194136688,76309007,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,"4-[[4-(2,3-Dichlorophenyl)piperazin-1-yl]methyl]-3-[4-[[4-[4-[[4-(2,3-dichlorophenyl)piperazin-1-yl]methyl]-5-oxidooxadiazol-3-ium-3-yl]phenyl]methyl]phenyl]oxadiazol-3-ium-5-olate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906601,NULL,1106967,194143551,76312685,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,"4-[(4-Benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)methyl]-3-[4-[[4-[4-[(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)methyl]-5-oxidooxadiazol-3-ium-3-yl]phenyl]methyl]phenyl]oxadiazol-3-ium-5-olate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906602,NULL,1106967,194157378,76319906,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,"4-[[4-(2,3-Dichlorophenyl)piperazin-1-yl]methyl]-3-(4-methylphenyl)oxadiazol-3-ium-5-olate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906603,NULL,1106967,194164316,76323562,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-(4-Methylphenyl)-4-(piperidin-1-ylmethyl)oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906604,NULL,1106967,194136689,76309009,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-(4-Methylphenyl)-4-[(4-methylpiperazin-1-yl)methyl]oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906605,NULL,1106967,194164315,76323560,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,4-[(4-Methyl-3-phenylpiperazin-1-yl)methyl]-3-[4-[[4-[4-[(4-methyl-3-phenylpiperazin-1-yl)methyl]-5-oxidooxadiazol-3-ium-3-yl]phenyl]methyl]phenyl]oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906606,NULL,1106967,194157380,76319908,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-[4-[[4-[5-Oxido-4-[(4-phenylpiperazin-1-yl)methyl]oxadiazol-3-ium-3-yl]phenyl]methyl]phenyl]-4-[(4-phenylpiperazin-1-yl)methyl]oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906607,NULL,1106967,194171171,76327135,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-(4-Methylphenyl)-4-[(4-phenylpiperazin-1-yl)methyl]oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906608,NULL,1106967,194184841,76334395,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-(4-Methylphenyl)-4-[(4-methyl-3-phenylpiperazin-1-yl)methyl]oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906609,NULL,1106967,194136686,76309003,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-[4-[[4-[5-Oxido-4-(piperidin-1-ylmethyl)oxadiazol-3-ium-3-yl]phenyl]methyl]phenyl]-4-(piperidin-1-ylmethyl)oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906610,NULL,1106967,194178039,76330793,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-(4-Methylphenyl)-4-(piperazin-1-ylmethyl)sydnone,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906611,NULL,1106967,194184843,76334399,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-[4-[[4-[5-Oxido-4-(piperazin-1-ylmethyl)oxadiazol-3-ium-3-yl]phenyl]methyl]phenyl]-4-(piperazin-1-ylmethyl)oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906612,NULL,1106967,194136687,76309005,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,4-[[4-(3-Chlorophenyl)piperazin-1-yl]methyl]-3-[4-[[4-[4-[[4-(3-chlorophenyl)piperazin-1-yl]methyl]-5-oxidooxadiazol-3-ium-3-yl]phenyl]methyl]phenyl]oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340906613,NULL,1106967,194178040,12710352,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-(4-Methylphenyl)-4-(morpholin-4-ylmethyl)oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340907343,NULL,1106967,194184840,76334393,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,"4-[(4-Benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)methyl]-3-(4-methylphenyl)oxadiazol-3-ium-5-olate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340907344,NULL,1106967,194150365,76316210,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,4-[(4-Acetylpiperazin-1-yl)methyl]-3-[4-[[4-[4-[(4-acetylpiperazin-1-yl)methyl]-5-oxidooxadiazol-3-ium-3-yl]phenyl]methyl]phenyl]oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340907345,NULL,1106967,194171170,76327133,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,4-[(4-Acetylpiperazin-1-yl)methyl]-3-(4-methylphenyl)oxadiazol-3-ium-5-olate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340907346,NULL,1106967,194148011,198878,NULL,NULL,Literature-derived,20180925,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella-zoster virus infected in HEL cells assessed as reduction in plaque formation,3-(4-Methylphenyl)sydnone,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
340987285,NULL,1077428,194140787,76311212,NULL,NULL,Literature-derived,20180929,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus,"[4-[3-[(4-Methylphenyl)methyl]-2,4-dioxopyrimidin-1-yl]cyclopent-2-en-1-yl] benzoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
340987286,NULL,1077428,194154531,76318431,NULL,NULL,Literature-derived,20180929,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus,"[4-(3-Benzyl-2,4-dioxopyrimidin-1-yl)cyclopent-2-en-1-yl] benzoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
340987287,NULL,1077428,194161480,76322099,NULL,NULL,Literature-derived,20180929,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus,"[4-[3-[(3,5-Dimethylphenyl)methyl]-2,4-dioxopyrimidin-1-yl]cyclopent-2-en-1-yl] benzoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
341075578,NULL,1067839,194139963,76310685,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N'-(4-chloropyrimidin-2-yl)-N-(7-chloroquinolin-4-yl)decane-1,10-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075579,NULL,1067839,194146820,76314306,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,7-chloro-N-[3-(4-chloropyrimidin-2-yl)oxypropyl]quinolin-4-amine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075580,NULL,1067839,194153680,71736284,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N'-(2-chloropyrimidin-4-yl)-N-(7-chloro-4-quinolyl)propane-1,3-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075581,NULL,1067839,194188142,76336060,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N'-(4-chloropyrimidin-2-yl)-N-(7-chloro-4-quinolyl)butane-1,4-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075582,NULL,1067839,194160658,76321598,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,N-(7-Chloro-4-quinolinyl)-N'-(2-chloro-4-pyrimidinyl)ethylenediamine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075583,NULL,1067839,194160659,71736286,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N-(7-Chloro-4-quinolinyl)-N'-(2-piperidino-4-pyrimidinyl)-1,3-propanediamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075584,NULL,1067839,194181279,76332442,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N'-(2-chloropyrimidin-4-yl)-N-(7-chloro-4-quinolyl)octane-1,8-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075585,NULL,1067839,194139962,76310684,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N'-(4-chloropyrimidin-2-yl)-N-(7-chloro-4-quinolyl)octane-1,8-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075586,NULL,1067839,194188144,71736287,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N-(7-Chloro-4-quinolinyl)-N'-(2-morpholino-4-pyrimidinyl)-1,3-propanediamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075587,NULL,1067839,194167566,76325208,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N-(7-Chloro-4-quinolinyl)-N'-(4-piperazino-2-pyrimidinyl)-1,3-propanediamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075588,NULL,1067839,194181277,76332441,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,N-(7-Chloro-4-quinolinyl)-N'-(4-chloro-2-pyrimidinyl)ethylenediamine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341075589,NULL,1067839,194188143,76336061,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N'-(4-chloropyrimidin-2-yl)-N-(7-chloro-4-quinolyl)heptane-1,7-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341076206,NULL,1067839,194160657,76321597,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N'-(4-chloropyrimidin-2-yl)-N-(7-chloro-4-quinolyl)dodecane-1,12-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341076207,NULL,1067839,194146821,824643,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,4-(4-Chloropyrimidin-2-yl)morpholine,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341076208,NULL,1067839,194146822,76314307,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N-(7-Chloro-4-quinolinyl)-N'-(4-morpholino-2-pyrimidinyl)-1,3-propanediamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341076209,NULL,1067839,194139964,76310686,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N-(7-chloro-4-quinolyl)-N'-(4-pyrrolidin-1-ylpyrimidin-2-yl)propane-1,3-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341076210,NULL,1067839,194174408,76328769,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N-(7-Chloro-4-quinolinyl)-N'-(4-piperidino-2-pyrimidinyl)-1,3-propanediamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
341076211,NULL,1067839,194181278,71736285,NULL,24354322,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity,"N'-(4-chloropyrimidin-2-yl)-N-(7-chloro-4-quinolyl)propane-1,3-diamine",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
342583775,NULL,1135402,103328095,457954,NULL,189032,Literature-derived,20181003,0,0,Active,NULL,NULL,NULL,ChEMBL,Antiviral activity against type 3 herpes simplex virus infected in human KB cells assessed as reduction in cytopathic effect after 72 hrs incubation,Tiazofurin,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,350,10335,NULL,NULL
342584027,NULL,1135402,242351982,335825,NULL,189032,Literature-derived,20181003,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against type 3 herpes simplex virus infected in human KB cells assessed as reduction in cytopathic effect after 72 hrs incubation,"4-Thiazolecarboxamide, 2-(5-(hydroxymethyl)-2-furanyl)-",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,350,10335,NULL,NULL
342584028,NULL,1135402,242629757,10000206,NULL,189032,Literature-derived,20181003,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against type 3 herpes simplex virus infected in human KB cells assessed as reduction in cytopathic effect after 72 hrs incubation,"[(2R,3R,4R,5R)-3,4-diacetoxy-5-(4-carbamoylthiazol-2-yl)tetrahydrofuran-2-yl]methyl acetate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,350,10335,NULL,NULL
342584029,NULL,1135402,242629756,54517588,NULL,189032,Literature-derived,20181003,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against type 3 herpes simplex virus infected in human KB cells assessed as reduction in cytopathic effect after 72 hrs incubation,"2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-carbothioamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,350,10335,NULL,NULL
342584030,NULL,1135402,104252438,444233,NULL,189032,Literature-derived,20181003,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against type 3 herpes simplex virus infected in human KB cells assessed as reduction in cytopathic effect after 72 hrs incubation,"2-(1,5-Dideoxyribose)-4-amido-thiazole",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,350,10335,NULL,NULL
342584031,NULL,1135402,242629758,54342144,NULL,189032,Literature-derived,20181003,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against type 3 herpes simplex virus infected in human KB cells assessed as reduction in cytopathic effect after 72 hrs incubation,"2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-5-carboxamide",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,350,10335,NULL,NULL
342734827,NULL,1135425,242629766,90673515,NULL,191611,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human WI-38 cells assessed as inhibition of virus-induced cytopathogenicity measured at 7 days post-virus infection by Microtest 2 plate based microscopic analysis,"(2S,3S,4S,5R)-2-(7-amino-5-methylsulfonyltriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,551,10335,NULL,NULL
342734828,NULL,1135425,242629765,90673514,NULL,191611,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human WI-38 cells assessed as inhibition of virus-induced cytopathogenicity measured at 7 days post-virus infection by Microtest 2 plate based microscopic analysis,"(2S,3S,4S,5R)-2-(7-amino-5-methylsulfanyltriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,551,10335,NULL,NULL
342734829,NULL,1135425,242629767,90673516,NULL,191611,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human WI-38 cells assessed as inhibition of virus-induced cytopathogenicity measured at 7 days post-virus infection by Microtest 2 plate based microscopic analysis,"(2S,3S,4S,5R)-2-(7-amino-5-methoxytriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,551,10335,NULL,NULL
342734830,NULL,1135425,242629769,90673518,NULL,191611,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human WI-38 cells assessed as inhibition of virus-induced cytopathogenicity measured at 7 days post-virus infection by Microtest 2 plate based microscopic analysis,"(2S,3S,4S,5R)-2-(7-amino-5-azidotriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,551,10335,NULL,NULL
342734831,NULL,1135425,242629763,90673513,NULL,191611,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human WI-38 cells assessed as inhibition of virus-induced cytopathogenicity measured at 7 days post-virus infection by Microtest 2 plate based microscopic analysis,"(2S,3S,4S,5R)-2-(6-amino-2-methylsulfanylpurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,551,10335,NULL,NULL
342734832,NULL,1135425,242629762,90673512,NULL,191611,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human WI-38 cells assessed as inhibition of virus-induced cytopathogenicity measured at 7 days post-virus infection by Microtest 2 plate based microscopic analysis,"(2S,3S,4S,5R)-2-(6-amino-2-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,551,10335,NULL,NULL
342734833,NULL,1135425,242629764,53672648,NULL,191611,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human WI-38 cells assessed as inhibition of virus-induced cytopathogenicity measured at 7 days post-virus infection by Microtest 2 plate based microscopic analysis,"(2S,3S,4S,5R)-2-(6-amino-2-hydrazinylpurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,551,10335,NULL,NULL
342734834,NULL,1135425,242629768,90673517,NULL,191611,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against Varicella zoster virus Ellen infected in human WI-38 cells assessed as inhibition of virus-induced cytopathogenicity measured at 7 days post-virus infection by Microtest 2 plate based microscopic analysis,"(2S,3S,4S,5R)-2-(7-amino-5-hydrazinyltriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,551,10335,NULL,NULL
345513522,NULL,1167617,312363220,101875585,NULL,25282652,Literature-derived,20200625,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antimicrobial activity against Varicella-zoster virus,"3',4'-Difluorocordycepin",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
345513523,NULL,1167617,312363219,118717403,NULL,25282652,Literature-derived,20200625,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antimicrobial activity against Varicella-zoster virus,"(2R,3S,4R,5S)-2-(6-aminopurin-9-yl)-4,5-difluoro-5-(hydroxymethyl)tetrahydrofuran-3-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
345513524,NULL,1167617,312363221,118717404,NULL,25282652,Literature-derived,20200625,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antimicrobial activity against Varicella-zoster virus,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-4,5-difluoro-5-(hydroxymethyl)oxolan-3-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
345513525,NULL,1167617,312363218,118717402,NULL,25282652,Literature-derived,20200625,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antimicrobial activity against Varicella-zoster virus,"(2R,3S,4R,5R)-2-(6-aminopurin-9-yl)-4,5-difluoro-5-(hydroxymethyl)tetrahydrofuran-3-ol",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
353662793,NULL,1283362,103504725,135398513,NULL,26819664,Literature-derived,20200623,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV infected in human ARPE19 cells at 50 uM treated at 2 hrs post infection measured 48 hrs post infection by luciferase assay relative to control,Acyclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
353663222,NULL,1283360,103558814,454239,NULL,26819664,Literature-derived,20200623,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV infected in human ARPE19 cells at 10 uM treated at 2 hrs post infection measured 48 hrs post infection by luciferase assay relative to control,"(2S,3R,4S,4aR,11bR)-2,3,4-trihydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363162221,NULL,1427843,381837836,137632270,NULL,27750154,Literature-derived,20200620,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"Potency index, ratio of acyclovir EC50 to compound EC50 for thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation","1-[(2-Benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]-3-[(4-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363162521,NULL,1427843,381862664,137648967,NULL,27750154,Literature-derived,20200620,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"Potency index, ratio of acyclovir EC50 to compound EC50 for thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation","1-[(2-Benzyl-3-diethoxyphosphoryl-1,2-oxazolidin-5-yl)methyl]-3-[(2-fluorophenyl)methyl]quinazoline-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363242947,NULL,1457792,381846705,134382706,NULL,28682067,Literature-derived,20200621,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,"Potency index, ratio of (S)-9-[3-Fluoro-2-(phosphonomethoxy)propyl]adenine EC50 to compound EC50 for thymidine kinase deficient Varicella-Zoster virus 07-1",dipentyl (2S)-2-[[[(1S)-1-[(6-aminopurin-9-yl)methyl]-2-fluoro-ethoxy]methyl-phenoxy-phosphoryl]amino]butanedioate,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363539704,NULL,1382166,103208535,60613,NULL,29407990,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363539706,NULL,1382166,103504490,135398740,NULL,29407990,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07/1 infected in HEL cells assessed as reduction in viral plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363626308,NULL,1394845,103504490,135398740,NULL,29550734,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363626309,NULL,1394845,103208535,60613,NULL,29550734,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation measured after 5 days post infection,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363641928,NULL,1402825,103208535,60613,NULL,29268134,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against TK-defecient VZV 07-1 infected in HEL cells assessed as reduction in plaque formation after 5 days,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363648559,NULL,1410507,103567639,135398748,NULL,29670705,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,Penciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363648712,NULL,1410507,103504490,135398740,NULL,29670705,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363648713,NULL,1410507,103208535,60613,NULL,29670705,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 assessed as inhibition of plaque formation measured after 5 days post-infection,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363693097,NULL,1407618,103504490,135398740,NULL,30098481,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363693102,NULL,1407618,103208535,60613,NULL,30098481,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854823,NULL,1451464,381840776,137634213,NULL,28829913,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,"ethyl (2S)-2-[[5-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-2-oxo-1,3,2$l^{5}-dioxaphosphinan-2-yl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854826,NULL,1451464,381852540,137642102,NULL,28829913,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,"benzyl (2S)-2-[[5-[(2-amino-6-chloro-purin-9-yl)methoxy]-2-oxo-1,3,2$l^{5}-dioxaphosphinan-2-yl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363854828,NULL,1451464,103504490,135398740,NULL,28829913,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899305,NULL,1457768,103208535,60613,NULL,28682067,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363899309,NULL,1457768,103504490,135398740,NULL,28682067,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908488,NULL,1462034,103504490,135398740,NULL,28757102,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908713,NULL,1462035,103208535,60613,NULL,28757102,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363908758,NULL,1462034,103208535,60613,NULL,28757102,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against wild type thymidine kinase expressing Varicella-Zoster virus Oka infected in HEL cells assessed as inhibition of virus-induced plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
363909043,NULL,1462035,103504490,135398740,NULL,28757102,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against wild type thymidine kinase-deficient Varicella-Zoster virus 07-1 infected in HEL cells assessed as inhibition of virus-induced plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366237222,NULL,1536102,440122836,138973459,NULL,30612845,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV assessed as inhibition of viral replication by cell-based assay,"1-[(1R,3S,5S)-3-(hydroxymethyl)-2-oxabicyclo[3.1.0]hexan-1-yl]pyrimidine-2,4-dione",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366237223,NULL,1536102,440142365,155531856,NULL,30612845,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV assessed as inhibition of viral replication by cell-based assay,"propan-2-yl (2S)-2-[[[(1R,3S,5S)-1-(4-amino-2-oxopyrimidin-1-yl)-2-oxabicyclo[3.1.0]hexan-3-yl]methoxy-methoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366237224,NULL,1536102,440126892,155521727,NULL,30612845,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV assessed as inhibition of viral replication by cell-based assay,"4-amino-1-[(1R,3S,5S)-3-(hydroxymethyl)-2-oxabicyclo[3.1.0]hexan-1-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366237225,NULL,1536102,440126631,155521551,NULL,30612845,Literature-derived,20220318,0,0,Inactive,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV assessed as inhibition of viral replication by cell-based assay,"propan-2-yl (2S)-2-[[[(1R,3S,5S)-1-(2,4-dioxopyrimidin-1-yl)-2-oxabicyclo[3.1.0]hexan-3-yl]methoxy-methoxyphosphoryl]amino]propanoate",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366391633,NULL,1572734,103504490,135398740,NULL,30738653,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366392095,NULL,1572734,103208535,60613,NULL,30738653,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella-zoster virus 07-1 infected in HEL cells assessed as reduction in virus plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393303,NULL,1572733,103208535,60613,NULL,30738653,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
366393306,NULL,1572733,103504490,135398740,NULL,30738653,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella-zoster virus Oka harboring thymidine kinase infected in HEL cells assessed as reduction in virus plaque formation,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
367489612,NULL,1661190,103208535,60613,NULL,32676147,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367489785,NULL,1661190,103504490,135398740,NULL,32676147,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490053,NULL,1661189,103208535,60613,NULL,32676147,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
367490270,NULL,1661189,103504490,135398740,NULL,32676147,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in plaque formation measured after 5 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,1,10335,NULL,NULL
372127852,NULL,1684816,103208535,60613,NULL,33479570,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372127853,NULL,1684816,103504490,135398740,NULL,33479570,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster virus 07-1 infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372128086,NULL,1684817,103504490,135398740,NULL,33479570,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372128088,NULL,1684817,103208535,60613,NULL,33479570,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase positive Varicella zoster virus OKA infected in human HEL cells assessed as reduction in virus plaque formation measured on day 5 post-viral infection,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
372355555,NULL,1726781,103504490,135398740,NULL,34124679,Confirmatory,20220830,0,0,Inconclusive,NULL,EC50,NULL,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
372355556,NULL,1726781,103504490,135398740,NULL,34124679,Confirmatory,20220830,0,0,Inconclusive,NULL,EC90,NULL,ChEMBL,Antiviral activity against VZV infected in human HFF cells assessed as reduction in virus-induced cytopathic effect incubated for 14 days by cell-titer glo assay,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,Foreskin
380549610,NULL,1854966,482061253,168279388,NULL,35933787,Confirmatory,20230629,0,0,Unspecified,NULL,Activity,NULL,ChEMBL,Antiviral activity against Varicella zoster-virus OKA strain harboring thymidine kinase infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,"4-amino-5-fluoro-1-[(3S,5S,6R)-5-hydroxy-6-(hydroxymethyl)piperidin-3-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380549720,NULL,1854967,103504490,135398740,NULL,35933787,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster-virus O7-1 strain infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380549724,NULL,1854967,103208535,60613,NULL,35933787,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster-virus O7-1 strain infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380549725,NULL,1854967,482061253,168279388,NULL,35933787,Confirmatory,20230629,0,0,Unspecified,NULL,Activity,NULL,ChEMBL,Antiviral activity against thymidine kinase deficient Varicella zoster-virus O7-1 strain infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,"4-amino-5-fluoro-1-[(3S,5S,6R)-5-hydroxy-6-(hydroxymethyl)piperidin-3-yl]pyrimidin-2-one",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380549816,NULL,1854966,103208535,60613,NULL,35933787,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella zoster-virus OKA strain harboring thymidine kinase infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,Cidofovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380549817,NULL,1854966,103504490,135398740,NULL,35933787,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,NULL,ChEMBL,Antiviral activity against Varicella zoster-virus OKA strain harboring thymidine kinase infected in HEL cells assessed as reduction in plaque formation by microscopic analysis,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613442,NULL,1869619,103504490,135398740,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC50,NULL,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380613540,NULL,1869619,103504490,135398740,NULL,35754374,Confirmatory,20230629,0,0,Unspecified,NULL,EC90,NULL,ChEMBL,Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days,Ganciclovir,Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
380801219,NULL,1915671,482088298,168297977,NULL,33218683,Literature-derived,20230629,0,0,Unspecified,NULL,NULL,NULL,ChEMBL,Antiviral activity against VZV infected in human thyroid gland assessed as inhibition of virus induced cytopathic effect incubated for 11 days by crystal violet staining assay,"1-Oxido-7-[12-(1-oxido-[1,2,5]oxadiazolo[3,4-d]pyrimidin-1-ium-7-yl)-3,12-diaza-6,9-diazoniadispiro[5.2.59.26]hexadecan-3-yl]-[1,2,5]oxadiazolo[3,4-d]pyrimidin-1-ium;dihydrochloride",Human alphaherpesvirus 3 (Varicella-zoster virus),/taxonomy/10335,NULL,NULL,NULL,NULL,10335,NULL,NULL
